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Abstract 
Introduction 
With 5,665 community pharmacies in Australia, the nature and value of their services 
have been explored in some detail. However, the differences in practice between the 
17% of rural pharmacies, compared to urban pharmacies, have not been investigated 
thoroughly. This thesis used several approaches to quantify and qualify the perceived 
and promoted differences in rural community pharmacy practice both in Australia and 
internationally. 
The following research questions were proposed. 
Primary questions: 
• How and in what aspects does rural community pharmacy practice differ from that in
urban areas?
• What are the implications and significance of these differences for development, support
and implementation of new programs for rural community pharmacy practice?
Secondary questions: 
• What are the influences in rural pharmacy practice today?
• What knowledge and skills define rural pharmacy practice today?
• What are the implications on recruitment and retention of pharmacists in rural areas?
• What are the implications for undergraduate and postgraduate training?
Methods 
An extensive literature review was conducted of academic papers, government reports, 
popular articles and professional documents, which examined rural Australia, health in 
Australia and pharmacy. A systematic literature review was then undertaken to find 
comparative studies of rural and urban community pharmacy practice internationally. 
Key opinion leaders were interviewed on two occasions to investigate potential changes 
in their views over time, about the profession and rural practice (2008–2010, 2016). 
Pharmacists, who participated in a cardiovascular research pilot project, Pharmacist 
Assessment of Adherence, Risk and Treatment in Cardiovascular Disease (PAART CVD), 
vii 
were also interviewed (2009). A survey of pharmacists was undertaken to gauge their 
views on current and future practice (2014). Practitioner and consumer data, 
previously unpublished, was reviewed from the Third Community Pharmacy Agreement 
(3CPA) (2005) and the Fourth Community Pharmacy Agreement (4CPA) (2010) Quality 
Care Pharmacy Program (QCPP) evaluations, for differences between rural and urban 
practice. Finally, previously unpublished data from the Pharmacy Cardiovascular Health 
Care Model (PCHCM) (2005) examined differences in rural and urban community 
pharmacy practice from a consumer perspective. This then generated a body of work 
over a 13–year period with relevant papers from the systematic literature review going 
back to the 1990s. 
Results and conclusions 
The systematic literature review and other investigations, showed there was a lack of 
comparative data between rural and urban pharmacy regarding day-to-day practice, 
both in Australia and internationally, over the investigated time-period. In two 
published studies, rural pharmacies had a larger regular patient cohort, and the 
pharmacist was more likely to proactively engage in health conversations with patients. 
While investigating data for practice differences, it was found that there was a lack of 
definition for what a ‘professional service’ entails, which caused confusion in the results 
obtained. Consumers and practitioners had quite different ideas on the extent of the 
availability of professional services within pharmacies. Rural consumers thought their 
pharmacy was capable of providing a service, but then they were unlikely to use it 
(2005). They also only had an idea of service based on what is currently available, or 
asked in the surveys conducted (2005, 2010). 
Using 3CPA and 4CPA data there was no significant differences in professional service 
provision by rural and urban pharmacies (2005, 2010) using pharmacists and 
customers views. Patients with cardiovascular disease in 2005, were more likely to use 
their pharmacy for lifestyle advice (p<0.00) or dispensing (p<0.00), but there was no 
statistical significance between patronage by rural and urban customers for other 
professional services at this time. 
Rural practitioners, who were interviewed, thought the pace of life and collaborations 
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with local health practitioners were two distinctive aspects of their practice. During the 
systematic literature review, conducted until the end of July 2018, it was found that 
sometimes more professional services were conducted in rural areas, but this difference 
was then discounted by some authors, suggesting the geographical circumstances 
accounted for this difference. Other studies found that if a pharmacy was located in a 
rural area, it was not a significant factor for professional service delivery, but any 
difference depended more on pharmacy size, type and staff numbers. 
Pharmacists were concerned about a lack of improvement in wages or conditions over a 
number of years, yet there was an expectation to introduce new services within existing 
practice. Although some were ambivalent, pharmacists were interested, had confidence 
and enjoyed provision of new services, but were apprehensive about the time taken, 
given the other requirements of their current roles. However, this concern appeared not 
to be specific to rural community pharmacy. 
Overall, pharmacists were reticent to charge the patient for time taken to deliver 
professional services, and would instead prefer the Government to pay. Historically, 
many pharmacists have not charged for any additional professional services or advice. 
A lack of collaboration with other local health practitioners was shown by the degree of 
uncertainty about the practitioner relationships, expressed by pharmacists if 
professional services were introduced in the pharmacy. This sentiment was reflected by 
many practitioners, and this result was no different in rural practice, despite earlier 
suggestions that inter-professional collaborations were better. 
In 2014, pharmacists would like to change their practice in the future, but they thought 
this would not happen; they were uncertain about the future, and felt no real change 
would take place in the profession. While key opinion leaders were at the forefront of 
the profession, and were positive about change, this change appeared to be slower at 
the practitioner level. Many ‘at-the-coal-face’ pharmacists were despondent; however, 
again, this sentiment was not specific to rural practice. 
Examining policy reports over the past 20 years, the literature, and interview data, 
found that pharmacy as a profession does not ‘have a seat at the table’, when many 
national and state rural policies were, and are developed. Consequently, the profession 
was not mentioned as a significant ‘player’ in rural health. Community pharmacy was 
ix 
often only seen as a place where prescriptions could be dispensed, and some primary 
health care services were provided. Pharmacists were only viewed in their roles within 
a community pharmacy and not in any broader role. 
Recommendations 
More comprehensive research is required in all areas of practice, to dismiss or confirm 
the disparities found in practitioner and patient beliefs, of current community 
pharmacy practice. This is not just an Australian phenomenon or a rural one. The 
profession has clear guidelines for minimum standards for ‘professional services’ but 
these must be acknowledged and consistently adhered to in every community 
pharmacy. In Australia, there needs to be an acceptance of payment for professional 
services by practitioners, whether the service be in part paid by the Government, or as a 
service charge paid by patients. There is a strong case for better remuneration and 
conditions for all pharmacists to enable a competent and sustainable workforce. A new 
modelling of suggested pharmacist staff ratios should be undertaken to consider 
incorporation of multifaceted complex professional services into day-to-day business 
across rural and urban community pharmacy practice in Australia. The profession and 
its associated professional organisations should clearly articulate the skill set of 
pharmacists to promote relevant competent practice at the highest level. A review of the 
current rurality classification system is required, to allocate funding and enable those 
practicing in rural locations, to take advantage of the opportunities available. New 
funding models should be implemented to allow for those who travel from urban 
settings to practice in rural areas and are not covered by current funding models. 
Models of pharmacy practice in rural areas should be supported by long-term funding 
to attract pharmacist practitioners. Finally, as a profession, there needs to be more 
pharmacy/pharmacist involvement in rural health policy nationally by professional 
associations, and locally by practitioners improving their own links with other health 
professionals.  
There was little found to substantiate the assertion that rural pharmacy practice is 
overall different from that in urban areas. This lack of evidence, or at least 
documentation thereof, potentially jeopardises the profession, professional 
organisations, teaching institutions and the practitioners in attempting to lever off a 
x 
‘difference’ for funding, recruitment and retention in rural and remote areas of 
community pharmacy practice. 
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With 5,665 community pharmacies in Australia [1], the nature and value of their 
services have been studied in relative detail. However, the differences between rural 
pharmacy practice compared to urban practice has not been explored as thoroughly. 
This thesis used several approaches to quantify and qualify the perceived and promoted 
rural practice differences both in Australia and internationally. 
The following research questions were proposed. 
Primary questions: 
• How and in what aspects does rural community pharmacy practice differ from
that in urban areas?
• What are the implications and significance of these differences for development,
support and implementation of new programs for rural community pharmacy
practice?
Secondary questions: 
• What are the influences in rural pharmacy practice today?
• What knowledge and skills define rural pharmacy practice today?
• What are the implications on recruitment and retention of pharmacists in rural
areas?
• What are the implications for undergraduate and postgraduate training?
In this introductory chapter, the results of the literature review start with a broad 
discussion on health, demography and geography, governance and health policy in this 
country. Also discussed will be what is meant by the word ‘rural’, and the many differing 
standard classifications that have been used and changed over time, using Australian 
geographical and population indicators, to allocate federal, state and local funding. 
Finally, the specific rural health policies and frameworks used to guide health services 
will be reviewed. 
1.1 Aims 
The aims of Chapter 1 were to: 
Chapter 1: Background review of rural health in Australia      2 
• provide a background of health, rural health and health policy in Australia 
• examine rural policy documents and the inclusion or not, of pharmacy, its coverage and 
potential place 
1.2 Background and demography of health in Australia 
In 2014–5, 85% of Australia’s population over 15 years of age considered their health to 
be ‘good’ or ‘better’ [2]. However, those who live in rural communities traditionally 
have lower health outcomes than those who live in urban areas. In these urban areas, 
there is more access to a wider range of medical options and services, and they are often 
associated with larger hospitals, with more health professionals. This section will 
explain ‘health’ in the Australian context and discuss the associated differences in rural 
areas of this country. 
Following, will be a description of health services in Australia, which are provided by a 
combination of public and private organisations and businesses. Underpinning these 
entities are the health policies and frameworks, developed as a measure of action and 
improvement of the health for all; not just for those who live in regional, rural and 
remote areas. Nationally, various strategies, policies, frameworks and guidelines have 
also been written and used to guide planning, delivery and design of health services [3], 
initially focusing on common chronic conditions, and now currently on disease risk 
factors [4]. 
The majority of people in Australia live in what is considered as the Major Cities. These 
are the areas of Sydney, Newcastle, Wollongong (NSW), Tweed Heads and the Tweed 
Coast, Brisbane and most of the Gold and Sunshine Coasts (QLD), Melbourne and 
Geelong (VIC), Adelaide (SA), Perth (WA), and Canberra and Queanbeyan (ACT). Darwin 
(NT) and Hobart (TAS) are sometimes not included in this Major Cities group [5]. 
The latest spread of population found in the literature is described in Table 1.1 below 
using the Australian Standard Geographical Classification (ASGC) classification system 
which is outlined later in this chapter: 
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Table 1.1: Australia’s population 2014 
Geographical area 
Population 
percentage 
Population 
numbers 
Major Cities 71% 16.6 million 
Inner Regional 18% 4.3 million 
Outer Regional 8.9% 2.1 million 
Remote Areas 1.4% 324,000 
Very Remote Areas 0.9% 208,000 
Australia’s health 2016, Australian Institute of Health and Welfare (AIHW), 2016 [6] 
Just under 30% of the Australian population live in areas which are not Major Cities. 
They live in those areas considered as Inner or Outer Regional, in this classification 
system, with a further 2.5% living in Remote or Very Remote Areas of Australia [6]. 
Over time, the rural population has been decreasing. In 2001, assuming similar 
classification systems to describe areas that were not in the major cities, just under 7 
million (35%) of the Australian population lived outside cities [7]; this dropped to 31% 
in 30 June 2009 [5], and further decreased by 2016, to only 29.2% [8] of the population. 
Australia enjoys a good life expectancy and in 2015, with a population of nearly 25m 
people—life expectancy was 81 years for men, and 85 years for women found using the 
World Health Organisation (WHO) data [9]. In Australia, the expenditure per capita on 
health in 2014 was INT$4,357 (the INT$ is the international dollar, i.e. the United States 
of America (USA) dollar) and in the same year, 9.4% of the Gross Domestic Product 
(GPD) was spent on health [9]. For other countries, this is different. This compared to 
the USA with a population of nearly 320 million in 2015, where the total per capita 
health expenditure was INT$9,403, and where 17.4% of GDP (2014) was spent on 
health-related services and items. Life expectancy was less than in Australia, 77 years 
for males, and 82 years for females [9]. By contrast with both previously mentioned 
countries, South Africa, with nearly 55 million people, had a health expenditure per 
capita of INT$1,148, and the proportion of GDP spent on health was only 8.8%. Life 
expectancy was 59 years for men and 66 years for women [9]. 
The figures in the above paragraph do not delineate between those living in capital 
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cities, and those in rural areas or differences in the health status of any Indigenous 
people. For those living outside urban areas, for each country, the reality of the word 
‘rural’ belies the complexity of the health, community, culture and financial support 
required to maintain this portion of the population. 
1.2.1 What is rural? 
The Australian Bureau of Statistics defines ‘rural’ as ‘not urban’, using a statistical 
geographical standard [10]. Hart et al. (2004) argues that this assumption was incorrect 
[11], an assertion confirmed by Wakerman and Humphreys (2008) [12, 13]. 
Dictionaries, such as the Oxford Dictionary, define ‘rural’ as: 
In, relating to, or characteristics of the countryside rather than the town. [14] 
According to the Macquarie dictionary, the word ‘rural’ means: 
1. of, relating to, or characteristic of the country (as distinguished from towns or 
cities), country life, or country people; rustic 
2. living in the country 
3. of, or relating to, agriculture; rural economy [15] 
However, ‘rural’ does not necessarily mean an agricultural environment such as a cow 
in a paddock or a barren landscape. Rural communities include coastal communities, 
which have an income derived from tourism, or fishing, inland communities with an 
income from fruit orchards, light industry, mining or even those that act as satellite 
communities for larger regional towns and cities. Also associated with this industry, are 
the other professions and services of retail, education, government, manufacturing, 
processing and health [7]. 
These rural population areas could be classified as regional, small towns, or islands as 
well as remote or very remote areas of the country. Inherent in this nomenclature, many 
differing classification systems have been used alone, or concurrently, over time in 
Australia, to describe the complex service and funding allocation in health, community 
services or education. 
1.2.1.1 Current classifications systems 
The recent series of rural classification systems in Australia started with the Rural and 
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Remote Metropolitan Area Classification of Australia (RRMA) [16], developed by the 
Department of Primary Industry in 1994, using the Statistically Local Areas (SLA) as a 
base measure to show metropolitan, rural and remote zones using a whole number 
scale. Following on, the Accessibility/Remoteness Index of Australia (ARIA) system [12] 
was developed by the Commonwealth Department, Health and Aged Care, and the 
National Key Centre for the Social Application of Geographical Information Systems 
(GISCA), in 1997. It used five classes (Highly Accessible, Accessible, Moderately 
Accessible, Remote and Very Remote) with a range of levels within from 1 to 12. ARIA 
classifications used additional fractional values within the SLAs to identify different 
areas more accurately. This system used road distances, not straight lines, to set its 
classifications. ARIA was then further refined to an ARIA+ system, which used an island 
weighting for islands such as Tasmania. Five, instead of four, categories of distance to a 
service centre were extrapolated to a 15 value fractional range within. A further 
refinement, ARIA++, used six categories and 18 fractional values to describe the rurality 
of various population areas in Australia. 
According to the then GISCA website of the time, the difference in the two approaches 
was: 
It (RRMA) is an unambiguously geographical approach to defining remoteness. The 
ARIA index has a number of advantages over the RRMA index; these include flexibility, 
clarity, precision and stability over time. [16] 
The next model used to replace RRMA and ARIA was the ASGC (2001) [17], which used 
Census Collection Districts (CDs) as a base to define Remoteness Areas (RAs). RAs were 
defined as the distance from the nearest urban centre, according to population size. One 
advantage of this model was that it was used by other Government agencies, such as in 
education and community services. Classification groups used were Major Cities, Inner 
Regional, Outer Regional, Remote, Very Remote and Migratory (Table 1.1). 
In 2012, General Practice in Medicine used as a base the ARIA classification, to further 
investigate retention of long-serving General Practitioners (GPs) in rural areas in the GP 
Rural Retention (GPARIA) Project [18]. It identified an ‘Inner Regional’ classification, to 
recognise those living on the urban fringes, who may have the same difficulties in access 
to health services associated with more remote locations. 
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The newer GIRS model (Geographically-adjusted Index of Relative Supply) (2014) [19] 
took into account workforce, using a score system of 0–8, with 0–1 being for the most 
challenged areas. The ‘one-hour drive time’ measure to a health service, was considered 
the acceptable maximum time for a patient to take to see a health professional. It also 
used a complex combination of workforce supply, population density, land size and the 
percentage of those who could reach a service within the hour in the calculations 
(Figure 1.1). 
Figure 1.1: Geographically-adjusted Index of Relative Supply components 
 
Spatial distribution of the supply of the clinical workforce: relationship to the distribution of the 
Indigenous population, AIHW,2014 [19] 
Currently, the most up-to-date system used in Australia is the Modified Monash Model, 
developed in 2015 [20, 21], based on the ASGC Model [17] (Australian Standard 
Geographical Classification) which incorporates health service data, and not just 
distance. It can also identify small towns and localities rated inequitably under the later 
ASGC-RA (Australian Standard Geographical Classification-Remoteness Areas) system 
[22], and can thus identify specific areas in need of health services. This detailed system 
is used for many health services, but not for community pharmacy and its funding 
allocations from the Community Pharmacy Agreements (CPAs) [23]. 
1.2.1.2 Current community pharmacy rural classification system 
Despite newer and detailed models of geographical and population information and 
systems, the pharmacy profession still uses a simplified system similar to ARIA+, called 
PhARIA, to cater for its own specific needs [24]. Developed in 2000, the classifications 
are 1 to 6 (See Table 1.2 below), and are updated annually. This is managed by what is 
now called the Hugo Centre for Migration and Population Research, University of 
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Adelaide [24], and previously called GISCA. For PhARIA, the classification rankings are 
allocated to CDs within postcode regions. Thus, many rural and remote areas have a 
PhARIA rating, but do not have a pharmacy. In this system, a professional isolation 
component is calculated using the road distance to the five closest pharmacies. 
Additional rules also apply to the PhARIA system: 
• There is a buffer zone around a population centre so the whole area will receive the 
same rating as the populated area. This is a 30km radius of an external boundary of a 
population centre of more than 250,000 people, and 10km if the population is more than 
18,000. 
• Centres of more than 8 pharmacies are always classified as PhARIA 1 [25]. 
The following table (Table 1.2) shows examples of PhARIA categories compared to 
ARIA+ (2011), and examples of the current PhARIA rating of various population centres: 
Table 1.2: PhARIA classification system 2017–2018 
PhARIA 
category 
PhARIA location 
example 2017–8 
ARIA+ 
equivalent 
category 
ARIA+ 
description 
ARIA+ location example 
2017 
Category 1 
Melbourne, Sydney 
Darwin 
Hobart, Launceston, 
Devonport, Burnie 
(Tasmania) 
0–0.2 
Highly 
accessible 
Melbourne, Sydney 
Category 2 Sorell (Tasmania) >0.2–2.4 Accessible 
Darwin 
Hobart, Launceston 
(Tasmania) 
Category 3 
Beaconsfield 
(Tasmania) 
   
Category 4 
Campbell Town 
(Tasmania) 
>2.4–5.92 
Moderately 
accessible 
Beaconsfield, 
Devonport, Burnie 
(Tasmania) 
Campbell Town 
(Tasmania) 
Category 5 Swansea (Tasmania) >5.92-10.53 Remote Swansea (Tasmania) 
Category 6 
Currie, King Island 
(Tasmania) 
>10.53-15 Very remote 
Currie, King Island 
(Tasmania) 
ARIA–PhARIA, Hugo Centre for Migration and Population Research 2017 [24, 25] 
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Hobart, Launceston and Burnie in Tasmania are rated as PhARIA 1 within the PhARIA 
system, the same as Melbourne and Sydney, despite not being considered as Major 
Cities by ASGC, and the other classification systems previously discussed. 
The PhARIA and ARIA system ratings appropriate to the time of the particular study, 
will be used in the various investigations and projects described later in this thesis. 
1.2.2 What is rural health? 
Over time, health status in rural Australia has not changed significantly. In 2004–5 in 
regional and remote areas, compared with major cities, data was lacking as to the 
prevalence of chronic disease. It was reported then, that in rural areas: 
• the self-reported prevalence of injury was at least 20% higher 
• death rates due to chronic disease were higher [7] 
Australian social trends data from the ABS, which used the 2007–8 National Health 
Survey, the 2007 Mental Health and Wellbeing Survey and 2008 Census data [5] found 
that outside major cities people: 
• lived 4 years less on average 
• had no significant difference in occurrence of diabetes, high cholesterol, hay fever, 
cancer or ischaemic heart disease 
• compared to those in major cities were more likely to: 
o die from ischaemic heart disease (44%) or stroke (31%), three times more likely 
to die from transport injury or 66% more likely to die from suicide 
o have arthritis (13%), deafness (27%), back pain (23%), and a mental health 
problem (16%) 
o have incurred a long-term health condition as a result of an injury (30%) 
o be a smoker (30%) or long-term risky drinker (32%) [5] 
In 2011, the health of those in the major cities was in many ways similar to those in 
rural areas, but people in rural areas were more likely to die of their illness [5]. 
The latest available data from the Health Survey 2014–5 showed that at least one in 
eight people lived with a chronic health condition, and the impact on health and 
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longevity was worse in rural and remote areas of Australia [6]. Compared to the 
previous health survey, in 2014–5, the rates of diabetes, arthritis, cardiovascular 
disease, asthma, mental health problems and deafness, increased outside population 
major centres. Back pain and its associated problems, blindness and chronic obstructive 
pulmonary disease (COPD) increased in the inner regional areas, but then decreased in 
outer regional and remote areas. Cancer rates were similar in all areas [6]. Overall, the 
rate of cardiovascular disease was 4.7% in major cities, 6.7% in inner regional areas and 
5.8% in outer regional and remote areas of Australia. [6].  
Risk factors for chronic diseases such as smoking, low exercise levels and alcohol 
consumption, increased the more remote the population. Obesity increased for those 
living outside major cities. These risk factors for different geographical areas are 
described in the table (Table 1.3) below taken from the report, Australia’s health 2016 
[6]. 
Table 1.3: Health behaviours and risk factors in different geographical areas of Australia 2016 
 
Australia’s health 2016, AIHW, 2016 [6] 
In addition to differing rates of disease and risk factors in rural areas, a combination of 
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environmental enablers and specific essential requirements, underpins the provision of 
rural health services. Supportive policy, cohesive relationships between different levels 
of government, and community readiness are the environmental enablers are 
mandatory [13]. Workforce organisation and supply, adequate funding, adequate 
governance with management and leadership, linkages between agencies and physical 
infrastructure are essential requirements of health care, stated by Wakerman and 
Humphreys in 2008 [13]. In the text on rural health, Bourke and Sheridan (2008) [26] 
stated that a rural health service must be affordable, available, accessible, 
accommodated and acceptable. 
‘Rural health’ is often defined in terms of distance from a larger population centre 
(Wakerman and Humphreys, 2008) [13]. Bourke et al. (2004) [27], however, described 
characteristics of rural-urban health differentials as access, confidentiality, cultural 
safety or cultural security and team practice. Others below, argue that the local social 
and economic determinants of health, create the differences between health in rural 
areas, not the conventional disease differences often quoted previously. 
Wakerman and Humphreys (2002) [28] also suggested earlier that rural health was a 
significant issue because it is different to urban health, and the health differentials such 
as geography, access, and sociological, cultural, spiritual and economic differences [28], 
are integral to rural and regional development in Australia. The authors advocated that: 
…good health does not result from access to health services alone [28] 
They suggested that lessons for all could be learned from innovative rural practice 
models involving local need and community action, which used a primary health care 
framework model. Consumer satisfaction with rural health services in Australia 
depended on availability, geographical accessibility, choice, continuity and economic 
accessibility according to Smith et al. in 2006 [29]. The survey they conducted showed 
that although one-third of rural consumers had an unreported complaint (60% with 
doctors, 31% with hospitals), only 11% actually made a complaint, and overall, the 
general satisfaction level was high [13]. This survey had a relatively low level of 
response (16.5%), and so may have been contaminated with bias towards 
complainants. Yet, compared to urban counterparts, rural consumers in this survey 
were 25% per capita less likely to complain. 
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Demographical modelling of Australia’s rural regions indicated a higher number of 
older people, in part due to migration to the cities by younger adults [30]. However, 
Aboriginal and Torres Strait Islander populations usually had a greater proportion of 
younger people, who also had a higher level of fertility and overall less migration. 
Larson in 2007[30], claimed that the need for health services was skewed towards the 
demographic profile of those in the cities, thus adding another layer to the complexity of 
adequate rural service provision requirements. 
Rural health care is not necessarily ‘poor’ because a particular service is not available in 
that area. However, this lack of equality, not equity, to health services in urban areas, 
were how some health services are assessed as stated by Bourke and Sheridan (2008) 
[26]. 
Figure 1.2: The complexity of assessing rural population requirements in Australia 2016 
 
Australia’s health 2016, AIHW 2016 [6] 
From the data in Figure 1.2 above, taken from 2014–5, the questions posed 10 years 
previously, were still unanswered as to the actual status of health for those living in 
rural and remote areas of Australia. 
1.3 Governance of health services in Australia 
In Australia, health services are controlled and delivered by a number of layers of the 
public sector, together with the private sector. Each has a specific role; however, there is 
often an overlap in service, funding and staff. In 2013–4, the total cost of health 
provision was predicted to be AUD$155b, two-thirds of which came from the various 
levels of government [6]. 
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The three levels of government (federal, state and local) provide health services 
differently in the various regions and states of Australia. The Commonwealth 
Government, Department of Health, either funds the states to deliver services, 
distributes lump-sum payments to states for delivery, or funds those organisations 
which coordinate services, such as the Medicare Locals, now the Primary Health 
Networks (PHNs) (as of June 2016). It also funds various non-government agencies. 
Services coordinated at a national level are Medicare, the Pharmaceutical Benefit 
Scheme (PBS) and the CPAs, the Therapeutic Goods Administration, purchasing of 
vaccines, aged care services subsidies, education (funded university places and schools), 
pandemics and national coordination of other health emergencies. The Department of 
Health also manages a number of rural and regional health programs mainly related to 
doctors [31] and some other medical, pharmacy and allied health programs. 
Registration, regulation and accreditation of 15 health practitioners providing  services 
is managed by the Australian Health Practitioner Regulation Agency [32]. 
Funding for health services provision for all areas in Australia is a complex combination 
of differing sources, government support together with local delivery. Pharmacy 
funding is nationally provided through the CPAs, negotiated at a national level for local 
implementation [33]. 
1.4 Health policy in Australia 
Health policy in Australia is developed by a number of organisations and departments, 
under the auspices of what was the Department of Health and Ageing, and what is 
currently, the Commonwealth Government Department of Health. Examples of policy 
include Primary Care or Primary Health Care, Chronic Disease Frameworks and 
preventative policies to cover the ‘out-of-hospital’ population health requirements, and 
necessities of the community, especially the local communities. In addition, state-based 
policies have also been developed, to incorporate local health requirements of state 
specific issues of concern. The original focus of the policies was on health targets, but 
they are now currently focused on risk factors such as smoking and obesity, lack of 
exercise and hypertension (as shown in Table 1.3). However, general health policy 
documents do not take into account specific rural requirements. 
Chapter 1: Background review of rural health in Australia      13 
1.4.1 Strategy and health targets in Australia 
The National Chronic Disease Strategy (2005) combined principles and action areas, to 
attempt to contain the chronic disease burden on the Australian community, and was 
approved at the 2005 Australian Health Ministers’ Conference [34]. Lifestyle changes, 
such as reduction of tobacco smoking and alcohol use, weight reduction, decrease in 
high blood pressure and high cholesterol, an improvement in diet and nutrition, and an 
increase in physical activity, were the seven preventable disease risk factors to alleviate 
the potential financial and community impact of chronic disease. Coupled with the 
demographic changes as Australia’s population ages, and major advances occurring in 
treatment, the chronic disease burden was considered the major health concern. 
In 2016, the Atlas of Australia’s Health, Australia’s Health Tracker [35] was released and 
predicted various health targets based on the WHO Global Action Plan for the 
Prevention and Control of Noncommunicable Diseases (2013–2020) [36]. The Tracker 
showed risk factor rates in local areas and thus provided local health targets, to enable 
local health planning and research, for all areas of Australia. Examples of overall targets 
suggested include the reduction of obesity from the current levels of 27.9%, to 24.6% 
for those 18 years or over, a decrease in hypertension from 23% to 16.1%, and a 
decrease in elevated cholesterol levels from 32.8% to 24.6% [35]. 
1.4.2 Chronic disease strategy and frameworks 
Going back to 2006, the National Chronic Disease Strategy [34] was developed as a high 
level policy guide to inform policy makers and practitioners. To support the strategy, 
the National Disease Frameworks [34] focused on prevention, critical intervention and 
action points, risk reduction, early detection, care and support during acute, long term 
and advanced stages of specific diseases. There were frameworks for asthma, cancer, 
diabetes, rheumatoid arthritis and osteoporosis, as well as heart, stroke and vascular 
disease. The frameworks still exist today, but have now been overtaken by more up-to-
date policy documents. 
In 2016 the frameworks above were superseded by the National Strategic Framework 
for Chronic Conditions [4]. Rather than focusing on specific diseases again, this 
framework focuses on the shared underlying health determinants, risk factors and 
multi-morbidities shared by common chronic conditions in all Australia, such as weight 
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reduction and smoking prevention.  
Updated in 2017 [37], and current until 2025, the National Strategic Framework for 
Chronic Conditions still concentrates on prevention and management of chronic 
conditions, supporting coordinated care but it acknowledges the use of innovative 
solutions in management. Reforms to deliver a more sustainable, ‘person-centred’ 
health system include pharmacy and medicine price reforms, and the introduction of 
Primary Health Care Networks [37]. People living in remote, rural or regional locations 
are a priority population. The planning and delivery of health services with an 
appropriately distributed workforce should recognise the diversity of the population in 
all locations. Health services should be culturally appropriate, accessible and provide 
flexible options for all [37].  The National Strategic Framework for Chronic Conditions 
provides guidance to enhance disease-specific approaches to address the increase of 
chronic conditions in Australia and in particular for those in regional, rural and remote 
areas.   
1.4.3 National Preventative Health Strategy 2009–2020 
Following on, another seminal health framework document, Australia: The Healthiest 
Country by 2020, the Roadmap for Action [38], was published in 2009. Written by the 
National Preventative Health Taskforce, this primary health care approach to improved 
health outcomes focused on prevention, with a vision of people making healthy choices 
the easiest choice, and the tag, ‘prevention is everyone’s business’. Obesity, tobacco and 
alcohol reduction within a supported infrastructure, with effective implementation, and 
a primary health care approach, were the three areas chosen as the initial goals. 
Each risk factor above, had key action areas to reduce the risk, with a series of 
interventions aimed at adults, children and the Aboriginal and Torres Strait Islander 
population. The role of pharmacy is mentioned briefly. In this document, pharmacy 
weight-loss programs were specifically cited as lacking in evidence, with many making 
unsubstantiated claims. The taskforce called for a national accreditation, and trained 
consultants. Pharmacy also was cited for providing tobacco cessation advice and 
information. 
This framework aimed to refocus primary health care settings towards prevention. 
Community pharmacy is included as one of the professions which provide primary 
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health care, and it can provide the necessary services to achieve this aim. Albeit, only 
some of the possible contributions were listed from those that could be made by the 
profession. 
In addition to the above policies and frameworks, the National Partnership Agreement 
on Preventative Health was announced at the Council of Australian Governments 
(COAG) in 2008 [39]. In 2012, this partnership was extended until June 2018. 
Concentrating on lifestyle issues, which added to the chronic disease burden, the 
agreement had a whole-of-life approach to improving health outcomes for all 
Australians. 
1.4.4 Primary health care policy 
Pharmacy as a profession, can contribute at the primary health level, but is often not 
specifically mentioned or included. Definitions of primary care and primary health care 
were often intertwined, but are generally considered to be the ‘first’ contact with the 
health system, whether this occurs between a patient and a doctor, nurse, pharmacist or 
any other allied health professional. This contact is usually considered in a ‘non-
admitted’ context. 
Berbatis et al. (1986) [40] maintained pharmacy was the first contact primary care 
service for individuals in Australia with 125 million paid and unpaid health-related 
services provided annually in the 1980s. By 2002, the National Pharmacy Database [40] 
estimated this figure had increased to 220 million visits. In 2018, it was claimed by the 
Pharmacy Guild of Australia, the number of visits had increased to 440 million per year 
[1]. However, Berbatis et al., in 2003, pointed out that pharmacists could not be 
regarded as ‘primary care professionals’, because they cannot legally diagnose, do not 
keep long term records of patient-care or provide comprehensive health care. In the 
author’s view this may be argued as semantics and is not the case today given additional 
practice roles for pharmacists [41-43]. 
Primary health care policy has been developed in various forms, with strategies, and 
preventative and clinical frameworks. In 2011, the Australian Government established 
61 independent Medicare Locals, each with a primary care focus. They were introduced 
to provide better-coordinated, and less fragmented care, particularly to those with a 
chronic health condition. Extensively funded, Medicare Locals [44], had an increasing 
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budget over a five-year funding cycle. 
The Medicare Local approach to health fund management changed on 30 June 2015, by 
competitive tender, to become Primary Health Care Networks (PHCN or PHNs), as part 
of the then Australian Liberal Government policy. Each state now has fewer PHNs 
compared to some states, which had many Medicare Locals. The common focus is that: 
PHNs have been established with the key objectives of increasing the efficiency and 
effectiveness of medical services for patients, particularly those at risk of poor health 
outcomes, and improving coordination of care to ensure patients receive the right care 
in the right place at the right time [45]. 
1.5 Rural health policy in Australia 
There have been various rural health policy documents, strategies and frameworks 
developed over the past 20 years. Organisations of rural health professionals, such as 
the National Rural Health Alliance (NRHA) [46] and its individual member bodies, have 
had a great impact on the recognition, and change, of rural health issues at a policy level. 
However, Humphreys et al. in 2002 stated that there were a number of ‘impediments’ to 
improvement [47]. These include city dominance as foci of health service provision, a 
lack of rural community consultation, rural health ‘specialist-generalists’, medical 
dominance, turf wars, existing federal and state governments with their ‘silo mentality’, 
and current funding arrangements. The authors also suggested that ‘governments view 
health, as with education and other collective consumption goods, as a social expense 
rather than a social investment’. The impact of the media and rural health as a political 
tool has also hindered overall progress over the years. 
The various documents found that relate to rural health will be discussed in more detail. 
1.5.1. National Rural Health Strategy 1994, and Update 1996 
Initially, the National Rural Health Strategy (1994) [48] and the 1996 update [49] were 
written with aims to provide access to appropriate health services that maximise the 
health, and minimise the barriers to effective health care, for regional, rural and remote 
Australians. A review in 1998 concluded that many programs had failed in meeting 
these objectives [50]. 
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1.5.2 Healthy Horizons Frameworks 
In 1999, the Healthy Horizons Framework—a Health Framework for Rural, Regional 
and Remote Australians 1999–2003 [51], was the next document developed to describe 
the improvements required for better rural health. It was written by the National Rural 
Health Policy Forum and the NRHA, to provide direction and guide health programs and 
resource allocation. It highlighted the poorer states of health in the 32% of the 
population (at this time), who made up those living in rural and remote Australia. Death 
rates were higher in remote areas compared to rural areas, in part due to the health of 
the Aboriginal and Torres Strait Islander population. This framework aimed to improve 
primary health, and public health, through the principles of community need, capability, 
participation, access and sustainability, and to allow its members to promote a healthy 
lifestyle and manage their health problems. The seven framework goals were to: 
• improve the highest priorities first 
• improve the health of Aboriginal and Torres Strait Islanders 
• undertake research and provide better information to rural, regional and remote 
Australia 
• develop flexible and coordinated services 
• maintain a skilled and responsive workforce 
• develop needs-based flexible funding arrangements for rural, regional and remote 
Australia 
• achieve recognition of rural, regional and remote health as an important component 
of the Australian health system [51] 
Each interdependent goal had a number of priority areas, to address, and to measure 
success. The overall vision stated that: 
People in rural, regional and remote areas will be as healthy as other Australians [51]. 
When this framework was written there were only five National Health Priority Areas 
(mental health, diabetes, cardiovascular health, injury prevention and control, and 
cancer control), which were reflected in the priorities and measurable outcomes. 
In 2003, Healthy Horizons evolved into the Healthy Horizons Outlook 2003–8 [52], an 
updated framework to improve the overall health goals, and thus reduce inequities in 
outcomes and service delivery. 
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Neither document mentioned pharmacy, pharmacists or medication supply as a 
community health service, or those pharmacists who worked in hospitals, specialist 
medical services or Aboriginal community-controlled health services, outreach services, 
nursing home care, multipurpose services, air services, ambulances and transport, 
public and environmental health, or in training and support of health practitioners. 
Pharmacists were only mentioned as providing primary health care advice [52]. 
Pharmacy services were quoted in the framework, by explaining that the National 
Medicines Policy strategy required judicious, appropriate, safe and efficacious need for 
medicine be addressed. Section 100 access to the PBS for Aboriginal communities, was 
also mentioned briefly [52] in the documents. Overall, these policies showed little 
involvement, and acknowledgement of the current and potential contribution, by the 
pharmacy profession. 
1.5.3 National Strategic Framework for Rural and Remote Health 
In 2011, the National Rural Strategic Framework for Rural and Remote Health [3], 
superseded the Healthy Horizons frameworks, to provide continuity of strategic 
development for regional, rural and remote Australians—all those who lived outside 
major cities, or 30.4% of the population (at the time). It was developed by the Rural 
Health Standing Committee (RHSC) and the Australian Health Ministers’ Advisory 
Council (AHMAC). The key outcomes areas were: 
• access—improved appropriate and comprehensive 
• service models and models of care—that are effective, appropriate and sustainable 
• health workforce—that is appropriate, skilled and well-supported 
• collaborative partnerships and planning—which includes policy development 
• strong leadership, governance, transparency and performance—which includes 
accountability 
The vision was the same as in 1999; only the goals had been altered. Still, the same basic 
issues were identified as those requiring change. Services mentioned included 
prevention and screening, early intervention, treatment and aged care services, and 
delivery of ‘specific’ primary health services, hospital and emergency care, dental 
health, maternity and preventative health, many of which could be delivered by the 
pharmacy profession. 
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Pharmacy was only mentioned in this document as an allied health profession engaged 
in ‘primary care’, which was also called ‘primary medical care’—thus reinforcing the 
medical model approach. Primary Health Care incorporated not only the medical 
profession, but also all other allied health professionals (none in particular were 
highlighted) and health workers. 
1.6 Rural health expenditure 
In 2011, the NRHA argued in its report, Australia’s health system needs re–balancing: a 
report on the shortage of primary care services in rural and remote areas [53], that 
many of the costs in rural health were not reported properly [54]. It suggested that 
people in rural, regional and remote areas did not access primary health services and 
were more likely to go to hospital as an inpatient. In monetary terms, the primary care 
deficit was estimated as AUD$800m, with an additional pharmacy expenditure deficit of 
AUD$850m (adjusted for the concessional cardholder number differences). For the 
pharmacy profession, this equated to 11 million fewer prescriptions for rural people 
compared to those who lived in a major city. In rural, regional and remote areas of 
Australia, there was a AUD$3b deficit of primary and aged care services. In contrast, 
there was an overspend of AUD$829m in hospital expenses. 
Per capita spending on the PBS decreased by remoteness, and the AIHW report [54] did 
take into account 53% of the cost of medications (being the PBS and Section 100 
components of total pharmaceutical expenditure), but did not take into account the 
remaining 47% for non-PBS medication. These calculations showed that, in 2006–7, 
while the non-card holding population in regional areas overspent roughly AUD$10 per 
capita, the concession card holders in regional areas (45% of that population) 
experienced an underspend of between AUD$140 and AUD$190 per capita. The 
expenditure for non-PBS medications in rural, regional and remote areas was estimated 
to be AUD$1.7b per annum coupled with a shortfall AUD$350m for PBS medications—a 
total of at least AUD$2b lost to provision of pharmacy services. These figures suggest 
the Australian rural and regional populations may not be taking advantage of health 
services. 
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1.7 Summary 
Health, and specifically rural health, is a complex combination of factors, both at the site 
of service, and the overarching policies developed to support the health services. The 
various classification systems affect local funding and services, and except for 
pharmacy, have changed over time to reflect the population and geographical factors 
specific to the areas of need. 
Overall health in rural areas of Australia is worse than for those in major cities of this 
country, and not all services are available in rural areas, to address its needs. Equity of 
service is required, not equality. Many documents have been written over time to guide 
and frame not only health, but also rural health services, yet the health disparity still 
exists within this country. 
There are additional factors that need to be considered, especially in rural areas, such as 
access, appropriate service models of care, the health workforce, collaboration and 
cultural appropriateness of services. Anecdotally, rural health services are often 
considered innovative and the leadership, governance, transparency and performance 
need to be allowed to emerge. However, specific policies and frameworks developed for 
rural areas to date, have not improved the health of this population compared to the 
population as a whole. This is despite measures put in place over time, to address the 
specific concerns of equity, access, capacity and sustainability of service provision in 
Australia [55]. These issues of concern also are not unique and occur overseas [56]. 
Pharmacy, as a profession, is not usually mentioned in generic or health policy 
documents. The role of the pharmacist is not separated from the value of the premises 
as a location, for the dispensing of prescriptions and administering of primary health 
advice. The policies and frameworks documents did not include the potential 
contribution of the profession to primary health care, the diminution of disease risk 
factors and its contribution to chronic disease prevention and management. While rural 
people were less likely to complain about their health service, they also did not spend or 
access health care provided or use the PBS as much as their urban counterparts. 
As a pharmacy profession, the service contribution in rural areas is restricted using the 
PhARIA system, which was developed in 2000, and used to decide any funding 
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allocation and identification of rural and remote practice recipient sites. Its rigidity, 
compared to other rural classification systems described, restricts practice and funding 
apportionments to some regional and rural areas by classifying them as urban under 
this system. 
Currently, Australian community pharmacy is defined by its services under the CPA, 
which will be further described in the following chapter. The contribution of the 
profession is still hampered by lack of current data and research, and the focus remains 
currently on the pharmacist in the community pharmacy itself, whether this be in urban 
or rural locations. Many risk factors to good health have been reported in this chapter, 
and the pharmacist is able to address these. As shown by the various competency [57, 
58] and professional practice standards developed over the years [59-62], the 
pharmacist can contribute to improve health outcomes for those engaged in risk taking 
behaviours (smoking, obesity, lack of exercise and alcohol consumption) and assist 
those with chronic conditions of concern such as cardiovascular disease and diabetes. 
Reports such as a Grattan Report: Access all areas: new solutions for GPs in rural 
Australia by Duckett et al. (2013) [55] suggested a wider role for pharmacists in rural 
areas in this country, one supported by the Pharmaceutical Society of Australia (PSA) 
[63] rather than a role as merely a provider of primary health services, medicines and 
medication information. This will be discussed in the following chapter, which will focus 
on the current role and governance of the pharmacists and the pharmacies in Australia. 
Future chapters will then describe the studies undertaken to demonstrate the 
pharmacist role in improving rural health outcomes, and results of comparative studies 
investigating services in rural and urban areas. 
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Chapter 2: Pharmacists and the factors influencing rural and urban 
community pharmacy in Australia 
The profession of pharmacy is an integral part of the country’s health landscape, and 
has its own rules, guidelines, and standards to describe competent practice. There are 
many professional bodies guiding and shaping this practice, as well as many other 
factors affecting the pharmacy workforce of today, and into the future. The specific 
activities in recruitment, retention and the workforce, the roles of rural community 
pharmacy itself, and the influence of customer expectations and satisfaction, will be 
discussed in this chapter. 
In Australia, only 17% of community pharmacies [64, 65], and their workforce, assist 
the nearly 30% of people who live in regional, rural and remote areas [5, 8]. It was 
considered that there was a deficit of pharmacy service provision in rural areas as 
reported by the NRHA (2012) [66], despite the many measures enacted so far to 
alleviate this shortfall such as those through the Community Pharmacy Agreements 
(CPAs) [33, 67-72]. 
Community pharmacy as a profession, considers itself as the front-line for health and 
health information, screening or treatment options, and not just for medicine provision. 
The previous chapter showed how pharmacy as a profession is not comprehensively 
included in health or rural policy documents. In addition, some organisations, do not 
even include community pharmacy as an allied health profession at all, such as the 
Allied Health Professions Australia (AHPA), 2017 [73]. Hospital pharmacy is listed, but 
community and the other forms of pharmacy practice are not. 
2.1 Aims 
The aims of Chapter 2 were to describe the: 
• historical and current roles, and the features of community pharmacy practice and 
its workforce 
• various government constraints and professional bodies which guide this practice in 
all areas 
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• current differences and opportunities for rural community pharmacy practice and 
its workforce 
• consumer perceptions and expectations of community pharmacy practice 
2.2 Role of the pharmacy and the pharmacist 
The roles of the community pharmacy and the pharmacist him/herself are often 
intertwined in the literature. Pharmacy (or pharmacists) are quoted as the ‘most trusted 
profession’, in various media releases and newspapers. The 2016 Roy Morgan [74] 
rated pharmacists again equal second with doctors behind nurses, for ethics and 
honesty. In 2017, pharmacy dropped another place (nurses 94%; doctors 89%; 
pharmacists 84%) [75]. A similar survey by Readers Digest ranked pharmacists 7th 
behind paramedics, in 2014 [76]. The latter survey used 50 professions, while Roy 
Morgan only used 30, and did not include paramedics. However, Smith and Newby in 
2011 challenged this trust with examples of questionable sales ethics [77]. Suggestions 
of pharmacy being only interested in profit are often in the popular media, thus 
implying questionable trust, professionalism and knowledge. Community pharmacy is 
the usual public face of the profession in Australia, and will be described further below. 
2.2.1 Community pharmacy 
The Pharmacy Guild of Australia (PGA) stated in 2007 that: 
In Australia, community pharmacy plays a pivotal role in the healthcare system. 
Through a network of over 5000 shop-front centres across the county [sic], Australians 
receive access not only to affordable medicines but also free healthcare and medicine 
management advice and information. 
Community pharmacists and their staff are highly trained professionals who act as a 
first port of call for many health issues. They are able to provide you with direct advice, 
information or treatments as well as refer you to other appropriate health professionals 
or community services if required [78]. 
In 2016, there were 5,587 community pharmacies in Australia, with about 20% in rural 
and remote PhARIA 2–6 areas [64] as quoted by the PGA’s website [79]. There has been 
no information found as to the number of pharmacies in regional towns. In 2017, there 
were 425 one-pharmacy towns [79], a decrease from ‘480+’ (13.5%) in surveys 
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undertaken in 1990 and1991 by the Isolated and Essential Pharmacists Association 
[80]. 
Further correspondence with the PGA [64, 81] indicated only 17% or 964 community 
pharmacies, were in rural Australia using the PhARIA classification system. The number 
of pharmacies in the various PhARIA areas is shown in Table 2.1. In August 2018, there 
were an additional 78 pharmacies according to the PGA [1] with the proportions in each 
PhARIA area remaining the same [65], and these have been added into the table below. 
Table 2.1: Location of community pharmacies in Australia by PhARIA rating 2017–2018 
PhARIA 
rating 
Percentage of 
pharmacies in 
each PhARIA area 
February 2017 
Number of 
pharmacies 
(whole 
numbers) 
February 2017 
Percentage of 
pharmacies in 
each PhARIA area 
August 2018 
Number of 
pharmacies 
(whole 
numbers) 
August 2018 
1 83 4,637 83 4,702 
2 3 168 3 170 
3 7 391 7 397 
4 3 168 3 170 
5 3 168 3 170 
6 1 56 1 57 
Rounded 
total 
 5,588 
 5,666 
Correct 
total 
 5,587 
 5,665 
Email communication, PGA, 2017–8 [64, 65, 81] 
There is an obvious mismatch between the number of pharmacies, pharmacists and the 
population, that is evident in this geographical spread of pharmacy services, 17% of 
pharmacies service nearly 30% of Australia’s population [8, 65]. 
2.2.2 Activities of pharmacists 
Pharmacists have been working as a profession for many centuries, first as herbalists, 
then as apothecaries, then pharmaceutical chemists before the nomenclature 
‘pharmacist’ became widely accepted. Initially taught by an apprenticeship system, a 
university course is now the accepted form of study in most countries, allowing a 
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pharmacist to own and/or manage a pharmacy. However, this is not always the case, 
and in some countries unqualified shopkeepers can still sell unregulated drugs in 
medicine shops. 
In 1979, Eaton and Webb [82] reviewed the development of pharmacy as a profession 
using older papers by McCormack, in 1956, in which he suggested pharmacy was a 
‘marginal profession’. Ten years later, Denzin and Mettlin (1968) [83], concluded 
pharmacy was an ‘incomplete profession’. The association with trade and industry 
‘muddies the waters’, as to whether role of pharmacy practice is professional or 
commercial. Moving on, Eaton and Webb [82] suggested the 1971 Royal Commission on 
the National Health Service in Great Britain recommended an expanded role for 
pharmacy, one that was beyond the current dispensing and compounding activities, to 
one of direct contact with patients. It was also proposed that retail pharmacists could 
give advice and treat ‘minor ailments’, but not diagnose or prescribe. Throughout this 
time, medical practitioners could still dispense in Great Britain, but this option was 
limited to those in rural areas. Today, this is still current practice [84, 85], if no 
pharmacy is within a mile of the dispensing doctor’s practice. A change has been 
suggested, and in 2016, it was promoted that with ‘tact and diplomacy’ the medical 
practitioner could be persuaded to use the skills of the pharmacy. 
Holland and Nimmo in four papers (1999) [56, 86-88] suggested that there were five 
factors impacting on the role of the pharmacist in health care. Using information from 
the 1980s, these were: 
efforts to reduce drug costs, changes to market economy forces, changes in technology, 
increases in territorial competition from other professions, and reallocations of 
pharmacy staff 
The authors suggested that threats to the profession came from: 
• the increased availability of information to the consumer from sources other than 
the pharmacist 
• the dependent role of the profession and its reliance on prescriptions 
• lack of evidence to support the effectiveness of pharmacists’ intervention 
• the attempts by the profession to encroach into other health professional domains 
such as public health and medication reviews 
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However, this latter practice of public health and medication reviews is accepted today 
as part of the pharmacist’s role. In 1999, these authors nominated two broad roles for 
the profession—technical and clinical. Nimmo and Holland (1999) [87] stated that even, 
in current times, the manual technical role continued to impact on the cognitive clinical 
role: 
Pharmacists outwardly reinforce other’s expectations by their own perception of a 
limited professional role, thus making any change more difficult. Rigid structural 
barriers of the location of pharmacists—in a pharmacy itself and within the dispensary 
away from customers, payment of a supply rather than a service and reimbursement of 
payments support these obstructions to change in practice. [87] 
The authors of this set of papers, concluded that pharmacy had resilience and flexibility, 
as demonstrated by the pharmaceutical care and self-care roles, but the profession 
needed to move on from a ‘quasi-professional technical status to one of full 
professionalism’. This is something that many might argue, has still not happened today. 
A few years later, in 2003, Taylor and Harding [89] espoused the same sentiments: 
The practice of contemporary pharmacy extends beyond pharmacists exercising their 
specialist drug knowledge. 
In 2006, the WHO [90] together with the International Pharmacy Federation (FIP) 
developed the pharmacist activity role components, and called this the ‘seven-star 
pharmacist’. The eighth arm, ‘research’, was added in 2006 [90]. The activities of a 
pharmacist are described in the following diagram (Figure 2.1): 
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Figure 2.1: The eight-star pharmacist (adapted from FIP 2006) 
 
Developing pharmacy practice–a focus on patient care, World Health Organisation, 2006 [90] 
Pharmacists are described, by the profession itself, as the most accessible health 
professional, because of the community pharmacy location, and its extended hours, thus 
giving the customer the ability to just walk-in for advice and professional service. Yet 
the profession is still generally perceived by others, as one of dispensing prescriptions 
only. Within the profession, delivery of professional services in the areas of chronic 
disease prevention and advice, or health promotion, are seen as secondary roles. In 
2003, Berbatis et al. [40], suggested that community pharmacists spent on average 75% 
of their time in the dispensary and its associated activities, leaving little time for any 
other roles. 
Therefore, inclusion of any additional services would require a change of professional 
direction, to include, e.g. primary health services or enhanced services, now called by 
the profession—professional services—as mentioned in the National Pharmacy 
Database Project [40]. In this database, it showed that the pharmacy did not 
differentiate between this service being the practice of the pharmacist him/herself, or 
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one using unqualified staff, in for example, the area of weight loss. Using the example of 
the advertisements for ‘Weight Loss Consultants’ for the Tony Ferguson Diet, the 
consultants needed no qualifications, and would be trained, and did not require any 
prior experience in this area, according to Adams in 2007 [91, 92]. At the time of the 
advertisement, pharmacists were not considered suitable, or necessary, for this 
particular weight management role, confounding delivery expectations of professional 
services in the pharmacy. 
The role of the pharmacist has expanded from a traditional dispensing role, which is 
also still the definition supplied by many common dictionaries, to one of medication 
management and pharmaceutical care [61]. Current expanding and future roles also 
include those in public health, population health and community health, medication 
reviews, disease state management and screening activities, and ‘collaborative 
prescribing’. There are many models of pharmacy practice outside the community 
pharmacy such as roles in general medical practices, community health centres and in 
public health. Some specific Australian models include services in Aboriginal 
communities by practitioners such as  ‘Robbo’ [43], who provides medication reviews 
and extended support in the Ngaanyatjarra Health Service in WA, Freeman et al. [41] in 
the role of the non-dispensing pharmacist providing patient-level, clinician-level and 
practice/system-level activities in a general medical practice or Huxhagen [42] in 
integrating care and targeting self-management for patients with pain as part of the 
Mackay Pain Support Group.  
However, in Australia, the factors of the competitive threat of deregulation of pharmacy 
ownership, recruitment and retention of staff, the financial pressures to run a successful 
business, and the accompanying legal and professional requirements, overshadow a 
potential change and expansion to many pharmacists’ roles. Surviving as a business is 
typically to the fore for any community pharmacy and its staff. 
2.2.3 Consumer perceptions and satisfaction of community pharmacy 
service 
Customers are the basic requirement for a financially viable business, whether this be in 
a rural or urban community pharmacy, or any other form of pharmacy practice. The 
aspects of satisfaction, expectations, external opinions and perceptions of customers, 
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will now be discussed further, as it is suggested in some popular pharmacy literature, 
that these could differ between metropolitan, urban, regional, rural, and remote 
practice. The results of some consumer surveys will be used later in this thesis to test 
this premise. 
Patient satisfaction is a combination of the expectations and perceptions of services 
rendered [93]. The measurement of satisfaction is service-driven, including tangible 
matters and motivated factors such as waiting times, provision of information, layout of 
the pharmacy or friendliness of staff. Various authors believe patients only comment on 
the service they have received, and not any additional services that could be expected in 
a community pharmacy practice. The PGA maintains pharmacists are one of the most 
trusted health professions, and their research over time, has shown that 95% of 
patients were satisfied with their pharmacy [1, 94, 95]. 
Public perceptions and patient satisfaction with pharmacy practice have been 
investigated by observation of practice, and by surveys of patient opinions of practice. 
Aslani et al. (2009) [96] quoted the work of Heffernan et al. (1993) [96], which 
investigated Australian public perceptions of pharmacy practice. One of their 
conclusions was that the customer’s own experiences shaped their expectation of 
practice. They also suggested pharmacists have a lot to offer in an advisory role in 
health education and health promotion but this role, albeit positive, was defined by 
existing customer knowledge. 
The other requirement for patient satisfaction is in relationship marketing—finding out 
if the patient wants the service offered in the pharmacy. The traditional 4Ps of 
marketing are used—product, price, promotion, place and a fifth, positioning change, 
with cognitive or service approach compared to a ‘material good’ [97]. An example is a 
cognitive service, the product, its price, promotion and place are self-explanatory, and 
positioning identifies the niche that makes the product attractive to patients who come 
to the pharmacy. 
Panvelkar et al. [98] in 2009, reviewed the literature of the measurement of patient 
satisfaction in community pharmacy and developed a theoretical framework, taking into 
account the various theories proposed by a number of authors, but without 
accompanying marketing components. The diagram below (Figure 2.2) shows the 
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complexity of factors and the various theories involved in patient satisfaction 
investigations, and acknowledged that more than one theory was needed to attempt to 
explain the many factors involved with patient satisfaction research.
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Figure 2.2: Theoretical patient satisfaction framework developed by Panvelkar, Saini and Armour 2009 
 
Measurement of patient satisfaction with community pharmacy services: a review, Panvelkar et al., 2009 [98].   
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The usual method of elucidating the consumer view is by survey or interview. Overseas, 
early survey data on patient satisfaction [99] investigated access to care, financial 
aspects, availability of resources, continuity of care, technical competence, interpersonal 
manner and overall satisfaction. Later, Schommer and Kucukarslan [100] in 1997, 
developed a pharmacy-specific satisfaction measurement model. This work, was based 
on patient satisfaction on performance, expectations, emotional response to 
assessment, and perception of fairness of assessment. Using some of the concepts 
above, prior experiences, ideal referents or market-based expectations were 
investigated by Kucukarslan and Schommer in 2002 [101]. They sought to differentiate 
patient satisfaction on cognitive services (information) or tangible aspects of the 
services (pamphlets, waiting time). 
More recent work by Kassam et al. (2012) [102] looked at satisfaction with 
pharmaceutical care consultations of at least 15 minutes, which discussed medical 
concerns, including those about medication, care plan interventions, and monitoring. 
Although surveys were sent to rural and urban locations in Canada, no location 
differential analyses were found. The differences found were store-to-store only. 
Pleasant and courteous staff, privacy, and explanations, were some of the expectations 
for customers in a pharmacy for satisfactory pharmaceutical care. However, these could 
be considered as expectations in all satisfaction surveys. 
The role and consumer perceptions of the pharmacist has also been studied. The 
opinions of community pharmacy patients in Portugal were tested using semi-
structured interviews (15) and focus groups (28 participants) by Cavaco et al. (2007) 
[103, 104]. The actual role of the pharmacist was described from one who was a ‘health 
professional’, to a ‘mercantile professional’, to one who is ‘randomly present with 
minimal responsibility’. Customers thought of pharmacists on a ‘product level’, not in a 
primary or public health role, and one who did not have professional duties, but acted to 
‘counterbalance perceived deficiencies, from other health care providers’. 
Pharmacies generally do not provide surveys, undertake focus groups, or promote their 
services to customers, in order to find out what sort of services the customer would like, 
and would subsequently use, in the pharmacy. This is distinct from brief satisfaction 
surveys undertaken in and about current practice. Best practice was considered to be 
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consulting and comparing pharmacy performance with other pharmacies, to identify 
‘service’ gaps [102]. The authors noted that asking if services or practices were 
‘satisfactory’, did not provide an ‘anchor’ to compare the transaction experience against 
any expectations with other pharmacies. 
Surveys testing consumer’s opinions of pharmacy practice and satisfaction with service 
in Australia include the 4CPA survey in Appendix 4, and the PCHCM survey in Appendix 
5. There are also many marketing surveys promoted in the popular pharmacy literature, 
usually showing customers like a particular pharmacy group, without any depth of 
information or detail about the services being tested. The focus in the Australian 4CPA 
survey is on the pharmacy itself, including waiting times, opening hours, greeting 
received and confidence in staff, and availability of products. Only three questions 
related to professional information and explanations provided by the pharmacy, 
services, illness prevention and staying healthy messages. Consumers were asked if 
they were satisfied with the pharmacy with a simple Likert scale from poor to excellent, 
without a neutral option. In this survey, there was no differentiation of ‘pharmacy staff’, 
into assistant, technician or pharmacist. This survey was given opportunistically to 
customers by the staff. 
The PCHCM consumer survey did question a randomly selected group of consumers 
about the features that attracted them to a pharmacy. It then asked about various 
professional services, whether the pharmacy was capable of providing these, and if the 
consumer would use them. This latter survey not only used satisfaction data, but service 
use data to test if the consumers would use a particular professional service should it be 
offered or if available. The results of both surveys will be analysed later in this thesis. 
Customer satisfaction survey literature reviewed thus far, was used to gain information 
about the present pharmacy roles and the services provided, roles and services known 
to the consumer. Most did not investigate potential expanded or future roles and 
opportunities within the profession, or in the retail community pharmacy itself. Many 
provided a simplistic response option only. Any potential differences between rural and 
urban practice was not a focus of the papers and reports reviewed thus far. 
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2.3 Governance and standards for pharmacy in Australia 
Governance and standards underpin all pharmacy practice in Australia. The profession 
of community pharmacy is regulated, and supported by, the Pharmacy Board of 
Australia and the Australian Health Professional Regulation Authority (AHPRA), and the 
professional organisations, the Pharmaceutical Society of Australia (PSA) (which in 
2016 had 41% of the registered pharmacists as members) [105], the Pharmacy Guild of 
Australia (PGA) (representing owner pharmacists) and the Society of Hospital 
Pharmacy (SHPA) (representing, and not restricted to hospital pharmacists). Some 
pharmacists are members of more than one professional organisation. In all, there were 
28,065 general registered pharmacists in March 2018 [106]. Pharmacists with inactive, 
provisional and limited practice were excluded in this figure. Further discussion on the 
demographics of the profession will take place in the section on the pharmacy 
workforce later in this chapter. 
The 5,665 community pharmacies [1] in Australia, continue to be owned by 
pharmacists, Friendly Societies and some corporations of pharmacists and/or relatives 
of pharmacists. Each pharmacist can only have an interest in or own, a maximum of 4–5 
pharmacies per state. Thus, one pharmacist may own up to 40 pharmacies (8 states and 
territories in Australia). However, the reality is that there are major buying groups (e.g. 
Terry White Chemmart), with approximately 500 pharmacies [107, 108], and the 
franchised model conglomerations (Chemist Warehouse, My Chemist), with 
approximately 330 pharmacies [109] with fractional ownership by many pharmacists, 
but with a core leadership group. Other owners use companies such as Pharmacy 
Alliance (650 member pharmacies) [110], to assist in differing levels of pharmacy 
management and retail services. In 2014, in Australia, less than 11% of pharmacies 
were regarded as truly independent [111], and not affiliated with any buying or brand 
group. 
2.3.1 The organisations and professional bodies controlling pharmacy in 
Australia 
There are many professional organisations listed below, that control, guide and 
represent the pharmacists themselves in the variety of practices and locations in 
Australia. 
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2.3.1.1 Pharmaceutical Society of Australia (PSA) 
The PSA describes itself: 
As the peak pharmacists’ body, we lead and support innovative and evidence-based 
healthcare service delivery by pharmacists [112]. 
PSA’s mission is achieved through the following objectives: 
• PSA ensures pharmacists have the opportunity to have rewarding careers through 
advocacy and innovation 
• PSA provides lifelong professional support for pharmacists and the pharmacy 
profession, and advocates for their appropriate recognition and remuneration 
• PSA has a strong and engaged membership base which supports and enhances the 
Society’s influence 
• PSA values its people, and applies best practice management and governance to 
ensure organisational effectiveness and sustainability [112] 
It’s vision currently is: 
Improving Australia’s health through excellence in pharmacist care [112]. 
Formed as a federation of state societies in 1997, PSA has undergone the process of 
becoming a national organisation [113]. It was awarded ‘peak’ body status in 2016 by 
the Australian Government Peak and Advisory Bodies Program [63]. It is the only 
pharmacy organisation to sit on the NRHA, the peak body of national organisations 
promoting good health and wellbeing in rural Australia. 
2.3.1.2 Pharmacy Guild of Australia (PGA) 
The PGA, established in 1928, originally considered the peak body for pharmacy, 
represents community pharmacy owners in Australia [114]. It is the principal 
negotiator of the CPAs, which shapes much of the financial income of the community 
pharmacies themselves, through the PBS, and related Community Pharmacy Programs 
(CPP) [33]. Managed by the PGA, is the Rural Pharmacy Support Program, which 
supports pharmacies and those practitioners in rural practice. 
The PGA describes itself as: 
The Pharmacy Guild of Australia is a national employers’ organisation with over 80 
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years of experience in representing and promoting the value of the role of community 
pharmacy in the Australian health care system. Community pharmacies are a vital part 
of our national health system with the potential to make an even bigger contribution to 
the health of all Australians [115]. 
2.3.1.3 Society of Hospital Pharmacists’ of Australia (SHPA) 
SHPA was formed in 1941 in Victoria, is the professional body which maintains 
‘excellence in medicines management’ [116, 117], for those in, or have an interest in, 
hospital practice or other health care settings. Pharmacists in this organisation often 
provide input for the profession as an allied health profession, when the retail 
community cannot [73]. 
2.3.1.4 Other organisations 
Professional Pharmacists Australia (PPA) [118] represents pharmacists, and is a union 
focused on workplace conditions and career progression, for employed community 
pharmacists in Australia. Although a respondent to the Pharmacy Industry Award 
(2010), which covers both community pharmacist employers and employees, except 
those in hospitals or government, this organisation does not enjoy a wide pharmacist 
membership. 
2.3.2 Standards of practice and codes of conduct in Australia 
Overarching the professional practice of community pharmacy in Australia, whether it 
be in urban or rural areas, is legislation, the codes of ethics, competency standards and 
professional practice standards. The Australian Pharmacy Board also publishes codes, 
guidelines and policies to support practice. The schema in Table 2.2 below from the 
current PSA Code of Ethics (2017) [119], shows the order and linkage of the legal and 
guiding documents for the profession in Australia. 
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Table 2.2: Hierarchy of pharmacy practice guidance in Australia (PSA) 
A Legislation: Federal, State and Territory 
B 
Pharmacy Board of Australia: Registration standards, 
codes and guidelines 
C Code of ethics/codes of conduct 
D Competency standards 
E Professional practice/quality standards 
F Professional/practice guidelines 
Code of ethics for pharmacists, Pharmaceutical Society of Australia, 2017 [119] 
2.3.2.1 Codes of ethics and conduct 
Both PSA and SHPA have codes of ethics for the profession, valid in any form of practice 
or location. The original PSA Code of Conduct, stated that pharmacists should uphold 
the health and wellbeing of the community and ‘clients’ with confidentiality, display 
current competence, uphold the reputation of the profession and co-operate with other 
health professions to optimise health outcomes [120]. 
The PSA Code of Ethics, revised in 2017, encourages patient-centred care, as well as a 
community focus in ethical practice [119]. 
2.3.2.2 Competency standards for pharmacists in Australia 
Competency standards for entry-level pharmacists in Australia were developed initially 
by PSA in 2003 [58]. Although some previous versions existed, this particular version 
gained widespread acceptance within the profession, and was used as a blueprint for 
pharmacy practice and education. The eight domains of practice for a pharmacist were 
supported by multiple standards and performance criteria. Some of these criteria were 
compulsory, and some desirable. An updated version was published in 2010 [121] and 
reviewed in 2014 [122]. In 2017, the 2016 National Competency Standards Framework 
for Pharmacists in Australia [57], was released with now 6 domains of competency in 
practice, to set the new standards for all registered pharmacist practitioners. 
2.3.2.3 Professional practice standards and guidelines 
Version 5 of the PSA Pharmacy Professional Practice Standards was released in 2017 
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[62]. Described in this document, are the basic tasks that a pharmacist carries out 
within their professional scope and activities, and the associated levels of practitioner 
proficiency. Not all pharmacists would carry out all activities. Some, such as those in 
health promotion, are overarching, and others are more specific, such as cytotoxic 
medication dispensing. All pharmacy activities and professional services should adhere 
and practice to the levels described in these standards. 
Each professional pharmacy organisation has also produced guidelines for specific 
activities within the pharmacy, or those undertaken by the pharmacists, in or outside 
the pharmacy itself, whatever the location. 
Other countries have similar standards and policies to guide community pharmacy 
practice. In addition to the documents developed by the profession in Australia, many of 
the activities of community pharmacy practice itself are set by the components of the 
current CPAs. 
2.4 The Community Pharmacy Agreements 
CPAs in Australia, dictate the amounts that community pharmacy and pharmacists can 
be reimbursed, or paid, for various services both within and outside the pharmacy 
premises. Negotiated between the Commonwealth Government Departments of Health 
(the name dependent on that of the time) and the PGA, these agreements have guided 
the profession for nearly 30 years since 1990. Prior to the agreements, prices for 
dispensing, mark-up and pharmacy rebates for prescription medication were 
negotiated on an ad hoc basis, since the beginning of the PBS in 1948 [123]. The PBS 
was originally introduced to cover costs to the public, of life-saving and disease 
preventing drugs. The agreements have evolved and provide support for all community 
pharmacy practitioners, and some of these components have changed markedly over 
the years. 
2.4.1 1st, 2nd, and 3rd Community Pharmacy Agreements 
In Australia, the PGA and the Commonwealth Government have negotiated six five-year 
agreements to set dispensing fees and other pharmacy services. Over the years, various 
other parties have come to the table to assist in the negotiation of these agreements, but 
always the final pharmacy signatory, has been the PGA. 
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The initial agreement was signed in December 1990, between the Minister for the 
Department of Community Services and Health and the PGA [72]. It focused on 
dispensing fees, mark-up of medication and information for consumers to be made 
available regarding price, new pharmacy approval numbers, pharmacy closures and/or 
amalgamation packages. Support was introduced for pharmacies in rural areas. This 
took the form of an essential pharmacy allowance to ensure provision of, and access to, 
pharmaceutical services. It was given to the pharmacy when the distance to the nearest 
pharmacy was greater than 10km by road, and the pharmacy was open at least 20 hours 
per week. 
The Second Agreement, between the Minister for the Department of Human Services 
and Health and the PGA was signed in April, 1995 [71]. The Community Pharmacy 
Authority was established, to make recommendations on approvals and relocations, 
payment of Isolated and Remote Pharmacy Allowances, and payment of supplementary 
allowances for additional professional services. The Authority committee consisted of a 
chairperson, two members of the PGA, one member of PSA and an officer of the 
Department [71]. 
The Isolated Pharmacy Allowance (IPA) was paid to pharmacies, which were in ‘isolated 
and rural areas’ to provide a better access to the PBS. The criteria to determine these 
pharmacies was: 
5.4 Eligibility for the payment if the IPA will be that the shortest lawful access route 
from the applicant's pharmacy to the nearest other approved pharmacist, measured 
door to door, is equal to or greater than 10 kilometres [71]. 
The allowances paid were, if the ‘shortest lawful route’ rule qualified, and ranged from 
AUD$1,041 (25km to less than 40km); AUD$1,724 (not less than 40km and less than 
60km) to AUD$2,839 (not less than 60km, or an island not connected by road). 
Other dispensing and relocation components were similar to those in the first 
agreement. Additional ‘professional services’ in primary health care, also attracted a 
payment. 
The Third Agreement (3CPA) in 2000, again between the Minister of the Department of 
Health and Aged Care and the PGA, was the first to expand the community pharmacy 
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role. The principles were: 
a) providing consumers with reasonable equality of access to quality pharmacy 
services in their local community 
b) ensuring that consumers receive quality patient care and outcomes 
c) expanding community pharmacy’s professional roles 
d) providing a stable and predictable environment for community pharmacy 
e) extending the cooperative approach evident in the first two Agreements between 
the Guild and the Commonwealth 
f) maximising the value to the taxpayer by encouraging an effective and efficient 
community pharmacy network [67]. 
The objectives of the agreement specified increased access to provision of pharmacy 
services in rural and remote areas. The use of medication reviews and primary health 
services helped achieve a multidisciplinary approach to health and pharmacy services, 
to ensure a viable community pharmacy network. Again, PBS remuneration for 
prescriptions was the primary focus of the agreement. 
Funding allocations for rural pharmacies used the ARIA system, until the PhARIA 
system was introduced in 2000 [40]. Rural initiatives to the value of AUD$74m, over the 
five-year course of the agreement, were introduced, and paid to approved pharmacists 
and pharmacies. The workforce programs included encouragement of recruitment and 
retention of approved pharmacists. There were three additional allowances, the Rural 
Start-Up Allowance, Succession Allowance and the Pharmacy Maintenance Allowance, 
with the amount dependant on remoteness and script volume. The Rural Pharmacy 
Workforce Development Program (as it was known) included a number of initiatives: 
an emergency locum scheme, the rural and remote infrastructure scheme, scholarships 
for pharmacy students from rural and remote areas, academic positions at the 
University Departments of Rural Health, the continuing education scheme, and 
identification and recruitment of pharmacists from an Aboriginal or Torres Strait Island 
background 
According to the agreement, a review was to take place after the third year of the 
agreement. This review was never publicly released. 
In this agreement, the Pharmacy Development Program provided AUD$15m in research 
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funds, and a further AUD$114m was allocated to Medication Management Services 
(residential aged care services, domiciliary medication reviews, case discussions and 
care planning, and provision of pharmacy facilitators in Divisions of General Practice). 
The Quality Care Pharmacy Program (QCPP) for quality improvement started with this 
agreement. 
2.4.2 4th Community Pharmacy Agreement (4CPA) 
The 4CPA began in 2005 [69], with amendments in 2007 [124]. There was specific 
program funding for Medication Management Reviews (AUD$150m) and the Rural 
Pharmacy Allowance and Support Program (AUD$111m). 
Priorities agreed for the Rural Pharmacy Allowance were: 
a) rural pharmacy maintenance allowance 
b) new pharmacy start-up and support allowance 
c) succession planning and incentives: a, b, c in total AUD$25.3m 
d) rural pharmacist pre-registration incentive AUD$10.4m 
e) rural pharmacy workforce program AUD$25.3m [69]. 
Better Community Health allowances (AUD$192m) and the supplementary funding 
were used to build on the asthma and diabetes research from the previous agreement, 
in order to incorporate what was previous seen as additional pharmacy services, into 
‘mainstream care’. 
Also included were payments for dose administration aids (DAAs), activities related to 
prevention of communicable diseases, counselling for emergency contraception, 
medication profiling for patients, practice change and education incentive, research and 
development, and other projects ‘as decided’. Price disclosure was also introduced. 
The relocation and opening of new rural pharmacies had strict guidelines to ensure 
access to community pharmacies, for those living in rural and remote areas of Australia. 
2.4.3 5th Community Pharmacy Agreement (5CPA) 
The 5CPA in 2010 [68], reiterated the importance of community pharmacy in primary 
health care, and the need for accessible and viable pharmacies in rural and remote 
Australia. A total of AUD$15.4b was negotiated with the Commonwealth Government 
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for this agreement. 
The Program Reference Group providing advice to the Agreement Consultative 
Committee (ACC), which guided expenditure, had changed to incorporate two members 
from the ACC (one member representing the PGA, one as Chair representing the 
Department), one from each of PSA and SHPA, and three members having expertise in 
the following areas: practicing in rural pharmacy, health economics and program 
evaluation. There were an additional six members appointed by the minister including a 
consumer, a representative from Aboriginal and Torres Strait Island primary health 
care, and representatives from allied health and general practice. 
The professional programs (AUD$386,413m) included Medication Management 
Programs (Medicine Review and Diabetes Management), Rural Support, Aboriginal and 
Torres Strait Islander Programs, Pharmacy Incentive and Accreditation, Research and 
Development, and Medication Continuance. In this agreement, AUD$37m was allocated 
to the Rural Pharmacy Workforce Programs (as it was known), and AUD$70m to the 
Rural Pharmacy Maintenance Allowance. This was a decrease in allocation. 
2.4.4 6th Community Pharmacy Agreement (6CPA) 
The current agreement, the 6CPA [33], was signed in 2015 and valued at AUD$18.9b. 
The parties who signed the agreement, the Department of Health and the PGA, no longer 
listed rural and remote pharmacy as a specific ‘common interest’. The CPP (AUD$613m) 
was expanded in allocation. Two of the foci listed were Aboriginal and Torres Strait 
Islander peoples, and consumers living in rural and remote areas. Rural Support 
Programs were allocated AUD$6.9m, and AUD$14.3m for the Rural Pharmacy 
Maintenance Allowance, a decrease of AUD$85.8m (80%) from the previous agreement. 
There is no ongoing broad workforce group to provide input; rather this was negotiated 
at the time of the signing of the agreement, as part of the CPP section. 
The agreement suggests that: 
Both parties acknowledge that input and support in the design and implementation of 
Community Pharmacy Programmes is expected to utilise involvement from a range of 
stakeholders and bodies from the public, pharmacy, pharmaceutical and medical sectors 
[33]. 
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The agreements guide the funded activities of community pharmacy practice in 
Australia. All other activities within the pharmacies would be supported and funded by 
management, and ultimately by the owners of the business. These include services that 
may be free to customers, community and public health initiatives, or those provided on 
a cost recovery basis, or other services developed with the intent of profit. 
Various investigations carried out in the course of this thesis, have used data from the 
times of the 3CPA, 4CPA and 5CPA, to examine changes and activities unique to rural 
pharmacy. 
2.5 Rural pharmacy position statements, policy, reports and frameworks 
Policy and frameworks, specific to the rural pharmacy profession, have been developed 
by some of the professional organisations. Rural pharmacy support is part of the 
various CPAs and consists of a number of programs designed to support rural 
community pharmacies, undergraduates and the professional development needs of 
rural pharmacists [125, 126], as previously described. 
The latest PGA position statement, Access to Community Pharmacy Services in 
Rural/Remote Australia (2012) [125], stated all Australians should have equity and 
access to community pharmacy services, and cited a number of programs managed by 
them at the time. The PGA currently receives strategic advice from the Community 
Pharmacies for Rural and Indigenous Australia Advisory Group and Rural Pharmacists 
Australia on national rural issues [126]. 
PSA has a position statement on Improving Access to Pharmacy Services in Rural and 
Remote Areas (2009) [127] and mentions a number of areas for improvement such as 
alternative models of service provision, a business rule review, and funding to allow 
more rural and remote programs within Schools of Pharmacy. This has not been 
updated, but PSA supports rural pharmacists by using submissions, advocacy, and 
providing professional development opportunities [63]. The PSA Federal Budget 
Submission Senate Inquiry (2017–8) [63] promoted an amendment in funding 
arrangements, to allow rural pharmacists to participate in a minor ailments scheme, as 
well as primary and public health initiatives. PSA cited the Grattan Report (Access all 
areas: new solutions for GP shortages in rural Australia) [55] as suggesting rural 
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pharmacists could diagnose, treat and refer, especially after hours, services that would 
assist in medically underserved areas. PSA as an organisation, receives advice from its 
PSA Rural Special Interest Group, a rural pharmacist support and information network 
for members of the organisation. 
SHPA does not have a specific rural position statement or policy [128] but mentions 
rural and remote services, under the position statement for pharmacists working in 
interdisciplinary teams (2015) [129]. It has a rural practice arm providing additional 
services such as representation of some national committees (Rural Pharmacy 
Workforce Advisory Committee (now non-operational), and the Allied Health 
Professions Rural and Remote group. 
In 2014, the NRHA commissioned a discussion paper looking at access to medicines and 
pharmacy services for rural and remote Australia [130]. Data in the report was not 
available to clearly show the specific lack of services in rural and remote areas. 
However, issues to be explored further were: 
1. improving advice, information and review of medicines for people in more remote 
locations or marginalised situations: 
• professional medicines review, registered locations and pharmacy depots, non-
medical prescribing by pharmacists, supply of medicines to Aboriginal Health 
Services (AHSs) under Section 100 arrangements, transport, pharmacy 
technicians and Aboriginal Health Workers 
2. improving access of people in rural and remote areas to pharmacies and 
pharmacists (i.e. a workforce numbers issue): 
• enhancing opportunities for and reporting of young pharmacists to work in rural 
and remote areas, PhARIA and the ‘8 pharmacy rule’ (these rural pharmacies 
will always be classified as PhARIA 1 because of their proximity to other 
pharmacies) 
3. and data reporting issues: 
• dispensing and supply of medicines, information to quantify prescribing [130]. 
2.6 The Australian pharmacy workforce 
The rural pharmacy workforce is crucial to the survival of rural and remote community 
pharmacy. This section will describe changes to the pharmacy workforce in Australia 
over time, the differences, and the factors that might affect the future workforce of 
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pharmacy. 
2.6.1 The current workforce 
In March 2018, there were 30,984 pharmacists of whom 28,065 (90.6%) were general 
registered pharmacists with the balance having provisional, limited or non-practicing 
registration [106]. Nearly two-thirds (62.2%) of general registered pharmacists, were 
women (17,466 female: 10,599 male). 
The number of general registered pharmacists, and thus those being eligible to work 
independently, has increased slowly over the past 5 years. Using the second last and last 
columns representing the same time frame in Table 2.3 below, the numbers of general 
registered pharmacists have increased by 681 (2.4%, 27,384 to 28,065) between March 
2017 and March 2018. Assuming all provisionally registered pharmacists (excluding 
those on limited registration and non-practicing registration), proceed to full 
registration, in 2017, the number of pharmacists would be expected to be 
approximately 29,193. However, in March 2018, there were only 28,065 general 
registered pharmacists, a ‘loss’ of 1,128 pharmacists in one calendar year. Presumably, 
some have retired and/or left the profession, but this data shows that there is only a 
slight increase in registered pharmacy practitioners annually. 
Table 2.3: Registered pharmacists in Australia 2012–2018 
Registration type 
Dec 
2012 
1 Oct 
to 31 
Dec 
2013 
1 Oct 
to 31 
Dec 
2014 
1 Oct 
to 31 
Dec 
2015 
1 Oct 
to 31 
Dec 
2016 
1 Jan to 
31 Mar 
2017 
1 Jan to 
31 Mar 
2018 
Total registrants 26,434 27,560 28,883 29,751 30,368 30,287 30,984 
General registration 24,741 24,867 26,096 26,905 27,452 27,384 28,065 
Provisional registration 1,770 1,763 1,724 1,751 1,777 1,809 1,794 
Post graduate training 
or limited registration 
10 13 16 13 7 6 9 
Non-practicing 
registration 
904 917 1,047 1,082 1,132 1,088 1,116 
AHPRA annual general reports, statistics and newsletters [106, 131]. Not all data was available in exactly 
the same timeframe. 
Data from the AIHW, broke down the spread of pharmacists, but the latest available 
dataset was from 2014, and published in 2016 [2]. There were 28,751 registered 
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pharmacists in Australia with 85.1% (22,500) employed in a pharmacy field, excluding 
provisionally registered pharmacists [2]. Six in ten of those employed were women, and 
the average number of hours worked per week was 35.6. In major cities, the full-time 
equivalent employment rate for all pharmacists was 96.8%, in inner regional areas it 
was 73.6%, outer regional areas 77.3% and in remote/very remote areas down to 
57.7%. This data used the Australian Bureau of Statistics Census of Population, which 
used the ASGS system. About 90% of the 22,500 employed pharmacists (19,792: 88%) 
considered themselves as clinicians, with no data available to separate the setting into 
community, hospital or into ‘other’ practice. The remaining pharmacists in the report, 
identified themselves as an administrator, teacher or educator, independent consultant 
or ‘other’ (1972; 12%) [2]. This data was not divided into work location, such as that in 
a rural or urban community pharmacy. 
In 2012, more women than men worked in Major Cities, in Inner and Outer Regional 
areas, but this trend decreased the more remote the location as can be seen in Table 2.4 
below. Pharmacists in remote and Very Remote areas worked an average of 40.6 hours 
per week [132], approximately five hours per week more than their Major City 
counterparts. 
Table 2.4: Pharmacist work characteristics in geographical areas of Australia 2012 
Characteristic (ASGS) 
Major 
cities 
Inner 
regional 
Outer 
regional 
Remote/ 
very remote 
Total 
Number of pharmacists 76.1% 13.3% 7.1% 1.3% 100% (21,331) 
Average hours worked per week 35.7 35.9 37.3 40.6 35.9 
Number of women 59.9% 52.6% 53.8% 51.6% 58.2% 
Allied health workforce 2012, AIHW, 2013 [132] 
In 2014, pharmacists were still in short supply in very remote areas of Australia. The 
map below (Figure 2.3) [19], indicates in yellow, the areas where the consumer has a 
one-hour or less drive to the pharmacy. This figure used the GIRS model, together with 
2014 workforce data, population dispersion, land size and proximity to services. In this 
country, 0.79% of the population are more than 1 hour’s drive to a pharmacy in a 
remote area. Inland areas have fewer community pharmacies, and consequently less 
access to services. It should be noted that some of the remote area services use the 
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Section 100 pharmacy supply program. 
Figure 2.3: Map of pharmacist GIRS scores, by SA2, with drive time boundaries and mesh block 
populations added 
 
Spatial distribution of the supply of the clinical workforce: Relationship to the distribution of the 
Indigenous population, 2014, Figure 6.3 , AIHW,[19] 
The GIRS model is one of workforce supply, not service provision. As can be seen in 
Table 2.5 below, the pharmacy profession, although in short supply, was not as scant as 
midwives and optometrists in rural and remote Australia [19]. Overall, however, was 
still a lack of pharmacists and pharmacies in some areas of rural Australia, to provide an 
adequate service for its population. 
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Table 2.5: Spatial distribution of the supply of the allied health clinical workforce in Australia 
2014 
 
Spatial distribution of the supply of the clinical workforce: Relationship to the distribution of the 
Indigenous population, AIHW, 2014 [19] 
Moving forward to 2017, according to state-based employment departments [133], as 
shown in Table 2.6 below, there was still an identified lack of pharmacists, in some rural 
and regional areas of Australia. Regional areas with staff shortages were Tasmania, 
Queensland, South Australia and the Northern Territory. Other rural areas did not 
appear to have shortages. Victoria was the only state with an improvement from 2016, 
while in 2017 Tasmania now had difficulty recruiting regional pharmacists. As shown in 
the table, Victoria only filled 30% of regional positions but had no shortages, and South 
Australia filled 25%, and continued to have a regional shortage. 
Concerning was the number of applicants that were deemed unsuitable. In NSW, 79% of 
applicants fitted this category. The reasons given by the employers in any area were as 
follows: 
• not qualified as a pharmacist (AHPRA registration) 
• lack of experience in hospital or retail—hospital employers thought retail 
pharmacists were unsuitable to work in a hospital environment as they had non-
transferable skills 
• lack of soft and customer relations skills, poor interview, poor team fit 
• lack of willingness to work the hours required or work on a casual roster which 
included extended hours, evenings or weekends 
• newly registered and therefore seen as lacking experience 
• limited English skills from overseas trained pharmacists 
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Table 2.6: Hospital and retail pharmacist labour force vacancies in Australia June 2017 
State/ Territory 2016 2017 
Metropolitan: 
filled 
Regional: 
filled 
Australian Capital Territory 
(ACT) 
No shortage No shortage 71% overall  
New South Wales (NSW) No shortage 
Metropolitan 
shortage 
50% 88% 
Northern Territory (NT) Shortage Shortage 73% overall 
Queensland 
Regional 
shortage 
Regional 
shortage 
89% 57% 
South Australia 
Regional 
shortage 
Regional 
shortage 
100% 25% 
Tasmania No shortage 
Regional 
recruitment 
difficulty 
100% 
Regional areas 
unfilled 
Western Australia No shortage No shortage 57% 
Hospital/retail pharmacists occupational reports, Department of Small Jobs and Business, 2017 [133] 
It should also be noted that the vacancies did not differentiate between a highly skilled 
oncology pharmacist, in a hospital setting, or a community pharmacist generalist, in a 
regional or rural setting. Other data found about recruitment shortages, have been 
opinion pieces. This departmental data in Table 2.6 was an analysis of job 
advertisements, and so may not represent the true shortages. This also does not give an 
indication of shortages commensurate with the PhARIA or other classification system 
areas. 
Currently, pharmacist data in Australia is gathered by annual surveys filled on 
registration by pharmacists. Previously, the research arm of the CPAs conducted 
research into the community pharmacy workforce. Most data found was two or more 
years old when available, and detailed data was limited for those practicing in rural 
areas. In addition, systems other than PhARIA were used for workforce analysis thus 
making a realistic comparison difficult. 
2.6.2 The rural pharmacy workforce, practitioner characteristics and 
possibilities 
Many papers have been written about the characteristics of rural practitioners and 
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personal experiences by the rural pharmacists themselves. In 1993, Mahony [80] 
suggested that rural pharmacists have extensive community involvement and often act 
as a coordinator of other allied health services. Their catchment area is over a wide 
geographical area. The ‘other’ activities listed in this publication, are those any 
community pharmacist would undertake in the course of everyday business. Later in 
1997, he suggested that: 
Rural Australia is the best place to be a pharmacist...We are used to working together. 
We are used to being multi-skilled and we are used to adapting things to make them 
work [134]. 
Various countries have an expanded role for rural pharmacists, compared to that in 
Australia, allowing them to practice in such a way that is supported by both other health 
professionals and the public [135]. 
In 2007, in Australia, interviews [136] were used to investigate, the personal and 
professional factors affecting pharmacist’s commitment to staying in rural and remote 
areas to practice. An ability to solve problems and feeling valued were key positive 
factors, but barriers included lack of peer support, inability to attend professional 
development and inadequate social and cultural facilities. Also in NSW, the factors 
impacting on recruitment and retention in pharmacy were investigated (2006) [137]. 
Previous experience or preference were factors in recruitment, and professional 
satisfaction and rapport in retention. A negative perception of rural practice by 
undergraduate students was noted. However, respondents emphasised many different 
aspects making an overall conclusion difficult [137]. The authors concluded that more 
research was required. 
Rural practitioners may have specific characteristics that entice them to this style of 
practice. Following on from their work with undergraduate medical students, Eley et al. 
(2008) [138] found the following characteristics for those who wanted to work in rural 
practice: 
novelty seeking, harm avoidance, reward dependence, persistence, self-directedness, 
cooperativeness, and self-transcendence [138] 
Rural background and a preference for smaller communities, were associated with 
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successful recruitment and retention, in the USA. Student loan relief and the availability 
of training programs encourage recruitment, but ‘financial incentives, professional 
opportunities and desirability’ were required for retention of health professionals  
[139]. Daniels et al. (2007) surveyed students from the south west of the USA about 
their proposed initial practice location, as well as possible retention factors. Spousal 
needs were not a recruitment incentive here. Student loan relief financed by the state 
was an incentive to rural practice. New Mexico (USA) offered USD$12,000 per year as a 
scholarship while a student, for those who intend to practice in under serviced areas of 
the state. Sufficient work, ‘opportunity for professional experiences, income potential 
and the desire to serve community needs’, were the drivers for any practitioner but the 
last reason, ‘the desire to serve community needs’ was more important to rural 
practitioners. 
It has been shown that pharmacy students from a rural background were more likely to 
practice in rural areas (2009) [140], and completing a qualification in a rural area and a 
positive rural placement, were also significant factors in career choice. Much work has 
been done in this area for other professions, in particular medicine, to alleviate the 
shortage of doctors in rural areas. Monetary support and scholarships for students 
through the CPAs, has not translated into additional practitioners, as there are still gaps 
in the rural workforce. 
In the Northern Territory, the use of social networks for new health professionals and 
their families, were used as additional recruitment and retention strategies, for the 
dental workforce in 2007 [141]. It was found that those who stayed for more than 5 
years in a rural location, invested in housing, social and cultural activities. Conversely, if 
they were recruited with financial incentives, most appeared to stay no more than 5 
years. Recently, in 2018, financial incentives for pharmacists have been promoted for 
the same territory. Classifying ‘retail pharmacy’ as a ‘hard to fill’ job, with the high 
priority classification [142], scholarships of AUD$3,000 for individuals and up to 
AUD$7,000 for families, to assist with moving and living costs. A ‘local benefit’ of 
AUD$1,250 is available for a 2-year stay, and further payment is offered if the health 
professional stays for 5 years [143]. Only available for ASGC-RA 3 to 5 areas, this does 
include the capital city, Darwin. 
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In 1998, in South Africa [144] an expansion for the role of the pharmacist practicing in 
rural and under serviced areas was instigated, which included patient examination and 
assessment, resuscitation, airway and/or intubation, intravenous and intraosseous 
cannulation [135]. For some, this may be too extreme a practice. 
Reports such as the Grattan Report (Access all areas: new solutions for GP shortages in 
Rural Australia) (2013) [55] suggested expanded roles for pharmacists in rural and 
remote areas, to support the health workforce overall. Activities such as disease state 
management and immunisation, could assist doctors and others. Many of these 
suggested activities are currently taught in Schools of Pharmacy, so younger 
pharmacists have the skills but not the imprimatur. 
The Canadian Review of Pharmacy Services in 2016 [145], looked at the economic 
evidence of various services. It was not the focus, but the conclusions do refer to 
potential practice differences for rural pharmacy: 
In terms of the operating environment (where pharmacists practise in the community), 
the pharmacist who practises in rural and remote areas and in smaller independent 
stores may face different challenges than their counterparts who practise in chain stores 
where there is often greater support and capacity for pharmacists to practise to 
expanded scope [145]. 
In this report, rural practice was equated to a pharmacist who might work in a smaller 
independent pharmacy, presumably in an urban or rural setting, implying size, not 
location was the difference. This assertion will be revisited later in this thesis. 
Data using job advertisements described earlier in this chapter, may not represent the 
true shortage of pharmacists, if this exists. Recruitment and retention in rural areas has 
been studied, and extended practice in some rural areas was suggested. These are often 
promoted in opinion pieces. Is this the best way to ascertain the pharmacist roles and 
workforce shortages, particularly those in rural areas? Practitioner views will be sought 
as part of these investigations in this thesis, and will be discussed in subsequent 
chapters. 
2.6.3 Factors affecting the pharmacy health workforce of the future 
Part-time workers, the female workforce, employed pharmacists and generational 
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differences will affect the future pharmacy workforce. 
Using the latest available data, women make up an increasing proportion of pharmacists 
in the Australian workforce (61.7% generally registered pharmacists in 2017, compared 
to 56.5% in 2012) [131, 146]. As in England, women tend to be employed rather than 
own or manage a pharmacy business [2, 147], thus impacting on staff availability. 
In 2003, in Australia, 47% of female pharmacists worked part-time, compared to only 
21% of male pharmacists (part-time was defined as less than 35 hours per week) [148]. 
Ten years on, in 2012, 32.8% of pharmacists worked part-time. From the report it 
appears that 69.6% of these pharmacists were women (2,100 men; 4,800 women)  
[132]. Also, no later data has been found to confirm this is still the case, but the female 
part-time labour force is a substantial section of the overall pharmacy workforce [2]. 
There was no data as to the actual hours worked, which could have an impact on any 
statistical analyses. 
Generational differences will also affect the workforce of the future. The Generation X 
workers (born: 1965–1980) and Generation Y (born: 1981–2000) [149] are the current 
and upcoming workforce. These will be the pharmacists who will seek meaningful 
careers, with good mentors and supervisors. They will tend to stay in a job for two to 
four years. Career is important and, provided it comes with rewards, they will stay in 
the job, but not have one job for life. 
In contrast, the current generation of soon-to-retire workers, the Baby Boomers (born: 
1946–1964) have an independent philosophy of doing the work themselves, and 
consider those younger do not have a good work ethic. Baby Boomers are workaholics, 
Generation X want a balanced approach while Generation Y, the future, are ambitious, 
and show tenacity and enterprise [149]. They will balance work, life and community 
involvement, thus providing a generation of workers who might be prepared to practise 
outside the current guidelines, and expand the role of the pharmacist. However, some 
research indicates the generational differences may not be as strong as previously 
suggested [150]. 
Generational differences may affect the future rural pharmacy workforce, but 
expectations of long-term employment, and commitment to a single location, cannot 
now be relied upon, by both employer, and employee pharmacists. Part-time practice 
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for all might also be preferred, and this will affect availability, recruitment and retention 
of pharmacists in rural areas. 
Now and into the future, in Australia, if a community pharmacy is not viable or the 
travel time too great, there is a lack of employment pathways for community 
pharmacists. Existing models in hospital and medication reviews are funded, but 
potential models in community health centres or doctor’s surgeries, do not attract any 
ongoing government funding and so are at the discretion of the business themselves.  
Consequently, employment opportunities are limited for a rural pharmacy practitioner. 
2.7 Summary 
Competent ongoing rural community pharmacy practice is a cornerstone of the rural 
health landscape. The community pharmacy is a vital link in the health care 
requirements for many in rural and remote areas in Australia. Over time, the profession 
has been supported by specific funding allocations from the CPAs, which acknowledges 
the different aspects of rural community practice. However, this funding has decreased 
over time. 
There are a variety of organisations supporting pharmacy in Australia, and providing 
codes of ethics, guidelines and position statements for the profession. Supporting and 
maintaining a competent rural community pharmacy workforce is essential for this 
country. The current numbers of part-time and female pharmacists do affect the 
workforce, and it would be expected, that this in turn, could affect the rural workforce, 
where there are shortages, especially if permanent and locum staff are not readily 
available. Recruitment and retention of pharmacists in rural areas, is one area that has 
been explored, but continued research is required, given generational changes and work 
preferences in pharmacists, and the current change in ownership and pharmacy models 
especially if the community pharmacy is not viable. 
Patient satisfaction is key to keeping a community pharmacy viable. Various authors 
have researched patient satisfaction and proposed complex models to explain the facets 
of this process. Some surveys have been simplistic in approach, asking the customer ‘if 
they were satisfied’ without the ability to define the service in question. Fewer studies 
have investigated whether the patient thought the pharmacist was capable of providing 
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a particular service, and if indeed this service would then be used. 
The CPAs both support and limit the role of all pharmacy practice in Australia. In 
addition, the contribution of the rural pharmacy profession is still hampered by a lack of 
data and research. The focus remains on the pharmacist in the pharmacy itself, whether 
this be in urban or rural locations. Reports and papers [55, 151] suggest a wider role for 
pharmacists in rural areas, one supported by professional organisations such as PSA 
[63]. 
Pharmacists could be more than a just a provider of primary health services, medicines 
and medication information in the pharmacy. The next chapter will focus on a 
systematic literature review, examining examples found which have compared rural 
and urban community pharmacy practice in the Australian and international literature. 
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Chapter 3: Systematic literature review of comparisons in rural and 
urban community pharmacy practice 
This chapter will focus on a review of community pharmacy practice, and investigate 
examples from the literature, where rural and urban community pharmacy activities 
have been compared and contrasted. The review will provide some background and 
evidence for the further thesis investigations in the following chapters. Using the 
community pharmacy literature, a systematic review was conducted. 
3.1 Aims 
The aims of Chapter 3 were to: 
• find, using national and international examples, where current roles and features of 
rural and urban community pharmacy practice have been compared and contrasted 
• analyse the results for commonalities and differences across countries in rural 
community pharmacy practice 
3.2 Background 
The literature contains many articles about individual rural community pharmacy 
practice, or rural and urban combined studies, where practice differences were not the 
focus of the publication [79, 80, 152-158]. Also, there are suggestions of practice 
differences between rural and urban locations in the popular Australian pharmacy 
literature [159-164]. 
The Pharmacy Guild of Australia promotes this practice to their members: 
Working in rural and remote pharmacies across Australia offers unique opportunities which 
pharmacy professionals in urban areas may find hard to imagine [165]. 
Health differences exist between urban and rural populations, with those in rural areas 
experiencing more health issues and having less access to services. For instance, rural 
people in Australia are more likely to have diabetes, arthritis, cardiovascular disease, 
asthma and mental health problems, than their urban counterparts [6]. In 2014, death 
rates due to chronic disease were higher for rural people and they lived, on average 4 
years less [166]. 
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Inherent in living in rural and remote areas, is travel to and relatively limited access to 
doctors and other health services [166, 167] including pharmacies. In Australia, for 
example, a 2014 survey conducted by the PGA found that capital city residents typically 
live within 1km of a pharmacy, while for those outside capital cities, the average driving 
distance to a pharmacy was 6.5km [168], which is an overall figure, and would vary 
enormously. The previous survey, in 1998 [168], found similar results, but also found 
those in remote areas lived 57.9km away from a community pharmacy. In other 
research for those in remote Australia, 0.8% of the population was found to be more 
than one hour’s drive from a pharmacy [19] thus making access more difficult. 
Given the clear differences, in health status and pharmacy access, along with anecdotal 
reports of rural and urban pharmacy practice differences, a systematic review, of the 
international literature together with an additional supplementary review were 
conducted, to find studies that have compared community practice in the two settings. 
3.3 Methods 
3.3.1 Data source and search strategy 
The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 
guidelines for systematic reviews were followed. A comprehensive literature search 
was undertaken from the inception of each database using PubMed, Embase, 
Cumulative Index to Nursing and Allied Health Literature (CINAHL) and International 
Pharmaceutical Abstracts (IPA) up until 28 February 2018 using the terms ‘pharm*’ and 
‘rural’. This search required the terms to be in the title, abstract or as a keyword. A 
starting group of 3,830 publications was produced. The search approach taken is 
outlined in Table 3.1 below. A supplementary search was also completed using the same 
search terms to find studies up to 31 July 2018 and found an additional 228 papers. The 
approach for the supplementary review will be described later in the chapter. 
3.3.2 Study selection 
Duplicates and publications not in English were excluded. Publications were then 
screened by title and abstract, and those deemed irrelevant were excluded (e.g. related 
to pharmacognosy and traditional medicine, in vitro studies, history, opinion and news 
articles, editorials, conference abstracts without an accompanying paper, or about a 
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retail medicine outlet without a pharmacist). Also excluded were publications about 
rural hospital pharmacy, rural pharmacy only, or without an urban comparison, urban 
community pharmacy only, the dispensing processes, undergraduate and postgraduate 
education, interprofessional practice, pharmacy practice not in a community pharmacy 
(e.g. General Practice or a community health facility) or telepharmacy. The residual 
community pharmacy articles were reviewed and only those, which compared 
community pharmacy practice in differing geographical locations, were retained for a 
detailed review (15). 
An example of an excluded study, where both rural and urban pharmacies were used to 
test various professional service models was undertaken by Benrimoj et al. (2003) 
[158]. In this study, 54 pharmacists were recruited, trained and recorded clinical 
interventions. Although conducted across different geographical regions, no analysis 
was evident comparing rural and urban practice settings. 
Additional information was sourced from five Australian studies [40, 158, 169-171], for 
comparison using project reports, as the research publications did not contain the 
information required, but suggested it might be available in the final report document. 
All but one by Berbatis et al. (2003) [40], were rejected. The project by Peterson et al. 
[171], for which the original data was obtained directly from the author, had additional 
capacity for a comparison to be made, and will be analysed at in Chapter 7. Two 
additional papers were found after further reading, and the article by Muhleisen et al. 
[172] fitted the criteria and was included. 
The final 17 publications from these searches were evaluated by two reviewers (PhD 
supervisors) to confirm eligible inclusion. Any disagreements were resolved after 
discussion. Included were those publications and reports in which the 
intervention/survey compared rural/regional and urban/metropolitan community 
pharmacy practice. 
3.4 Results 
The resultant papers, published between 1993 and 2017, compared rural and urban 
community pharmacy practice and fitted the final criteria set. A summary table of the 
publications is provided in Table 3.5 at the end of this chapter. The majority were from 
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North America and Australia, followed by, Europe and Africa. The studies used a variety 
of designs, including interview, survey and observation of both current and potential 
future community pharmacy practice, as well as some customer perceptions. 
The results are depicted in the PRISMA flow chart is shown below in Table 3.1: 
Table 3.1: Search strategy with exclusion criteria and final inclusion criteria up to 28 February 
2018 
Flow chart for study selection: Search of whole data bases up to 28 February 2018 
PubMed Mesh (pharmac* AND rural) 1,080 
Embase (pharmacist*/exp OR pharmacist AND rural) 1,032 
CINAHL (pharmac* AND rural) 713 
IPA (pharmac* AND rural) 998 
Others: 5 reports: PAATH/HAPPy/Diabetes/Cardiovascular Project/National 
Pharmacy Database; 2 articles referred to in texts: Mulheisen, Bell 
7 
Total number of publications 3,830 
Initial exclusion criteria: Duplicates, the article not in English; not relevant 
Final exclusion criteria: Rural hospital pharmacy, rural pharmacy only, those using rural 
pharmacy only without an urban comparison, urban community pharmacy only, dispensing 
processes, undergraduate and postgraduate education, interprofessional practice, pharmacy 
practice not in a community pharmacy such as a General Practice or community health facility 
or telepharmacy. 
Final inclusion criteria: The article was required to be about current or future community 
pharmacy services, an academic or a project report, written in English, with some comparison 
of rural and urban community pharmacy practice about information gained or an intervention 
within the community pharmacy. 
Final number of relevant publications 17 
Across the publications, there were specific and varying definitions of ‘rural’, ranging 
from the number of people within a geographic area, to more complex systems which 
included the quantity and nature of other health services, within a particular 
geographical area, or that were relatively close by. The rural definitions used in the 
various publications from different countries are explained in Table 3.2 below. 
Nevertheless, as each author defined ‘rural’ for the studies as per their own country 
guidelines, this therefore was accepted, and the article examined. 
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Table 3.2: Rural area classifications in different countries 
Country Rural classification system  
Australia [24] 
Australian pharmacy uses the PhARIA system, which includes geographic 
remoteness based on ARIA (Accessibility/Remoteness Index of Australia) and a 
professional isolation component using road distance to the closest five 
pharmacies. Locations are ranked between 1 and 6, with 1 being the most 
populous and containing 83% of pharmacies. 
Also, classified as PhARIA 1 are those in a ‘buffer zone’ of 30km around major 
centres of a population of more than 250,000 and a 10km radius for those 
populations of more than 18,000; and the ‘8 pharmacy rule’ which means any 
centre in which there are more than 8 pharmacies. 
Canada [173] 
In Canada, rural areas are all those outside urban areas, including those on the 
fringe of census metropolitan areas and agglomerations. An urban area has a 
minimum of 1,000 people and a population density of at least 400 persons per 
square kilometre, based on the current census population count. 
South Africa 
For areas outside metropolitan there was no standard definition [174]. 
In 1996, there were urban, semi-urban and rural areas [175]. 
The province used for the Ward et al. study [176] was the Western Cape region, 
which has the most densely populated main areas (2001 data) and includes Cape 
Town. 
United States of 
America (USA) 
[177]  
The Census Bureau identifies two types of urban areas, urban areas of 50,000 
people or more, and urban clusters of at least 2,500 to 50,000 people. 
Rural areas are all other areas not included in the urban area. 
Ranelli and Coward [178] used the classification of urban as 130,000 people. 
Despite the usual definition of rural with a population of less than 2,500, the 
authors chose to use 4,000 people. 
Haag and Stratton [179] used Metropolitan and Micropolitan Statistical Areas in 
Minnesota based on the county population [180]. 
Other publications: No definition so the approved standard was assumed. 
United Kingdom 
(UK) 
The Rural Urban Classification (introduced in 2004) defines rural areas as those 
outside settlements with more than 10,000 people [181]. There are many 
different classifications within the rural areas such as small towns, villages and 
dispersed population [182]. 
In Scotland [183], in 2003-4, rural areas were specifically population defined as 
5: Accessible Rural (less than 3,000 people and within a 30-minute drive to a 
settlement of 10,000 people or more; and 6: Remote Rural, with settlements of 
less than 3,000 people but more than a 30-minute drive to a settlement of 10,000 
or more. Accessible Small Towns (Category 3) and Remote Small Towns 
(Category 4) had populations of between 3,000 and 10,000 and similar drivetime 
categories to the more rural settlements. 
New Zealand 
[184] 
Urban minimum population 30,000. Rural areas population 300–999  
Rural areas either have high, moderate or low urban influence, or are highly 
rural/remote areas (2001) 
The supplementary literature review contains a paper from New Zealand. 
Of the final 17 publications (Table 3.5), three articles used patients only as the 
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investigated cohort, while 14 used pharmacists and pharmacy assistants, and one used 
both, as discussed below in the results. Some only used a small number of pharmacies, 
pharmacists, pharmacy assistants and/or customers. The studies were diverse and 
were difficult to compare or use to make generalisations. Sample selection varied (e.g. 
purposive, random), as did the data collection methodology (e.g. written or telephone 
surveys, focus groups, telephone or face-to-face interviews). 
Of the 17 relating to pharmacist services, six were from the USA [178, 179, 185-188], 
five were from Australia [40, 172, 189-191], three from Canada [192-194] two from the 
UK (England and Scotland) [195, 196] and one from South Africa [176]. There were 
three studies in which customers were face-to-face or phone interviewed, one each 
from the USA [178], Canada [193] and the UK [196]. 
Topics ranged from the provision of pharmaceutical care [185, 186], pharmacist 
prescribing [194], public health services [188], or enhanced pharmacy services [40], 
current and proposed pharmacy services comparison [179, 196], services for opioid 
substitution [172, 189], provision of medication and support for those with Sexually 
Transmitted Diseases (STDs) [176], Human Immunodeficiency Virus (HIV) and 
Hepatitis B and C [195] or requiring contraception advice [192], ophthalmic 
chloramphenicol [191], asthma services [190], and providing support for those living 
with cancer [187]. Customers were surveyed as to their opinions on pharmacy practice, 
and use of the pharmacy services, in both rural and urban areas [178, 193, 196]. The 
outcomes of the 17 publications will be discussed in more detail. 
A series of small focus groups [193] undertaken by pharmacy students in Canada, found 
price consideration was a factor for those visiting an urban pharmacy, and rural 
customers were more likely to ask the pharmacist for personal advice (e.g. for 
contraception.) Conducted in 1993, this study was very small with only four focus 
groups and results were classed as topic–specific and inconsistent by the author. 
In 1996, a study in Florida (USA) surveyed or interviewed customers on the provision of 
pharmaceutical care and cognitive services [178]. It found customers were significantly 
more likely to speak to the rural pharmacist about health or non-related health topics. It 
was reported that, compared with urban pharmacists, rural pharmacists talked longer, 
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more often, and frequently initiated the conversation. This study used a population of 
4,000 people to define a rural cluster, instead of the USA–accepted 2,500 people. 
Customer interactions were analysed by Christensen and Hansen (1999) [186] as part 
of a larger project, in which payment was given for clinical services, in Washington 
(USA). Medical centre and rural pharmacies had higher intervention documentation 
rates. These same groups also had a good rapport with local patients and physicians. 
Sisson and Israel (1996) [185] used a survey to identify levels of pharmaceutical care 
given by a group of randomly selected Virginia (USA) community pharmacists. The 
authors noted that selection for this study was challenging as there is no overall 
pharmacist database, and more women replied to the survey, suggesting a cohort, which 
was not indicative of the state pharmacist population. They found 57.7% of rural 
pharmacists were more likely to deliver a higher level of pharmaceutical care. This care 
occurred more in independently owned pharmacies (71.4%) and by those who worked 
less hours per week. For this study, rural areas were defined as having a population 
base of less than 2,500 people. 
In England (UK), Rogers et al. (1998) [196] interviewed pharmacists and pharmacy 
assistants regarding their roles. More clinical advice was likely in areas with fewer 
doctors, and this was found to be unrelated to location, but those in rural areas 
provided more general health and over-the-counter medication advice. With no 
statistical analysis, this small study used the geographical term ‘place’ (a location that 
means different things to different people with various levels of attachment, belonging, 
and connection). In England, a rural area is one outside a population base of 10,000. 
Berbatis et al. (2003) [40] in their study of 1,131 Australian pharmacies, found no 
statistical difference in the provision of many professional services, including for 
hypertension and diabetes, but more rural and remote pharmacies offered extra 
services for Aboriginal people and in herbal medicines. For data about other 
professional pharmacy services, PhARIA 1 pharmacies (urban) and PhARIA 2–3 (rural) 
were grouped together thus preventing any conclusions in practice differences. The 
overall study was extensive, but this professional service area was chosen for analysis. 
There was a lack of multivariate analyses to isolate the independent effect of rural and 
urban locations. 
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In Georgia (USA), Spruill and Wade (2004) [187] surveyed pharmacists and found rural 
pharmacists were more interested in supporting patients living with some cancers. No 
other comparison was possible. In Scotland, in the largely rural Grampian area, there 
were no geographic differences in attitudes to the provision of information, products 
and support for customers about HIV, Hepatitis B and C [195]. 
Using a postal survey, Kritikos et al. (2005) [190] found that Australian regional 
pharmacists saw their role as wider, and included providing more counselling about 
asthma, than did the urban pharmacists. There was no difference in opinion regarding 
commercial gains for this service. 
In 2010, Haag and Stratton [179] found that rural Minnesotan pharmacists delivered 
more professional service using data from 2004. Minnesota (USA) is 53% rural. 
Although both urban and rural pharmacists spent approximately 70% of their time 
dispensing, similar that found by in Australia [40, 197], and later in New Zealand [198] 
(see supplementary review). Haag and Stratton found that rural pharmacies offered 
significantly more drug information (rural, 55.7%: urban, 45.6%), medical equipment 
services (rural, 43.4%: urban, 32.6%), dyslipidaemia management (rural, 7.8%: urban, 
3.8%), hypertension management (rural, 14.6%: urban, 7.3%), and medication 
therapeutic management (rural, 29.4%: urban, 18.7%) (Figure 3.1). Overall, rural 
pharmacies provided significantly more medication therapeutic management and point-
of-care testing. Geographic isolation and the suggestion rural pharmacists have more 
first line contact for care, were the reasons suggested for the higher level in services. 
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Figure 3.1: Comparison of Minnesota patient care services in rural and urban community 
pharmacy 2015 
 
Patient care in rural Minnesota community pharmacies, Haag and Stratton, 2010 [179]. Superscript 
references in this figure relate to the original article. 
 
In Iowa and North Dakota (USA), Scott et al. (2016) [188] looked at public health 
services provided by pharmacies. Of the total cohort of 602 pharmacists, 297 were 
identified as rural pharmacists. Rural pharmacists reported a higher frequency of 
service delivery in the areas of medication therapy management (MTM), immunisation 
services, tobacco counselling, and medication take-back programs (p<0.05). 
Independently owned rural pharmacies provided greater levels of pharmacy services, 
partnerships in the community and conducted community needs assessments (p<0.05) 
(Table 3.2). 
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Table 3.3: Comparison of urban and rural pharmacist public health services in Iowa and North 
Dakota USA 2015 
 
Assessment of pharmacist's delivery of public health services in rural and urban areas in Iowa and North 
Dakota, Scott et al., 2016 [188] 
However, rural pharmacists did report that lack of training was a barrier for 
professional services such as public health service provision. They were also less likely 
to provide laboratory and diagnostic testing; the reason suggested was due to low 
volume and equipment cost. 
Pharmacists in Alberta Canada, with prescribing rights, were surveyed about their 
current practice by Guirguis et al. (2017) [194]. One-quarter practiced in a rural setting. 
Overall, three-quarters practiced in community settings, either in a community chain or 
in independently owned pharmacy. Rural pharmacists prescribed more than urban 
pharmacists (p<0.05), but had similar prescribing patterns. Most prescribed for 
continuity of therapy, dose alteration, repeat prescriptions and substitution medication, 
but the authors stated that this could be explained by the practice setting; there are 
more independently owned pharmacies in rural areas. A multivariate analysis was not 
performed. Prescription renewal was the most common prescribing right practiced by 
all community pharmacists. Again, lack of access to training was the main barriers 
reported by rural pharmacists. 
Rural pharmacists (90%) were prepared to take on more clients in South Australia and 
provide opioid substitution, compared to urban pharmacists (48%) [189]. Rural 
pharmacies had a lower number of clients per pharmacy (4, rural: 6, urban) but the 
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study suggested they had a higher degree of cooperation and communication with the 
GP prescriber. Muhleisen et al. (1998) [172] found less disruptions, theft or payment-
related problems in rural pharmacy with methadone clients, presumably because 
clients had fewer local treatment options. 
Alkhatib et al. (2015) [191] found provision of over-the-counter ocular chloramphenicol 
in Western Australia was less frequent in rural pharmacies (1–2 times per week: 3–4 
times per week in urban pharmacies), a finding suggested as unexpected, by the authors 
despite extensive statistical analysis. 
In South Africa, Ward et al. (2003) [176] found female pharmacists were less likely to 
treat STDs compared to male pharmacists in this proposed practice model. There was 
no difference in willingness to diagnose, give sexual health advice or prescribe medicine 
if needed between rural and urban pharmacists. Prescribing for this service was not 
legal in South Africa at the time of the study. In Canada, Norman et al. [192] found that 
there was no difference between pharmacists in rural and urban areas willing to 
prescribe oral contraceptives, but shorter opening hours in rural areas, was considered 
a barrier. 
3.5 Supplementary search results 
The systematic literature review was re-run to capture any further articles from 1 
March 2018 to 31 July 2018. The search terms were the same except for those used for 
the IPA. Using the previous search terms did not provide any additional papers, 
however using ‘pharmacist AND rural’ provided two papers as shown in Table3.4 
below. The same definitions of ‘rural’ were assumed, and an explanation for the New 
Zealand classification has been added to Table 3.3. The same inclusion criteria were 
used, with each evaluated and checked by two reviewers (PhD supervisors). 
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Table 3.4: Search strategy with exclusion criteria and final inclusion criteria 1 March 2018–31 July 
2018 
Flow chart for study selection: Search of whole data bases to 1 March 2018–31 July 2018 
PubMed Mesh (pharmac* AND rural) 112 
Embase (pharmacist*/exp OR pharmacist AND rural) 72 
CINAHL (pharmac* AND rural) 42 
IPA (pharmacist AND rural) 2 
Total number of publications 228 
Others referred to in texts:  0 
Initial exclusion criteria: Duplicates, the article not in English; not relevant 
Final exclusion criteria: Rural hospital pharmacy, rural pharmacy only, those using rural 
pharmacy only without an urban comparison, urban community pharmacy only, dispensing 
processes, undergraduate and postgraduate education, interprofessional practice, pharmacy 
practice not in a community pharmacy such as a General Practice or community health facility 
or telepharmacy. 
Final inclusion criteria: The article was required to be about current or future community 
pharmacy services, an academic or a project report, written in English, with some comparison 
of rural and urban community pharmacy practice about information gained or an intervention 
within the community pharmacy. 
Final number of relevant publications 3 
Three papers were found that met the criteria for this supplementary systematic 
literature review. All were surveys, one each from the USA on proposed naloxone 
provision service [198], Canada on immunisation and the role of the pharmacist [199], 
and New Zealand which reviewed patient-centred care in community pharmacies [200]. 
Stewart et al. (2018) [198] surveyed 211 pharmacists, to test their knowledge, attitude 
and roles in naloxone provision before it was legal to do so in Michigan (USA). Although 
with a low response rate (8%), it appeared, rural practitioners were more likely to take 
responsibility for patients after dispensing the dose (p=0.01), compared to urban 
pharmacists. In this survey, 36% of the respondents were from a rural area, and 48% 
practiced in a community setting. However, it is not known exactly how many were 
rural community pharmacists. Other practice options listed were outpatient clinic, 
speciality-managed care pharmacy, health system, academia or ‘other’. 
In Ontario, Canada, Alsabbagh et al. (2018) [199], studied the pharmacist immuniser 
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cohort and found urban pharmacists were twice as likely to be certified to provide 
influenza immunisation (p=0.04). The authors suggested that more urban residents 
were vaccinated than rural consumers, and this may account for the findings. Another 
influencing factor on the results was that the rural pharmacies were more likely to be 
independently owned. 
In New Zealand, Smith et al. (2018) [200] investigated the patient-centred service 
provided by community pharmacies using a survey. With a response rate of 72% 
(690/958), there were no differences in services between rural and urban pharmacies. 
It was found that pharmacists spent 74% of their time on core services, 18.3% on Long 
Term Care (LTC) patients, and 7.7% on other services. There was no difference in 
barriers to services, but rural pharmacies reported a lack of uptake for some specific 
services by customers (p=0.03). While rurality was not a factor, those from a banner 
group provided significantly more services, than pharmacies which were not. It was 
suggested that more support might be needed, to assist rural pharmacies in service 
provision. 
3.6 Discussion 
In rural areas, healthcare and consequently community pharmacy practice has a unique 
set of challenges related to geographic location and availability of staff and services as 
discussed in previous chapters of this thesis. Inherent also in rural and remote locations 
for community pharmacy, are the challenges of stock availability, staff availability and 
options for referral of patients to medical and allied health services. Within the 
pharmacy, other challenges include the ability of staff to carry out not only dispensing 
and its associated activities, but also professional services such as pharmaceutical care, 
medication reviews, screening, support, primary health care and treatment services. 
This systematic review was conducted using data up to 28 February 2018, with a 
supplementary review conducted up to 31 July 2018. The aim was to find papers in 
which the activities of rural and urban community pharmacy practice, other than 
dispensing and its associated counselling, were compared. No starting date was used, 
and the oldest relevant study found was from 1993. There were substantial differences 
in the study types and size, which fitted the final inclusion criteria, that is, studies that in 
some way compared rural and urban community pharmacy practice. For most papers, 
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comparison was not the core purpose of the study. Numerous studies were excluded 
from the original search strategy because they were only conducted in a rural location, 
or the study data was combined for analysis, and the reporting format did not allow for 
comparisons. 
These studies were diverse in their subjects, age, numbers of participants and 
geographic locations. Some looked at proposed services, others current services. For 
some services, there was no statistical significance, while others did not conduct 
additional statistical tests such as logistical regression on data. 
It appeared that rural customers were more willing to talk about general health matters 
and ask advice from the pharmacist. The rural pharmacist initiated conversations and 
talked longer than in urban pharmacies [178, 186, 190, 193, 196], however two studies 
found no differences [192, 195] in the specific areas of contraception and assistance 
with HIV, Hepatitis B and C treatment options. A study regarding opioid substitution 
clients, found that those in rural areas significantly caused less disruptions (verbal, 
payment problems) in the pharmacy [172] but also these clients had less location 
treatment options. Rural pharmacists also had a better relationship with the 
pharmacotherapy prescribers. Pharmacists practicing in rural areas were also more 
likely to follow-up on clients administered naloxone, should the service be introduced 
[198]. There was only one study in which the gender of the pharmacist in a rural area 
affected a willingness to examine, diagnose and treat STDs [176]. Rural pharmacists in 
one Canadian province were less likely to be certified influenza immunisers than their 
urban counterparts [199]. 
Despite the same amount of time spent on dispensing, the levels of professional service 
provision were higher in rural areas [179, 188], but not in all cases [40, 200]. Many 
reasons were given in the papers as to why this could happen, including patient access 
to a pharmacy, socio-economic status of customers, or how busy the pharmacy was. It 
also acknowledged the survey by Haag and Stratton [179] did not obtain levels of 
service provision, just if it was provided or not, thus challenging the validity of the 
results. Scott et al. [188] also explained away any differences instead suggesting as 
there were more independent pharmacies in rural areas, and this attributed to the 
differences in practice. He also suggested that the reasons rural pharmacists deliver 
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more services was because they have more time, or there is a greater community need 
Guirguis et al. (2017) [194] found more prescribing in rural practice but also suggested 
the difference was due more independent rural pharmacies. Berbatis et al. (2003) [40] 
suggested only certain services were higher in remote areas of practice, but no data was 
available for rural/regional areas as this was combined for analysis in the report. 
Alsabbagh et al. (2018) [199] suggested that the urban population was more likely to 
have an influenza vaccine compared to the rural population, refuting the possible value 
of more certified immunisers in rural areas where the immunisation rate is usually less. 
Despite apparent increased levels of service provision, it was unfortunate some authors 
chose to explain the differences away. 
There was only one study [196] which compared rural and urban practice using the 
geographical concept of ‘place’, while the others focused on the activities conducted by 
pharmacists and pharmacy assistants, in the community pharmacy setting. 
In many discarded studies, rural pharmacies were usually included in larger projects in 
order to get a spread of participants, similar to the appropriate geographic spread of 
community pharmacy locations. However, comparison data was not evident in the 
papers or associated reports. Often there were limited numbers of participants and/or 
pharmacies in the research activity, providing only small numbers of participants in 
individual geographic areas, with no statistical analysis. Despite including rural and 
urban pharmacies, data was often pooled for overall analysis. 
Overall, there is very little data to differentiate the two areas of practice, with many 
publications found to be more than 10 years old. Each paper investigated different areas 
of pharmacy practice, except the earlier papers, which investigated the overarching 
concept of pharmaceutical care. It appeared the rural pharmacies were more interested 
and able to talk to their customers, but it could be argued that usually these pharmacies 
are smaller and quieter, thus allowing this interaction. It was also found there was more 
medication management (review of medication or prescribing), point-of-care service 
provision and public health programs in rural areas. Nevertheless, it appears the extent 
and nature of the differences between rural and urban community pharmacy practice 
has not been thoroughly investigated or defined. 
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3.7 Conclusion 
Only four studies set out to show differences between rural and urban community 
pharmacy practice. One [196], used the concept of ‘place’ and the second pharmacy 
used customer interviews [178]. Both were conducted in the 1990s. The third study 
identified increased service provision in rural areas of one state in the USA [179]. The 
final study [188], found more public health service provision in rural pharmacies in two 
states of the USA. 
The systematic reviews conducted found current comparative data was essentially a by-
product of the results of the intervention or investigation, into various forms of 
community pharmacy practice. Many other studies selected a range of geographic 
locations in which to investigate interventions, or assess pharmacist or patient 
knowledge and opinion, but pooled data in order to analyse the results. 
There was some evidence that rural pharmacists were seemingly more willing take on 
new roles, deliver a higher level of pharmaceutical care and public health services, take 
on more clients for opioid substitution, initiate conversations about health or non-
related health topics and talk longer to their customers. However, this conclusion is 
based on a small number of studies, often with a limited number of respondents, from a 
wide variety of contexts, and simplistic data analysis, without adequate control for 
potential confounding variables. Further high-quality research is required to ascertain 
and characterise any differences in community pharmacy practice between rural and 
urban settings. 
A poster and abstract prepared for the Pharmaceutical Society of Australia Conference 
(2018) can be found in Appendix 1, for the Systematic Literature Review up to 28 
February 2018. The Australian Journal of Pharmacy daily news feed picked up the 
poster [201] and promoted the results. The following chapter will build on this 
difference, or lack of, using a series of analyses of interviews with Australian key 
opinion leaders to ratify or challenge these findings.
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Table 3.5: Systematic review references summary up to 28 February 2018 
Author/ year/ 
country/ 
region 
 Study aim 
Number of 
pharmacy 
sites/customers 
Type of 
intervention 
/measurement 
Findings Comments 
Stratton et al. 
1993 [193] 
Canada, 
British 
Columbia (BC) 
To explore the 
attitudes of rural and 
urban consumers to 
community pharmacy. 
 
Customers 
2 rural groups, 5 
customers each 
2 urban group 5 and 
7 customers 
Focus group 
interviews by 
pharmacy 
students 
Customers were more 
comfortable speaking about 
health concerns in rural 
pharmacies on a topic such as 
contraception. Rural 
participants considered the 
pharmacists as health 
professionals but not part of 
the health care team, only 
there to fill the prescription 
provided. 
Findings were considered topic 
specific and inconsistent. Small 
numbers hamper the conclusions, 
but the authors acknowledge this. 
Ranelli and 
Coward 1996 
[178] 
USA, Florida 
To compare the 
opinions of adults 
from two 
communities about 
their pharmacy choice 
and pharmacist 
communication 
experiences. 
Urban: 200 patients  
Rural: 200 patients 
Total: 400 patients 
Used rural town of 
up to 4,000 people 
for survey, 
metropolitan city 
was 130,000 people. 
Exploratory 
randomly 
selected written 
survey; phone 
interviews 
No statistical differences in 
health between the rural and 
urban group. Elders live in 
more sparsely populated 
areas, more likely to purchase 
from an independent 
pharmacy, had lower incomes, 
less education but would 
speak to the pharmacist more, 
although not necessarily 
about medicines and health 
related topics. There were no 
residential differences in how 
often the respondents spoke 
about medicines or other 
health-related matters with a 
pharmacist. 
Geographic spread of pharmacies 
seen as source of critical health-
related information. In addition, 
communication with the 
pharmacist was positive but a large 
number never talk to their 
pharmacist from either location. 
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Author/ year/ 
country/ 
region 
 Study aim 
Number of 
pharmacy 
sites/customers 
Type of 
intervention 
/measurement 
Findings Comments 
Sisson and 
Israel 1996 
[185] 
USA, Virginia 
To compare the 
characteristics and 
components of 
pharmacists’ 
perception of 
pharmaceutical care. 
236 rural 
pharmacists 
168 urban; 256 
suburban 
pharmacists 
Written survey 
of Virginian 
Pharmacists 
Association. Only 
community 
pharmacists’ 
information was 
analysed. 
Response rate 
39% 
Rural pharmacists (57.7%) 
and independently owned 
pharmacies (71.4%) more 
likely to conduct a higher level 
of pharmaceutical care, and 
appeared to have good 
rapport with their patients 
and local doctors. 
Authors expressed concern for 
bias, as there was no overall 
pharmacist database for Virginia at 
the time. Respondent group had 
more females than the general 
pharmacy population. 
Rogers et al. 
1998 [196] 
UK, England 
To describe the 
nature and factors 
affecting advice given 
in community 
pharmacies. 
10 diverse 
pharmacies 
Rural population: 
less than 10,000 
people 
Random 
selection 
customers with 
follow-up phone 
interview. 
Pharmacists and 
pharmacy 
assistants 
interviewed 
about their roles. 
Pharmacists more likely to 
give advice if in ‘poorly 
doctored’ areas both urban 
and rural. Highest levels of 
over-the-counter medication 
(OTC) advice given in rural 
areas. 
Little general health and 
illness advice given by all 
pharmacies. 
Small qualitative study. Three 
diverse groups of pharmacies 
analysed, and it suggested that the 
relationships between staff and 
customers were better in rural 
pharmacies compared to inner city 
pharmacies. 
Muhleisen et 
al. 1998 [172] 
Australia, 
Victoria 
To describe the 
attitudes and 
experiences of 
pharmacists in the 
delivery of 
methadone services. 
All authorised 
community 
pharmacies who 
had methadone 
clients 
Written survey 
with 1–2 phone 
calls as follow-up 
Response rate 
77% 
Urban pharmacies were 
significantly more likely to 
experience disruptions such 
as verbal abuse, theft or 
payment related problems. 
Suggestion that rural clients 
have fewer treatment options. 
This small study was conducted in 
1995 but had a good response rate. 
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Author/ year/ 
country/ 
region 
 Study aim 
Number of 
pharmacy 
sites/customers 
Type of 
intervention 
/measurement 
Findings Comments 
Christensen 
and Hansen 
1999 [186] 
USA, Washing-
ton State 
To determine which 
barriers and 
incentives such as the 
influence of pharmacy 
setting, and 
demographics affect 
cognitive service 
provision in 
pharmacies. 
200 community 
pharmacies 
Self-recorded 
written survey 
and record of 
cognitive 
services for 
Medicaid 
pharmacies. 
Randomised 
groups: payment 
and non-
payment groups 
of pharmacies 
for cognitive 
services. 
Response rate 
73% study, 75% 
controls. 
Investigated location 
influencing pharmaceutical 
care given. Documentation 
was higher in rural areas. 
No data about pharmacy location 
and environment influencing 
advice given. Rural pharmacies and 
those in medical centres had higher 
documentation rates of 
interventions but this could be a 
factor of the time pressure, script 
volumes, Medicaid patients or if the 
pharmacist was the owner or 
manager. 
Watson et al. 
2003 [195] 
UK, Scotland 
To assess the activity, 
knowledge and 
attitudes of 
pharmacists for HIV 
and Hepatitis B/C 
prevention. 
22 rural pharmacies 
15 urban; 29 
suburban; 29 town 
Written cross-
sectional survey 
to all pharmacies 
in the largely 
rural Grampian 
area. 
Response rate 
77%. 
No differences between rural 
and urban pharmacies, 
negative responses such as 
lack of demand and 
knowledge in potential 
service provision.  
Area surveyed is mainly rural but 
time, lack of training and lack of 
privacy in pharmacy were barriers 
for rural pharmacies.  
Ward et al. 
2003 [176] 
South Africa, 
Western Cape 
To assess the role and 
potential future of 
community 
pharmacists in the 
treatment of STDs. 
30 rural 
pharmacies. 16 
(53.3%) had male 
head pharmacist 
Random 
selection of 
cross-section 
pharmacists in 
Western cape 
No differences in opinions 
between rural and urban 
pharmacists after multivariate 
analyses. Women pharmacists 
less likely to treat STDs. 
No legislation currently to allow 
this practice. 
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Author/ year/ 
country/ 
region 
 Study aim 
Number of 
pharmacy 
sites/customers 
Type of 
intervention 
/measurement 
Findings Comments 
55 urban 
pharmacies. 47 
(85.5%) had male 
head pharmacist 
region Phone 
survey followed 
by face-to-face 
interview. 
Response rate 
95% 
Berbatis et al. 
2003 [40] 
Australia 
To construct a 
database of Australian 
pharmacy service 
characteristics 
including 
comparisons by 
rurality (PhARIA). 
1,131 pharmacies 
(482 PhARIA 1, 649 
PhARIA2-6) 
Written survey 
Response rate 
81% 
Survey the extent of services 
provided by community 
pharmacies. 
Remote pharmacies (PhARIA 
4–6) offered more Aboriginal 
health services and herbal 
medicines. 
Lack of some statistical analysis did 
not allow for detailed comparison 
between rural and urban practice 
PhARIA 1–3 pharmacies were 
grouped for analysis despite 
pharmacies in PhARIA 2 and 3 
classed as rural. 
Spruill and 
Wade 2004 
[187] 
USA, Georgia 
To survey 
pharmacists’ 
knowledge of cancer 
awareness and 
prevention services. 
Rural pharmacists: 
121 male, 43 female 
(26.2%) 
Urban pharmacists: 
103 male, 69 female 
(40.1%) 
Total respondents 
489 
Written survey 
using University 
of Georgia data 
base (largest 
professional 
development 
provider) 
Response rate 
33% 
Preliminary survey indicated 
pharmacists were interested 
in learning more on how to 
support those with cancer. 
Rural pharmacists were 
marginally more interested in 
receiving knowledge and 
education for skin and breast 
cancer only. 
All settings analysed together so 
there is no significant real 
differentiation of rural and urban 
community pharmacy settings. 
Lawrinson et 
al. 2008 [189] 
Australia, 
South 
Australia 
To examine practices, 
experiences and 
attitudes in a sample 
of South Australian 
pharmacists involved 
with Opioid 
Substitution Therapy. 
9 pharmacies (18%) 
rural; (population 
greater than 5,000) 
10 pharmacies 
(20%) rural; 
Telephone 
recruitment, 
written survey, 
random sample, 
stratified by 
geographic 
location.  
Rural pharmacies were more 
willing to increase their 
number of opioid replacement 
clients but had less initially 
(current median number of 
clients 4 rural: 7 
metropolitan). 
Previous survey by Muhleisen et al. 
[172] showed problems more 
likely in urban areas. 
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Author/ year/ 
country/ 
region 
 Study aim 
Number of 
pharmacy 
sites/customers 
Type of 
intervention 
/measurement 
Findings Comments 
population less than 
5,000) 
31 pharmacies 
(62%) metropolitan, 
centre, inner and 
outer areas 
Response rate 
100% (Target 
50) 
Urban pharmacists more 
likely to want more 
cooperation between 
prescriber and pharmacist. 
No differences in problems 
with clients if different 
geographic locations. 
Haag and 
Stratton 2010 
[179] 
USA, 
Minnesota 
To compare 
medication 
management, point of 
care testing and 
disease management 
resources between 
rural and urban 
Minnesota community 
pharmacies. 
564 community 
pharmacies 
220 rural; 344 
urban 
Written survey Rural pharmacies provided 
significantly more medication 
therapeutic management and 
point-of-care testing. 
Survey conducted in 2006. 
Suggested reasons for higher rural 
involvement in services—
pharmacists more likely first 
contact, lower patient income, 
higher poverty and the community 
pharmacy being more accessible. 
Findings are in Minnesota only, 
which is 53% rural, compared to 
the national average of 21%. 
Kritikos et al. 
2010 [190] 
Australia, 
New South 
Wales 
To explore 
pharmacists’ roles 
and perceptions in the 
provision of asthma 
care. 
52 pharmacies 
(69%) urban 
pharmacists 
23 pharmacies 
(31%) rural 
pharmacists 
Convenience 
postal survey 
Response rate 
89% 
Regional pharmacists 
identified a wider role than 
urban pharmacists did. 
Regional pharmacists were 
more likely to see their role 
encompassing counselling 
about asthma control. No 
significant difference in 
perceived barriers or 
interprofessional contact 
between urban and regional 
pharmacists. 
Only used postcodes to identify 
rurality. Regional is undefined in 
the article. 
Urban pharmacists worked longer 
hours than regional pharmacists 
did. 
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Author/ year/ 
country/ 
region 
 Study aim 
Number of 
pharmacy 
sites/customers 
Type of 
intervention 
/measurement 
Findings Comments 
Alkhatib et al. 
2015 [191] 
Australia, 
Western 
Australia 
To evaluate factors 
influencing 
pharmacists’ supply 
of ocular 
chloramphenicol. 
25 pharmacies 
(21%) PhARIA 2–6 
rural 
94 pharmacies 
(79%) PhARIA 1 
metropolitan 
Total 119 
responders 
Written survey, 
random sample, 
urban and rural 
Response rate 
49.5% 
More chloramphenicol eye 
products appropriately 
supplied by urban 
pharmacists than rural (3–4 
times per week compared to 
1–2 times per week). 
It was expected more rural than 
urban pharmacies would provide 
chloramphenicol. 
Norman et al. 
2015 [192] 
Canada, BC 
To study the 
willingness of 
pharmacists to 
prescribe hormonal 
contraception. 
128 rural 
pharmacists; 15 
urban pharmacists, 
2 unknown 
Total 146/375 
responders. 
17 rural, 2 urban 
pharmacists 
interviewed 
Mixed methods: 
randomised 
written/electron
ic survey with 
follow-up, and 
optional 
interviews 
Response rate 
39.8% 
No differences between rural 
and urban pharmacists on 
willingness to prescribe 
independently oral 
contraception hormone 
therapy. 
Suggestion rural/small town 
pharmacies could stay open longer 
to allow this service. 
Scott et al. 
2016 [188] 
USA, Iowa and 
North Dakota 
To assess the delivery 
of pharmacist public 
health services in 
rural and urban areas. 
602 pharmacists: 
297 rural, 305 
urban pharmacists 
Survey of 
practice 
Rural pharmacists more likely 
to deliver medication therapy 
management, immunisation, 
tobacco counselling, and 
medication take-back 
programs. Independent rural 
pharmacist delivered more 
services, community 
partnerships, needs 
assessments. 
Rural pharmacists reported lack of 
was a training barrier for public 
health service provision. 
Less likely to provide lab and 
diagnostic testing due to low 
volume and equipment cost. 
Reasons suggested rural 
pharmacists deliver more services 
were that they have more time or 
greater community need. 
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Author/ year/ 
country/ 
region 
 Study aim 
Number of 
pharmacy 
sites/customers 
Type of 
intervention 
/measurement 
Findings Comments 
Guirguis et al. 
2017 [194] 
Canada, 
Alberta 
To characterise 
pharmacist 
prescribing in Alberta, 
Canada. 
350 pharmacists, 94 
in rural practice 
Survey Rural pharmacists prescribed 
more frequently, similar 
reasons to those in urban 
practice. Community 
pharmacists were more likely 
to renew prescriptions. 
Single province in Canada, one with 
the largest range of prescribing 
rights. 
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Table 3.6: Supplementary systematic review references summary 1 March 2018–31 July 2018 
Author/ year/ 
country/ 
region 
Study aim 
Number of 
pharmacy 
sites/customers 
Type of 
intervention 
/measurement 
Findings Comments 
Stewart et al. 
2018 [198] 
USA, Michigan 
To identify 
knowledge gaps 
and attitudes to 
naloxone 
provision. 
211 pharmacists 
36% rural, 59% 
urban. 
Survey Rural pharmacists more likely 
to provide follow-up care after 
provision of naloxone. 
Low response rate (8%). 
Smith et al. 
2018 [200] 
New Zealand 
To understand the 
profile and types 
of services 
provided by 
pharmacies in 
New Zealand. 
528 pharmacists Survey 
Response rate 
72% of pharmacist 
cohort (690/958). 
Assumed both provincial town 
and rural included as ‘rural’. 
No differences in provision of 
services, but rural pharmacies 
more likely to report 
consumer uptake as a barrier 
for some services. 
Banner pharmacies provide 
more services than 
independent pharmacies. 
More assistance may be required in 
rural areas. 
No evidence of the standard of 
services provided. 
Alsabbagh et 
al. 2018 [199] 
Canada, 
Ontario 
To describe 
pharmacist 
immunisers, their 
pharmacies and 
services. 
708 community 
pharmacists, 603 
certified 
immunisers 
71.9% urban, 
17.3% rural, 
10.8% missing 
Survey Urban pharmacists twice as 
likely to be certified as an 
immuniser than rural 
pharmacists (p=0.04). If the 
pharmacy was with a banner 
group, this was just as 
significant. 
Influenza vaccine provided free to 
pharmacies. 
Authors state that demand for 
vaccinations was higher in urban 
areas compared to rural areas. 
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Chapter 4: Analysis of pharmacy key opinion leader interviews, on 
rural pharmacy practice, the challenges, and the future of community 
pharmacy practice 
There is a scarcity of literature in which the components of rural and urban community 
pharmacy practice have been compared. Very few studies, as shown in Chapter 3, have 
been conducted where the aims were to compare practice and activities [178, 179, 188, 
196]. Some reported comparison data as a secondary outcome. Overall, the studies 
found were relatively small, considering the potential pharmacist and pharmacy 
cohorts—from 10 pharmacies [196] up to 708 participants conducted in only one 
province of Canada [199]. 
Key opinion leaders in any profession are more likely to be responsible, and have the 
vision and ability to shape the profession, now, and into the future. As a group, the 
combined views of opinion leaders in pharmacy have not been found, in any searching 
of the literature to date. Consequently, it would be valuable to gain an insight into the 
views of those who provide spoken, and written opinions on aspects of the pharmacy 
profession—in particular, their views relating to rural and urban community pharmacy 
practice differences. It was thought that these leaders would have a broad view of the 
profession and of the supposed barriers or enablers, even if they had not specifically 
practiced in rural areas. 
Given the aim of this research was to identify any differences in rural and urban 
pharmacy practice and answer the research questions posed in Chapter 1, opinion 
leaders in Australia were asked for their views using their wide-ranging knowledge and 
experience in the profession, in the areas of apparent practice differences, barriers, 
opportunities, challenges, changes and the future. A follow-up set of interviews was also 
conducted to see if any change in opinion had occurred over time. This data would add 
to the knowledge gained from the systematic literature review (Chapter 3) and guide 
further studies into the initial research questions. 
4.1 Aims of the study 
The aims of the study in Chapter 4 were to: 
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• elicit the views of Australian key opinion leaders on rural community pharmacy 
practice (and differences from urban-based practice) 
• compare and contrast these views between the initial interview series (2008–2010) 
and the follow-up interview series (2016) 
4.2 Method 
With ethics approval, from the Tasmanian Social Sciences Human Research Ethics 
Committee, opinion leaders were selected, approached, and interviewed using the 
process described below. The interview itself was transcribed and analysed, to allow for 
review and reflection on the transcriptions. These results will be discussed in the 
following section. 
4.2.1 Selection of interviewees 
A list of key opinion leaders was developed for the two-interview series using the 
following criteria—pharmacists who: 
• had published opinions and editorials in the academic pharmacy literature 
• were principal officeholders of professional pharmacy organisations 
• were employed in a variety of professional pharmacy organisations 
• were known opinion leaders and spokespeople in the rural community pharmacy 
domain 
This list was objectively reviewed with independent scholars, to select the final 13 
interviewees, who were deemed as representative of the various spheres of pharmacy 
practice and knowledge. Participants were approached by email, once ethical approval 
was received. Eleven subjects accepted the request. 
Ten key opinion leaders accepted the follow-up interview request using the same 
method of approach, to investigate and compare practice or changes that had occurred 
over time, since the first interview series. 
4.2.2 Method of conducting the key opinion leader interviews 
Semi-structured interviews of key opinion leaders were undertaken using interviewees 
from professional and student organisations, academia, medicine information 
organisations and research, as well as current practitioners who were rural pharmacy 
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owners or staff pharmacists. Many had multiple roles, both current and in the past, 
within various organisations, and in many voluntary professional areas. Some, not all, 
had expertise in rural practice, but it was considered that the participants would have a 
familiarity with this area, as part of their numerous and varied ongoing roles within the 
profession itself. 
The pharmacy profession key opinion leader codes, with examples of their expertise, at 
the time of each interview, are listed in the table below: 
Table 4.1: Pharmacist key opinion leader interview list: Interview series one and follow-up series 
Code 
Role at time of initial 
interview 
Role at time of follow-up 
interview 
PhARIA 
work 
base   
S1 
Key pharmacy opinion leader 
and academic, drug regulatory 
body representative, 
pharmacist 
Same role as listed for the 
initial interview 
1 
S2 
Past Chair AACP, accredited 
pharmacist, PSA committee 
and national representative, 
community pharmacist and 
rural pharmacy owner 
Clinical pharmacist, 
accredited pharmacist, rural 
pharmacy owner, educator, 
PSA national committee 
member on policy and the 
profession 
1, 5 
S3 
Rural opinion leader, rural 
community pharmacy 
manager, PSA rural 
spokesperson 
Rural opinion leader, rural 
community pharmacist locum, 
HMR, RMMR, QUM 
pharmacist, PHN pharmacist 
1, 
S4 
PGA representative, 
pharmacist  
ACP representative, 
pharmacist  
1 
S5 
NPS Facilitator, accredited 
pharmacist 
NPS MedicineWise Clinical 
Services Specialist (expanded 
role), accredited pharmacist, 
tutor School of Medicine for 
medical students 
1 
S6 
Past Chair NAPSA, pharmacy 
student 
Community pharmacy owner 
(PhARIA 1 but in a 
rural/regional location) 
1 
S7 
Community pharmacist and 
rural pharmacy owner 
Same role as listed for the 
initial interview 
1 
S8 
SHPA rural spokesperson, 
rural academic, rural hospital 
pharmacist 
Rural and pharmacy 
academic, rural hospital locum 
pharmacist, educator 
1 
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Code 
Role at time of initial 
interview 
Role at time of follow-up 
interview 
PhARIA 
work 
base   
S9 
Rural pharmacy group owner, 
pharmacist 
Unavailable. 
*Not interviewed for follow-
up series 
1 
S10 
Head of School, School of 
Pharmacy (not Tasmania), 
pharmacist 
Same role as listed for the 
initial interview 
1 
S11 
Past pharmacy owner, 
business lecturer, PSA branch 
director, pharmacist 
Same role as listed for the 
initial interview 
1 
Despite an initial request, there was no representation from the CPA funding body i.e. 
the Commonwealth Department of Health and Ageing (at the time), or the selected CEO 
of a pharmacy chain. After consultation with colleagues, some substitutions from similar 
fields of practice were made for the first round of suggested people, to ensure the same 
varied representation. For the second round of interviews pharmacist S9 had retired 
and was not contactable. 
Codes for each of the participants and the interview origin will be shown in the text as 
follows: 
• S1.1 is participant 1, using data from the first interview series 
• S1.2 is the same participant, using data from the follow-up series of interviews 
The interview question design was developed with supervisors, to illicit information 
from the interviewees about their knowledge, skills and factors affecting the profession 
overall, as well as what they considered to be the practice differences and issues, 
specific to rural and remote community pharmacy in Australia. Each question was 
considered generic, and could be answered by all participants. At the start of the 
interview, the current role and background for each interviewee was requested, to 
provide a demographic base for this study. The first series of interviews was conducted 
in late 2008 to early 2010. 
The following groups of topics were explored: 
• influences, challenges, changes and the future in pharmacy 
• pharmacist work model issues e.g. time spent in the dispensary, professional services, 
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health promotion and medication adherence 
• opinions of any differences in rural practice (versus urban practice) were actively 
sought at each step from each participant 
In the 2016 follow-up series, the questionnaire was again developed with supervisor 
input. Interviewees were again asked to describe their current role at the start of the 
interview. For this interview series, most questions focused on the influences, 
challenges, changes and the future of pharmacy. This enabled a comparison to be made 
to the first set of interviews. Opinions on rural pharmacy practice were included with 
each question asked. 
The following topics were explored: 
• influences, challenges, changes and the future in pharmacy 
• opinions of any differences in rural practice (versus urban practice), were actively 
sought at each step from the participants 
Interviewees were asked about changes over time, and given an example of their 
comments from the initial series when needed, as a prompt, if any differences in opinion 
between the two interviews emerged. If the opinions were essentially the same, it was 
acknowledged by the interviewer. 
With informed consent, the key opinion leaders were interviewed, using a semi-
structured interview process, with a single interviewer/PhD student (HH). The 
questions were open-ended and informal; in order to engage the participants, and 
encourage more detailed responses. 
Each semi-structured interview took approximately one hour to complete, with some 
longer. Interviews for the first round were face-to-face (5/11) and the rest by telephone 
if the participant was interstate (6/11). Most interviews were via telephone (8/10) for 
the second round. Subjects were encouraged to talk, and often some reflection on 
previous questions occurred, particularly at the end of the interview, so the opinions 
and answers were not necessarily in question sequence. 
Each participant was continually prompted to comment on possible differences or 
similarities in urban or metropolitan, versus rural or remote pharmacy practice. 
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4.2.3 Transcription methods 
Most of the interviews in the first round were transcribed by the interviewer and the 
remainder by a commercial transcription service. All were commercially transcribed for 
the follow-up interviews. The same service was used for each round of interviews. Each 
interview was checked by the interviewer/PhD student (HH) for accuracy, together 
with tonal emphasis and pitch variations, which were then annotated onto the written 
record. 
Participants were offered a copy of the transcript to confirm accuracy, but most were 
satisfied with notification of quotes or comments used in the final work. After the 
second round of interviews, participants were sent both transcripts for verification, 
with none being returned for corrections. 
4.2.4 Analysis methods 
The qualitative research approach, looking at the meaning and rationale behind the 
responses, can give information that may not be available in quantitative research 
methods [202]. This provides a new perspective to the attitudes and beliefs of the 
participants, and an in-depth understanding of their collective views. The discourse 
analysis approach was used in this investigation, in which identification and 
examination of the common thoughts and constant ideas of the participants, were 
grouped and regrouped. This method ensures consistency, and is used to confirm 
correct concepts and categories were identified, from the whole of the interview cohort. 
This method also diminishes the possible selection bias with incomplete data sets [187], 
and incomplete analyses [196], two of the traps in qualitative research analysis, that can 
occur when identification of themes, does not progress to a model, or to challenging or 
confirming existing understandings. 
The transcribed interviews were analysed by constant comparison using a combination 
of the NVivo© qualitative data analysis Software (QSR International Pty Ltd) thematic 
analysis program, and by using paper-based copies to allow visual comparison with 
highlighting of various sections and segments. 
As required by the qualitative analysis approach, continual reading, grouping and study 
of the transcripts, enabled the common themes to be identified and classified. The 
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classification sections were continually reviewed reflectively. Some additional 
regrouping of themes took place when all were classified, to finalise the resultant 
groupings. 
Although this interview cohort was small, it was considered representative of key 
opinion leaders in Australia. It was expected there would be divergent and inconsistent 
views, but triangulation using further studies, would allow the emerging themes to be 
further explored and corroborated. 
4.2.5 Ethics approval applications 
The two interview schedules and ethics applications were submitted and approved, by 
the Tasmania Social Sciences Human Research Ethics Committee (H0010055 and 
H0015844) (Appendix 9). Copies of the approved interview schedules are in Appendix 2 
and 3. The final ethics report approval confirmation email is in Appendix 9. 
Information sheets were provided, and acceptances were given to each, and completed 
consent forms received from the participants, prior to being interviewed. 
4.3 Results 
In the first interview series, the interviewee pharmacy practice experience, ranged from 
one still being an undergraduate, to 40 years as a qualified pharmacist. In the follow-up 
series, practice ranged from five to over 45 years’ experience. Many described the 
extensive and high-profile range of roles and positions they had held, during the course 
of their careers. Anonymity of this group was a concern during analysis, and all 
attempts were made to preserve this for the interviewees, during the interview, and 
subsequent data investigation. It was acknowledged by the interviewees, that because 
they were key opinion leaders in Australia, their identity might be deduced by a reader. 
All interviewees accepted this may occur, and proceeded with the interview. 
For the initial analysis, the interview content was then divided into clusters of question 
responses, and the following results were found. There was some overlap between 
questions, but consistency was found in opinion when the results were further grouped. 
These areas and themes were consistent in both sets of interviews, although some of the 
details were different. 
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Overall, these opinion leaders had a big-picture approach to the topics they raised, 
which will be shown to be distinctly different to the opinions of the ‘at-the-coal-face’ 
practicing pharmacists, interviewed after the PAART Healthy Hearts project [203] in 
2009, the analysis of which is described in the following chapter (Chapter 5). 
For each series of interviews, participants provided a variety of opinions, with each 
being passionate about the profession, but divergent in their view of the issues of most 
concern. Due to low numbers, there were a variety of opinions and only some saturation 
of themes. Each interviewee did have a particular focus, some visionary, and some more 
specific. The opinion leaders were chosen because of their high profile, so a visionary 
answer was expected, but the variety of answers was not. 
The following themes emerged from the interview material and will be discussed in 
more detail. 
4.3.1 Theme: Participation, teamwork and collaboration 
Pharmacy was considered as being on the outside of national health policy development 
and not included as a stakeholder, except in a limited capacity. Interviewees commented 
on the general lack of involvement and engagement with health policy, particularly at a 
developmental stage with all three levels of government—national, state and local. 
Pharmacists appeared to be locked into pharmacy premises and not seen outside the 
‘four walls’ of the community pharmacy itself. They suggested that pharmacists 
themselves should be proactive on many levels to change this: 
I think pharmacists should be more involved in policy areas, looking at how 
pharmaceuticals are used in practice, for example there are a number of significant 
bodies where pharmacy isn’t represented on them…We need to be involved 
professionally, be more involved in high-level policy committees… (S9.1) 
The participants implied that the politics within the profession prevented more 
participation in various spheres of health policy development, and this added to the lack 
of outside knowledge of the ability of the profession and how it could contribute in 
other domains. They thought that some pharmacy organisations have specific objectives 
aligned to their members’ requirements (such as the PGA), and did not act for all 
pharmacists, but still had a considerable influence and profile within the profession, and 
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thus portrayed a narrow view: 
...I think we sit on the perimeter…I mean the Guild are a particularly astute operation 
group, they define their area well, they stick with it and they produce good outcomes 
within their own area, but that is a very limited view of what pharmacy is. (S10.1) 
Participants voiced the view that other professions do not appreciate, or know what a 
pharmacist can ‘do’. Additional aspects of this same idea will be mentioned in other 
themes discussed in this chapter: 
But we have do a hell of a lot of work to be working with the other professional bodies, 
podiatry, optometry, the whole lot of them to explain what pharmacists do, what we are 
capable of, what abilities we have to work with the patients….what we could be doing as 
a team… (S3.1) 
This theme continued in the follow-up interviews. To change this view of the profession, 
however, the profession itself needs to change: 
I think that pharmacists for too long have kept themselves isolated from any other 
healthcare professionals, they’re seen as an adjunct to the whole healthcare cycle as 
opposed to part of the team and I think that lacks forethought… (S7.2) 
One participant commented: 
…it’s because pharmacy is seen in the pharmacy itself and we don’t play in the same 
sandpit that health professionals do. (S5.1) 
Locally, pharmacists have to be proactive and build professional relationships to 
improve patient outcomes: 
…I think many pharmacists have had the view well the doctors aren't asking me for my 
input so I'm not going to give input, as opposed to looking at it from the other point of 
view saying, I know I can help the patient by providing this information to the doctor, 
and the pharmacists are looking how can I build a relationship with the doctor to say, 
value my opinion—what I'm giving you is useful, it’s going to have an increased clinical 
outcome. Without putting the doctor offside but I think it’s definitely an opportunity that 
pharmacists they used to take and need to take regularly. (S7.2) 
Pharmacists can contribute to local health care teams but have to make the first step. 
The expanded role for pharmacists is often talked about, but the pharmacists 
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themselves have to promote and offer their services, payment or no payment. Results 
from the second round of interviews, suggested that the evidence indicated 
multidisciplinary teams are in the best interests of the patient. Better teamwork and 
collaboration with local health professionals, was considered as one way forward for 
the pharmacy profession. One respondent commented on the challenge in pharmacy 
was to become a team member itself, and not see itself as being in control: 
I think the challenges are that it has to remove itself from being an isolated profession 
that it sees itself to be in control of the healthcare of their customers… (S10.1) 
And also not to be defined by the CPAs and associated rebates and payments, however: 
…remuneration to the agreement largely shapes practice… (S4.2) 
Again, the isolation, and the view and excuses given by the profession itself: 
Pharmacists have been very insular and they think they're wonderful but not everybody 
thinks they're wonderful. It’s really, lack of communication and lack of integration with 
others. (S5.2) 
I’d like to see them more involved in the health teams. But it’s really hard to do that sort 
of thing—shared care type stuff, when you can’t get out of the shop, also traditionally; 
we haven’t been seen as part of the health team... (S8.1) 
Rural community practice was one area, in which participants thought that this 
teamwork does occur. Participants stated that rural practitioners usually had good 
collaboration with the local health teams and health team management, through their 
personal relationships with local health practitioners. The relationships with the local 
GPs were considered closer than for urban pharmacists—for some, but not for all. These 
relationships were crucial, and enabled and supported practice, especially in the area of 
professional services: 
Yeah, I think that am certainly there are great opportunities…for greater collaboration. 
But having said that—there seems to be, there’s always been good collaboration 
between health professionals in the rural areas that doesn’t occur in metropolitan areas 
now. (S9.1) 
Relationships between pharmacists and GPs are crucial to be able to deliver these 
professional services, irrespective whether they are financial and professionally viable 
or not. Now if you haven’t got a good relationship with your GP you’ll have you know, a 
 Chapter 4: Analysis of pharmacy key opinion leader interviews, on rural pharmacy practice, the 
challenges and future of community pharmacy practice      90 
great difficulty in getting referrals, and even if you do get referrals convincing the GP of 
your suggestions and their appropriateness and in implementing those 
recommendations. So without a good relationship—the whole service is fraught with 
difficulties. (S2.1) 
However, the implied collaboration that was talked about, was restricted to the areas 
related to medicine supply: professional requirements of the pharmacy, prescriptions 
and referrals and was often one–way. 
In the follow-up interviews, this thinking was still evident, that rural pharmacists could 
do more: 
Sure, there is a lot more cooperation but I think you know rural areas and you know 
small towns would be the best place for a pharmacy practice to develop within a 
coordinated team care arrangement. I see rural pharmacy if they have the ability, and 
the staff and the resources, they could actually do a lot more community-wise in 
collaboration with their other primary healthcare colleagues. (S5.2) 
However, some pharmacists should stop looking inwards and be part of the local 
community: 
So, I think pharmacists have to stop always looking inward to their own business. They 
need to join community groups so they can actually get a much better view what the 
community needs. (S10.2) 
There should be expanded roles for pharmacy in local health care teams, but the skills of 
pharmacy needed to be included, and not just used as someone to tidy up and fill a drug 
cupboard. Outside knowledge of the capability of the pharmacist is still needed, and the 
pharmacy profession needs to be visible and vocal, in and out the pharmacy. If not, 
other professions, such as nursing, were identified as taking over the pharmacist roles: 
I think one of the biggest influences, and I’m probably a lone wolf in crying this one is 
the nursing profession has seen the golden glow of money and what they can be doing, 
and where they could go as clinical nurse consultants and all the other names they call 
themselves these days. (S3.1) 
4.3.2 Theme: Public perception, customer loyalty and societal influences 
The following three areas emerged as themes related to the public and pharmacy 
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customers: public perception, customer loyalty, and societal influences. 
Public perception 
The consumer was seen as the most powerful influence on pharmacy practice. Coupled 
with the actual day-to-day activities of the pharmacist, the opinion leaders questioned if 
pharmacists were actually practicing as they say they do, and how and if, the profession 
complies with professional standards and guidelines. Consumers expected rapid 
dispensing times, and this may be the imperative of the individual pharmacy, without 
allowing the time or be given, any accompanying counselling and professional service 
input, by the pharmacist: 
...if the consumer goes in, and they don’t get what would we say we get then the whole 
profession loses credibility. (S4.1) 
…our biggest problem is drugs because they all think that we can give out a box of 
medicines…I think that the most important value of pharmacists is not the medicines 
but the advice that goes with it… (S11.2) 
…but if you actually ask pharmacists what they do to improve medication compliance in 
practice they really don’t do a lot—however, what they should do is a lot… (S9.1) 
…they know they’re supposed to do things but they don’t do with routinely…pharmacy 
is too opportunistic. It’s both a strength and a weakness, the consumers love it they can 
just walk in any time, but it is its greatest weakness because opportunistic is not 
systematic. (S4.1) 
It was also suggested in the follow-up interviews that the public do not know what to 
expect, or should expect, from their pharmacy and pharmacist: 
So, if you go into your pharmacy and Joe Blow who’s the pharmacist and has a chat to 
you about the footy and asks you how your wife is and those types of things, you'd think 
Joe Blow’s a good bloke, and you'd rate him highly on any satisfaction scores. But if you 
know that Joe Blow the pharmacist should be doing these types of activities to improve 
your healthcare, then you might start to say hang on there's bit of a gap here between 
what I'm getting, and what I should be getting, so I don't think a lot of patients or 
consumers know what the reference point should be for community pharmacies. (S2.2) 
The interviewees in follow-up interviews said that the consumers have now been 
offered a price-focused model and so some standards of care and service cannot 
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compete. Discount pharmacy is now very much the norm, compared to when the first 
series of interviews was conducted. Several interviewees said pharmacy is complacent 
and doing things the way it has always done, instead of taking the opportunities to 
change practice: 
Discount Pharmacy stuff has been to me, it’s really devaluing the professionalism and 
people see, you know, pharmacy more as a discount shop you know, to me the 
professional component of certainly community pharmacy has diminished, so I see that 
as being quite sad really. (S8.2) 
However, another key opinion leader observed the discount pharmacies served an 
additional purpose, in halting the potential threat of supermarket pharmacy in 
Australia. 
Customer loyalty 
In rural practice, customers were seen to be more loyal and appreciative of the services; 
although it was pointed out that, there might not be competition close by, to challenge 
this assertion. Consumers tended to visit the same pharmacies over a lifetime, and the 
next generation then continued the tradition. They were often personally known to the 
pharmacist and pharmacy staff. In rural pharmacy: 
…customers are very loyal in rural pharmacy… (S8.1) 
…rural customers were um, more relaxed, more happy to wait a lot more appreciative of 
a lot of the services that were provided… (S6.1) 
So we have our customers with us in a lot of cases for life, and going into the next 
generation as well, so I think the pharmacy respect is very strong in rural environments. 
(S9.1) 
It was acknowledged, that still services in rural areas must be competitive and realistic, 
even if there was no nearby competition. Not all towns could support a community 
pharmacy, or one that provided pharmacy professional services. There were differing 
models of community practice such as the discount model, now in rural areas, and thus 
now providing an alternative form of community pharmacy practice for consumers. 
One particular rural example raised, was that the local hospital, as a customer, was 
usually supplied with medications centrally. However, it would call on the local 
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pharmacist if a crisis occurred, either for stock or information. It was suggested that 
local suppliers should be used for all stock, and thus local health services in turn would 
support the local community pharmacy: 
Why would you isolate a community pharmacist in a rural setting, from the supply of the 
hospital, except he’s asked to go up there at midnight, if something, if the person’s 
medicine (has) not been delivered? (S1.1) 
In the second round, consumer loyalty was still a positive issue in rural areas but the 
wider introduction of the discount models of pharmacy, was thought to have now 
changed this allegiance somewhat. 
Societal influences 
Society itself might lead the future change in pharmacy, to one of more professional 
services and advice, in all practices. It was suggested that price ultimately drives 
consumers, and the two models of pharmacy (discount and service) could co-exist as 
described below using a Primary Health Care Model, developed by this practitioner: 
…the Primary Health Care Model actually will focus on patient care diagnosis, 
information and health solution, with or without the product and you will find the 
consumers actually need both and they quite often visit both type of pharmacy. When 
they want to buy things, they will go to My Chemist, because it is cheaper and so on, if 
they have a cold or whatever, they will go to a pharmacy where they know that they are 
going to get that advice and professional input. (S11.1) 
In the follow-up interview, the participant was asked if this model was still applicable: 
Absolutely, because pharmacy is actually in the front line of primary care and primary 
care has a major impact in just about every single step in the health system. (S11.2) 
This interviewee then commented that a number people who have GP consultations for 
problems, could have been seen by a pharmacist, thus preventing a waste of valuable 
health resources. 
Discounted medication and lack of consumer service was also mentioned in the follow-
up interviews. Price was still a major factor influencing customers, even in rural areas, 
over and above the model of practice, as described by this rural pharmacist: 
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I think the major influence is, in any pharmacy, whether rural or metropolitan or 
whatever, is price… (S7.1) 
…so it’s to find the balance between being a discount pharmacy and the whole 
warehousey type thing and being a traditional pharmacy with good prices… (S7.1) 
4.3.3 Theme: Controlling organisations and governance of pharmacy in 
Australia 
Pharmacy organisations, and the accompanying funding/payment models and 
regulations, together with the pharmacist categories, which the profession has created 
for itself, influences its practice. This regulation of pharmacy practice externally, also 
influences how the profession acts—what it can do within the political, and within its 
own environment. Professional politics at various levels affect practice, and how the 
profession is perceived as a whole, from both interview series: 
...the regulation of pharmacy, how its—competition policy. (S4.1 and S4.2) 
…it’s the politics at national, national and state level…that is the big barrier rather than a 
micro, micro level. (S5.1) 
Comments on the pharmacy organisations, representing pharmacists in different 
spheres of practice, were hard to draw from the participants, as these were well-known 
opinion leaders in the profession in Australia, and they did not want some of the 
comments linked to them personally. On the other hand, some were more vocal with 
their opinions, encouraging organisations to work together: 
I do think…the Guild and the Society need to work together… (S4.1) 
This sentiment was still evident in the follow-up interviews. 
The PGA represents ‘pharmacy’ in the CPAs, but its full members are pharmacy owners, 
and it is perceived as a very strong organisation. All other member pharmacists are 
associate non-voting members. One suggested that, as a sole signatory to the CPAs, the 
components of the agreements might be what is good for the PGA, but not necessarily 
good for the profession. One interviewee said: 
Yeah, the Pharmacy Guild is regarded as an organisation that really wants to control the 
pharmacy profession but there’s a problem there in…they represent an increasingly 
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small number of pharmacists… (S5.1) 
The funding arrangements with the Commonwealth Government for the PBS under the 
CPAs, are regarded as the commercial mainstay for community pharmacy practice in 
Australia. The majority of the funding is for drug supply and dispensing, and other 
professional programs were considered secondary. Dispensing fees were considered to 
be the centre of each CPA, as they usually provide the income necessary to make 
community pharmacies viable. In the first series of interviews, some argued that 
dispensing supply could be seen as a professional service, but current pharmacy 
nomenclature in Australia, perpetuates the terminology assuming dispensing is the act 
of labelling, counselling and handing out of medication, and that professional services 
are different. This debate of various aspects of health care in pharmacy, supply or 
service, usually takes place within the profession itself and without any resolution to 
date: 
…what’s this profession has got to ask itself is whether it wants to be in the supply game 
alone or whether it wants to be in the service game. (S1.1) 
…the influence of drug supply—people involved in drug supply over professional 
services. (S5.1) 
Reimbursement by the CPA payment for professional programs, when the initial set of 
interviews were conducted in 2008–2010, was in its infancy and relatively poorly 
rebated compared to those in the current 5CPA and 6CPA. These programs still would 
not support a pharmacy business to be financially viable, without the accompanying 
dispensing revenue: 
…the funding arrangement—the PBS, the Guild Government Agreement and so on, 
because at the end of the day, no matter what your ideology is, whatever, what your 
approach, you still have to make it work for you as a worker, as a health professional 
and funding arrangement is the basic reason for that. (S11.1) 
Since the first series of interviews, funding for professional services in pharmacies was 
still through the CPAs. Some programs, such as HMRs, had been capped to 20 per 
month, while others for diabetes (DMAS) and asthma were no longer funded. In the 
5CPA and 6CPA, some programs were funded by a finite monetary pool, so 
reimbursement depended on the number of claims. Payments for MedsChecks and 
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Clinical Interventions were, and are made to the pharmacy in this manner. 
The CPA still shapes community pharmacy. However, with decreased income from 
drugs, and restrictions to increases in dispensing fees, pharmacies have to look now and 
into the future, to other avenues to maintain business viability: 
Agreements do shape where we go and what we can do…. (S4.1)  
It is a matter of time, I don’t know whether it is going to be five years or ten years or fifty 
years, but I think the government movement and the Guild Agreement will sooner or 
later stop, the ownership restrictions are likely to be eased or removed… (S11.1) 
Lack of pharmacy leadership, was again mentioned by most, as well as that the 
profession was holding itself back, and not reaching its potential: 
People aren't seeing the positive, although we’re creating half the problem, I think we’re 
actually holding ourselves back. We need leadership in the profession to say OK, you 
know we need to unite behind this and say look this is the direction we should take. 
(S6.2) 
These organisations do control the profession despite that: 
There are a lot more pharmacists out there than there are pharmacies. (S3.2) 
4.3.4 Theme: Ownership of pharmacies 
Pharmacy ownership is currently restricted to registered pharmacists, with a few 
exceptions. The community pharmacy owners are thus a strong influence on any 
practice change: 
…I do not think the ownership model hinders it, the owners hinder it. So, the people 
we’ve got in ownership hinder what we’re actually doing so whether it’s the mindset, 
whether it’s how they’re going about things, whether it’s how they’re thinking, about 
how the profession should work, how their pharmacy should work. (S2.1) 
In the first series of interviews, it was suggested that profitability of the pharmacy was 
not assured in the current climate, compared to a decade previously, and some 
pharmacies had gone into receivership. In the follow-up interviews, the issues of price 
disclosure on prescription medicine, the cost or buying and owning a pharmacy and its 
competition, especially from the discount pharmacies, had impacted the stability of the 
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business as a whole. But one suggested: 
The ownership status doesn't determine what the level of service might be. (S1.2) 
It was also thought the funding models of community pharmacy agreements would 
change or disappear in time, and pharmacy ownership restrictions would cease, leading 
to open ownership. One owner opinion leader thought that this would be detrimental to 
the pharmacy profession, but others did not concur with this opinion. From the first 
series (2008–2010): 
…open ownership, we are one of the last bastions of closed pharmacy ownership 
worldwide, so that will have to change. I think at the present we are safe, I would 
realistically say for three to five years… (S7.1) 
In the follow-up interviews, in 2016, interviewees then thought ownership would still 
stay with the profession. The King Review (Review of Pharmacy Remuneration and 
Regulation) [204], has investigated this issue as part of its report. It was noted, 
however, by participants, that there are currently many corporate groups of pharmacies 
with multiple owners, representing the majority of the pharmacies. This different 
emerging ownership model, compared to the much older model of single owner 
pharmacies was discussed in Chapter 2. 
4.3.5 Theme: The pharmacist role 
Management training, professional services and other specialist services are now 
necessities of current practice. However, a reluctance to change practice and roles, still 
affects staff numbers (pharmacists, technicians and assistants), service and reliability in 
all areas of pharmacy. Some pharmacists were hesitant to leave the dispensary, such as 
for a blood pressure measurement. From series one, one pharmacist considered: 
The barriers are actually the pharmacists themselves. (S9.1) 
…you ask them to go out and actually do a blood pressure test or do an actual skin 
penetration or whatever, you know, they get into a bit of a tizz. (S9.1) 
Participants thought that the dispensary was where most income for the pharmacy was 
generated, and thus where most time should be allocated. It was proposed by most 
interviewees that counselling was part of the dispensing process; however the original 
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2003 National Pharmacy Database project [40] separated this action from the drug 
selection, labelling and computer entry functions required for legal dispensing. Some 
thought the figure of 75% of a pharmacist’s time spent in the dispensary suggested by 
Berbatis et al. [40] should be reversed, with 75% of time spent out of the dispensary. 
The confounder of the pharmacy having a forward pharmacy model of practice, which 
might have affected the responses in the survey, was questioned by some key opinion 
leaders interviewed. 
It was proposed by the National Pharmacy database report that the use of a dispensary 
technician would decrease the time in the dispensary, and this was confirmed by the 
participants. However, it was acknowledged that some pharmacists preferred to be in 
the dispensary ‘hiding’, and they had to accept that the dispensary may not solely be the 
pharmacist’s domain, and that other models of practice exist: 
…you don’t need a university degree to dispense, you definitely don’t, there’s no point in 
spending four years of university and one year doing a registration to learn to dispense, 
I can train a dispensary technician in six months on-the-job training to be excellent. 
(S7.1) 
Comment was made about the inflexibility of the current legal dispensing requirements, 
in allowing the innovative use of a video link for rural and remote areas, where a 
complete pharmacy service, would not be sustainable due to staffing shortages. In South 
Australia, an example of this model was forced to close. Legislation has hampered rural 
innovation, and others have confirmed this: 
Lack of any concept by the bureaucrats, including pharmacy bureaucrats about the 
‘come on, let’s get real here—don’t tell me why you can’t do it, tell me how are you going 
to do it’… (S1.1) 
It was suggested that additional qualifications such as a Master of Business 
Administration (MBA), could make the pharmacist approach problems within their role 
in a different manner, one that accepted that change and uncertainty, were a natural 
part of today’s business and management approaches. However, this option was not 
usually taught at undergraduate level, but had to be gained post-graduation by 
pharmacists: 
…one of the major hurdles of the pharmacy profession…the ability to accept uncertainty 
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and the ability to make decisions in an imperfect world. (S11.1) 
This is what I did, I went and got an MBA, by doing these sorts of things, I pulled myself 
out of our old pharmacy confinement, and I was able to look at things differently (S11.1) 
Within pharmacy practice, there was a perceived professional service and dispensing 
mismatch, with dispensing seen as a supply function, with or without, the 
accompanying counselling service and professional services. The participants thought 
professional services should be part of pharmacy practice, and reliance on supply alone 
would be to the detriment of the profession, and ultimately to pharmacy businesses. 
However, from the follow-up interviews, one interviewee had changed his previous 
opinion, and pharmacists did not necessarily have to be involved with supply, but could 
focus on the professional service side of practice. In the first series, it was suggested 
that pharmacies cannot ‘do it all’, and may have to decide their preferred approach to 
practice and business—supply only, or supply and professional service. Community 
pharmacy now, and into the future, cannot rely on dispensing alone, from the first 
series: 
I am nervous about the future of pharmacy…we can’t rely on dispensing anymore (S7.1) 
But also: 
I don’t think that you can do it all...I think we are kidding ourselves to think we can… 
(S10.1) 
It’s just not simple—really isn’t and people who go ‘gung ho’ for one model are actually 
doing detriment—you know creating problems with the others. There just needs to be a 
balanced approach, you really needs to be balanced. (S2.1) 
However, in both series, they thought that something needs to change, for ongoing 
survival of community pharmacy: 
We need to go back to being health providers not retailers. (S6.2) 
...we’ve seen a supply dominating any professional services and that is the dissociation 
of supply and professionalism, which is going to be the detriment of this profession. 
(S1.1) 
Whereas in the past, you could just run a business and provide your services and not 
necessarily have to think too much about the profitability of the pharmacy, whereas 
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nowadays there’s so much competition. (S6.1) 
The participants felt the profession was still unsure of its role in health care, which was 
coupled with a pharmacist generalist and specialist practice incongruity. Evidence was 
required, such as a demonstration and commitment to the pharmacist role: 
Pharmacists are the most educated proponents of drug therapy there is within the 
health system. The complexity of drugs, the complexity of management, complexity of 
comorbidity, the complexity of co-administration absolutely requires a person with the 
knowledge in therapeutics which can only be provided by the profession of pharmacy, 
under the current structure. (S1.2) 
In the follow-up interviews, several mentioned that nurses were taking a pharmacist–
like role in providing medication reviews and advice. It was a concern that if the 
pharmacy profession does not become more prominent in this role, other professions 
will take it up, more so than is done already: 
What I'm saying is, if the model in which that distribution operates at the moment, is so 
strangling, is so suffocating for development, that if we are not careful the need will be 
there—there are no question the need will be there, the void will simply be replaced by 
someone else. (S1.2) 
Despite the practice restrictions, rural practice was still considered the area, in which 
most innovation can take place. Its pharmacists were proactive, and often the only 
health professional, but they still had the same practice restrictions as those in urban 
areas. From the follow-up series: 
So, your role may well be significantly greater from a primary care perspective, minor 
illness sort of perspective than somebody who has a medical centre pharmacy in the 
CBD. People come to you first because you're accessible yet you can only do the same 
things that somebody else in a CBD pharmacy can do. (S2.2) 
In rural areas, pharmacists were seen as senior community figures and: 
…the role that the community pharmacist plays in rural communities I think is quite 
unique in a way—particularly because of the much closer inter-multidisciplinary 
interactions that occur. (S1.2) 
Yet some do not take advantage, or make the opportunities to expand and extend 
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practice and say “no, we just do what we've always done” (S4.2) and thus do not support 
the local health professionals and the community. Alternatively, it was suggested that 
rural pharmacists are problem solvers, and ‘see a job that needs to be done, and do it’, 
and collaborate to use the finite resources available for the best outcomes. 
…in some respects the rural areas will be more rewarding because of that close 
collaboration and you just do things because you have to. (S2.2) 
The participants thought that members of the profession as a whole, were considered 
trustworthy and the personal touch enhanced this trust: 
I think you know, overall, we’re very trusted…we ought to protect that. (S4.1) 
I don’t want to see us getting so big that we lose the personal touch…and if we lose that 
people contact, I think we’ve lost a lot. (S4.1) 
In series one, advocating for medication adherence was considered as core business by 
the participants: 
…the bottom line is, that’s a core part of professional practice…We have to understand 
the importance of what the drugs are doing and why and how—I mean that’s a part of 
our role in the health team, so it involves liaising with the patient, liaising with the 
doctor, understanding what’s going on, and just liaising with the general health team so I 
think it’s absolutely crucial… (S8.1) 
Promoting health was seen as a part of business and health promotion was considered 
to be the same concept. Differences were expressed as to whether health promotion 
was a philosophy, or an activity of practice. Even the pharmacy student in series one 
had seen the apparent conflict: 
…you’re extremely highly skilled at a lot of health aspects, um, and I don’t see that fully 
utilised at the moment. (S6.1) 
From the pharmacist practitioners themselves: 
Ohhh absolutely—health promotion…is a core service for community pharmacy and for 
pharmacists in general, health promotion, we need to be doing that. However, we under 
do it and we don’t promote preventive health as much (as) we should. (S2.1) 
One suggested that younger pharmacists would know more about health promotion, 
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than older pharmacists, and the community talk approach may be suited to one 
personality over another, but in this group, it was considered as an activity done by only 
a few: 
I think, very few pharmacists do it in what period—over the life of their career they’ve 
probably done, you know most pharmacists would of done one or two I would have 
thought. (S4.1) 
Other professions, such as nurses, have taken on the health promotion role. This was 
despite the availability of what one participant considered the 5,000 community 
pharmacies, which were an existing network of health promotion sites. Lack of time was 
considered a barrier to undertake these activities: 
I think time is a barrier for us, Helen, and like in getting out there. Like, our pharmacists 
are stretched to the nth degree, there’s not enough…..love them to, but in reality it’s not 
happening. (S9.1) 
Overall, pharmacists had a specific approach to health promotion, which could be seen 
by other professions, as a fraction of the available scope of the health promotion 
practices and activities, and was usually conducted in an elementary form in the 
pharmacy. A change of practice philosophy was needed to make better use of the 
pharmacy profession, and thus provide a significant influence on Australia’s health 
focusing on risk factors of lack of exercise, smoking and improving diet, in addition to 
promoting the use of medication. In series one and the follow-up series this interviewee 
thought: 
Now, health prevention has got to be a major key platform for health of the future. You 
know, you know, if you look at our disease processes in this country, about 60% are 
preventable—by three simple things—exercise, smoking and diet. Sixty percent of the 
disease burden in this country will disappear with exercise smoking and diet. Why 
wouldn’t government be interested in preventative health programmes? (S1.1) 
We should be remodelling our pharmacies to be centres of preventive health care and 
service delivery as opposed to um, you know discount operations… (S2.1) 
Interviewees thought that in the future, professional services would become more 
widespread. It was not until the 5CPA, and the PPI Program, which included primary 
health care, that some specific disease state services, also called QUM services, which 
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received financial support. Pharmacists can change, and future could be as suggested 
below: 
…I think that’s one of our main challenges, to deliver professional service, so patients 
see us as a profession of health care providers, government see us as a profession of 
health care providers as opposed to what we’re seeing is as purveyors of product. (S9.1) 
I think you will see a gradual extension, think that probably in the medium term, that 
would see the goal—every pharmacy does diabetes, asthma and Home Medicine 
Reviews, and every pharmacy does medication profiling, and if we can get all of 
those…I’d like to have another crack at smoking cessation with spirometry. (S4.1) 
I believe it’s in like counselling and preventative-type approach. Definitely not staying 
behind the counter and certainly in professional development and running programs 
like whether it be weight, through blood cholesterol, diabetes or whatever. I think our 
future rests there, in both preventative and knowledge, like, helping the patients. (S9.1) 
The opinion leaders interviewed agreed that pharmacists were capable of conducting, 
with appropriate business models in place, enhanced or professional pharmacy 
services. However, over time, it was felt that many opportunities have been lost. In 
addition, not all of the profession charges for these services, thus making it inconsistent 
across the country. Many were already providing the services suggested by the table 
(National Pharmacy Database Table DB7-1, 2003) (Appendix 2) but questioned the 
wording and exact nature of the service given the titles. For example, the inclusion of 
body piercing as an enhanced pharmacy service was questioned with laughter. 
Ambiguity was demonstrated as one participant interpreted a commercial weight 
management program as nutrition support, instead of a professional weight 
management service as referred to in Chapter 2. 
Nutritional support, we have already jumped into that. In fact, like, albeit like a retailing 
product in Kate Morgan©, it really has had a dynamic effect on some of our businesses 
(S9.1) 
However, some participants felt pharmacy assistants were much better at conducting 
some of these activities in the areas of smoking cessation, blood pressure readings or 
weight reduction, because of their life experiences. Remarks were made that the 
pharmacy profession had done itself a disservice over time by introducing practitioners 
such as iridologists, when it could have had health professionals such as nurses, 
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mothercraft nurses, or diabetic educators, in the pharmacy, assisting in service 
provision: 
We had the opportunity in the last decade and some have been saying this, the last 20 
years…to see pharmacists as the Community Health Centre. So what are we to do? We 
don’t have Mother Craft Nurses. We don’t have a Diabetes Educator, coming in once a 
fortnight, we have an iridologist coming in. And you wonder why the mainstream of 
medical, from which our interaction must enhance, is being impeded by the perception 
that we are not serious... (S1.1) 
The ability or lack of ability, by the profession to charge for services has been 
mentioned previously. Reiterating: 
It’s just that when you’re asking them to go out to say charge a fee, oh, we can’t do that. 
Well, why can’t you do that? (S9.1) 
I think a lot of those services should be charged and can be charged, and in fact in my 
pharmacy, I didn’t charge and people were surprised I didn’t charge and they were quite 
willing to pay. The only problem is that it has to be an industry approach, if one 
pharmacist is not charging, then the whole thing just collapses. (S11.1) 
In addition, any service must be a quality service and meet industry standards, despite 
non-payment: 
But you’ve got to make sure that people who are doing it…are doing it well and can do it 
to a decent standard. (S2.1) 
…there's a lot of stuff they could do if they had the opportunity to and if they're trained 
appropriately that they can do to improve patient health, but when you don’t get paid 
for it, then it really limits the opportunity to do it and do it well. (S8.2) 
However, in the follow-up series quality service is the key: 
What I'm more concerned about is the quality of the service that offers, because if you 
offer quality service and you offer wide-ranging quality service it will be profitable. If 
you provide…a service people will pay for the service, be it people, individuals or even 
governments. Governments will pay for services which improve self-outcomes which is 
an investment, no matter what it costs it’s an investment. (S6.2) 
Historically, other professions employed within the pharmacy have conducted 
screening, thus providing some credibility but consequently, the ability of the 
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pharmacist to also conduct screening, was underestimated and ignored: 
…but why wouldn’t you have, why wouldn’t you expect a distribution network of 
community-based practitioners, right, of preventative health-care strategies. I mean, if 
we go back 15 years, when we tried to put in the APF the guidelines for blood pressure 
and cholesterol testing and all the hue and cry that this profession, we could have had a 
nurse practitioner in there or practice nurse in—do those things screening—what a 
magnificent context it would be, all right, and why, and that’s the tragedy. You have a 
network of some 5,000 pharmacies in this country…highly educated people with a 
professional ethos that is there…it’s either of overt or covert, but is still there—it’s got to 
be drawn out. And we are not deemed to be relevant players when you’ve got the 
distribution network of over 5,000 for this country? (S1.1) 
Opinion was expressed again in this section of questions about other health 
professionals not realising the skills and competence of pharmacists. This was 
confounded by the retail nature of community pharmacy practice and the sale of 
spurious and non-evidenced based products and services: 
…I don’t think our allied health professionals and GPs truly understand pharmacists, 
what pharmacists do, and our education levels, and our competency levels. They do tend 
to see us as glorified shop-keepers and they particularly pick up on the fact that we sell 
some pretty dubious gear at times, um, and ‘they all use that’, their mindset will be, ‘oh, 
well, you sell FatBlaster so, what do you know about weight loss? (S3.1) 
Hospital pharmacists, on the other hand, have expanded their roles because they were 
not restricted by the same regulatory framework, and could push the boundaries of 
their practice: 
…hospital are the trail blazers as for a number of areas because they often don’t have the 
regulatory framework that our community practitioners have to deal with, and often do 
pharmacist prescribing, pharmacist anticoagulation clinics, pharmacist pre-assessment 
clinics, write up drug charts... (S9.1) 
However, overall, participants still thought pharmacists were perceived as suppliers of 
products, and not suppliers of health care services. Customers go to pharmacies for a 
product, with or without a service, not a service alone. 
In the follow-up interviews, one interviewee said that the profession needs to take more 
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responsibility for its actions: 
To be honest with you I think we have a very much a low base. 
(Interviewer) So when you say the high level you mean clinical skills? Interventions? 
A level where pharmacists take responsibility for medication outcomes. 
(Interviewer) OK, so more than ‘lick and stick’? 
More than ‘lick and stick’. It is unfortunately we don’t take responsibility for that across 
the board. We take responsibility for discrete activities medication management sort of 
cycle, likely around the supply of the medicine as prescribed by the prescriber safely. 
We don’t necessarily take responsibility for the outcomes associated with that 
medication use and I think we need to. (S2.2) 
This low level of responsibility described, means many are working below their 
potential level of expertise, and this is compounded by the solitary environment in 
which pharmacists work. Apart from one interviewee, who suggested the need for 
change management facilitators, there were no co-ordinated ideas on how to move the 
profession in this direction. The following comment was made about what has been 
holding the profession back in the past five years in the second series: 
Oh the lack of advancement, the lack of innovation, the lack of disruption in the 
community pharmacy environment it’s just been the status quo and the biggest risk to a 
profession. The biggest risk to service delivery is just to stay the same and we've stayed 
the same, and it’s really unfortunate because we haven't advanced, we haven't 
developed, we haven't used the platform of 5 years of security around the Community 
Pharmacy Agreement to catapult forward and to deliver services and to improve our 
health outcomes, so largely inactivity has being the biggest challenge—we just haven't 
developed and again it’s unfortunate. (S2.2) 
Overall, unfortunately there was no significant change in practice or in pharmacist roles, 
suggested by the interviewees, between the two series of interviews, or differences in 
rural and urban practice. 
4.3.6 Theme: The pharmacist workforce 
Participants thought that workforce shortages, the availability of positions, especially 
for current undergraduate students; wages, cultural issues, lifestyle and associated 
 Chapter 4: Analysis of pharmacy key opinion leader interviews, on rural pharmacy practice, the 
challenges and future of community pharmacy practice      107 
costs were the issues of concern for all, and especially for rural pharmacists. From 
series one: 
…from the student’s point of view, you look forward to anything when you get, got into 
this profession and you enrolled in pharmacy five years ago, you know, you could walk 
into a job basically, after graduation, where as I’ve seen the increase in, I think 4 schools 
in the last 4 years, and the number of graduates, the number of students within existing 
schools, that’s going to have an impact on our profession as well. (S6.1) 
Opinion leaders were only asked about the immediate future, of that in 5 to 10 years’ 
time. Most of these comments related to the status quo of pharmacy practice and the 
workforce, as we know it in Australia, and did not suggest a long-term approach to any 
significant change of practice and workforce. Remuneration and pharmacists leaving 
the profession, were the main issues in the area of workforce, for the follow-up 
interviews. With university debt, and dissatisfaction by the younger pharmacists, it was 
thought that some were looking outside for another profession, e.g. medicine. Another 
interviewee also spoke of cultural issues, and lack of family support especially for those 
with strong family group ties, such as those from Asian and Middle Eastern 
backgrounds, which essentially stop this group of pharmacists from ever moving to 
rural locations, distant from their family. In both series, retention of younger 
pharmacists, was described as an issue, because current models, focusing on supply and 
dispensing, were thought not to interest these practitioners, so much so, that they chose 
to leave the profession: 
…Why are they leaving us? Why do they dislike pharmacy? Because that’s what we are 
looking at. Why aren’t we keeping them interested? And if we don’t deal with that we 
have actually got people who say ‘I don’t want to be a pharmacist any more’. Why don’t 
they want to be a pharmacist? Because they’re busy, ah…they see themselves as just a 
machine churning out prescriptions. (S2.1) 
What we are in danger of is actually not realising that when the good people are leaving, 
provide crappy service which will stuff up everything and people will lose faith in the 
profession and somebody else will take over this role. (S11.2) 
Negativity expressed by some does not help alleviate this issue: 
…the negativity with the profession and just a general negative sentiment about the 
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profession… (S11.2) 
In the first interview series, one participant suggested the current shortages of rural 
pharmacists would not be overcome, and another suggested that there was a lack of 
‘good’ pharmacists in rural areas. Another comment made, was that locums could work 
in a rural area without engaging with the community, but for those practitioners 
working there already, the relationships with other health professionals were good. In 
the second round, one commented that pharmacists worked in rural areas, but then 
moved back to larger centres for domestic reasons such as school for their children. 
Wages were an important factor mentioned in the follow-up interviews. They were 
considered low, as expressed by one interviewee: 
…because the pharmacy award is so out of date that pharmacists can be employed at the 
wage that is comparable to a check out person in a supermarket… (S11.2) 
It was suggested that discount pharmacies pay less, and the wages for pharmacist have 
decreased over the past 10 years. In addition, a contributing factor was the number of 
schools of pharmacy, with a consequent increase of registered pharmacists available, 
and many of those looking for variety in their work. Compared to the first series, 
pharmacists are now in general medical practices, but unless they were undertaking 
HMRs, they had no access to any other funding, other than that provided by the practice 
itself. 
The rural workforce itself was thought to be more stable and self-sufficient. However, 
there were recruitment and retention issues, although it was suggested the situation 
had not worsened in the past 10 years. One of the keys to assisting retention was 
providing a good graduate experience, to encourage instigation and continuing 
employment. However, one leader thought the lack of availability of pharmacists for 
rural areas will never be answered, so alternative measures to deal with this problem 
should be explored: 
…regardless of what initiative the government has put in, what initiatives the profession 
put in, I think one thing we have got to accept is that, in general, on the balance of 
probability, rural health work force, the shortage will never be overcome. (S11.1) 
I think that is the key, pharmacists in the bush providing good graduate year 
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opportunities and good rural placement opportunities for kids from the bush to say, 
look this is what a pharmacist does and you don’t have to settle for just packing 
Websters© or dispensing 500 scripts a day. (S7.1) 
Rural pharmacists do have less peer support, and can be isolated from other health 
professionals, but there were suggested lifestyle advantages in rural practice. Those 
interviewed who practiced in rural areas, were passionate about living and working in 
the bush, and would not work elsewhere. Marketing the lifestyle and the community 
approach, and not just the professional nature of the position, was suggested as one 
initiative. In addition, a ‘come and try’ approach to practice could be used, with a short–
term contract given, as proposed by one staff pharmacist. However, the comments were 
made about the need for ‘good’ pharmacists, and employers will not accept just any 
applicant. The profession wants ‘good’ pharmacists who are prepared to stay: 
And it’s also harder, because you’re a peer isolated, being unable to ring someone up and 
say ‘I’m trying to do this stupid PMP and I can’t get the website to work’. They don’t 
often have that sort of peer integration sort of thing happening, so there’s…..to a degree 
Auspharm* and the SIG groups do address, but there nowhere near as much is needed. 
(S3.1) 
*Auspharm online pharmacist discussion and news forum at the time. 
…people in smaller areas perhaps have to be more self–sufficient…less peer 
support…less people to be locums…better health team management…because more 
personal sort of relationships…dynamics of a small community. I think those sorts of 
things really affect rural community pharmacy. (S8.1) 
It was suggested that lifestyle benefits should be promoted, as distinct from 
professional benefits, in order to entice staff: 
…we have to market the lifestyle, so we can get people to come to the rural areas. (S8.1) 
…it is a good lifestyle in the country… (S7.1) 
I…like being a pharmacist in the bush… (S7.1) 
In recent years, one idea for improving the workforce was to set up a School of 
Pharmacy in a rural location, to attract rurally based students. The participant 
suggested this school, however, only attracted students who were not able to get into 
metropolitan schools, and did not specifically attract the original target group, those to 
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be trained and retained as rural practitioners. 
In series one, examples of personal costs to live in rural or remote areas were identified 
as a satellite phone, internet, and the expected associated travel costs. It was noted that 
these expenses were not reimbursed by existing allowance schemes within the CPAs: 
IT needs to be sorted… (S4.1) 
…you’ve got travel costs are higher, maintaining your competency and your education 
has issues to be able to access and get to things. Ah, your costs tend to be higher... (S3.1) 
In the follow-series, this had changed: 
…the absolute increase in social media use, internet, and cheap airfares, means that 
connectivity and access to regional areas to people who can say, I can do it for 12 
months it’s not such a huge issue anymore… (S7.2) 
The primary issues for rural pharmacy were not related to pharmacy professional skills 
and knowledge but to location, innovation, lifestyle and the ability of the practitioner to 
be inventive and collaborative, with other health professionals in the local community. 
In the follow-up interviews, these opinions were reiterated. Payment incentives have 
not provided a solution to increase the rural workforce. However, current funding 
models also prevent more opportunities and innovation in rural and regional areas by 
assuming pharmacy practice is the same, wherever the location. 
4.3.7 Theme: Differences in rural community pharmacy in Australia 
Many comments about rural pharmacy practice have been made in the previous themes’ 
results. Rural practitioners see a problem and solve it; they are innovators, because this 
is the nature of living in a rural location: 
I think the rural differences are purely ‘on the ground’ differences. So, there's the same 
sort of system influences with regards to funding, with regards to internal and external 
drivers but often pharmacists who are located in rural areas do things, because things 
need to be done. (S2.2) 
Staff consistency 
Some issues relating to rural practice have been mentioned in the previous sections; 
however, there are staff issues when there is no long-term pharmacist present. One 
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participant suggested employed and rotated pharmacists do not stay long in any 
location, and thus do not provide an ongoing continual ‘local’ face of the pharmacist 
within the pharmacy, especially in rural areas: 
...someone comes in every three months, so you never know who the pharmacist is going 
to be there, you never know their name. I don’t (know) how there is any continuity of 
care, they just seem to rotate them through…that’s how it is and I think that to me is a 
bit sad from the point of view, you know, the community supporting their local 
pharmacist, because it’s not their local pharmacist at all—so to me that’s, you know to 
keep your credibility especially in a rural area, that sort of thing really detracts from it 
(S8.1) 
Workforce stability, particularly for new services implementation, was considered 
crucial for best practice, and reflected on the whole profession whether rural or urban, 
if new services were withdrawn because of staff changes: 
It is, because you can’t start doing anything or expanding your services or whatever if 
you don’t have a stable workforce, because there’s nothing worse than putting in a great 
new thing and then people chuff off and then you’ve got to withdraw the service, I mean 
those sort of things are particularly damaging to the profession generally. (S8.1) 
These sentiments were reiterated in the interviews from the follow-up series, in that the 
discount and corporate structure is now becoming the norm for pharmacy in Australia. 
Lifestyle and collaboration with other health professionals were two positive features of 
rural practice, but on the negative side, remuneration, practice models, and job 
expectations were the issues for these practitioners. Getting the right rural practitioner 
was paramount, but not a panacea. 
Innovators in rural pharmacy practice 
Rural practitioners were seen as innovative and adaptable to change, which occurred 
much faster than their city counterparts. They could overcome professional boundaries. 
They were regarded as having more skills and knowledge to manage a wide range of 
services within a community pharmacy, those skills not usually seen in the city. 
However, when asked to name the specific differences, the activities named were not 
particular to the pharmacy profession, but services such as banking or accountancy. 
…rural pharmacists are more of a jack-of-all-trades... 
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(Interviewer) What do you think, pharmacists have to do in rural areas to get that 
expression ‘jack-of-all-trades’ that’s different to..? 
Well, I mean, they’re an accountant, they manage a bank, bank transactions or these—
Medicare stuff. (S9.1) 
Drivers for innovation were personality type, scarcity of practitioners, as well as 
knowledge of the local community and health workforce: 
…I have come to conclusion on about rural pharmacy is that they are the leaders in 
innovation because of the scarcity. (S10.1) 
DMAS, we have a diabetes educator in town, but there is a 12-month waiting list to get 
in, and so, I say to somebody we can offer this service, it is not exactly the same as the 
diabetes educator… (S7.1) 
…people in rural areas tend to be more innovative um, because they can and because 
that’s the type of people that they are. (S2.1) 
I think in rural remote areas, they adapt much faster to a changing health environment 
…is scarcity of workforce and therefore they tend to respond quickly by picking up 
opportunities when they can, so my experience of rural workforce, was that they 
actually participate more broadly in healthcare provision than urban retail pharmacies 
do, because they see the need and respond to it. (S10.1) 
This innovation philosophy by rural pharmacists was reiterated in the follow-up 
interviews. However, the additional jobs of being an accountant or bank manager 
suggested might not appeal to all. 
4.4 Diagrammatic models of pharmacy practice—discussion and results of 
key opinion leader interviews 
The leaders expressed many opinions about rural pharmacy practice. However, many of 
the issues raised were not specifically about rural practice, but rather the profession as 
a whole. There were many recurring themes with little to separate the two interview 
series. Additional issues that were discussed in the follow-up series, were teamwork 
and expanded collaborative models of practice, together with professional services. 
In both series, the lack of pharmacist involvement in policy at all levels was raised as an 
issue. It was suggested some professional organisations represented relatively few 
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pharmacists, but have influence over many. The interviewees said that pharmacists as a 
profession, did not mix and collaborate with other health professionals. This issue was 
particularly brought out in the follow-up series of interviews. Many suggested that the 
public, other professions, and organisations still did not know what a pharmacist could 
do—the breadth and depth of this role. This was hampered by the current visibility of 
the retail pharmacy, and the lack of visibility of the pharmacists themselves, be they 
employees or owners. This concern resonates continually in the pharmacy literature, 
and has done so over many years. Whether in urban or rural practice, this is a constant, 
and relates to not only to views of consumers, but also the views of other health 
professions. Many of these issues could be identified from the literature, with no 
apparent progress towards improvement. 
In the follow-up series, the leaders thought culture was an issue, as this may affect rural 
recruitment, as some pharmacists do not want to leave the family support structure. 
Comment was also made about additional Schools of Pharmacy, but as can be seen in 
Chapter 2, this has not been reflected in a substantial increase in pharmacist numbers, 
despite interviewees suggesting that this might be the case. These factors will in turn 
affect the availability of long-term staff in rural practice. Observations were also made 
of locum pharmacists, on short-term contracts, who did not engage with the community. 
Consequently, there was a lack of attachment, not only with the customers, but to local 
health professionals and the community as a whole. This hampers professional 
collaboration, and any building of trust. 
The pharmacist leaders considered rural pharmacists were innovators, with a ‘can do’ 
attitude. They questioned the amount of time in the dispensary, and suggested 
professional services were the way of the future. Payment for services was raised as an 
issue, as pharmacists were reluctant to charge, despite the need for income. Dispensing 
income may not always be relied upon, so other professional income streams need to be 
explored. 
Comment was made about the profession as a whole, of the standard and public 
expectations, of the services given. It was suggested that there was a potential lack of 
consistency in professional services, health promotion activities and medication 
adherence activities within pharmacies. Consequently, the public do not know what to 
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expect when entering a pharmacy. The public do however, expect a reasonable price 
model and many frequent the discount models of practice. These issues were not 
specific to rural community pharmacies. 
After the two series of interviews the proposed model of the critical issues for pharmacy 
in Australia, and for those in rural practice were suggested in Figure 4.1 below: 
Figure 4.1: Critical issues for pharmacy: Model of key opinion leader interviews and follow-up 
interview series 
 
*Interview follow-up series only 
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Figure 4.2: External and internal issues for rural community pharmacy: Combined model for 
opinion leader interview series one and follow-up interview series 
 
The issues summarised above in Figure 4.2 have a somewhat different focus in rural and 
remote Australia. These external and internal issues will be compared to those 
identified by practitioners themselves in Chapters 5, 6 and 7. 
4.5 Summary 
In summary, the diagrammatic models can be used to highlight the main points that 
have evolved from the analysis of the opinion leader interviews. The rural context of 
lifestyle was considered different, but no professional pharmacy knowledge and skills 
specific to rural practice were identified by the participants. Rural pharmacists were 
seen as innovative and adaptable, with good relationships with local health 
professionals. Interviewees thought that rural workforce issues may be something for 
which there is no solution, and in this area, remuneration was inadequate and staff 
turnover and rostering problems, did exist. Areas of concern for rural pharmacists were 
IT, professional development and the concern of peer isolation. Additional personal 
costs were pointed out by the interviewees, but for some rural areas recruitment was 
no longer an issue. The key opinion leaders suggested that rural customers were loyal, 
but still cognisant of prices of goods and services. 
Many of the issues identified by the opinion leaders, related to the profession as a 
whole, and how the broad and varied skills of the profession, were not understood by 
other health practitioners. To compound this, many pharmacists did not provide 
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comprehensive professional services, in preventative health, chronic disease support, 
health promotion and medication adherence. It was suggested, that in addition to some 
of the services provided, pharmacies were not adhering to the models and depth 
required by the professional practice standards. However, these concerns were not 
specific to those pharmacists in rural or remote practice. 
Interprofessional collaboration, and working together, involved each profession 
providing specific input or advice, and clarification of issues, as a part of normal daily 
practice. The opinion leaders did suggest that a pharmacist as a health professional 
could provide a number of skills, not just those pertaining to medicine knowledge and 
QUM and thus could contribute to the broad interprofessional approach to health care. 
This could happen at any level, from national policy development to a local community 
health professional collaboration. Overall, the opinion leaders were concerned about 
the current professional approach to pharmacy practice in Australia. Again, this was not 
specific to rural practice. 
Participants talked not about conflict between health professionals, but just that the 
pharmacy profession was not included in plans, committees and decisions made in 
health care in this country. Two interviewees spoke of the nursing profession, taking 
over the role of pharmacists, but not what the pharmacy profession could do to reverse 
this trend. 
Participants suggested that the differences in rural practice related to the context. They 
did not relate to any different professional skills and competencies required as a 
pharmacist, but more an acceptance of the lifestyle requirements of living and working 
in a rural or remote part of Australia. 
One interviewee said that the future of the profession as a whole requires: 
Vision…..leadership…..commitment to change…..getting out of the past…..creating its 
own future.….I am very frustrated and very angry with members of this profession to 
see what’s going on…All I know is that it’s not a shared vision, and it should be a shared 
vision, and we have a mission—this profession should have a mission statement. (S1.1) 
The same practitioner said in the follow-up series, the driver for the future and change 
is in the profession and: 
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It’s up to itself. (S1.2) 
The next chapter (Chapter 5), will describe a similar qualitative analysis of interviews 
with community pharmacists and research practitioners, who participated in the 
Pharmacist Assessment of Adherence, Risk and Treatment in Cardiovascular Disease 
(PAART CVD which was often simplified to PAART) project. This pilot project 
investigated cardiac care support services in community pharmacies, and thus the 
participants’ views could be used to provide a comparison to that of the key opinion 
leaders interviewed for this chapter of the thesis. 
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Chapter 5: Analysis of interviews of pharmacist practitioners from the 
PAART study, on rural pharmacy practice, the challenges and the 
future of community pharmacy practice 
The 4CPA PAART pilot study project, was also known as the ‘Healthy Hearts’ Project 
(2012–3) [203, 205, 206]. The community pharmacists and research team pharmacists 
were interviewed for their opinions on rural community pharmacy practice, for this 
chapter of the thesis. 
The PAART study itself investigated the role community pharmacists could play in 
preventing cardiovascular disease (CVD) complications in their customers. The 
pharmacies recruited for the project were located in Tasmania and Victoria, with half 
from rural areas (PhARIA 2 and above) and the rest were in urban/metropolitan 
locations (PhARIA 1). These community pharmacists also completed a written survey as 
part of the overall study and together with their interview opinions of the project; these 
particular results were included in the final report. However, the analysis of the PAART 
pharmacists’ interviews presented in this chapter have not been described elsewhere in 
the literature or project reports. The core interview questions used, were the same as 
those given to the key opinion leaders in series one, interviewed in Chapter 4, which 
thus enabled a comparison in opinions, between those ‘at-the-coal-face’ with key 
opinion leaders about rural/urban differences in community practice. 
Pharmacists do have the knowledge and ability to conduct basic cardiovascular 
screening programs, as many projects in the past attest. The PAART study described 
below used a more complex intervention, than some previous CVD prevention research 
examples [207, 208]. After a two-day face-to-face education workshop describing the 
project, its aims, and objectives, and presentations including background clinical 
updates, the participant community pharmacists recruited up to 10 patients each, based 
upon the following criteria: 
• aged 50 to74 years 
• taking prescribed antihypertensive and/or cholesterol-lowering medication 
• no history of a cardiovascular event or established CVD 
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Baseline medication, health (nutrition status, alcohol consumption, levels of physical 
activity, screening for possible depression diagnosis and cardiovascular history) as well 
as body measurement assessments, were conducted by a consultant research 
pharmacist who had also undergone additional training. This research pharmacist then 
wrote a management plan, which was sent to the participating community pharmacist 
for implementation. The community pharmacist then conducted multiple interventions 
over five face-to-face sessions: the initial session taking an average of 34 minutes, and 
subsequent meetings taking on average 16–22 minutes. It was found that 78% of 
patients attended all five sessions. The community pharmacists used motivational 
interviewing techniques, to encourage better lifestyle choices (smoking cessation, 
decreased alcohol consumption, weight reduction, increased physical activity and mood 
improvement), and also promoted medication adherence, with the aim to improve the 
patient’s overall heart health, and therefore a consequent decrease in their CVD risk. 
Replications of the initial measurements, were undertaken by the consultant research 
pharmacist, after the interviews were completed. The data was analysed to see if 
patients could achieve a significant decrease in CVD risk factors, in the approximately 
six-month active period of the project. The results showed the PAART approach 
produced a significant reduction in patients’ waist measurement, increased weight loss, 
improved nutrition status and a reduced CVD risk. This success has been reported 
elsewhere [203, 205, 206]. 
This chapter will look at the pharmacist participants’ views of community pharmacy 
practice, especially any potential differences between that in rural and urban areas, 
with this motivated group who took part in the PAART project. 
5.1 Aims of the study 
The aims of the study in Chapter 5 were to: 
• elicit the views of community pharmacist practitioners and researchers, who took 
part in the PAART study, and their opinions of community pharmacy practice 
• gather their views on differences between rural and urban community pharmacy 
practice 
• compare and contrast these views with those of key opinion leaders interviewed 
previously 
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5.2 Methods 
The community pharmacists and pharmacist researchers who participated in the 
PAART pilot program were interviewed, with ethics approval. The questions used, were 
those given to the key opinion leaders in the first interview series, described in the 
previous chapter. This enabled a comparison of responses between the different 
participant groups. The interviews were transcribed and analysed. 
5.2.1. Selection of participants 
The community pharmacist participants and pharmacist researchers were selected by 
the project team using purposive selection. Half practiced in rural, and half in urban 
areas, as pharmacies from both geographic areas were required under the project 
funding guidelines. These participants were also identified as having an interest in the 
provision of new professional practice services. 
The project and interview requirements for each participant group are listed below. 
Community pharmacy participants: 
• attend the PAART education workshop 
• recruit up to 10 participants per pharmacy 
• conduct the series of 5 intervention interviews with each patient 
• complete final project reporting and be available for follow-up face-to-face 
interviews 
In addition, for the project management and review consultant pharmacists: 
• for both, the ability to attend the PAART education workshop specific to their role 
• review consultant pharmacists—the ability to conduct medication and health 
reviews and produce a management plan, repeat the assessments and report at the 
end of the project, for each patient participant 
• project management pharmacists—the ability to liaise with all community and 
review consultant pharmacists 
• for both, the ability to complete final project reporting and be available for follow-up 
face-to-face interviews 
The final participant pharmacist list was reviewed and accepted by the project 
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management committee. The researcher and project management pharmacists were 
selected and employed by the project team. 
The researcher and project management pharmacists were included in this analysis 
because of their varied experiences in pharmacy practice. They had worked in many 
rural and remote areas of Australia during their career with experiences (past and 
present) ranging from that of community or hospital pharmacist, pharmacy owner, 
accredited pharmacist, university academic and researcher. Thus, their familiarity with 
rural community pharmacy practice warranted their inclusion in this interview cohort. 
5.2.2 Method of conducting the participant interviews 
Each interview question was designed to be generic for all practice locations. Opinions 
were sought from all for each question, about possible differences between urban and 
rural or remote community pharmacy practice. The questions asked were grouped for 
analysis, and the numbers did not necessarily correlate with the order used in the 
interview schedule (Appendix 4) to encourage interview flow. The current position and 
background for each interviewee was also requested in their own words, to provide a 
demographic base for this sub-study of the PAART project. 
The nine community pharmacist participants and four research pharmacists, identified 
by a code below, together with their location and skill area is shown in Table 5.1 below. 
Table 5.1: Pharmacist PAART project participants interview list 
Code Pharmacy role and location (Tasmania and Victoria) 
RP1, 2, 5, 7, 9 Rural pharmacists: PhARIA range 2–5 
UP3, 4, 6, 8 Urban/metropolitan pharmacists: PhARIA 1 
RTP1, 2, 3, 4 Research team and project management pharmacists: PhARIA 1 
One rural community pharmacist was not approached for an interview because he did 
not recruit any patients, despite attending the initial education workshop, and provision 
of additional project support. 
The interview schedule developed (by HH) was reviewed and approved by the PAART 
management committee. Conducted in 2009, the first part of the interview schedule 
used the same questions for the key opinion leaders in series one. The second part of 
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this interview contained questions about the PAART program. Only the anonymous 
survey questions and pharmacist opinions of the project were used in the final report 
[203]; the qualitative interview responses described in this thesis, were not used in the 
report. 
The interviews used open-ended questions, and were conducted by a single 
interviewer/PhD student (HH). All except two interviews, were conducted face-to-face, 
with the final two researcher interviews, conducted by phone due to distance and 
interviewee availability. 
Each semi–structured interview took approximately one hour to complete, with some 
longer. The subject was encouraged to talk, and provide reflection on previous 
questions asked. This additional reflection often happened at the end of the interview. 
5.2.3 Transcription methods 
The interviews were transcribed by the same commercial transcription service as used 
in the previous chapter interviews. Each interview was checked by the interviewer/PhD 
student (HH) for accuracy together with tonal emphasis and pitch variations, which 
were then annotated onto the written record. 
Participants were offered a copy of the transcript, to confirm accuracy, and was sent to 
each electronically, with none being returned for corrections. 
5.2.4 Analysis methods 
As before, the transcribed interviews were analysed by constant comparison, using a 
combination of the NVivo© qualitative data analysis Software (QSR International Pty 
Ltd) thematic analysis program, and the use of paper-based copies, to allow visual 
comparison using highlighting of various sections and segments. 
Again, as required by the qualitative analysis approach, and described in Chapter 4, 
continual reading, grouping and study of the transcripts enabled the common themes to 
be identified and classified, despite the small number of interviewees [187, 196, 202]. 
The classification sets were reviewed reflectively by the researcher (HH). Some 
regrouping of themes took place when all were classified to finalise the resultant 
groups. 
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5.2.5 Ethics approval applications 
As this PAART project was conducted by two universities, approval was required and 
given from both the Monash University Standing Committee on Ethics in Research 
involving Humans (SCERH) (Approval Number CF08/0305–2008000110) and the 
Tasmanian Human Research Ethics Committee (H0009995). (Appendix 9). The final 
ethics report approval confirmation email is also in Appendix 9. 
5.3 Results 
The interview content was divided into clusters of question responses for exploration 
and analysis. There was some overlap between questions but consistency was found in 
opinion when the results were divided into broad areas—issues relating to internal 
practice within the profession, and those external and imposed upon the profession. 
This will be discussed later in this chapter and again in Chapter 8, of this thesis. 
Although some questions were not necessarily, specifically about rural practice, it was 
important to get a sense of the overall feeling about community pharmacy practice, 
from all the participants. The following themes were derived from this analysis. 
5.3.1 Theme: Participation, teamwork and collaboration 
Two participants thought that pharmacists were still considered not integrated into the 
local health care team, and had to earn their place to contribute in any way. 
Complicating this was the changing persona of some health professionals such as 
doctors. Described by rural pharmacists: 
I reckon no matter where you are, you have to be just part of the team, in your local area, 
you have to be part of the team that provides healthcare… (RP5) 
...at the moment is that we are not seen as part of the core, you read any document and 
the pharmacist is never included as part of the team and yet we as pharmacists know, 
that person can be absolutely key, especially if there’s medication involved. (RP7) 
Moreover, from another, pharmacists must earn the right: 
We have got to earn our place or earn the respect to be part of the team, rather than 
being just an aside, you know, which is somehow, sometimes how you feel that you are 
looked at by any GP practice.... (RP5) 
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One participant also thought that newer rural GPs put up constraints on collaboration, 
influencing the pharmacist’s ability to be part of the local health care team, and 
contributing to community and patient health care: 
…what I am saying is that the new lot coming up are less sure of themselves… they put 
this gruff behaviour because they didn’t want to be questioned and, now everybody is a 
lot more rational about no-one can know everything, so.... (RP5) 
5.3.2 Theme: Public perception 
Patients or customers were seen by some as the biggest influence on any community 
pharmacy, in rural or urban practice: 
…I would say that it is your patients that are the biggest influence, but I think that is a 
very old-fashioned thing to think, because I think that a lot of pharmacies now are 
geared towards turnover really, the way their shelves are stocked... (RP9) 
The public’s expectations are probably the greatest thing... (UP3) 
Customers influence the makeup of community pharmacy, with their product price 
expectations, particularly compared to those prices charged by discount pharmacies. 
This in turn affects staffing, marketing, the appearance, stock choices, health promotion 
activities and service delivery of the pharmacy itself. Pharmacists also thought that the 
discounters themselves influenced practice, because they in turn could influence any 
customer. There is also an impact on other pharmacies such as: 
…when the catalogue comes around that tells you what, your local Terry Whites are 
doing, you think, shit, that is cheaper than I can buy it! (RP5) 
Interviewees considered discounter pharmacies were there for a ‘quick buck’. The 
question of perception of the profession’s credibility as a health professional, was the 
inferred result of this style of practice. In rural areas the concerns were: 
I think price, whatever you call it…with discounters and things like that, and so 
undermining, the fact that it is a community pharmacy. (RP9) 
...competition is a huge influence and these new super cheap pharmacies opening have a 
huge influence on the pharmacy. (RP1) 
However, it could be argued that this also occurs in current urban practice as one 
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described: 
our credibility and being perceived to be professional health givers rather than just 
money grabbing... (UP1) 
All considered that pharmacists still needed people contact, a side of the profession 
particularly valued by this group of practitioners—whether this is by dispensing and 
counselling, or by the opportunities available through professional programs. However, 
I think we have got to be careful that we don’t get too professional, that we lose the 
contact with people, but you just get so tangled up in all those other programs and 
everything. (RP2) 
In addition, there are opportunities that do exist now: 
…there is a bloke back at-the-coal-face, dispensing all the scripts but it is huge 
opportunities for younger ones but I think that, I think probably in the future that there 
won’t be… (RP2) 
These pharmacists thought that pharmacies in supermarkets could be considered the 
future, due to financial pressure from both customers and the Government. This could 
lead to a consequent loss of community pharmacies, as they are today, and the innate 
customer knowledge they have: 
Unfortunately, people won’t realise how much information and support they’ve had 
from pharmacy unless it’s gone. And it will be too late, to all of a sudden you know to 
replace your local pharmacist who knows you and knows your kids, and that sort of 
thing, until they’ve already gone. (UP3) 
I honestly believe that retail pharmacy will end up in supermarkets. (RP1) 
5.3.3 Theme: Controlling organisations and governance of pharmacy in 
Australia 
Rural participants commented that the major influence on practice was by the owners, 
and from the PGA. The PGA’s performance was questioned by rural pharmacists: 
I think PBS pressures, as in the constant grind to reduce government expenditure on it 
and also the wheeler dealing that goes on behind the scenes with the Guild and the 
generic companies and all of that sort of stuff... (RP9) 
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...the poor action of the Guild, I think the Guild are very weak and allow us to be treated 
very poorly, Government get stuck into us at every opportunity. (RP1) 
Overall, in Australia, rural participants thought that all practice was dictated by money, 
competition and rules: 
Money. The National Health is obviously our major, because they are a major customer, 
they are our biggest customer, but they are also the one that actually then changes the 
rules. (RP5) 
…your biggest competition is from the government itself. (RP5) 
…well you have a set of rules and you have got to obey them, everything is the rules. 
(RP2) 
5.3.4 Theme: Ownership of pharmacies 
Restriction on ownership and pharmacy location were considered challenges, because 
of the potential costs for anyone wishing to become an owner. Lack of change has 
occurred over time, because an adequate income could be made from the existing 
practice models. 
One of the researchers, an ex-owner, thought: 
...so you are in a protected situation where you don’t have to push yourself to be better 
and find new ways and do new services, you can just keep doing whatever you have 
been doing for thirty years… (RTP2) 
Others thought ownership was an area not understood by those outside, and was one 
that was essentially unachievable to most. From rural respondents: 
I sometimes struggle to agree with some of their (owners) impacts even though it 
doesn’t impact me because I’m not an owner… (RTP4) 
…money, because no-one else can get in... (RTP2) 
Nevertheless, these comments on ownership were not specific to those from rural 
practice as urban respondents also had the same sentiments. 
5.3.5 Theme: The pharmacist role 
The comments below on the differing roles of the pharmacist focussed both on current 
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and future roles, which, it was hoped, would incorporate professional services such as 
those, provided in the PAART project. However, there is a wide range of current roles 
with some focused on service, others on profit. This approach is not new: 
…ever since I have been in pharmacy, which is, well I registered in 1970, I have been told 
by leaders at conferences, “pharmacy is at the cross roads” and it is still at the cross 
roads, and that is because there is this great dichotomy between professional service 
and profit and if you go way back, I mean I did that History of Pharmacy, it was a history 
of pharmaceuticals and it was the same then, in the 1880s you had the guys who were 
just out there trying to sell stuff, and you had the other ones who wanted to concentrate 
on education, getting the students trained, raising the standards of the profession… 
(RTP1) 
It was acknowledged that dispensing was still the primary role of community pharmacy 
practice. When asked if 75% of a pharmacist’s time was spent in the dispensary, 
pharmacists and researchers answered ‘yes’, that this was a correct estimate, but 
change was possible: 
…that is 25% over-the-counter stuff, 75% scripts so within that 75% there is the scripts 
and the counselling for the scripts. (RTP3) 
Well it is my intention to change that, and I don’t know what my percentage would be 
personally but I know that the way it is set up here, we can spend a lot more time in the 
shop rather than in the dispensary. (RP9) 
It was thought that some pharmacists might feel more comfortable and ‘hide’ in the 
dispensary. Rural pharmacists said: 
Look, it depends on the pharmacy but probably, yeah. I mean, you know, they’re really 
comfortable in the dispensary too (laugh). Well, that’s who we are. (RTP4) 
However, it was said that pharmacists could spend 50% of time with customers, 
particularly if a technician was used. Two commented that the structure of their 
workplaces allowed for discussion and counselling while dispensing, and this could be 
interpreted as work ‘in the dispensary’ or ‘in the shop’. Three commented that this 
figure (75%) was location and premises specific, but overall dispensing and its 
associated services was their role, whether this is in rural or urban practice. 
Two suggested rural customers were more likely to wait and accept counselling, or ‘a 
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chat’ that would be offered, while urban/metropolitan customers did not expect this 
service. One commented that the outer urban pharmacy in which she worked was small, 
and this personal approach occurred, but admitted this was not the norm for other 
pharmacies in this particular area. 
Professional services were seen as a facet of pharmacy practice that was professionally 
satisfying to the pharmacist, and a benefit to the patient. Rural pharmacists in particular 
thought after the PAART project: 
...it is much more satisfying I would have to say and there are occasions when you really 
feel you have been of benefit to the patient. (RTP1) 
I think that can only be a good thing and the people who are taking them on, are going to 
change customer’s perception of what is involved. (RP9) 
Whilst adding to their workload, interviewees also thought that these services did add a 
level of excitement to practice, and allowed pharmacists to be challenged: 
...these extra things that keep adding in and adding in, it is not just coming to work, it is 
what makes it interesting too, but it is not just coming to work and rote doing 300 
scripts. (RP2) 
Some pharmacist interviewees, who had experience with the DMAS program, suggested 
that pharmacy practice should be more focussed on service, not necessarily on product. 
As there is no existing payment for such services, this could then influence business 
viability: 
...I just think that some pharmacies are just way too focused on making a dollar…because 
they are not getting remunerated for services and it has to be on product… (RP7) 
The PAART project was one that these pharmacists acknowledged had both motivated 
lifestyle changes in their patients, using their newfound abilities, while expanding their 
own professional capabilities. 
A number of other different professional programs and services were mentioned by the 
participants, with the opinion that these could become routine practice, e.g. ‘Healthy 
Hearts’, DMAS, asthma education and International Normalised Ratio (INR) monitoring, 
together with some limited prescribing such as dose adjustment of some continuous 
medications. This approach would also support the counselling provided by hospitals, 
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as it was suggested that patients currently ‘do not take it in’ at the time of discharge. 
I am not really sure these days, whether all the clinical input is always warranted, 
because 90% of patients really don’t really take it on board, while they are in hospital. 
(RP5) 
Expanded pharmacist roles could include: 
I think we will end up in community pharmacy doing more, I don’t know whether you 
would call it associated...or not main core medical things, but we will do a whole lot 
more things like the weight loss and the blood pressure monitoring, the drug 
discussions with the patients… (RP5) 
Limited prescribing, not necessarily to a degree where a doctor would give you a 
diagnosis and you do the prescribing, but helping with things like warfarin dosage and 
cholesterol monitoring, maybe changing the strength of medications determined by 
results, blood pressure, those sorts of things. (RP9) 
Pharmacists still need people contact in their role, a side of the profession valued by 
these practitioners—whether this is by dispensing and counselling, or participation in 
professional programs. Younger, and not the older practitioners, were considered to be 
the pharmacists who will take up these professional challenges and opportunities. This 
suggestion was not borne out by the average age of the pharmacy practitioners 
participating in this trial, one of whom had been a pharmacist for 3 years, and all others 
for more than 20 years. 
Some were concerned about the profession’s lack of wanting to change its role, or 
questioned if the voice of those who want change is not heard, or their views were 
expressed openly. Epitomised by a researcher: 
…so it concerns me that not everyone is embracing these opportunities there 
and....perhaps the people that want to embrace opportunities don’t have the vocal voices 
to make the change. (RTP3) 
Some had particular personal concerns about changes, and the negative perception of 
the practice role, such as the supply of S3 pain medications, and the time and cost 
impost of DAAs. However, overall, they thought that the visual premises could send the 
wrong message: 
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I think the biggest thing is maintaining our image and our professionalism and again 
about how the profession, whether we want to be more forceful about what’s acceptable 
and what is not acceptable, all of these programmes are great but if you have got, 
everything is half priced, flashed all over the front, then the rest of the health profession 
is not going to take us seriously enough, and that’s got to be one of the biggest issues. 
(RP7) 
However, on the positive side: 
…research in the University; it changes your perspective rather than just being under 
the ‘fluoros’ on the treadmill. (RP7) 
The final comment from a rural pharmacist, which was reflected by some of the key 
opinion leader statements in the previous chapter, was that pharmacists still need an 
income from their profession, whether this be a role be in service provision, or in 
supply. The dispensing role is still paramount: 
…because you do things for the love of the job, but you have still got to feed your kids 
and have an income, so you can’t say I am going to do everything for free and not do 
scripts, you are not going to last, so it is more the people that are organising the funding 
with the government I suppose. (RTP3) 
5.3.6 Theme: The pharmacist workforce 
This group did not focus on recruitment or retention of staff. The workforce issues 
spoken about were personal and included, having to ‘keep-up’, past and potential 
practice changes, wages, service expectations and remuneration, adequate time for the 
doing the job, and pharmacist value. 
The current pharmacist workforce is required to have up-to-date information, 
especially because patients themselves now have access to so much more information 
than in the past. Keeping up, and having a ‘bottomless pit’ of medication knowledge, was 
a workforce pressure felt by all: 
...there is a lot more information online for patients and there is also, I guess a lot more 
that pharmacists can do, or that have access to... (UP8) 
It is just all the things that you, I suppose you don’t have to do them but if you don’t do 
them, you feel like you are being left behind, you are not keeping up with everything, 
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otherwise you just sort of, you have got to keep up with all the latest and everything. 
(RP2) 
Since registration, these participants have seen many changes in practice over time, 
such as computerisation instead of hand-written prescription entries, and even talking 
to patients. The workforce has had to adapt to a patient-focused model: 
I think patient focus...It was a very, you know when I started we didn’t talk to patients 
unless they asked us. (UP3) 
Adding to existing workloads were the acceptance of more and more services. Apathy to 
change from within, and procrastination to change still existed amongst the profession. 
However, there are those who despite these challenges, continue to provide PAART 
additional services (after the completion of the project) because of the positive patient 
results, despite no monetary or time reimbursement: 
Yes, because pharmacists are pressed for time as we all know…You know how there are 
always the ones who will go that extra mile. (RTP2) 
However, balanced against this was the following sentiment: 
I am here to work for my boss and to get my wages, so a warm glow doesn’t do that. 
(RP9) 
The pharmacist’s ability to charge, together with an appropriate payment for this 
service was questioned by all participants. One discrepancy between the anonymous 
survey [203], and the face-to-face interview, was that on interview, it was thought that 
this service should attract a charge. However, previous expectations and experience of 
free advice might deter customers even to the extent of retaining their allegiance to the 
pharmacy. It was thought that customers would not pay, even though each session ran 
for 10–30 minutes with a pharmacist. The anonymous PAART pharmacist participant 
survey suggested charges per visit of AUD$1–5 (median) with the range from AUD$0 to 
AUD$6–10 for up to 30 minutes of time were appropriate. Pharmacists said: 
...we always undervalue ourselves and I think it is historical. (RTP2) 
Since this survey, there have been programs supported through the 5CPA and 6CPA, 
where pharmacists can claim for a service, and this can be offered to customers without 
charge (e.g. MedsChecks). For instance, the Chemmart pharmacy group in Australia now 
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also offer a ‘Healthcheck’, at an approximate AUD$20 cost, but statistics on its 
acceptance and use have not been found. 
There were comments about the pharmacist not charging at all, for professional 
services, or the concern the customer would not pay. From rural pharmacists: 
Pharmacists in general do far too much for nothing and that’s one of my pet hates of the 
job, and people expect it and the government expects it and it is just not right, we don’t 
get...we are professionals, we should be paid for it. (RP1) 
...if I had of said that it is going to cost you [AUD]$10 each time you come in, which 
wouldn’t have covered the cost, then probably wouldn’t have gotten anyone to join... 
(RP9) 
Urban pharmacists concurred: 
Maybe because as pharmacists we are not used to charging for professional service... 
(UP8) 
Pharmacists are currently paid for supply, above service, under the CPA. An additional 
comment was made that currently pharmacists can always refer to doctors, and 
therefore are not used to making final decisions, that will ultimately impact on patient 
care. 
I think a bit of lack of courage in leadership, I think doctors are braver in a way, because 
they are used to putting their heads on the line, they are used to having to make a 
decision and stick with it, whereas pharmacists can always, if they are worried, they can 
always just say, it is too hard for me, go and see the doctor, they are not used to making 
bold decisions, so I think that is something that might develop. (RTP1) 
The suggestion was that professional service models, may thus provide a form of 
leadership allowing for ‘bold decisions’ to be made on patient care: 
Yes, being paid for our knowledge and our service rather than for selling goods. (RTP1) 
Time for training for delivery of professional services was considered a workforce issue 
by one urban pharmacist, together with the probable negligible cash return of this type 
of service currently: 
I mean we probably need some more training but then that takes time. Most 
pharmacists work long hours. And at the end of the day you don’t feel like going and 
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doing more training…Also like if there’s no cash return on it, you know. (UP6) 
Convincing others, especially owners, of value of this program could also be difficult: 
...Inertia, as in you know getting it rolling, getting things rolling, getting people to try it 
out…return on investment for owners… (RP9) 
Thus, the ability and willingness to take up these opportunities, despite uncertain 
payment or return on investment, rests with the professional workforce. Barriers of 
training, time and staff availability, together with inertia and procrastination within the 
profession, mean opportunities are not taken up. Supply still supplants service, in any 
current pharmacy workforce—rural or urban. 
5.3.7 Theme: Differences in rural community pharmacy in Australia 
The participants were constantly asked about what they thought were the differences in 
rural pharmacy practice compared to urban practice. It can be seen using the 
participants’ codes in the previous quotes, that there were no firm or obvious 
differences, between those in rural and urban practice. 
Some differences proposed are discussed below. The acceptable pace of current rural 
practice, combined with the requirement for a personal life balance, and recruitment 
issues, were concerns for those practicing in rural areas: 
...it is just the pace, the pharmacies… (RP2) 
…unable to get pharmacists, that is probably the biggest challenge. (RP1) 
You are on call twenty-four hours a day, seven days a week, you never can be 
anonymous, which is good and bad but that can be a bad thing because they know where 
you live and they know you are happy to go out at night, all that sort of stuff, and yeah, 
so you are always on call and that is a bad thing. But the good things far outweigh that, 
absolutely. (RP1) 
Rural pharmacists enjoyed their relationships with customers. They knew their 
customers, and could single out prospective participants in the PAART project at the 
introductory education workshop. Even though they considered themselves to be on 
call for 24 hours per day, the good aspects of rural practice outweighed the bad: 
Probably the biggest difference…is the rapport you have with your customers. The 
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loyalty that customers show their pharmacists, in most cases and look that may be the 
case in city pharmacies but I doubt it, and the fact in country pharmacies, you not only 
know your customers as customers or patients, but you know them socially too 
probably, and you know them to say hello to them up the street and you see them 
everywhere, you see them at football and talk to them so that’s probably the biggest 
difference between, the biggest advantage of rural pharmacy, you just know everybody 
so well. (RP1) 
Working with a local health team for this project was important to the participants, and 
particularly mentioned by those from rural areas. However, in the PAART project 
feedback, participation from local doctors was rare. Different to urban pharmacist 
participants, one rural pharmacy was going to continue with the program as presented, 
with patients nominated by the local doctor: 
We would probably do the same type of format, but of course, the doctors will do the 
original set of data... (RP5) 
Again, it was the rural pharmacists who primarily commented on maintaining a version 
of the service, by still ‘having a chat’ with patients who were involved, to encourage 
further improvements in heart health. The in-depth knowledge provided by the project 
enabled these pharmacists to feel empowered to contribute to their patient’s continuing 
health care: 
Look I’ve got one of those who still comes in once a month and we just sit down and 
have a little chat. Jumps on the scales and I measure his circumference because that was 
something that he and I found was beneficial for us... (MP3) 
Well...I am not continuing to do it but they are still actively talking to me about it... (RP1) 
I am going to miss having a sit down and chat and we have just kept that going, it means 
that you have a better relationship, a deeper relationship... (RP7) 
Comment was made that rural practice models were specific to rural areas, due to the 
nature of the population, and expected service provision. This was described by one 
owner practitioner as: 
…what attracts someone to buying in a rural area, is that they do want to have that 
community connection…and again it harps back to the fact that they can’t, if you are in a 
rural area, where no one is passing through, you can’t choose the model of high volume 
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turnover, you have to choose this model of forward pharmacy and professional services 
and that sort of thing, because it is the only model that will actually work for you. (RP7) 
5.4 Diagrammatic models of pharmacy practice–discussion and results of 
PAART pharmacists’ interviews 
Both the community pharmacists and research pharmacists, and the key opinion 
leaders, in the previous chapter, expressed many similar concepts and ideas. But in this 
PAART group, the emphasis was more on internal issues, issues pertinent to the 
individual practitioner, and their own practices and local health professionals, rather 
than those which were external, visionary or ‘big picture’ and affected the profession as 
a whole. 
External influencing issues relating to the PBS and government policy were not 
mentioned as often by the PAART pharmacists. They were concerned if payment for 
professional services would come from existing CPA funds, implying some other 
services would be cut back. Some pharmacists had specific issues of concern, such as 
S2/S3 schedules and overuse of pain medication, and the time impost for preparation of 
DAAs. 
These pharmacists believed that their ‘biggest customer’ was the ‘Government’, which 
in turn set the rules for community practice, and was therefore both a customer, and a 
competitor. Concern was expressed as to the efforts of the PGA to ensure a favourable 
deal for pharmacies. The influence of discount pharmacies on the profession was a 
concern as customers sought a better price over potential services. 
Participants talked about the significant changes that have occurred over time, 
including the use of computerisation and pharmacy practice itself. One did point out 
that change and practice differences have always existed in the profession. The need to 
‘keep-up’ was a concern, but for this group, the challenge of introducing new 
professional programs, and the consequent patient engagement and learning, was 
welcomed. Both groups recognised changing models of practice and business, as major 
components of transformation for the current and future pharmacy profession. 
Like the key opinion leaders, all participants were passionate about their profession 
with only one expressing a feeling of being ‘jaded’. These pharmacists may be 
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considered as different to the profession as a whole, because they were a group 
committed to trying new practices and engaging in research opportunities. Some even 
asked on interview if there were more research practice-change projects in which they 
could contribute. 
The following model shows the critical issues for PAART participant pharmacists. This 
model will be further discussed in Chapter 8, together with the models from Chapter 4 
to identify any further differences between rural and urban community pharmacy 
practice. It is hoped this could then assist in identifying specific knowledge and skills 
that exist or are required for rural pharmacy practice. 
Figure 5.1: Critical issues for pharmacists: Model for pharmacists from PAART CVD Study 
 
5.5 Summary 
Interviewing the PAART pharmacists and researchers gave another insight using the ‘at-
the-coal-face’ pharmacists’ thoughts and opinions about current differences in their 
profession, and its future practice. The views in this chapter were from the pharmacists 
who were hands-on practitioners, and were different to those from the key opinion 
leaders. The leaders concentrated on ‘big picture items’, such as the role of the 
profession of pharmacy in national policies, the influence and role of the professional 
organisations, the structure of the CPAs, and expanded practitioner roles. These were 
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extensive proposed changes, which would improve and expand the role of the 
profession. PAART practitioners identified issues that were internal in the profession 
and their local practice. 
However, many professional concerns were similar, such as the increasing influence of 
discounters, the culture and attitudes of the pharmacists themselves, adequate 
remuneration for usual work, extra additional services and the customer expectations 
of price and service. PAART practitioners thought about the roll out of the CPAs, and 
how it affected them, and specific practice concerns such as DAAs, analgesic or S2/S3 
sales. These issues were not necessarily specific to rural practice but mentioned by all in 
different sections of the interviews. 
The PAART practitioner interviews showed that pharmacists felt they were restricted 
by the CPAs, but overall accepted this traditional funding model format, despite some 
wish for change within their own practice. They felt customers were crucial to business, 
and thus should not be adversely affected by any practice change. However, the 
pressure to change and improve practice, was felt by all. Rural pharmacists were no 
different, but the context and willingness of customers to sit and listen was 
acknowledged as unique, compared to that experienced in most city pharmacy 
practices. All these views will be further discussed in Chapter 8. 
Other sources of data will be used in the next two chapters to investigate for potential 
differences in rural and urban community pharmacy practice. The following chapter 
(Chapter 6) will investigate two evaluations of the QCPP. The first used data from the 
3CPA, and examined what services were provided by pharmacies, while the second used 
data from the 4CPA consumer survey, for a contrasting perspective of community 
pharmacy practice. These two investigations will attempt to provide additional insight, 
and statistical analysis, using larger data sets to look for practice differences. 
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Chapter 6: Comparison of community pharmacy services and 
differences using two CPA QCPP data sub-analyses 
The Quality Care Pharmacy Program (QCPP) [209] is a nation-wide community 
pharmacy quality assurance program, which provides support and guidance for 
community pharmacies delivering all pharmacy-related undertakings, including their 
professional health services (Chapter 2). Pharmacies are accredited biennially. 
Evaluation of the QCPP is conducted every five years at the end of the CPA cycle, to 
measure the quality of professional services activity and customer care provided by 
accredited pharmacies. De-identified data, requested for these sub-analyses from the 
3CPA and 4CPA evaluation data, examined responses for possible differences of practice 
between rural and urban pharmacies. These evaluations allowed for comparisons with 
other investigations and analyses undertaken. 
Specific data from these two evaluations were obtained with permission from the 
authors. Permission was received from the data owner, the PGA. The 3CPA pharmacist 
data was from the second, and more the detailed of the three surveys conducted, and 
from the latter, 4CPA, the customer survey data was acquired. The focus of the 
published evaluations was the differences between QCPP accredited and non-accredited 
pharmacies, and not specifically rural and urban differences, thus allowing in this work 
further data analysis, which had not previously been conducted or published. 
6.1 Aims of the study 
The aims of these sub-analyses in Chapter 6 were to: 
• compare pharmacist and pharmacy responses from the selected sections of the 
3CPA QCPP evaluation data in relation to rural and urban areas of practice 
• compare patient/consumer responses from the selected sections of the 4CPA QCPP 
evaluation data in relation to rural and urban areas of pharmacy practice 
6.2 Sources of data 
The data for these analyses were from two consecutive CPAs. The surveys and 
evaluations analysed were from the 3CPA QCPP evaluation (2005) [210], and the 4CPA 
QCPP evaluation (2010) [211]. 
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Although the PhARIA system was added for the 3CPA evaluations, extensive further 
classification was required for the 4CPA evaluation data, which used postcodes rather 
than PhARIA rankings. A Microsoft Access© database was developed for this latter work, 
and the postcodes supplied were allocated a PhARIA ranking [16, 212] appropriate to 
the time and place to when the survey was undertaken. This then enabled a comparison 
to be made, using a two-fold urban/rural division with the results. 
Efforts have been made to compare data within the constraints of these differing 
systems, differing nomenclature and the differing years in which these projects were 
conducted. The projects, which were quite dissimilar in nature, will be described in 
more detail before the discussion and a comparison is made. 
6.3 Third Community Pharmacy Agreement QCPP evaluation sub-analysis 
The 3CPA was signed on 16 May 2000 and covered 1 July 2000 to 30 June 2005 [70]. 
The QCPP evaluation (2005) [210] was undertaken to assess the impact and value of the 
QCPP on community pharmacy practice by the Australian College of Pharmacy Practice 
and Management, Quality Medication Care Pty Ltd and the Therapeutics Research Unit, 
University of Queensland. 
The report did not specifically examine differences in perceptions and activities of rural 
pharmacy practice, but concluded that it was the size of the pharmacy, not the rurality, 
which contributed to practice differences. PhARIA 1 pharmacies were more likely to 
have a negative view of the future of pharmacy than those in PhARIA 2 or 3. Smaller 
businesses performed better than larger businesses, and those small businesses in rural 
locations performed better than PhARIA 1 sites. Using the raw data, given with 
permission from the researchers and the owners (PGA), the evidence was re-examined 
in order to investigate areas of the research questions about rural pharmacy practice 
being different to urban practice. 
6.3.1 Method 
The raw data from the second more detailed 3CPA QCPP pharmacist survey was 
examined for differences in practice between rural and urban pharmacies. A copy of the 
survey can be found in Appendix 5. The data requested by the researcher was 
anonymous, with postcodes and/or PhARIA rankings, to enable a rurality ranking to be 
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assigned. The original project report [210] was also studied to ensure comparisons and 
analysis had not been made or published previously by its authors. 
6.3.2 Results 
The initial survey (also called a census) was sent to 4,859 pharmacies and completed 
surveys were received from 4,085 pharmacies. A second more complete data set was 
then requested with replies received from 2,416 pharmacies, which was made available 
for this analysis by the original researchers. Completed by the pharmacy itself, the data 
obtained was presented in Microsoft Excel© spreadsheets but then required extensive 
reclassification prior to analysis, using IBM SPSS Statistics 22–24© (Armonk, NY: IBM 
Corp.). The original researchers also provided the rationale for the coding and 
explanation sheets. The initial spreadsheet did not have the information about 
professional services in pharmacies, and another spreadsheet was requested and 
received. This second sheet then had to be tallied against the first. Only postcodes were 
requested and sent, to protect the identity of the respondents. An ARIA geographic 
ranking was added to the more complete data set, then a PhARIA ranking was assigned 
for consistent analysis with other investigations undertaken for this thesis. 
Several questions in this evaluation, were of interest to the subject of this thesis. Some 
of the data that required recoding was described as missing, where it was previously 
coded under one of the following three headings: don’t know, not applicable or missing 
in the initial data. This was corrected in the final analysis. 
In this 3CPA evaluation pharmacist survey, the pharmacies were asked 31 questions 
based on what happened in a normal full working day. The results are shown, 
separating responses from urban PhARIA 1 areas and the combined rural PhARIA 2–6 
areas. Of the reply cohort of 2,416, 21.2% (511) pharmacies were PhARIA 2–6 and 
78.8% (1,903) were PhARIA 1, which is approximately the Australian ratio described 
previously for urban/rural pharmacy proportions (Chapter 2). 
The first pharmacy census asked for pharmacy details including location, size, if the 
pharmacy was part of a banner group, number of prescriptions dispensed, opening 
hours, staffing, turnover and proportion of prescriptions and front of shop sales, and 
about QCPP itself. Pharmacies could be identified as the Pharmacy Approval Number 
was also added. The second census added more details about the owner/managing 
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partner, manager if not the owner, if this person was accredited for medication reviews, 
qualifications of staff and benefits of the QCPP process. Also asked, was information 
useful to this study, to attempt to differentiate between rural and urban pharmacy 
practice. Pharmacies were asked about the proportion of customers who were regarded 
as regular, how many sought advice from the pharmacist, number of referrals made to 
GPs for a particular consumer enquiry or if the problem was resolved in the pharmacy, 
lifestyle advice given and provision of professional pharmacy services. 
A series of analyses were conducted using this de-identified data to find if any statistical 
evidence was pertinent to this thesis, and specific to rural community pharmacy 
practice. With nearly 80% of pharmacies in PhARIA 1, Table 6.1 shows the actual rural 
distribution of the remaining pharmacies. 
Table 6.1: Location of pharmacies by PhARIA using 3CPA QCPP evaluation data 
PhARIA 
1 
PhARIA 
2 
PhARIA 
3 
PhARIA 
4 
PhARIA 
5 
PhARIA 
6 
Missing 
PhARIA 
2–6 
Total 
1,903 
(78.8%) 
175 
(7.2%) 
179 
(7.4%) 
72 
(3.0%) 
52 
(2.2%) 
33 
(1.4%) 
2 
511 
(21.2%) 
2,416 
The answers to some of the specific survey questions were investigated further, and the 
results are as follows: 
Q15–6: Advice from the pharmacist, referrals to GPs and problems solved by the 
pharmacist 
Participants were asked to estimate numbers of customers seeking advice, referrals and 
the problems solved by the pharmacist. The number of people seeking advice below was 
grouped to allow ease of analysis. The outlier of 1,690 daily customers seeking advice in 
one pharmacy, and all unknown values were excluded for analysis. 
It can be seen in Table 6.2 below, that in 89.9% (1,654/1,840) of PhARIA 1 pharmacies, the 
pharmacist saw up to 20 patients per day compared to 93.8% (467/498) of rural pharmacies 
who saw this similar number. However, using a Chi-squared test there was no statistical 
difference. 
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Table 6.2: Number of people who sought advice from the pharmacist on a usual working day 
Number of people 
seeking advice per 
day 
Number of PhARIA 1 
pharmacies 
Number of PhARIA 2–6 
pharmacies 
Total 
1-10 1,165 (63.3%) 351 (70.5%) 1,516 
11-20 489 (26.6%) 116 (23.3%) 605 
21-30 65 (3.5%) 14 (2.8%) 79 
31-40 90 (4.9%) 13 (2.6%) 103 
More than 41 31 (1.7%) 4 (0.8%) 35 
Total 1,840 498 2,338 
The mean number of people seen daily by the pharmacist in PhARIA 1 locations was 
28.5, compared to 24.9 in PhARIA 2–6 areas (Table 6.3). Using Levene’s test and a t test, 
there was a significant difference in favour of PhARIA 1 pharmacies although the 
absolute difference is small (p<0.01 equal variances assumed; p<0.00 equal variances 
not assumed). In practice, there is no real difference in the number of people seeking 
advice from the pharmacist on a normal working day in either urban or rural 
pharmacies. 
Table 6.3: Mean number of people seeking advice per day from a pharmacist 
Pharmacy location n Mean 
PhARIA 1 1,839 28.48+/-27.94 
PhARIA 2–6 498 24.92+/-21.91 
Although the data was separated as per the pharmacy classification system, this data 
cannot be adjusted for pharmacy population, as the PhARIA system is multifactorial in 
nature, and there is no method available to find the population of the various 
geographic areas classified under this PhARIA system. Thus, the data cannot be adjusted 
for the actual population catchment of the individual pharmacy itself. 
The survey also asked for an estimate of the number of people referred by the pharmacy 
to a GP on a usual working day (Table 6.4) and if the problem was solved by the 
pharmacist (Table 6.5) or the pharmacy assistant (Table 6.6), before this referral was 
required. Similar numbers of customers were referred to the GPs per day in each 
geographical area. Although similar numbers of queries were solved by the pharmacy 
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assistant, more PhARIA 1 pharmacists (mean 87.3%) solved problems then PhARIA 2–6 
pharmacists (mean 66.9%). 
Table 6.4: Percentage of customer’s problems referred to a GP 
Pharmacy location n Mean 
PhARIA 1 1,850 14.6+/-13.56 
PhARIA 2–6 501 13.87+/-12.25 
Table 6.5: Percentage of problems resolved by the pharmacist 
Pharmacy location n Mean  
PhARIA 1  1,903 87.30+/-235.35 
PhARIA 2–6  511 66.87+/-194.95 
Table 6.6: Percentage of customer problems solved by the pharmacy assistant 
Pharmacy location n Mean 
PhARIA 1 1,715 79.38+/-25.52 
PhARIA 2–6 478 79.11+/-27.10 
A lower proportion of people had their problem resolved by the pharmacist in PhARIA 
2–6 areas, compared to those in PhARIA 1 (p<0.01). There was no statistical significant 
difference with a problem solved by the pharmacy assistant or the number of referrals 
to the GP in either location. 
Data was not available for Q17: What lifestyle advice or referrals to other health 
professionals or health services were most frequently given. 
Q23: What percentage of customers do you regard as regular? 
In PhARIA 2–6 pharmacies, 83% stated that more than 60% of their customers were 
regular, compared to 63.4% of PhARIA 1 pharmacies. Nearly one-third (578/1,888; 
30.6%) of PhARIA 1 pharmacies said 30-60% of customers were regular compared to 
the much lower percentage, 13.7% (70/511), for rural and remote pharmacies. Overall, 
significantly more rural pharmacies regarded their customers as regulars compared to 
pharmacies in PhARIA 1 locations (p<0.00). See Table 6.7 below. 
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Table 6.7: Portion of regular pharmacy customers comparing PhARIA 1 to PhARIA 2–6 
PhARIA/Regular Customers Up to 30% 30-60% >60% Total 
PhARIA 1 103 (5.4%) 578 (30.4%) 1,207 (63.4%) 1,888 (100%) 
PhARIA 2–6 11 (2.2%) 70 (13.7%) 424 (83%) 511 (100%) 
Q30: Main clinical and monitoring service provided by the pharmacy 
The survey questions did not specifically define what each clinical and monitoring 
service investigated entailed; however, the report did go into more detail. Elsewhere in 
the report, more consumer investigations were then undertaken for diabetes and 
asthma services, but this detail was not requested. Pharmacist respondents were asked 
to nominate their main professional activity from the following: blood pressure, 
diabetes, nutrition, asthma, wound care, methadone, community education, 
complementary medicines or other. Community education and complementary 
medicines were only nominated by a total of three respondents in the sample as their 
major service, while no pharmacy nominated wound care or methadone services as 
their primary service (See Table 6.8). 
Table 6.8: Relationship between PhARIA 1 and PhARIA 2–6 pharmacies providing monitoring and 
clinical services 
Service/ 
Location 
Blood 
pressure 
Diabetes Nutrition Asthma 
Written 
medication 
profiles 
Number of 
pharmacies 
PhARIA 1 
901 
(47.3%) 
380 
(20.0%) 
380 
(20.0%) 
198 
(10.4%) 
43 (2.3%) 
1,903 
(100%) 
PhARIA 2–6 
263 
(51.5%) 
97 
(19.0%) 
70 (13.7%) 67 (13.1%) 13 (2.5%) 511 (100%) 
Significance 
p value 
0.35 0.73 0.01 0.14 0.84  
Percentage as a whole—2,414 pharmacies offering services. 
Overall, while 47.3% of the total number of pharmacies in the study (2,414 which 
answered this question) which offered ‘Blood Pressure’, as it was termed, as their main 
clinical and monitoring service, were in PhARIA 1, 51.5% were in PhARIA 2–6 areas 
(Table 6.8 above). Marginally more PhARIA 2–6 pharmacies proportionally offered 
asthma services (PhARIA 1, 10.4%: PhARIA 2–6, 13.1%). Similar rates in both 
geographic areas occur for diabetes services (PhARIA 1, 20.0%: PhARIA 2–6, 19.0%), 
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and only a small number of pharmacies offered written medication profiles (PhARIA 1, 
2.3%: PhARIA 2–6, 2.5%) as their main service. More pharmacies in PhARIA 1 offered 
nutrition services (PhARIA 1, 20%: PhARIA 2–6: 13.7%), the only marginally 
statistically significant difference (p<0.01). 
6.3.3 Discussion similarities and differences for rural and urban 
pharmacies 
In this study of the evaluation of the 3CPA QCPP, pharmacies were asked 31 questions 
about the pharmacy itself, its size and business, staff and services provided. Rural 
pharmacies did have a more regular customer base, as would be expected, with 83% of 
pharmacies stating over 60% of their customers were regular. 
Pharmacists were asked if people sought health or lifestyle advice, and if customers 
were referred to, a GP, or the problem was resolved in the pharmacy, by the pharmacist 
or staff. More PhARIA 1 pharmacists solved problems that presented than rural 
pharmacists did. Pharmacists were also asked to indicate their main professional 
services from a range provided. Most pharmacies indicated blood pressure, diabetes, 
nutrition, asthma and written medication profiles as their main service from the list 
suggested. Very few suggested methadone, complementary medicine, wound care and 
community education as their main activity. 
The results indicated there were no significant differences between rural and urban 
pharmacies in monitoring and clinical service provision except in one area, which was 
statistically significant. Nutrition services were considered the main activity in more 
PhARIA 1 pharmacies than PhARIA 2–6 pharmacies (p<0.01) but the result is weak. 
However, there was no definition of ‘nutrition’ and it cannot be determined to what the 
difference actually related. As the pharmacy was not asked to define the detailed nature 
and components of, the service provided the following could occur to use a worst-case 
example. A weight management or nutrition service, could be interpreted as high 
vitamin or weight management product sales, or a more complex nutrition and wellness 
clinic conducted as an extended face-to-face counselling session within the pharmacy 
setting with the pharmacist. 
There was a trend for rural pharmacies to supply more blood pressure and asthma 
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services, but with no statistical significance. This further analysis of the survey did not 
shed any more real light on differences between rural and urban services using the 
parameters explored. The report of this evaluation [210] indicated pharmacy size was a 
significant factor in pharmacy service provision, whether this be this in a urban or rural 
location. 
Data from the following QCPP evaluation report for the 4CPA will also be analysed to 
look for any trends or changes in rural and urban practice, from a different perspective 
5 years later. The following analysis used a large customer survey database of 
responses. 
6.4 Fourth Community Pharmacy Agreement QCPP evaluation analysis 
The 4CPA was signed on 16 November 2005 (nearly five months after the completion of 
the previous agreement) and ended on 30 June 2010 [70]. Again, an evaluation of the 
QCPP was undertaken as part of the ongoing assessment of the overall 4CPA program. 
In 2012, 92% of Australian pharmacies were QCPP accredited [213]. The following 
comparative analyses looked for differences between rural and urban pharmacies. It 
had not been conducted previously and was not a focus of the initial analysis 
undertaken by the survey provider. This analysis will address the research question for 
potential differences between rural and urban community pharmacy practice using 
these customer responses. 
6.4.1. The consumer survey 
The 2011 4CPA QCPP Pharmacy Patient Questionnaire (Appendix 6) section of the QCPP 
evaluation, was conducted by Client-Focused Evaluations Program (CFEP), in turn 
managed by the Focused Evaluations Program Company [211]. Staff gave out consumer 
surveys, and these either were completed immediately or could be left with the 
pharmacy, or returned by post, for analysis. Each participating pharmacy was initially 
sent 60 forms, and while some completed far more, others contributed far less (range 
1–178). Analysis was conducted by CFEP. The de-identified data for this analysis was 
requested from CFEP with permission of the data owner, the PGA. The final survey data 
received from 921 pharmacies in 745 Australian postcode locations, with a total of 
36,668 individual survey replies, contained the postcode only as a location identifier. 
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The results of questions relating to professional services, information and advice, 
supply, customer satisfaction and presence of a chronic illness were requested. The 
survey response final data was completed in July 2012, and made available for this analysis. 
6.4.2 Method 
The survey replies were sent as a Microsoft Excel© spread sheet and further de-
identified by CFEP using codes for each pharmacy. Identification of the rurality ranking 
of each pharmacy was deduced using the Australian postcode provided, and compared 
to the PhARIA 2011–12 table [214] as this was the set closest in time, for the majority of 
survey replies. 
The data required extensive refinement to allow comparison analysis. A Microsoft 
Access© database was developed to allow the conversion from postcode to PhARIA 
ranking. Pharmacies were divided into urban (PhARIA 1) and rural (PhARIA 2–6). From 
a total of 2,885 postcodes in Australia, pharmacies in 745 locations provided data for 
this QCPP Evaluation survey. Some postcodes did have more than one PhARIA ranking 
so an average within the postcode was used to allocate a PhARIA number using the 
method below. Anomalies also existed between the different coding systems (postcode 
and PhARIA ranking) such as the use of apostrophes, brackets, spaces and full stops, 
which had to be taken into account, and an adjustment made so this additional data 
could be included. For 23 postcodes, no PhARIA ranking existed and one was allocated 
using the surrounding areas as a guide. Of these, 22 postcodes were ranked PhARIA 1 as 
they were clearly urban, such as a city post-box postcode or inner major city locations. 
The last one was ranked PhARIA 3, by looking at surrounding postcodes. The data 
provided was not divided to investigate the information from each pharmacy, but 
grouped into rural and urban, so the two individual data sets could be analysed. This 
grouping allowed all data to be used, even those with a small number of responses per 
pharmacy. 
Each postcode area in Australia can consist of a number of smaller towns or suburbs. 
Some postcodes relate well to the PhARIA system and all locations within that code will 
be e.g. PhARIA 1. However, for some areas, more than one PhARIA ranking exists. Using 
the Microsoft Access© database, analyses of all known PhARIA classifications for a 
particular postcode were taken into account, then averaged to provide an analysable 
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PhARIA ranking for each postcode provided. The assumption was made that if this 
average ranking for the suburbs and areas listed was more than PhARIA 1, the overall 
area was deemed to be rural, for this 4CPA QCPP analysis. 
The CFEP Pharmacy Patient Questionnaire (Appendix 6) used a Likert response 
sequence coded as 0–blank (no response); 1–poor; 2–fair; 3–good; 4–very good; 5–
excellent; and 6–don’t know. It could be argued that this style of sequence would 
produce a biased positive response, as there was no ‘neutral’ as the usual central 
response option, with negative and positive response possibilities either side. There 
were also no sets of positive and negative questions as described by MacKeigan and 
Larson (1989) [215], to alleviate bias and confirm the answers were the consumer’s 
intent. 
As staff handed out the survey, the cohort selected might be construed as biased, but on 
the positive side, it could be more representative of regular pharmacy customers. This 
survey format has been widely used in pharmacy, and other health service areas in 
Australia, and also in the UK. In Australia, surveys were centrally analysed compared to 
the UK, where the pharmacy customer satisfaction surveys could be either collated by 
the pharmacy itself, or sent away for analysis. Trustworthiness could be questioned 
with this initial analysis method in both countries. However, under the requirements of 
QCPP, this is only one part of the extensive analysis of the QCPP system undertaken 
during each CPA. 
The survey questions include those related to the pharmacy itself, the staff and other 
issues such as availability and information provided, as well as locality and 
demographic data. There was also an opportunity for free text suggestions for 
improvements within the pharmacy. Not all survey answers were requested for these 
analyses. Responses, which related to the access, appearance, comfort of surroundings, 
waiting times, greeting, respect shown, availability of products and opportunities for 
complaints, were not requested. The selection of data requested from the owners 
related to professional service provision, confidentiality and privacy, issues often 
mentioned in the rural literature. The following table shows the questions asked by the 
CFEP Pharmacy Patient Questionnaire and the abbreviations used in this chapter for 
further analysis. 
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Table 6.9: Questions of the 4CPA QCPP consumer survey 
Question 
number 
Survey question 
Abbreviations used 
in text or tables 
About the pharmacy 
6 
Availability of privacy where you could speak without being 
overheard, if needed 
Q6 Privacy 
7 
Extent to which your personal information is kept confidential by 
pharmacy staff 
Q7 Confidentiality 
About the pharmacy staff (whom you just saw) 
9 Overall satisfaction with my discussion with the staff was… Q9 Satisfaction 
11 
On the visit I would rate the staff’s ability to really listen to me 
as… 
Q11 Availability 
12 The staff’s explanations of things to me were…. Q12 Explanations 
13 The extent to which I trust this person is… Q13 Trust 
14 
My confidence in this staff member’s knowledge of medicine and 
health products is… 
Q14 Knowledge 
15 
The opportunity the staff gave me to express my concerns or 
fears was… 
Q15 Opportunity to 
express concerns 
Other issues 
18 
Information provided by the pharmacy about its services (e.g. 
prescriptions, leaflets, travel advice) 
Q18 Service 
information 
19 
The information provided by this pharmacy about how to 
prevent illness and stay healthy (e.g. skin care, health risks of 
smoking, diet habits, etc.) was… 
Q19 Preventative 
health information 
Demographic data 
26 Is this your regular pharmacy? 
Q26 Regular 
pharmacy 
28 
Do you have any chronic illness or disability that is likely to affect 
you over a long period of time? 
Q28 Chronic illness 
Two methods of data management were used to investigate any differences between 
urban and rural pharmacy survey responses. They were: 
• Method A that combined all responses into rural and urban, and excluded those, 
which were 0–blank (no response) or designated as 6–don’t know. 
• Method B used a mean response per pharmacy, excluding those pharmacies with 
less than 10 responses and excluded those, which were 0–blank (no response) or 
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designated as 6–don’t know. 
6.4.3 Results 
This analysis was undertaken using Microsoft Access© and IBM SPSS Statistics 20–24© 
(Armonk, NY: IBM Corp.) to group the data and then allow for statistical analysis. The 
following results in the tables below explored if there were any possible statistical 
differences existed between urban and rural survey respondent groups. 
Overall, 69 pharmacies had less than 10 responses each, for a total of 243 survey 
responses, only 0.06%, of the total of 36,668 responses received. Of these 69 
pharmacies, 54 (54/921; 5.9% of the whole pharmacy cohort) were in PhARIA 1, and 15 
(15/921; 1.6% of the whole pharmacy cohort) were in PhARIA 2–6, a lower ratio of 
urban to rural than for the rest of the database, but a small subset overall. Responses 
per pharmacy ranged from 1 to 118 with the mean number of responses being 40.2. 
It can be seen that there were no statistical differences between the two groups of 
respondents in urban or rural areas of Australia, with either method, except for one 
question. The only area in which respondents differed was in the pharmacist’s 
knowledge, which was considered greater in rural areas but this difference was very 
small in absolute terms and not a strong statistical difference (T (765)=1.98, p<0.05). 
Consumers considered all pharmacies provided a private area if required, and 
confidentiality, was maintained. Respondents were satisfied with the pharmacy. They 
trusted the pharmacist and staff, and the pharmacist was available if needed. 
Pharmacists provided adequate explanations about medicines, preventative health and 
service information, and there was opportunity to express concerns or make 
complaints. Ratings overall were in the ‘very good’ to ‘excellent’ range, except for the 
availability of a private area in the pharmacy, which was ranked as ‘good’ to ‘very good’. 
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Table 6.10: 4CPA Comparison of two methods for analysis of survey responses 
Question 
Method 
of 
analysis 
Urban pharmacy 
responses 
Rural pharmacy 
responses 
Significance 
 
Mean and 
Standard 
Deviation1 
No 
response/ 
Don’t know2 
Mean and 
Standard 
Deviation1 
No 
response/ 
Don’t know2 
 
Q6 Privacy 
A 3.72±0.36 8.2% 
(7.0% Don’t 
Know2) 
3.73±0.40 7.3% 
(6.1% Don’t 
Know2) 
T (765)=0.11, 
p=0.91 B 3.73±1.11 3.74±1.12 
Q7 
Confidentiality 
A 4.4 ±0.21 
13.1% 
(11.2% Don’t 
Know) 
4.47±0.20 
10.7% 
(9.3% Don’t 
Know) 
T (765)=0.69, 
p=0.49 
B 4.48±0.73  4.47±0.76  
Q9 
Satisfaction 
A 4.54±0.20 0.8% 4.54±0.19 0.9% T (765)=0.81, 
p=0.42 B 4.55±0.67  4.54±0.67  
Q11 
Availability 
A 4.56±0.21 2.0% 4.56±0.19 1.4% T (765)=0.31, 
p=0.76 B 4.55±0.67  4.55±0.67  
Q12 
Explanations 
A 4.52±0.68 2.7% 4.52±0.68 2.0% T (765)=0.16, 
p=0.88 B 4.52±0.20  4.52±0.19  
Q13 Trust 
A 4.50±0.70 3.2% 4.49±0.71 2.6% T (765)=0.88, 
p=0.38 B 4.51±0.23  4.49±0.21  
Q14 
Knowledge 
A 4.51±0.69 4.4% 4.48±0.71 3.6% T (765)=1.98  
p=0.048 B 4.51±0.22  4.48±0.20  
Q15 
Opportunity to 
express 
concerns 
A 4.54±0.72 
9.3% 
(7.0% Don’t 
Know) 
4.44±0.73 
8.1% 
(5.6% Don’t 
Know) 
T (765)=0.88, 
p=0.39 
B 4.45±0.22  4.32±0.21   
Q18 Service 
information 
A 4.42±0.74 5.7% 4.43±0.73 4.2% T (765)=1.02, 
p=0.31 B 4.42±0.22  4.43±0.21  
Q19 
Preventative 
health 
information 
A 
4.20 ± 
0.80 
14.3% 
(11.5% Don’t 
Know) 
4.21±0.78 
11.1% 
(8.4% Don’t 
Know) 
T (765)=0.57, 
p=0.57 
B 4.19±0.24  4.20±0.23  
1 Likert Items: 1–poor; 2–fair; 3–good; 4–very good; 5–excellent. 
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2 Likert Items 0–blank (no response); 6–don’t know. 
Method A: Urban and rural results excluding 0–blank (no response) and 6–don’t know. 
Method B: Urban-rural and rural results using a mean response per pharmacy, excluding 0–blank (no 
response) and 6–don’t know. 
In Table 6.11 below, to further investigate the data, two of the questions analysed 
requested a yes/no response and a Chi-squared analysis was conducted. Excluded were 
those responses, which were blank (no response) and were coded as 0. Rural 
respondents were slightly more likely to have a regular pharmacy (X2 (1, 
n=28,831)=99.37, p<0.00) but were as likely as urban respondents to have a chronic 
illness as shown in Table 6.11 below. 
Table 6.11: 4CPA Comparison of rural and urban pharmacy: Regular pharmacy and chronic illness 
 Urban 
pharmacy 
responses 
Rural 
pharmacy 
responses 
Chi-sq. 
Q26 Regular pharmacy 
yes 19,715 (91.2%) 4,302 (95.5%) X2 (1, n=28,831)=99.37, 
p<0.00 
no 1,899 (8.8%) 205 (4.6%) 
Total response 21,614 4,507  
Q26 No response 1,899 318  
Total no missing 
responses 
2,217 Total responses: 23,831 
Q28 Chronic illness 
yes 11,766 (53.5%) 2,434 (53.3%) X2 (1, n=34,387)=0.00, 
p=0.99 
no 10,223 (46.5%) 2,130 (46.7%) 
Total response 21,989 4,564  
Q28 no response 1,494 261  
Total no responses 1,755 Total responses: 28,308 
6.4.4 Discussion similarities and differences for rural and urban 
pharmacies 
This 4CPA QCPP Pharmacy Patient Questionnaire data indicated little difference in 
opinion between rural and urban pharmacy respondents. It was conducted later (2010–
1) than the previous 3CPA pharmacy surveys (2003, 2005) where again, little 
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differences were shown in service provision by the pharmacies. 
CPA funding of rural pharmacy programs has occurred in differing formats over the past 
few agreements. This support can allow rural pharmacies, now only those in an area 
rated PhARIA 2 and above to survive and thus support professional program 
development [79]. However, this did not appear to lead to any difference in service 
provision between rural and urban pharmacies. 
This extensive survey (36,668 respondents) was designed as a quick survey to ensure it 
was easy for consumers to fill in, and thus achieve a high response rate. There was a 
good rural response. It also could be argued that these surveys could be biased, as they 
are not random at all. 
They were: 
• given to existing pharmacy consumers 
• handed to those consumers more likely to fill them in 
• given to those who go to pharmacies frequently 
• worded to invite a positive response 
Consumers were not asked about services they would like in a pharmacy. No additional 
questions were asked in reverse, to negate bias or incorrect answers. An example of this 
potential bias could explain the lack of difference in the proportion of regular customers 
found in rural pharmacies, as compared to urban pharmacies, found in the previous 
3CPA evaluation. 
The Pharmacy Cardiovascular Health Care Model (PCHCM) [216], which will be further 
analysed in Chapter 7, used a random telephone call for consumer data, in comparison 
to both the 3CPA and 4CPA QCPP evaluation surveys. The PCHCM model was looking for 
opportunities for service change to pharmacy practice from respondents who may or 
may not regularly frequent a pharmacy. 
The surveys in this chapter investigated views of existing customers, pharmacists and 
staff. Nevertheless, the numbers of responses achieved are substantial and did show 
consumers valued their particular pharmacy. It would be expected that those living in 
rural areas would have a regular pharmacy, more so than those living in urban areas. 
This could be because there is only one option for a pharmacy nearby. However, this 
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could also imply that respondents prefer a local pharmacy to distant online services. 
The 3CPA and 4CPA surveys did provide valuable data for the pharmacy profession and 
the individual pharmacies, to thus change and refine their practice, to ensure customer 
satisfaction. Service provision and private consultation areas may be available, but they 
were obviously not evident in the pharmacy, so this 4CPA survey did show 
improvements should be made in practice. Half way through the survey process, the 
QCPP newsletter(Aug-Sept 2011) [95] promoted that 100% of 18,140 (49.5% of the 
overall final data set) respondents rated their pharmacy as ‘good’ or excellent’. For 
some, pharmacy practice being merely ‘good’ may be interpreted as inadequate, and 
‘excellent’ is the only acceptable response for the business. 
Existing rural pharmacy practice and urban pharmacy practice were similar in 
responses in the 4CPA patient response survey, and no substantial results were found 
apart from rural pharmacists having more knowledge, but this was a marginal 
statistically significant result. 
6.5 Limitations 
Limitations of this data include the variety of pharmacy data sources, age of the various 
data examined, various coding systems for rurality, which had to be modified, and the 
nature of the brief surveys used for the 3CPA and 4CPA QCPP analyses. 
Data was obtained from evaluations of the 3CPA (2003) Pharmacist and Pharmacy 
Censuses, and 4CPA (2010–1) CPEP Pharmacy Patient Questionnaires. The 3CPA model 
used the PhARIA ranking of the time. The 4CPA data used postcodes as an indicator or 
rurality, which required modification. To preserve pharmacy anonymity data was 
requested from the owner of the data in this form, which then required coding into the 
appropriate PhARIA ranking. The surveys overall were from different times using 
different PhARIA ratings, but the PhARIA rating was appropriate for the time of the 
survey. Some errors could have occurred using the coding assumptions explained 
previously. 
The first 3CPA QCPP survey did investigate professional services provided by the 
pharmacy compared to the 4CPA QCPP surveys, which examined consumer satisfaction 
with current pharmacy services using opportunistic consumers. 
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6.6 Summary 
Overall, there was little difference found between rural and urban pharmacy services. 
Rural pharmacies appeared to have a higher proportion of regular customers in the 
QCPP 3CPA second survey, compared to urban pharmacies. 
In the QCPP 3CPA second survey there were more nutrition services in urban areas, but 
this service without the benefit of details, could be argued as ambiguous and not well 
defined. There were no significant differences for the level of provision of other 
professional services. 
The pharmacy staff selected customers for the QCPP 4CPA surveys, and bias could have 
been introduced. Yet, this data is quoted as showing the benefit of community pharmacy 
in pharmacy literature [95], and was replicated in popular pharmacy literature again at 
the time. Rural pharmacies had a slightly higher proportion of regular customers, but 
the absolute difference was very small, suggesting that the survey was given to regular 
customers biased the result. 
The following chapter will investigate two more surveys, the Pharmacy Cardiovascular 
Care Model Project (PCHCM) consumer survey previously mentioned and a pharmacist 
practitioner survey, conducted to look for any differences in practice, between rural and 
urban community pharmacists and pharmacies.
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Chapter 7: Current, potential and future community pharmacy 
practice comparison using consumer and practitioner surveys 
The first section of this chapter, will provide an analysis of consumer expectations for 
cardiovascular screening and monitoring community pharmacy services, using data 
from the PCHCM [216] developed in 2005. Differences in opinion will be investigated, 
from the rural and urban consumers questioned, using data previously unanalysed with 
this as a focus. 
The second section will show the results of the Current and Future Pharmacy Practice 
Survey (2014), in which pharmacist respondents gave their opinions on current or 
future practice services, such as vaccination and disease state management. They were 
also asked about their views on their current, future and most probable future 
pharmacy practice roles, suggestions about the 6CPA and the state of the profession 
itself. This analysis explored opinion differences between rural and urban practitioners. 
The results will then be discussed to show similarities and differences in consumer 
expectations and the practitioners’ views of community pharmacy practice and services. 
These investigations are not without limitations, because of the age of some of the 
survey data, methods used to determine specific rurality locations and the overall 
number of pharmacist respondents in the second survey. However, the age of the data 
also provides a valuable understanding of practice changes and opinions over time. 
7.1 Aims of study 
The aims of these analyses in Chapter 7 were to: 
• compare consumer expectations of community pharmacy and the services that could 
be offered, and analyse the data for differences between rural and urban areas of 
practice 
• compare pharmacist opinions and expectations of their current and future practice, 
and analyse the data for differences between rural and urban practitioners. 
7.2 Sources of data 
The data for analysis were from two project surveys, the PCHCM undertaken in 2005  
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[216], and the Current and Future Pharmacy Practice Survey, which was distributed and 
completed in 2014. 
Two different classifications systems for defining rural were used in these projects. The 
PCHCM project [216] used the general location given by the consumer, postcode and the 
ARIA system to define geographic location, while the Current and Future Pharmacy 
Practice survey used a combination of PhARIA, postcode and suburb to accurately 
assign a correct PhARIA geographical ranking for each respondent. Some data was 
reclassified [16, 212], for both projects, to enable a comparison using a two-fold 
rural/urban division, similar to that previously used elsewhere in this thesis. 
Each project will be described in more detail, followed by analysis and conclusions 
drawn, before an overall chapter summary is provided. 
7.3 The Pharmacy Cardiovascular Health Care Model consumer survey 
The PCHCM, was a project undertaken by the University of Tasmania School of 
Pharmacy, Monash University School of Pharmacy and the Curtin University School of 
Pharmacy in 2005, as a 3CPA funded research project [216]. For this project, a 
cardiovascular health care model was developed for community pharmacy, which 
included components of public and preventative health promotion awareness raising, 
continuum of care transfer and follow-up, high-risk patient screening and referral, 
compliance with therapy and both medication management and review [216], as well as 
an extensive consumer telephone survey. 
7.3.1 The Consumer public survey 
Using this telephone survey data, the consumer perceptions and expectations of the 
roles and activities of pharmacists and pharmacies, were analysed and compared. 
Although the complete set of data was analysed and reported for the project itself, an 
analysis of any differences in views of urban and rural consumers was not undertaken 
or published at the time. The opinions of consumers, on service provision, perceptions 
and expectations of pharmacists and other health practitioners, were further explored. 
The potential and current professional services investigated were: 
• providing screening or testing for raised blood pressure 
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• testing or screening for diabetes 
• testing for raised cholesterol 
• diagnosing cardiovascular diseases 
• providing advice on lifestyle changes (weight loss, smoking, alcohol intake etc.) 
• prescribing drug treatment for cardiovascular diseases 
• supplying medicines for cardiovascular diseases 
• providing advice on over-the-counter and herbal medicines to be avoided by 
patients with a cardiovascular disease 
• providing information about cardiovascular diseases and their management 
• providing advice on how to take medicines properly 
• checking or monitoring the outcomes of drug treatment 
7.3.2 Method 
In 2005 [171, 216], 505 consumer interviews were conducted by telephone. A 
formatted copy of the survey transcript is provided in Appendix 7. The survey 
participants were: 
• those over 30 years of age 
• only those who had visited a pharmacy in the previous month 
In addition, the survey required quotas of 50% of consumers who: 
• had cardiovascular disease 
• did not have cardiovascular disease (this included those with family members with 
cardiovascular disease) 
Using a computer-assisted telephone interview (CATI) system from 8,874 calls, 505 
households that met the criteria and were successfully contacted for the 15-minute 
interview. Phone numbers were randomly chosen from the Electronic White Pages©, 
and a number of call-backs were made for contact. The CATI system included 
consumers from urban and rural areas, reflecting the Australian population distribution 
of the time, and consumers rung were from all states and territories. 
Respondents were aged from 30 years to 90 years, with a mean of 57 years. 
Approximately half (58%) were female. Half the respondents interviewed also worked 
part-time or full-time. Two-thirds (69%) had an ongoing illness which required 
medication, with 33% living with hypertension, 19% dyslipidaemia and 9% diabetes 
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[216]. 
The project asked respondents for their knowledge, and opinions of various services 
that were, or could be, provided by a pharmacist, doctor, nurse, dietician or naturopath. 
It also asked respondents about their likelihood of patronising these services, if 
available. The following results will give an analysis, using SPSS 20–24© (Armonk, NY: 
IBM Corp.), of the rural and urban consumer responses in relation to pharmacist 
services. 
7.3.3 Results 
The original published analysis looked at the results as a whole, and did not 
differentiate between rural and urban consumer respondents. This additional analysis 
was conducted to see if any differences existed in the consumer opinions of these sub-
groups. 
This survey used the ARIA system of population classification to define geographic 
locations of participants. Postcodes were also provided as part of the survey, and in 
addition, the consumer gave a broad area answer to their location, described either as 
‘capital city’ or ‘the rest of the state or territory’ in which they lived. A combination of 
postcode and ARIA classification, and not necessarily the consumer’s initial answer of 
their location, was used for an accurate geographical ranking. Using the ASGC and ARIA 
classification appropriate to the time the survey was undertaken, in 2005, the data was 
classified into the ASGC regions of Major City, while the other areas were combined for 
analysis (Inner Regional, Outer Regional, Remote and Very Remote) [16, 212]. This 
geographic separation was made to allow a comparison to other data in this thesis, 
which used the pharmacy version of this classification system (PhARIA). It should be 
noted that many ASGC Inner Regional centres were classified as PhARIA 1, the highest 
classification possible, and would therefore be categorized as urban if the PhARIA 
system, was used at the time. For this analysis, however, Inner Regional areas have been 
added to the non-major city group as some were classified PhARIA 2 (Chapter 2). 
Postcodes were used to confirm the classifications. 
Using the information provided, this additional analysis of the data showed that there 
were 179 respondents from a total of 505, who could be classified as living in regional 
or rural areas of Australia. The project report cited 189 regional respondents, and 316 
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urban respondents, but upon checking the data, this was changed to 179 regional and 
326 urban consumers. 
The respondents were asked a wide range of questions about their satisfaction and 
knowledge of their pharmacy, the capability of the pharmacy to provide certain 
services, and the likelihood of using these services if provided. Looking for any rural and 
urban differences, the following results were found. 
Q3–4: Customer satisfaction, ongoing illness 
As shown in Table 7.1, in rural areas, only 0.6% (1/179) of consumers were dissatisfied 
with their pharmacy and a similar percentage (1.2%; 4/326) was found for those in 
metropolitan areas. However, overall 96.6% (488/505) were satisfied with their 
pharmacy service, with no apparent difference between geographical regions. 
Table 7.1: PCHCM customer satisfaction with pharmacy services 
Satisfaction with pharmacy services 
Very dissatisfied/ 
dissatisfied 
Neither satisfied 
nor dissatisfied 
Satisfied/ 
very satisfied 
Major city (n=326) 1.2% (4) 2.1% (7) 96.6% (315) 
Inner Regional/Outer Regional, 
Remote and Very Remote Australia 
(n=179) 
0.6% (1) 2.8% (5) 96.6% (173) 
Total (n=505) 1.0% (5) 2.4% (12) 96.6% (488) 
Participants were asked if they had an ongoing condition or illness requiring medication 
(Q4) (Appendix 7). This data was cross-referenced with pharmacy satisfaction, but 
again there was little difference in opinion for these subgroups in rural and urban areas 
as shown in Table 7.2 below. 
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Table 7.2: Satisfaction with pharmacy for those with any chronic disease requiring medication 
Satisfaction with 
pharmacy services 
Any chronic 
illness requiring 
medication 
Very 
dissatisfied/ 
dissatisfied 
Neither 
satisfied nor 
dissatisfied 
Satisfied/ 
very 
satisfied 
Major city (n=326) 
Yes (n=228) 1.8% (4) 1.8% (4) 96.5% (220) 
No (n=98) 0% (0) 3.1% (3) 96.9% (95) 
Inner regional/outer 
regional, remote and very 
remote Australia (n=179) 
Yes (n=121) 0.8% (1) 2.5% (3) 96.7% (117) 
No (n=58) 0% (0) 3.4% (2) 96.6% (56) 
Total (n=505) 1.0% (5) 2.4% (12) 96.6% (488) 
Using data from the consumers with CVD-related conditions only, again, little difference 
and no statistical significance was found, using a Chi-square test, between those from 
rural and urban areas, as can be seen in Table 7.3 below. 
Table 7.3: Satisfaction with pharmacy for those with CVD 
Satisfaction with pharmacy 
services 
Very 
dissatisfied/ 
dissatisfied 
Neither satisfied 
or dissatisfied 
Satisfied/ 
very satisfied 
Chi-
sq. 
No CVD 
(n=254) 
Urban (n=158) 0.6% (1) 2.5% (4) 96.8% (153) 
0.710 
Rural (n=96) 0.0% (0) 3.1% (3) 96.9% (93) 
CVD 
(n=251) 
Urban (n=168) 1.8% (3) 1.8% (3) 96.4% (162) 
0.893 
Rural (n=83) 1.2% (1) 2.4% (2) 96.4% (80) 
Q7: Customer knowledge of pharmacy professional services currently provided 
Participants were asked about their knowledge of any CVD-related services provided by 
their pharmacy. Twenty participants did not provide an answer to this question, leaving 
a total cohort of 485, as could be seen in Table 7.4 below. 
Approximately one-third of participants equally knew that their pharmacy offered, did 
not offer or did not know if their pharmacy offered blood pressure testing. More 
consumers without CVD knew their pharmacy had this service, but there was no 
difference between rural and urban consumers’ knowledge of the service, if they had 
CVD. Slightly more rural consumers without CVD, did not know if the pharmacy had this 
service (33.7%: 28%), but there was no statistically significant difference. 
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Cholesterol screening was a service, which only one-fifth of respondents knew was 
available in their pharmacy. Most said ‘no’ or ‘don’t know’. Fewer urban consumers with 
CVD knew if their pharmacy had this service, compared to other groups. Again, there 
was no statistical significance. 
Knowledge for blood sugar testing was more even across the categories, without any 
statistical significance for those with or without CVD, and for those living in rural areas. 
Table 7.4: Knowledge of professional services provided by the customer’s pharmacy 
Knowledge of pharmacy services Yes No Don’t know Chi-sq. 
Q35 Pharmacy services offered—BP screening and testing 
No CVD (n=241) 
Urban (n=149) 22.1% (33) 35.6% (53) 42.3% (63) 
0.318 
Rural (n=92) 29.3% (27) 37.0% (34) 33.7% (31) 
CVD (n=244) Urban (n=158) 32.1% (52) 35.8% (58) 32.1% (52) 
0.796 
 Rural (n=82) 32.9% (27) 39.0% (32) 28.0% (23) 
 All (n=485) 28.7% (139) 36.5% (177) 34.8% (169)  
Q35 Pharmacy services offered—Cholesterol screening and testing 
No CVD (n=241) 
Urban (n=149) 18.8% (28) 37.6% (56) 43.6% (65) 
0.518 
Rural (n=92) 25.0% (23) 34.8% (32) 40.2% (37) 
CVD (n=244) 
Urban (n=158) 17.3% (28) 37.7% (61) 45.1% (73) 
0.248 
Rural (n=82) 14.6% (12) 48.8% (40) 36.6% (30) 
 All (n=485) 18.8% (91) 39.0% (189) 42.3% (205)  
Q35 Pharmacy services offered—Blood sugar screening and testing 
No CVD (n=241) 
Urban (n=158) 25.5% (38) 32.2% (48) 42.3% (63) 
0.992 
Rural (n=96) 26.1% (24) 31.5% (29) 42.4% (39) 
CVD (n=244) 
Urban (n=168) 27.2% (44) 34.0% (55) 38.9% (63) 
0.220 
Rural (n=83) 24.4% (20) 45.1% (37) 30.5% (25) 
 All (n=485) 26.0% (126) 34.8% (169) 39.2% (190)  
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Q8–18: Consumer opinions of pharmacy capability of providing professional 
services 
Participants were asked their opinion about the capability of a pharmacy to provide a 
variety of screening and/or monitoring services (Table 7.5). Data for those with CVD or 
without CVD, in rural or urban areas, was investigated further. 
Of the total number of completed surveys (505), the PCHCM final report stated that 
52.1% (263/505) agreed or strongly agreed that pharmacists were capable of providing 
screening or testing for raised blood pressure, blood sugar testing—50.7% (256/505), 
and only 36.6% (185/505) of pharmacists were capable of providing screening for 
raised cholesterol. Only 20.8% (105/505) agreed that pharmacists would be capable of 
prescribing for CVD but 80% (404/505) felt pharmacists could provide lifestyle advice 
(in the areas of weight loss, smoking or alcohol consumption) and 70.5% (356/505) 
could provide advice about herbal and OTC drug interactions. 
The Likert scale answers for this section were compressed into three groups as seen 
below, and data analysed for urban/rural differences. The results below show a high 
proportion of consumers who neither agree nor disagree with this option. The only 
statistically significant result was the capability of the pharmacy to provide a blood 
pressure service. Those consumers in rural areas with CVD thought their pharmacy was 
more capable of providing a blood pressure service (p<0.00) than those consumers with 
CVD living in urban areas. 
Table 7.5: Capability of a pharmacy providing CVD related professional services 
Capability of a pharmacy 
providing CVD Services 
Strongly 
disagree/ 
disagree 
Neither agree 
or disagree 
Agree/ 
strongly 
agree 
Chi-sq. 
Q8 Pharmacist capability of providing a BP service 
No CVD 
(n=254) 
Urban (n=158) 29.7% (47) 21.5% (34) 48.7% (77) 
0.13 
Rural (n=96) 18.8% (18) 21.9% (21) 59.4% (57) 
CVD 
(n=251) 
Urban (n=168) 19.2% (55) 23.2% (39) 44.0% (74) 
0.00 
Rural (n=83) 19.3% (16) 14.5% 12) 66.3% (55) 
Q9 Pharmacist capability of providing a blood sugar testing service 
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Capability of a pharmacy 
providing CVD Services 
Strongly 
disagree/ 
disagree 
Neither agree 
or disagree 
Agree/ 
strongly 
agree 
Chi-sq. 
No CVD 
(n=254) 
Urban (n=158) 24.1% (38) 25.9% (41) 50.0% (79) 
0.53 
Rural (n=96) 20.8% (20) 21.9% (21) 57.3% (55) 
CVD 
(n=251) 
Urban (n=168) 29.8% (50) 26.8% (45) 43.5% (73) 
0.06 
Rural (n=83) 22.9% (19) 18.1% (15) 59.0% (49) 
Q10 Pharmacist capability of providing a cholesterol monitoring service 
No CVD 
(n=254) 
Urban (n=158) 41.1% (65) 18.4% (29) 40.5% (64) 
0.23 
Rural (n=96) 32.3% (31) 26.0% (25) 41.7% (40) 
CVD 
(n=251) 
Urban (n=168) 44.0% (74) 25.0% (42) 31.0% (52) 
0.13 
Rural (n=83) 31.3% (26) 33.7% (28) 34.9% (29) 
Q12 Pharmacist capability of providing lifestyle information 
No CVD 
(n=254) 
Urban (n=158) 14.6% (23) 12.7% (20) 72.8% (115) 
0.84 
Rural (n=96) 12.5% (12) 11.5% (11) 76.0% (73) 
CVD 
(n=251) 
Urban (n=168) 11.9% (20) 8.9% (15) 79.2% (133) 
0.73 
Rural (83) 14.5% (12) 10.8% (9) 74.7% (83) 
Q13 Pharmacist capability of prescribing medication for CVD 
No CVD 
(n=254) 
Urban (n=158) 63.3% (100) 15.2% (24) 21.5% (34) 
0.73 
Rural (n=96) 58.3% (56) 17.7% (17) 24.0% (23) 
CVD 
(n=251) 
Urban (n=168) 71.4% (120) 14.3% (24) 14.3% (24) 
0.10 
Rural (n=83) 69.9% (58) 14.5% (12) 15.7% (24) 
Q15 Pharmacist capability of providing OTC and herbal drug interaction advice for CVD 
No CVD 
(n-254) 
Urban (n=158) 12.0% (19) 17.7% (28) 70.3% (111) 0.73 
Rural (n=96) 14.6% (14) 19.8% (19) 65.6% (63)  
CVD 
(n=251) 
Urban (n=168) 12.5% (21) 14.3% (24) 71.8% (123) 
0.90 
Rural (n=83) 14.5% (12) 14.5% (12) 71.1% (59) 
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Q19–19: Likelihood of consumers using pharmacy professional services provided 
Although 97% of consumer respondents would use a testing or screening service for 
blood pressure if provided by doctors, and 73% would use if this were provided by 
nurses, only 59% were likely to use this service if provided by pharmacists. However, 
concerning a medication information service, 90% would ask a doctor, 90% a 
pharmacist and only 61% would ask a nurse. 
The data on the likelihood of customers using the services listed in Table 7.6 below, if 
provided by a pharmacy, was further investigated to see if those with, or without CVD, 
would make more use of this service. Statistically significant results for rural consumers 
were found for only two of the services. Rural customers with CVD were less likely to 
use the following services, while urban consumers would go to a pharmacist to receive 
advice on lifestyle changes (p<0.00) or supply of medications (p<0.00). Rural 
consumers with CVD were more ambivalent about patronising a pharmacist-delivered 
lifestyle service compared to those from urban areas. 
There were no statistically significant results for customers using services related to 
hypertension, diabetes, cholesterol monitoring, CVD diagnosis, prescribing, advice on 
OTC or herbal medicines drug interactions, CVD information, medication advice or drug 
monitoring. The table below does show that there were still many consumers who 
would not patronise these services if offered in a pharmacy, and many who were 
ambivalent. 
Table 7.6: Likelihood of using professional pharmacy CVD related services 
Likelihood of using a pharmacy 
providing CVD services 
Strongly 
disagree/ 
disagree 
Neither 
agree or 
disagree 
Agree/ 
strongly 
agree 
Chi-sq. 
Q19 Likelihood of using a pharmacist hypertension service 
No CVD (n=254) 
Urban (n=158) 30.4% (48) 8.9% (14) 60.8% (96) 
0.42 
Rural (n=96) 25.0% (24) 6.3% (6) 68.8% (66) 
CVD (n=251) 
Urban (n=168) 40.5% (68) 10.7% (18) 48.8% (82) 
0.12 
Rural (n=83) 28.9% (24) 8.4% (7) 62.7% (52) 
 Total (n=505) 32.5% (164) 8.9% (45) 58.6% (296)  
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Likelihood of using a pharmacy 
providing CVD services 
Strongly 
disagree/ 
disagree 
Neither 
agree or 
disagree 
Agree/ 
strongly 
agree 
Chi-sq. 
Q20 Likelihood of using a pharmacist diabetes service 
No CVD (n=254) 
Urban (n=158) 27.2% (43) 11.4% (18) 61.4% (97) 
0.07 
Rural (n=96) 29.2% (28) 3.1% (3) 67.7% (65) 
CVD (n=251) 
Urban (n=168) 39.3% (66) 8.3% (14) 52.4% (88) 
0.39 
Rural (n=83) 31.3% (26) 7.2% (6) 61.4% (51) 
 Total (n=505) 32.3% (163) 8.1% (41) 59.6% (301)  
Q21 Likelihood of using a pharmacist cholesterol service 
No CVD (n=254) 
Urban (n=158) 32.9% (52) 10.1% (16) 57.0% (90) 
0.76 
Rural (n=96) 30.2% (29) 8.3% (8) 61.5% (59) 
CVD (n=251) 
Urban (n=168) 44.6% (75) 11.9% (20) 43.5% (73) 
0.52 
Rural (n=83) 47.0% (39) 7.2% (6) 45.8% (38) 
 Total (n=505) 38.6% (195) 9.9% (50) 51.5% (260)  
Q22 Likelihood of using a pharmacist CVD diagnosis service 
No CVD (n=254) 
Urban (n=158) 50.6% (80) 13.3% (21) 36.1% (57) 
0.10 
Rural (n=96) 50.0% (48) 13.5% (13) 36.5% (35) 
CVD (n=251) 
Urban (n=168) 63.1% (106) 11.9% (20) 25.0% (42) 
0.86 
Rural (n=83) 63.9% (53) 9.6% (8) 26.5% (22) 
 Total (n=505) 56.8% (287) 12.3% (62) 30.9% (156)  
Q23 Likelihood of using a pharmacist for lifestyle changes 
No CVD (n=254) 
Urban (n=158) 21.5% (34) 8.9% (14) 69.6% (110) 
0.08 
Rural (n=96) 15.6% (15) 3.1% (3) 81.3% (78) 
CVD (n=251) 
Urban (n=168) 32.7% (55) 1.2% (2) 66.1% (111) 
0.00 
Rural (83) 24.1% (20) 9.6% (8) 66.3% (55) 
 Total (n=505) 24.6% (124) 5.3% (27) 70.0% (354)  
Q24 Likelihood of using a pharmacist prescribing service 
No CVD (n=254) Urban (n=158) 41.8% (66) 13.3% (21) 44.9% (71) 0.52 
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Likelihood of using a pharmacy 
providing CVD services 
Strongly 
disagree/ 
disagree 
Neither 
agree or 
disagree 
Agree/ 
strongly 
agree 
Chi-sq. 
Rural (n=96) 39.6% (38) 9.4% (9) 51.0% (49)  
CVD (n=251) 
Urban (n=168) 58.9% (99) 7.7% (13) 33.3% (56) 
0.27 
Rural (n=83) 48.2% (40) 9.6% (8) 42.2% (35) 
 Total (n=505) 48.1% (243) 10.1% (51) 41.8% (211)  
Q25 Likelihood of using a pharmacist for supplying medicine 
No CVD (n=254) 
Urban (n=158) 22.2% (35) 8.2% (13) 69.6% (110) 
0.09 
Rural (n=96) 15.6% (15) 3.1% (3) 81.3% (78) 
CVD (n=251) 
Urban (n=168) 32.7% (55) 1.2% (2) 66.1% (111) 
0.00 
Rural (n=83) 24.1% (20) 9.6% (8) 66.3% (55) 
 Total (n=505) 24.8% (125) 5.1% (26) 70.0% (354)  
Q26 Likelihood of using a pharmacist for OTC or herbal medicines drug interactions for CVD 
No CVD (n=254) 
Urban (n=158) 15.8% (25) 17.1% (27) 67.1% (106) 
0.15 
Rural (n=96) 17.7% (17) 8.3% (8) 74.0% (71) 
CVD (n=251) 
Urban (n=168) 34.5% (58) 8.3% (14) 57.1% (96) 
0.38 
Rural (n=83) 27.7% (23) 6.0% (5) 66.3% (55) 
 Total (n=505) 24.4% (123) 10.7% (54) 65.0% (328)  
Q27 Likelihood of using a pharmacist for CVD information 
No CVD (n=254) 
Urban (n=158) 28.5% (45) 17.1% (27) 54.4% (86) 
0.17 
Rural (n=96) 24.0% (23) 10.4% (10) 65.6% (63) 
CVD (n=251) 
Urban (n=168) 45.2% (76) 11.9% (20) 42.9% (72) 
0.80 
Rural (n=83) 49.4% (41) 12.0% (10) 38.6% (32) 
 Total (n=505) 36.6% (185) 13.3% (67) 50.0% (253)  
Q28 Likelihood of using a pharmacist for medication advice 
No CVD (n=254) 
Urban (n=158) 6.3% (10) 7.0% (11) 86.7% (137) 
0.10 
Rural (n=96) 6.3% (6) 1.0% (1) 92.7% (89) 
CVD (n=251) Urban (n=168) 8.9% (15) 1.2% (2) 89.9% (151) 0.60 
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Likelihood of using a pharmacy 
providing CVD services 
Strongly 
disagree/ 
disagree 
Neither 
agree or 
disagree 
Agree/ 
strongly 
agree 
Chi-sq. 
Rural (n=83) 9.6% (8) 0.0% (0) 90.4% (75) 
 Total (n=505) 7.7% (39) 2.8% (14) 89.5% (452)  
Q29 Likelihood of using a pharmacist for drug monitoring 
No CVD (n=254) 
Urban (n=158) 31.0% (49) 17.1% (27) 51.9% (82) 
0.21 
Rural (n=96) 31.3% (30) 9.4% (9) 59.4% (57) 
CVD (n=251) Urban (n=168) 47.6% (80) 7.1% (12) 45.2% (76) 
0.14 
 Rural (n=83) 34.9% (29) 10.8% (9) 54.2% (45) 
 Total (n=505) 37.2% (188) 11.3% (57) 51.5% (260)  
7.3.4 Consumer survey discussion 
Pharmacists are capable of providing many professional services, but the public may 
not be aware of the depth and extent of the services, which could be provided, such as 
screening, monitoring and education for chronic disease, in addition to the conventional 
roles of dispensing and medication advice. In 2005 a public survey, as part of the 
PCHCM project, was undertaken to gauge the public knowledge and opinion of the 
current and potential roles that could be undertaken by pharmacists. This data was then 
further analysed to ascertain if consumers in rural areas had differing expectations for 
the services provided by pharmacists. 
Nomenclature and explanations as to the nature of these professional services differ in 
the literature. The PCHCM project used a loose description to explain different 
professional services such as a ‘providing a raised blood pressure screening or testing 
service’ to consumers, potentially those with low health literacy. In comparison, The 
National Database Project (2003) used the term ‘Enhanced Pharmacy Services’ (EPS) 
[40] to describe many professional services. They used the term ‘hypertension service’ 
without any precise definition of the service itself in the survey document. Other 
researchers have used the term ‘public health’ or aspects of pharmaceutical care to 
describe similar activities [185, 186, 188]. The list of such services from the Australian 
National Pharmacy Database, developed by Berbatis et al. (2003) [40], was also used as 
a question for the key opinion leaders and the pharmacist PAART participant 
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interviews, in Chapters 4 and 5 of this thesis. None of the studies mentioned above used 
a concise definition and described in detail the nature of the service provided. 
The National Database Survey (2003) [40] was conducted with data from 1,131 
pharmacies across Australia. Respondents were from the pharmacy itself with either 
the owner, manager or pharmacist available providing data. In 2002, 13.3% of 
pharmacies offered with trained staff, a ‘hypertension’ service but 44.7% did not 
(11.8% missing cases); 4.5% offered a ‘hyperlipidaemia’ service but 67.3% did not 
(4.8% missing cases) and 17.2% offered ‘diabetes’ services, 41.7% did not (10.1% 
missing cases). These were some of the services listed in EPS table, used also in the key 
opinion leader and PAART pharmacist interviews (Appendix 2). 
Comparison between all pharmacist respondents in the National Pharmacy Database 
survey and all PCHCM consumer respondents showed the following differences in 
consumer and pharmacist knowledge of the services available within the pharmacy. 
Assuming the interpretation of the professional service provided was similar to both 
pharmacist and consumers, and acknowledging the PCHCM project was 2 years later 
than the National Pharmacy database, clearly the public assumed more services were 
available in pharmacies at the time. Without specific definitions and activities of each 
service provided, this is difficult to confirm. 
Table 7.7: Comparison of knowledge of pharmacy services: National Pharmacy Database 
pharmacist survey and PCHCM consumer survey 
Services 
provided by 
pharmacies 
National Pharmacy Database project 2003: 
pharmacist responses 
PCHCM project 2005: 
consumer responses 
 
Service provided 
with trained staff 
Service offered 
with/ or without 
payment  
 
Hypertension 13.3% 39.7% 28.7% 
Hyperlipidaemia 4.5% 15.5% 18.8% 
Diabetes 17.2% 40.4% 26.0% 
National Pharmacy database, Berbatis et al. 2003 [40] 
Evidence from the 3CPA survey in 2005 (Chapter 6), also showed that PhARIA 1 and 
PhARIA2–6 pharmacies offered more services in the areas of blood pressure and 
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diabetes. These pharmacists responded that 47.3% of PhARIA 1 pharmacies offered 
blood pressure services, and 51.5% from PhARIA2–6 offered the same service. For 
diabetes, the results showed 20% of PhARIA 1 and 19% of PhARIA2–6 offered this 
service. Clearly, it is difficult to know the exact extent of service provision or the nature 
of the services provided in Australia. 
The National Database Project used the pharmacy classification system PhARIA. Those 
pharmacies in PhARIA 2–6 areas, tended to be more likely, especially those in PhARIA 5 
and 6, to offer one or more EPS (PhARIA 1, 43.8%: PhARIA 2–6, 56.2%) but this was not 
statistically significant. Other comparative data used PhARIA1–3 and PhARIA 4–6 
divisions of data, preventing further analysis. QCPP accreditation or an identified lack of 
appropriate knowledge/skills by pharmacists for provision of these services, was not a 
significant factor in provision of EPS, according to the authors [40]. Factors, listed in 
Part 2 of the project report, associated in a decision to implement EP services included 
the state, setting, opening hours, total area of premises, group membership, customers 
and turnover, but not the rurality [40]. 
Using a further analysis of diabetes, hypertension and hyperlipidaemia (also previously 
described as dyslipidaemia) services specified in the National Pharmacy Database, the 
following results were found. Details of the exact nature of these services were not part 
of this survey. Respondents could tick more than one box; consequently, the assumption 
was made to assume that ‘not provided’ included those pharmacies that indicated they 
did not offer the service, but not those pharmacies which were planning to offer the 
service within the next 12 months. The pharmacies that ‘provided’ the service included 
those which offered this service currently, at no charge or with payment. The numbers 
did not match up; as it was assumed there would have been some respondents who 
ticked more than one box. Never-the-less, it appeared there was little difference in 
provision between urban and rural pharmacies, but most did not charge for any 
services listed. Using this rationale, as can be seen in Table 7.8 below, more urban 
pharmacies provided dyslipidaemia services (PhARIA 1, 18.5%: PhARIA 2–6, 12.9%), 
hypertension services (PhARIA 1, 43.5%: PhARIA 2–6, 39.59%) and diabetes services 
(PhARIA 1, 47.0%: PhARIA 2–6, 40.7%). 
 Chapter 7: Current, potential and future community pharmacy practice comparison using consumer and 
practitioner surveys           171 
Table 7.8: National Pharmacy Database comparison of professional services provided by 
pharmacies in PhARIA 1 and PhARIA 2–6 areas 
Professional service PhARIA 1 PhARIA 2–6 Total 
Hypertension (n=997) 
No response 56 78 134 
Does not offer 205 301 506 
Trained staff 63 53 150 
No charge 187 223 410 
Receives payment 16 24 40 
Will offer in 12 months’ 
time 
16 23 39 
Offers/does not offer 
No response 56 (12.1%) 78 (12.5%) 134 
Does not offer 205 (44.2%) 301 (48.1%) 506 
Offers (with or without 
payment) 
203 (43.8%) 247 (39.5%) 450 
Total 464 (100%) 626 (100%) 1090 
Hyperlipidaemia (n=964) 
No response 74 93 167 
Does not offer 305 456 761 
Trained Staff 21 30 51 
No charge 80 70 158 
Receives Payment 6 11 17 
Will offer in 12 months’ 
time 
22 16 38 
Offers/does not offer 
No response 74 (15.9%) 93 (14.8%) 167 
Does not offer 305 (65.6%) 456 (72.4%) 761 
Offers (with or without 
payment) 
86 (18.5%) 81 (12.9%) 167 
Total 465 (100%) 630 (100%) 1095 
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Professional service PhARIA 1 PhARIA 2–6 Total 
Diabetes (n=1017) 
No response 51 63 114 
Does not offer 182 290 472 
Trained Staff 88 106 194 
No charge 200 231 431 
Receives Payment 7 11 18 
Will offer in 12 months’ 
time 
36 56 92 
Offers/Does not offer 
No response 51 (11.6%) 63 (10.6%) 114 
Does not offer 182 (41.4%) 290 (48.7%) 472 
Offers (with or without 
payment) 
207 (47.0%) 242 (40.7%) 449 
Total 440 (100%) 595 (100%) 1035 
National Pharmacy Database Project, Part B, Berbatis et al. 2003, [40]. 
The figures assumed here were also in contrast to others provided by Wibowo et al. in 
her repetition of the National Database Enhanced Pharmacy Services survey in 2006 
[152, 217]. Using the original data from the project, but only focusing on rural 
pharmacies, Wibowo et al. stated that in 2006 [152, 217], only about one-quarter of 
rural pharmacies offered diabetes services (similar in 2002) and nearly half offered 
hypertension services. Only 10% of pharmacies offered hyperlipidaemia services in 
2006, a decrease from 15.6% in 2002. It was assumed that rural pharmacies were those 
in PhARIA 2–6. Unfortunately, any differences or lack of differences could not be 
explained however, there was little, if any change in 4 years. 
The PhARIA ranking of rurality is not as sensitive as other measures, but for the data 
above, rural pharmacies appear less likely to offer these services. Berbatis et al. [40] 
stated that predictors overall for these services are a higher turnover, younger owners 
and an enclosed counselling area. Commitment to continuing education was also a 
predictor for those providing diabetes services; however, for some, diabetes and 
hypertension services were not considered part of the job. 
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This contrasts with the previous PCHCM data indicating provision of the professional 
services of diabetes and hypertension, and the likelihood of success from a consumer 
uptake perspective. No difference was found with consumers in the PCHCM who 
expected and would use these services from either rural or urban pharmacies, whether 
or not they had CVD. In the PCHCM survey, consumers with CVD were statistically more 
likely to use a pharmacist for discussing lifestyle changes or dispensing of medication 
but not the previously mentioned professional services, even though they thought their 
pharmacist was capable of providing a service for e.g. blood pressure measurement. 
This PCHCM survey did ask patients if they would like a service, and would then 
patronise that service. However, without a construct of the nature and format of the 
service to be provided, the question could give an answer that was not informative. 
These questions were directed to randomly selected patients who may frequent 
different styles of pharmacy (e.g. small rural community pharmacy, bigger discount 
model or online pharmacy), and might not have any knowledge of potentially differing 
services or pharmacy constructs. The survey also assumed that any pharmacy could 
provide this service, and then any patient would patronise and understand the service. 
It could also be argued that because these surveys did not ask about other possible 
services, they are only a measure of existing products and services, and did not give any 
idea of potential acceptance of any other proposed professional or cognitive service, as 
mentioned by one key opinion leader (Chapter 4). This simplistic data collection did not 
provide evidence of marketing, or investigation of the patient population, expectations 
and the nature of these services. 
It should be noted also that this PCHCM data was taken in 2005, and these services are 
more common today, but also this survey has not been replicated since. Pharmacist 
prescribing and monitoring are two areas in which the community pharmacist is taking 
part currently, particularly in other countries [188, 194], and the extent of this practice 
has also changed since the PCHCM survey was undertaken. 
To gain insight and contrast the views of the pharmacy customers with the pharmacists 
themselves, the following survey was then undertaken. 
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7.4 Future of pharmacy practice 
Leading up to the 6CPA, in 2014, an electronic survey was sent out to gauge the 
opinions, practice views and future expectations of pharmacy practitioners from both 
rural and urban areas of Australia. 
It was, in part, based on the Grattan Institute report on GP shortages in rural Australia 
by Duckett et al. (2013) [55] which suggested a wider role for pharmacists, especially 
those in rural practice, to substitute for some services provided by GPs, in country 
areas. Current and recent responses to alleviate the doctor shortage had previously 
included additional training for GPs, and monetary bonuses to help increase the medical 
workforce. The wider role suggested for pharmacists, one that does already exist 
overseas in some countries (Chapters 2 and 3), included issuing repeat prescriptions, 
providing comprehensive vaccination services, and contributing to management of 
chronic conditions, whilst working alongside the GP, and the rest of the health care 
team. This assistance for the GP would decrease their workload, thus allowing them 
more time for attending to more complex cases. 
Although the services in the report were only suggested for seven areas of Australia 
where an acute shortage existed, this survey was given to all pharmacists to gauge their 
opinions of this potential wider scope of practice. The recommended payments for 
these additional services in the areas of vaccination services and disease management 
services from the report, were also used in this survey to understand whether these 
Grattan Institute suggestions were acceptable to the pharmacy profession itself, should 
the services be introduced. 
Respondents were also asked about their views of the pharmacy practice of the future, 
professional services, as well as looking at their personal current and future ideal 
practice using both quantitative and qualitative approaches. Opinion was sought about 
what respondents would like in the 6CPA, their opinion of professionalism within 
pharmacy and, finally, their views on the state of the profession itself overall. 
7.4.1 Method 
This survey was developed using information from Duckett et al. (2013) [55] which 
suggested additional services could be provided by other health professions, rather 
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than doctors. One profession proposed was rural community pharmacists. The 
payments for services suggested by the report were used as a baseline remuneration 
recommendation in the survey. Respondent demographic information was requested to 
allow comparison in opinion between different geographic locations, such as rural and 
urban locations in Australia. After each section, comments were sought to provide 
additional data for analysis, especially if the practitioner did not want to add the two 
specific additional services of immunisation and disease state management to their 
practice. This allowed an explanation to be provided as to why the respondents thought 
that this was, or was not, an appropriate pharmacy activity. 
The main survey was constructed using the LimeSurvey© electronic program 
(Limesurvey GmbH. / LimeSurvey: An Open Source survey tool /LimeSurvey GmbH, 
Hamburg, Germany. URL http://www.limesurvey.org) and can be seen in Appendix 8. A 
separate survey was also created to allow those who wished to enter the prize draw, 
thus preserving participant anonymity. This prize draw entry was independent to the 
survey containing the data, and was not seen by the researcher. 
Ethics approval was successfully sought from the Tasmania Social Sciences Human 
Research Ethics Committee of the University of Tasmania (H0014020) (Appendix 9). 
The final ethics report approval confirmation email is also in Appendix 9. 
Requests were sent to the following organisations and the survey was distributed 
widely and repeatedly in the e-bulletins and e-news of PSA, the SHPA, the AACP, PPA 
and the ACP. The PGA would not distribute this survey and suggested asking each state 
branch, which was followed through. However, no responses were received from these 
branches, as to whether this survey was promoted and distributed to members, or not. 
The survey was also advertised twice in Auspharmlist, in Pharmacy News and on 
Twitter during August and September 2014. The advertisements allowed participants to 
click an embedded electronic link and enter the survey. Promotion in other electronic 
pharmacy newsletters was sought unsuccessfully. 
Quantitative analysis was conducted using IBM SPSS Statistics 21–24© (Armonk, NY: 
IBM Corp.) and qualitative analysis by grouping the data and looking for common 
themes as described in previous chapters. When qualitative responses were included in 
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the results below, the code used was the number of the survey respondent, and the 
PhARIA work location was added for clarity of a rural or an urban response. 
7.4.2 Results 
Despite extensive advertising, there were only 135 complete and 33 partial (total 168) 
survey responses. This could be construed as a small response rate. However, the 
response rate was difficult to determine because it was not known how many saw and 
decided to enter the survey. Entries without any content were removed before analysis 
(total 26). Seven responses were excluded for those who entered the survey site but did 
not contribute any information, other than some demographic data, leaving 161 for 
initial analysis with IBM SPSS Statistics 21–24© (Armonk, NY: IBM Corp.). Although this 
is a small proportion of the overall number of pharmacists in Australia, their opinions 
were valued and therefore analysed. 
There were 66 male respondents (41%) and 95 female respondents (59%) reflecting 
the Australian distribution at the time AIHW (2014) [218] which stated that 59% of 
pharmacists were women. It was acknowledged that not all respondents in this survey 
were generally registered pharmacists, as two were pharmacy students and eight others 
were interns (provisionally registered pharmacists), an unintended consequence of 
making the advertising target group broad, and not specifically excluding this group in 
the survey preamble. One student only entered demographic data, and so was excluded 
from the analysis, leaving only one who completed the survey in this investigation. 
In this survey, the mean participant age was 38.4 years (range 19–78 years), and the 
years of practice mean was 16.3 years (range 0–59 years). This was similar to AIHW 
(2014) [218], which stated the average pharmacist age in Australia was 38.9 years. 
Home and work PhARIA ratings were checked against postcodes provided and 
confirmed using 2014–5 PhARIA values [219], which were appropriate to the year in 
which the survey was conducted. Some PhARIA values provided by respondents were 
corrected, or added if missing, using the postcode and suburb provided, and the results 
were as follows: 
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Table 7.9: Pharmacist PhARIA rating for work and home location 
PhARIA value (n=161) Work Home 
PhARIA 1 131 (81.4%) 133 (82.6%) 
2 7 (4.3%) 9 (5.6%) 
3 9 (5.6%) 8 (5.0%) 
4 7 (4.3%) 6 (3.7%) 
5 4 (2.5%) 3 (1.9%) 
6 2 (1.2%) 2 (1.2%) 
Combined PhARIA 2–6 29 (18.0%) 28 (17.4%) 
Unknown 1 (0.6%) 0 
The figures above (Table 7.9) indicate 81.4% of participants worked in PhARIA 1 areas, 
and 18% worked in a rural or remote area (PhARIA 2–6). While 82.6% lived in a 
PhARIA 1 region, 17.4% lived in a rural or remote region. In 2014, the sample used 
work location, and had the expected distribution [218] of 91.5% from a Major City or 
Inner Regional area, and 8.5% from Outer Regional, Remote and Very Remote areas, as 
per the ASGC classification system used. However, as stated previously, the PhARIA 
system classifies some Inner Regional areas as urban while others are classed as rural 
(PhARIA 2–6). The PGA stated approximately 20% of pharmacies were in PhARIA 2–6 in 
2016, which concurred with the survey proportions obtained [220]. Data from the PGA 
in 2017 and 2018 showed that the percentage of pharmacies in rural areas (PhARIA 2–
6) was only 17% (Chapter 2), suggesting this survey data was still indicative of the 
spread of pharmacies and therefore community pharmacists in Australia. 
In 2014, the AIHW stated the average number of hours worked per week in all 
pharmacist roles was 35.7 hours, with 32.6% working part-time [218]. Each respondent 
in this survey worked a mean of 26.8 hours per week (range 0–55 hours) in his/her 
primary role, but 14 others had additional practice roles. 
The primary role of the participants is shown in Table 7.10 below. In the initial data, 
there was a disproportionate number of respondents describing their role as ‘other’, 
with activities such as an academic, researcher, National Prescribing Service clinical 
educator, project pharmacist, industry, government and in a Medicare Local. This list 
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was examined, and as many as possible were reclassified to existing groups, decreasing 
the 24 ‘other’ pharmacist group down to 10. 
The respondents were divided into PhARIA 1 and PhARIA 2–6 groups. Further 
subdivision showing percentages of roles in each PhARIA group, (PhARIA 1, 131: 
PhARIA 2–6, 29), percentages within the groups overall, and percentages within the 
whole respondent cohort (total 161). One pharmacist had missing work location data. 
In their primary role 47.8% (77/161) of the urban respondents, worked as a manager, 
employee, pharmacy owner or locum pharmacist in PhARIA 1 areas, while 79.3% of the 
rural respondents held these positions in the PhARIA 2–6 areas. Overall, there were 
61.1% (100/161) respondents in these primary roles. There were more hospital 
pharmacists and interns/student in urban areas. There were no medication review 
pharmacists (one was from an unknown location), or research/academic/education 
pharmacists who classed this role as their primary role in rural areas. For the remaining 
pharmacists, 90% who classed their role as ‘other’, were in PhARIA 1 areas. 
Table 7.10: Pharmacist participant primary role—adjusted 
Role 
 
PhARIA 1 
(n=131) 
PhARIA 2–6 
(n=29) 
Unknown 
(n=1) 
Total  
(n=161) 
Manager/employee 
44 
33.6% (44/131) 
78.6% (44/56) 
27.3% (44/161) 
12 
41.4% (12/29) 
21.4% (12/56) 
7.5% (12/161) 
0 
0% 
56 
(34.8%) 
Pharmacy owner 
20 
15.3% (22/131) 
74.1% (20/27) 
12.4% (20/161) 
7 
24.1% (7/29) 
25.9% (7/27) 
4.3% (7/161) 
0 
27 
(16.8%) 
Medication Review 
pharmacist 
16 
9.9% (16/131) 
94.2%/ (16/17) 
16/161 (99.9%) 
0 
1 
100% (1/1) 
5.8% (1/17) 
0.1% 
(1/161) 
17 
(10.6%) 
Locum pharmacist 
13 
9.9% (13/131) 
76.5% (13/17) 
8.1% (13/161) 
4 
13.8% (4/29) 
23.5% (4/17) 
2.5% (4/161) 
0 
17 
(10.6%) 
Hospital pharmacist 8 3 0 11 
 Chapter 7: Current, potential and future community pharmacy practice comparison using consumer and 
practitioner surveys           179 
Role 
 
PhARIA 1 
(n=131) 
PhARIA 2–6 
(n=29) 
Unknown 
(n=1) 
Total  
(n=161) 
6.1% (8/131) 
72.7% (8/11) 
5.0% (8/161) 
10.3% (3/29) 
27.3% (3/131) 
1.9% (3/161) 
(6.8%) 
Pharmacy Intern/student 
8 
6.1% (8/131) 
80% (8/10) 
5.0% (8/161) 
2 
6.9% (2/29) 
20% (2/10) 
1.8% (2/161) 
0 
10 
(6.2%) 
Project pharmacist/ 
Research/ Academic/ 
Education 
13 
9.9% (13/131) 
100% (13/13) 
8.1% (13/161) 
0 0 
13 
(8.1%) 
Other/blank 
9 
6.9% (9/131) 
90% (9/10) 
5.6% (9/161) 
1 
3.4% (1/29) 
10% (1/10) 
0.6% (1/161) 
0 
10 
(6.2%) 
Respondents were asked for the hours worked in their principal position only; however, 
14 had one (6 respondents) or two (8 respondents) additional pharmacy roles (8.9% of 
the total participants). Of these, two had additional community pharmacy roles giving a 
final percentage of 64% (103 pharmacists), which was closer to other reported 
community pharmacy work settings described below. 
The 2012 AIHW [218] data, published in 2014, suggested nine of ten pharmacists 
worked in a ‘clinical role’ but it did not differentiate between community, hospital or 
any other pharmacy role, as requested in this survey. The Allied Health Workforce 2012 
report [132] using earlier data did, however, differentiate the work settings as shown 
below in Table 7.11: 
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Table 7.11: Australia work setting of main pharmacy job from Allied Health Workforce report 
2012 
Pharmacy practice setting Number/percentage 
Commercial/ business (assumed to mean 
community pharmacy by this researcher) 
14,039 (65.8%) 
Hospital 3,762 (17.6%) 
Other 3,530 (16.6%) 
Total 21,331 
Allied Health Workforce 2012 Table 4.6, AIHW 2013 [132] 
It was also stated in the August 2018, PGA Vital Facts in Community Pharmacy Fact 
Sheet [1] that two-thirds of registered pharmacists work in community pharmacy. No 
more detail was provided in this publication, and the data was referred to as PGA data. 
Of the 27 respondents who identified as pharmacy owners in this survey, 20 were from 
PhARIA 1 work locations (74.1%), while 25.9% (7) had pharmacies in rural areas 
(PhARIA 2: 1, PhARIA 3: 1; PhARIA 4: 1; PhARIA 5: 4). 
Overall, the demographic range suggested the survey sample was one in which the 
respondents, reflected the approximate distribution of pharmacy practitioners in 
Australia at the time. Opinions on the individual pharmacy services of vaccination 
provision and disease state management will be examined in depth. Respondent 
numbers vary in all sections because not all pharmacists/interns/student answered 
each question. 
Q12–14: Vaccination services in pharmacies 
Respondents were asked their opinion of the delivery and cost of provision for 
vaccination services in pharmacies. They were also asked to order their preferences 
from the options given, for who should deliver this service in the pharmacy. The results 
suggested that the preferred person providing the vaccination service in a pharmacy 
was the pharmacist themselves (92), followed by a trained pharmacist employee (28), 
and a nurse or nurse practitioner (22). Not providing a vaccination service at all, was 
the least preferred option (21). 
Overall, half the respondents preferred to provide this service themselves but for those 
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in remote areas of PhARIA 5 and 6, their opinion was less polarised. 
Table 7.12: First preference for delivery of vaccination services in pharmacy by PhARIA from all 
respondents 
PhARIA 
Pharmacist 
themselves 
Employed 
pharmacist 
Nurse or nurse 
practitioner 
Would not 
provide this 
service 
PhARIA 1 (n=135) 77 (57%) 24 (17.8%) 18 (13.3%) 16 (11.9%) 
2 (n=8) 4 1 2 1 
3 (n=10) 6 2 0 2 
4 (n=5) 4 0 0 1 
5 (n=4) 1 1 1 1 
6 (n=1) 0 0 1 0 
PhARIA 2–6 combined (n=28) 15 (53.6%) 4 (14.3%) 4 (14.3%) 5 (17.9%) 
Total (n=163) 92 28 22 21 
Specific opinions of the provision of this service from the 27 pharmacy owners is listed 
in Table 7.13 below. The majority of both rural and urban pharmacy owners would 
prefer to provide this service themselves (66.7%; 18/27), more than the combined 
result for the whole respondent cohort (56.4%). Four pharmacy owners (14.8%) would 
not provide this service at all. 
Table 7.13: First preference for delivery of vaccination services in pharmacy by PhARIA from 
pharmacy owner respondents only 
PhARIA 
Pharmacist 
themselves  
Employed 
pharmacist 
Nurse/nurse 
practitioner 
Would not 
provide this 
service 
1 (n=21) 14 (66.7%) 2 (9.5%) 2 (9.5%) 3 (14.3%) 
2 (n=1) 1 0 0 0 
3 (n=1) 1 0 0 0 
4 (n=1) 1 0 0 0 
5 (n=4) 1 1 1 1 
PhARIA 2–5 combined (n=7) 4 (57.1%) 1 (14.3%) 1 (14.3%) 1 (14.3%) 
Total (n=28) 18 3 3 4 
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Respondents were asked under which conditions they would be prepared to provide 
this service (Table 7.14). Nearly half of rural pharmacists thought the Government 
should pay for this service, compared to only 40% of urban pharmacist respondents. 
Three-quarters of all pharmacists were of the opinion that the patient should pay full 
price for this service. Half of the urban pharmacists, suggested that AUD$12.10, plus the 
wholesale cost of the vaccine with or without the dispensing fee, was sufficient payment 
as suggested by Duckett et al. [55], but only one-third of rural pharmacists thought 
AUD$12.10 plus cost, was sufficient payment. This rural pharmacist component 
increased to half of respondents agreeing, once the dispensing fee was added to the 
transaction. There were still pharmacists uncertain about service provision, whatever 
the options provided, especially regarding the payment, should the pharmacist have to 
charge. 
Table 7.14: Preferences of provision of vaccination services in pharmacies 
Service Urban/rural Yes No Uncertain 
No answer: 
unknown 
urban/rural 
Only if the 
Government pays 
for the service 
Urban (n=120) 47 (39.2%) 44(36.7%) 22 (18.3%) 7 (5.8%) 
Rural (n=27) 13 (48.2%) 7 (25.9%) 7 (25.9%) 0 
Patient pays full 
cost  
Urban (n=120) 87 (72.5%) 9 (7.5%) 20 (16.7%) 4 (3.3%) 
Rural (n=27) 21 (77.8%) 1 (3.7%) 5 (18.5%) 0 
Patient pays 
AUD$12.10 plus 
wholesale cost 
Urban (n=120) 68 (56.7%) 19 (15.8%) 30 (25.0%) 3 (2.5%) 
Rural (n=27) 8 (29.6%) 6 (22.2%) 13 (48.1%) 0 
Patient pays 
AUD$12.10 plus 
wholesale cost and 
dispensing fee 
Urban (n=120) 68 (56.7%) 19 (15.8%) 30 (25.0%) 3 (2.5%) 
Rural (n=27) 14 (51.9%) 4 (14.8%) 9 (33.3%) 0 
Those participants who would not provide a vaccination service had a variety of 
reasons. These included that the remuneration suggested (AUD$12.10 plus wholesale 
cost, with or without a dispensing fee) was not sufficient, that the roles of the 
pharmacists would be blurred should service this be provided, medication services 
should be the focus of the pharmacists’ role, and concerns about this service affecting 
the existing relationship with their local prescribers. 
 Chapter 7: Current, potential and future community pharmacy practice comparison using consumer and 
practitioner surveys           183 
Q 15–17: Disease state management service in pharmacies 
Participants were then asked if they would consider introducing a disease management 
service in a pharmacy. First preference for almost all (98.7%; 122/152 using only those 
who answered the question), would be to notify the GP or health professional with 
information for the patient’s health plan. Secondly, 59.2% (90/152) would adjust doses 
e.g. in hypertension, but pharmacists were less confident (38.4%; 58/152) about 
discontinuing or adding another medication, for example, in the treatment of the same 
condition. About half (49.3%; 75/152) would be prepared to continue dispensing for 18 
months instead of 12 months. Not all participants filled in each section, so there are 
some missing values as can be seen below (Table 7.15). 
Table 7.15: Preferences of provision of disease state management services in pharmacies 
Service Urban/rural Yes No Uncertain 
No 
answer: 
unknown 
urban/ 
rural 
Adjust doses in e.g. 
hypertension 
Urban (n=132) 71 (53.8%) 25 (18.9%) 28 (21.2%) 8 (6.0%) 
Rural (n=29) 19 (65.5%) 4 (13.8%) 5 (17.2%) 1 (3.4%) 
Discontinue or start 
another medication 
in e.g. hypertension 
Urban (n=132) 48 (36.4%) 44 (33.3%) 32 (24.2%) 8 (6.0%) 
Rural (n=29) 10 (34.5%) 9 (31.0%) 9 (31.0%) 1 (3.4%) 
Notify GP and health 
professionals to add 
information to a 
patient’s health 
record 
Urban (n=132) 122 (92.4%) 1 (0.8%) 1 (0.8%) 8 (6.0%) 
Rural (n=29) 28 (96.6%) 0 0 1 (3.4%) 
Continue dispensing 
for 18 months not 
12 months 
Urban (n=132) 59 (44.7%) 32 (24.2%) 33 (25%) 8 (6.0%) 
Rural (n=29) 16 (55.2%) 5 (17.2%) 7 (24.1%) 1 (3.4%) 
Only if the 
Government pays 
for the service 
Urban (n=132) 63 (47.7%) 21 (15.9%) 32 (24.2%) 16 (12.1%) 
Rural (n=29) 17 (58.6%) 4 (13.8%) 6 (20.7%) 2 (6.9%) 
AUD$18.15/15-
minute consultation  
Urban (n=132) 69 (52.3%) 16 (12.1%) 31 (23.5%) 16 (12.1%) 
Rural (n=29) 17 (58.6%) 6 (20.7%) 4 (13.8%) 2 (6.9%) 
AUD$18.15/30-
minute consultation 
Urban (n=132) 17 (12.9%) 57 (43.2%) 42 (31.8%) 16 (12.1%) 
Rural (n=29) 7 (24.1%) 13 (45.8%) 7 (24.1%) 2 (6.9%) 
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Service Urban/rural Yes No Uncertain 
No 
answer: 
unknown 
urban/ 
rural 
Dispensing scripts 
for 18 months 
AUD$12.10/15 
minutes 
Urban (n=132) 57 (43.2%) 24 (18.2%) 38 (28.8%) 13 (9.8%) 
Rural (n=29) 16 (55.2%) 5 (17.2%) 6 (20.7%) 2 (6.9%) 
Dispensing scripts 
for 18 months 
AUD$12.10/30-
minute consultation 
Urban (n=132) 13 (9.8%) 55 (41.7%) 45 (34.1%) 19 (14.4%) 
Rural (n=29) 7 (24.1%) 13 (44.8%) 7 (24.1%) 2 (6.9%) 
Two-thirds, using the table above would like the Government to pay for these services 
(60.5%; 92/143). Sixty percent (60.1%; 86/143) would charge AUD$18.15 for a 15-
minute consultation but less than one-fifth (16.8%; 24/143) would accept AUD$18.15 
for a 30-minute consultation. If a fee was set for continued dispensing, half thought 
AUD$12.10 for 15 minutes (50%; 73/146) was suitable, but if the same service took 30 
minutes this figure was unacceptable (14.3%; 20/140). Many pharmacists were 
uncertain about most of these services, suggesting that they had not thought about 
undertaking the service, or were concerned about the impact on the health system 
within their community. Respondents also wrote that the remuneration was considered 
low for the work and time involved, in what was seen as an additional service within the 
workplace. 
Urban pharmacists were more uncertain about adjusting doses, whether or not 
AUD$18.15 was a suitable payment for 15 minutes of consultation time, and AUD$12.10 
suitable for 15 or 30 minutes for an extended dispensing service. Rural respondents 
were more likely to adjust doses, supply, or continued dispensing. They would also 
supply the service whether this takes 15 or 30 minutes of time. Half the respondents in 
each group preferred the Government to pay for disease management services (PhARIA 
1, 47.7%: PhARIA 2–6, 58.6%). 
The results of the following table (Table 7.16) show the unease about the potential 
alteration in the relationship with local health professionals, in this case the GP, should 
these services be introduced. Respondents were very unsure if the services would help 
or hinder their relationship with their local GPs. Fewer rural respondents appeared 
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uncertain about the impact of new services, on their current good relationships with 
GPs, compared to the respondent group as a whole. 
Table 7.16: Relationships with local GPs 
Relationship with local GPs Urban/rural Yes No Uncertain 
Currently good 
Urban (n=125) 107 (85.6%) 3 (2.4%) 15 (12%) 
Rural (n=28) 24 (85.7%) 1 (3.6%) 3 (10.7%) 
Would services improve the 
relationship? 
Urban (n=125) 37 (29.6%) 28 (22.4%) 60 (48.0%) 
Rural (n=28) 5 (17.9%) 2 (7.1%) 21 (75%) 
Would services impact 
adversely on the relationship? 
Urban (n=125) 25 (20.0%) 25 (20.0%) 75 (60.0%) 
Rural (n=28) 2 (7.1%) 5 (17.9%) 21 (75%) 
Some respondents thought these services were outside the scope of community 
pharmacist practice: 
Health must be approved holistically. You are making recommendations without having 
the GP there with you can complicate matters. As pharmacists we may not understand 
or know the whole diagnostic picture of the pt [sic) so suggestions may not be 
appropriate. You need the medical team with you in the discussion like they do in 
hospital. (8, PhARIA 2) 
Others commented that the GPs would see introduction of these services as decreasing 
their own revenue and business, as well as ‘service creep’: 
It would affect their income! (74, PhARIA 1) 
GPs currently have little awareness of [the] potential role for pharmacists in disease 
state management. Would need to be familiar and comfortable that those offering the 
service are skilled enough to do so. Immunisation GPs and nurses are concerned with 
‘scope’ creep, so is probably an area which will cause more angst. (112, PhARIA 1) 
Another said that they thought their GP would think this would be beyond the scope of 
pharmacy practice: 
Some of our nearest GPs (60km away) are ‘old school’ and I believe that they would see 
this as practicing beyond our capacity and stepping on their toes—they will not even 
write HMR referrals so doing these services is a big ask! (124, PhARIA 5) 
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However, some thought it would relieve GP workload, and might help show the 
potential scope of pharmacist practice to assist the health team: 
Again, the situation needs to be part of the ‘health team’ not a competitor. You just have 
to make it work. (67, PhARIA 5) 
Overall, despite the uncertainty and negativity in these comments, respondents had 
good relationships with GPs currently, and few thought it would influence negatively on 
these current relationships. It appears that not all respondents might have ever 
discussed these health service options with the local health professionals, to gauge 
opinion and agreement. More rural respondents did not know if the services would 
improve or adversely affect their relationship with local GPs, compared to their urban 
counterparts. 
Q18–19: Vaccination and disease state management service in rural areas 
When asked, if vaccination and disease state management services should only be 
provided by rural pharmacies, the majority believed that all pharmacies should be able 
to provide these services, not just those in rural or remote areas (Table 7.17). 
Table 7.17: Immunisation and disease state management services provision by rural pharmacies 
compared to all pharmacies 
Response (n=152) Immunisation Disease state management 
Yes, rural only 20 (13.2%) 22 (14.5%) 
No, all pharmacies 132 (86.8%) 130 (83.5%) 
Less than 15% thought that only rural pharmacies should deliver vaccination or disease 
state management services. This opinion was not specifically from rural respondents 
themselves as 75% of the respondents (15/20), worked in PhARIA 1, with the 
remaining 25% in PhARIA 2–6. Lower numbers suggested that disease state 
management service provision should only be in rural areas, with 9%, (5/22) of these 
working in a PhARIA 2–6 area. Over 80% of these respondents thought both services 
should be provided by all pharmacies, regardless of geographic location. 
Respondents were then asked about their current and future workloads to see if there 
were any differences between those in rural and urban practice. 
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Q22–23: Current workload and future workload aspirations 
Respondents were asked to record the percentages of their various pharmacy-related 
activities within their current work role, their future aspirations and their probable 
work activities in 5 years’ time. Ten activity options were given covering: dispensing 
and counselling, OTC sales and advice, management and administration, professional 
services such as MedsChecks or Diabetes MedsChecks, home or nursing medication 
reviews, PPI activities, training and education, ward-based clinical activities, research, 
professional development and ‘other’ activities not previously specified. 
Some respondents did not answer this section, and others answered only a part, 
implying they will either retire, leave the profession, or just did not want to complete 
this section of the survey. It was acknowledged that this was a complex question. 
Despite being asked to mark a percentage for each activity in each set, such as current 
pharmacy role, so that it would total 100%, many of the totals were over, or under this 
figure. It was assumed respondents used a different interpretation of this request. These 
errors were then recalculated, and adjusted, to ensure each activity group entry added 
up to a total of 100% for individual respondents. Table 7.18 below shows the amended 
results from all the participants, who answered this question. 
‘Other’ activities respondents noted in this question were: 
retirement, vaccinations, consultations on continued prescribing, other pharmacy–
based programs (e.g. sleep apnoea, bone density testing etc.), teaching allied health 
students, working with GPs, being an advocate, community workshops and other 
education roles within residential aged care settings, DAAs, front-of-shop duties (stock 
control) and other administrative duties (6), compounding and specialist products (2), 
opioid replacement services (2), marking and mentoring (4), working with the 
professional organisation and Medicare Local (as it was when the survey was conducted, 
now a Local Primary Health Care Network). 
It can be seen in Table 7.18, that dispensing/counselling was the main activity, with OTC 
sales and advice second. Respondents would like to do less dispensing in 5 years’ time 
but considered this proportion of time would remain the same. Respondents also 
wanted to do more MedsChecks, Diabetes MedsChecks and PPIs, and were confident 
they would increase this role in their practice. Respondents would like to decrease the 
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amount of time spent in administration, management and stock control but they didn’t 
expect this to happen, and suggested this might even increase in five years’ time. Those 
conducting Medication Reviews (HMRs and RMMRs), would like to increase this role, 
but did not think this would be a reality, and that this proportion of their workload 
would remain the same. 
It was interesting to note that respondents considered they spent 7.6% of their time in 
professional development, and would like to do more. They expected that in 5 years’ 
time this would increase slightly. Despite the desired increases in the areas of cognitive 
services and professional roles, respondents thought this would not happen in the 
future. The following tables use an average percentage of the activity from the cohort as 
a whole. 
For those in PhARIA 2–6 areas, current, possible and probable roles for those in rural 
areas of Australia differed from those in urban areas, as shown in Table 7.18. It appears 
that rural pharmacists did far more dispensing and associated counselling (PhARIA 1, 
28.3%: PhARIA 2–6, 41.6%). Rural pharmacists would like to halve these rates, but 
suggested only a small decrease will be achieved in five years’ time. Administrative 
duties were expected to rise, as well as levels of professional services (MedsChecks and 
Diabetes MedsChecks). Home Medicine Reviews were expected to decrease. Despite 
desired increases by these participants in the areas of cognitive service and professional 
roles, in five years’ time probable levels of activity would be similar to current levels. 
Rural participants did slightly less CPD then urban participants (PhARIA 2–6, 5.8%: 
PhARIA 1, 7.9%) when the survey was conducted, but in five years’ time expected to 
double this amount (PhARIA 2–6, 11.4%: PhARIA 1, 8.5%). 
Community pharmacy respondents were selected using the inclusion criteria of those 
who recorded their role as a manager/employee, pharmacy owner and locum or did any 
community pharmacy work in a secondary capacity. This thus removed the medication 
review pharmacist primary role group, who mainly worked in the PhARIA 1 area. The 
PhARIA 1 group, as shown in Table 7.18, appeared to do less dispensing, so this 
additional analysis was undertaken to confirm if this result was location, or activity 
specific. It can be seen from the table below (Table 7.19), there were wide ranges within 
the specific activities listed, for individual community practitioners.
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Table 7.18: Current workload activities, future aspirations and probable workload urban and rural participants 
Activity type 
Urban (PhARIA 1) 
or rural (PhARIA 
2–6) 
Current 
pharmacy role 
Aspirations for 5 
years’ time 
Probable workload 
in 5 years’ time 
Dispensing and patient counselling for prescriptions 
Urban 28.3% 19.9% 27.7% 
Rural 41.6% 24.6% 37.1% 
OTC S2/ S3 sales and advice 
Urban 12.3% 11.9% 12.2% 
Rural 17.4% 15.8% 12.7% 
Administration/management/stock control 
Urban 8.4% 4.6% 11.2% 
Rural 9% 7.7% 14.8% 
Pharmacy medication review programs (MedsCheck, 
Diabetes MedsCheck) 
Urban 3.2% 9.2% 7.5% 
Rural 1.7% 9.1% 5.9% 
Other medication review programs (HMR, RMMR) 
Urban 10.4% 21.1% 11.4% 
Rural 2.7% 12% 3.9% 
PPI programs (Clinical Interventions, Dose 
Administration Aids, Screening and Risk Assessment/ 
Disease State Management, Health Promotion 
activities) 
Urban 6.9% 11.1% 11.4% 
Rural 7.2% 13.9% 3.9% 
Training of interns/students within a pharmacy 
setting 
Urban 3.3% 6.5% 5.2% 
Rural 2.8% 7.5% 5.2% 
Educator or academic activities Urban 9.7% 13.4% 9.7% 
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Activity type 
Urban (PhARIA 1) 
or rural (PhARIA 
2–6) 
Current 
pharmacy role 
Aspirations for 5 
years’ time 
Probable workload 
in 5 years’ time 
Rural 2.8% 6.1% 2.3% 
Research 
Urban 3.5% 7.1% 5% 
Rural 0.4% 3.2% 1.5% 
Ward based clinical services 
Urban 3.2% 5.6% 4.6% 
Rural 7% 8.3% 7.7% 
Continuing professional development 
Urban 7.9% 8.4% 8.5% 
Rural 5.8% 8.9% 11.4% 
Other 
Urban 3.1% 3.1% 4.6% 
Rural 1.5% 0.1% 4.6% 
Numbers of participants 
Urban n=108 n=103 n=97 
Rural n=25 n=23 n=23 
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Table 7.19: Current workload activities—community practice compared to all respondents practice 
Activity type 
All current 
role 
PhARIA 2–6 
Community 
practice 
PhARIA 2–6 
(range) 
All current 
role 
PhARIA 1 
(range) 
Community 
practice 
PhARIA 1 
(range) 
 
(n=25) (n=20) (n=108) (n=83) 
Dispensing and patient counselling for prescriptions 
41.6% 43.6% 
(10%-80%) 
28.3% 40.3% 
(0%-100%) 
OTC S2/ S3 sales and advice 
17.4% 17.1% 
(5.9%-30%) 
12.3% 16.1% 
(0%-40%) 
Administration/management/stock control 
9% 9.8% 
(0%-25%) 
8.4% 10.8% 
(0%-25%) 
Pharmacy medication review programs (MedsCheck, Diabetes MedsCheck) 
1.7% 2.1% 
(0%-10%) 
3.2% 3.7% 
(0%-60%) 
Other medication review programs (HMR, RMMR) 
2.7% 2.8% 
(0%-21.1%) 
10.4% 3.7% 
(0%-60) 
PPI programs (Clinical Interventions, Dose Administration Aids, Screening 
and Risk Assessment/Disease State Management, Health Promotion 
Activities) 
7.2% 8.5% 
(0%-21.1%) 
6.9% 9.2% 
(0%-39.1%) 
Pharmacy medication review programs (MedsCheck, Diabetes MedsCheck) 
2.8% 3.0% 
(0%-12%) 
3.3% 3.7% 
(0%-18.2% 
Training of interns/students within a pharmacy setting 
2.8% 2.5% 
(0%-12%) 
9.7% 1.6% 
(0%-12.9%) 
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Activity type 
All current 
role 
PhARIA 2–6 
Community 
practice 
PhARIA 2–6 
(range) 
All current 
role 
PhARIA 1 
(range) 
Community 
practice 
PhARIA 1 
(range) 
Educator or academic activities 
0.4% 0 
(0%) 
3.5% 0.1% 
(0%-6.4%) 
Research 
7% 3.0% 
(0%-60%) 
3.2% 1.5% 
(0%-56.3%) 
Continuing professional development 
5.8% 6.2% 
(0%-23.8%) 
7.9% 7.6% 
(0%-43.4%) 
Other 
1.5% 1.4% 
(0%-20%) 
3.1% 1.8% 
(0%-80%) 
Totals 100%  100%  
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Both community practice groups now had similar levels of time spent dispensing and 
providing OTC sales and advice. There were no other points of difference between those 
community pharmacists practicing in an urban area compared to a rural environment 
In conclusion, pharmacists appeared to recognise the various aspects of their roles and 
would like to expand the professional areas. Some believe this may happen within 
community pharmacies, but many did not. Rural community pharmacists did more 
dispensing and counselling than urban counterparts but once the data was adjusted by 
removing those not assumed to be in community pharmacy practice, the results were 
similar. It is acknowledged that this data represents a small pharmacist sample and that 
there were far more education/academic pharmacists in the PhARIA 1 group, 
potentially affecting this analysis. 
Participants were then asked their opinion on the profession itself and potential 
changes for the upcoming 6CPA of the time. 
Q24–25:6CPA Participant opinions for next agreement changes 
Respondents were asked what changes they would like to see in the 6CPA, using the 
seven selected services listed in Table 7.20. They were also asked to provide any other 
service or activity suggestions that should be included or added to the 6CPA. 
Table 7.20: Pharmacist participant suggested changes for the 6CPA 
Service Decrease Keep the same Increase 
Dispensing (n=120) 15 (12.5%) 43 (35.8%) 62 (51.7%) 
MedsChecks/Diabetes MedsChecks (n=126) 20 (15.9%) 30 (23.8%) 76 (60.3%) 
HMRs/RMMRs (n=131) 4 (3%) 32 (24.4%) 95 (72.5%) 
Clinical Interventions (n=126) 14 (11.1%) 27 (21.4%) 85 (67.5%) 
DAAs (n=126) 8 (6.3%) 41 (32.5%) 77 (61.1%) 
Staged Supply (n=122) 8 (6.6%) 56 (45.9%) 58 (47.5%) 
Rural Workforce Program (n=111) 6 (5.4%) 58 (52.3%) 47 (42.3%) 
Participants wanted an increase for all services, apart from the rural workforce 
programs. This was the only statistically significant result (Chi-sq.=0.023) of the 
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suggested 6CPA changes. While only 42.7% of participants suggested increasing funding 
for the Rural Workforce Program (as it was known, now the Rural Support Program) 
nearly half suggested that funding should stay the same. This was in contrast to all other 
recommendations, in which a funding increase was suggested. It was acknowledged that 
this program was probably the least known service, especially by those who did not 
practice in rural Australia. 
Sixty-two respondents, 36.9% of the cohort, provided additional comments suggesting 
more reimbursement for services, many of which are currently provided without 
charge. A suggestion was made by two respondents, for reimbursement of extra time 
spent for counselling an initial supply. Also recommended was an audit of the programs. 
Comment was made about the lack of wage increases over time, and a suggestion that 
payments for services should go to the pharmacist who provided them, not the 
pharmacy owner. Some proposed a direct reimbursement from Medicare for services, 
with the introduction of pharmacist health professional Medicare numbers. Lifting the 
payment cap on HMRs and RMMRs was also suggested. 
Rural-specific comments included extending the locum service to all areas outside 
capital cities, and an acknowledgement of the cost and time of providing services in a 
regional, rural or remote pharmacy, and improved access to training. 
The following additional services and reimbursements for pharmacy services were 
suggested by the respondents: 
Pharmacy service reimbursement suggestions: 
vaccination, blood pressure measurement, INR measurement, pharmacotherapy, OTC 
counselling, prescription counselling with an additional payment for initial supply, 
counselling, health promotion and screening, clinical activities outside pharmacies. 
New reimbursement role suggestions for pharmacists: 
GP surgeries, disease state management, care plan participation. 
Q26: Opinions of the future of pharmacy in 5 years’ time 
Overall, the participants were generally pessimistic about the future of pharmacy, and 
half thought that pharmacy will be in a worse, or much worse position, in five years’ 
time (19.2% much worse; 30.8% worse), 16% thought it would remain the same and 
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17.3% thought it would be better, while only 3.2% thought it would be much better. 
Some answered ‘Not Applicable’ and it could be assumed that they will not be in the 
profession in five years’ time. If two answers were recorded (three cases), the more 
negative answer was chosen for analysis. (Table 7.22) 
Table 7.22: Pharmacist participant opinion of the future of pharmacy by PhARIA grouping 
PhARIA 
Much worse/ 
worse 
Neither worse 
nor better 
Better/much 
better 
Total 
PhARIA 1 64 (58.7%) 16 (14.7%) 29 (26.6%) 109 
2 4 3  7 
3 3 4 1 8 
4 4 1  5 
5 2 1 1 4 
6 1  1 2 
PhARIA 2–6 14 (53.8%) 9 (34.6%) 3 (11.5%) 26 
Total 78 (57.8) 25 (18.5%) 32 (23.7%) n=135 
Opinions were similar for rural respondents (PhARIA 2–6) and urban (PhARIA 1) 
pharmacists, and both thought pharmacy would be worse off in 5 years’ time. While 
one-third of rural pharmacists were ambivalent, only 14.7% of PhARIA 1 pharmacists 
had this view. One-quarter of PhARIA 1, pharmacists were confident that the profession 
would be better, or much better off, in 5 years; however, only 11.5% of rural 
pharmacists shared this view. 
Q27: Opinions of pharmacy professional qualities in 5 years’ time 
Participants thought some of the professional qualities of pharmacists would change in 
the next five years (Table 7.21). The parameters used were altruism, accountability, 
excellence, duty, honour and integrity and respect for others as suggested by Chisholm 
et al. (2006), and reiterated in the America Board of Internal Medicine’s Project 
Professionalism (1995) [221, 222]. 
While the respondents thought altruism might increase, decrease or stay the same in 
even proportions, almost half thought accountability would increase, while qualities of 
excellence in practice, duty of care, honour and integrity and respect for others would 
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stay the same. 
Table 7.21: Pharmacist participant opinion of professional qualities in 5 years’ time 
Professional quality (n=136) Increase Stay the same Decrease No response 
Altruism 41 (25.5%) 47 (29.2%) 48 (29.8%) 25 (15.5%) 
Accountability 78 (48.4%) 51 (31.7%) 7 (4.3%) 25 (15.5%) 
Excellence 47 (29.2%) 69 (42.8%) 20 (12.4%) 25 (15.5%) 
Duty 37 (23.0%) 75 (46.6%) 24 (14.9%) 25 (15.5%) 
Honour and integrity 30 (18.6%) 73 (45.3%) 33 (20.5%) 25 (15.5%) 
Respect for others 44 (27.3%) 67 (41.6%) 25 (15.5%) 25 (15.5%) 
Q28: Final respondent comments qualitative analysis 
Respondents were given the opportunity to give further comments at the end of the 
survey. They wanted greater roles in overall patient care, and to be part of the 
management team, despite the negative comments given, relating to lack of pay 
increases, and payment for additional services elsewhere in the survey. 
The following quotes exemplify the suggestions made by respondents: 
…greater availability for clinical disease management with a patient centred approach… 
(5, PhARIA 1) 
all pharmacist practitioners to be working to the same pharmacist care model;…to work 
collaboratively within the profession and with other health professions. Must have 
clinical handover standards to ensure patient’s current health care plan and medicines 
plan is accurate. (80, PhARIA 1) 
However, the existing dispensing workload influenced provision of these other services. 
The services suggested should not require additional pharmacy accreditation, and 
should be within the current business frameworks: 
For equity and transparency, being QCPP accredited should NOT be a requirement for 
receiving payments such as PPIs, DAA and even NDSS accreditation. (125, PARIA 1) 
Pharmacists acknowledged that their remuneration was an issue, and some had been 
employed without a pay rise for 5–10 years of service: 
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Would like to see less pressure on Pharmacists to keep providing the same services and 
yet expected to embrace more and more other services which entails more time note 
keeping and less actual contact time with clients. Remuneration is still one of the lowest 
in all professions. My wages have essentially not increased in 10 years and yet the 
demands on me have become greater and greater each year. I'm not sure how new 
initiatives can improve this without expecting more of Pharmacists who with increasing 
script loads struggle to sometimes maintain the status quo. (51, PhARIA 1) 
Actual $$$ for pharmacists. No real pay rises for 5 years. Quality of life being eroded 
yearly. More work, service supply time pressures without any monetary reward. (92, 
PhARIA 4) 
It was also suggested that the pharmacists themselves should be supported and receive 
the incentive payments, not the owners of the pharmacies. 
It is not only the matter of new initiatives. The incentives should be paid at least in part 
to the employee and not the employer. (22, PhARIA 2) 
I think our current activities need to be well supported and funded before new 
initiatives are burdened on businesses that are already stretched to survive. (151, 
PhARIA 1) 
Payment for services rendered, and adequate reimbursement, were two of the 
overarching themes, with adequate remuneration for the practitioners themselves. 
Respondents also called for audits of programs, and an ability for practitioners to 
charge under the Medicare Benefits Scheme (MBS), as well as for services provided 
within the pharmacy setting. 
One urban practitioner would like to see in rural practice more subsidies under the 
Rural Workforce Support Program: 
More subsidy should be available for rural & remote pharmacists to help provide locum 
services not just in emergency situations (i.e. for normal annual leave assistance on par 
with the 4 weeks every other worker is entitled to). (125, PARIA 1) 
7.4.3 Discussion: Differences and similarities for rural and urban 
pharmacies 
This survey was extensively promoted in the pharmacy journals and electronic 
communications, yet still received a relatively low number of participants. Never-the-
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less, some interesting findings could be drawn from the results. Although there were 
not many rural respondents (but an acceptable proportional representation compared 
to urban respondents) in the cohort, it appeared all respondents were supportive of 
practice changes for all pharmacies, and not just for the rural pharmacies. 
The participants were interested in providing vaccination services and disease 
management services themselves, but did not agree with the low payment options 
suggested by Duckett et al. (2013) [55]. More urban pharmacists were prepared to 
accept a lower fee for vaccination services, but overall having the patient pay was the 
preferred option for all. While almost all were prepared to notify GPs and other 
professionals about information to add to a patient’s health plan, only two-thirds would 
adjust doses (in the example given for hypertension medication), half would be happy 
to continue to dispense for 18 months instead of 12 months, but only one-third would 
discontinue or start medication. Rural pharmacists were more prepared to adjust doses 
or provide continued dispensing than urban pharmacists. They were also prepared to 
spend longer with patients if delivering disease state management services. The 
preference for all, was the Government funding this service. The low percentages 
overall in accepting these roles, suggested that additional clinical roles and requesting 
payment for services were out of the ‘comfort zone’ for many pharmacists. 
There was a high number of ‘uncertain’ responses as to whether or not, the relationship 
with GPs, would be changed if the pharmacy provides vaccination services and disease 
management services. The potential impact of this change, suggested that pharmacists 
had either not thought about introduction of these services, or discussed this with their 
local health professionals. Rural pharmacists had a higher degree of uncertainty about 
the impact on their relationship with local GPs, whether this be positive or negative. 
This could be indicative of a professional isolation, or a divide that exists between 
pharmacists and other local health services, as suggested by the key opinion leaders and 
PAART pharmacists previously (Chapters 4 and 5). 
When participants examined their own practice, they appeared to want to change their 
workload, and do less dispensing and counselling, as well as less participation in OTC 
sales and advice. However, they did not think this would change for them in the next 
five years. It appeared rural pharmacists were much more involved in these activities 
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than their PhARIA 1 counterparts, acknowledging that the PhARIA 1 respondents had a 
wider range of primary roles. When the data was re-examined using the cohort assumed 
to be in community pharmacy, the dispensing and OTC counselling levels were similar. 
The pharmacist dispensing portion of average workload was about 40%, much less than 
the approximately 70–75% for this role suggested as by others [179, 197, 200]. One 
could also argue the lower full-time equivalent workforce in rural and remote areas 
[218] would mean these quintessential pharmacy roles must be undertaken first before 
any additional professional services. 
Many participants would like to change their role, but did not think this would happen 
in the next 5 years, suggesting complacency or hesitancy, or an inability to make the 
move to another role, due to lack of local opportunity or educational payment 
requirements. It was also acknowledged that there could be personal reasons, which 
would override any capability or capacity, for these survey respondents to change. 
Participants suggested the funding in the 6CPA for staged supply and for rural 
pharmacies should stay the same or be increased, in contrast to, the definitive increases 
suggested for other 6CPA programs. It was probable that if participants did not have a 
working knowledge of the breadth and scope of rural programs, and this could limit 
their knowledge and consequent answers compared to the increases suggested for all 
other sections. 
More rural respondents were uncertain about the future of pharmacy in 5 years’ time. 
While half thought, it would be worse or much worse, only one-quarter of PhARIA 1 
pharmacists, and an even lower percentage of 11.5% of rural pharmacists thought this 
would improve. 
Respondents thought issues of workload, remuneration, practice and payment models 
hampered the profession’s progress. When asked for additional comments, the 
pharmacist wages were mentioned on more than one occasion, as many had not been 
given an increase for some years, despite the expectation to provide additional services. 
Comment was made that the payments currently go to the owner, not the pharmacist 
who may be using his/her increased level of skill to provide professional services, over 
and above those expected skills of dispensing, counselling and sales. Respondents 
commented about pharmacy not being part of the health care team and the challenge of 
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increasing prescription loads and additional services, which leaves little room for more 
professional roles. These responses appeared to be across the professional groups and 
there were no differences from those in rural practice. 
7.5 Limitations 
The data obtained from the research project to develop a PCHCM (2005), had to be 
recoded to simulate the PhARIA pharmacy system for comparative analysis. The age of 
this data examined also needed to be taken into consideration, but it did provide a base 
for community pharmacy practice comparison today. 
The main limitation of the Current and Future Practice Survey was the low number of 
respondents, despite repeated attempts to increase participation. 
7.6 Summary 
In 2005, as part of the PCHCM project, consumers were asked if they were satisfied with 
their pharmacy, its capability in providing CVD related professional services, and the 
likelihood the consumer would then patronise these services. Rural consumers with 
CVD thought their pharmacy was more capable of providing a blood pressure service 
compared to the other options provided, a result with statistical significance (p<0.00). 
However, these consumers were also less likely to use lifestyle change services or 
dispensing services compared to those with CVD living in urban areas. For other 
services, such as blood pressure screening, cholesterol measurement and diabetes 
services, there were no statistically significant differences for rural or urban consumers 
in their opinion of the pharmacist capability and likelihood of use, if the pharmacy 
provided the service. 
Pharmacists were the most likely person to ask about medicines and to monitor the 
outcomes of drug treatment. Consumers were very satisfied with their pharmacy 
service, and there was no difference in satisfaction between rural and urban 
pharmacies. 
There were discrepancies between the consumer perceptions of the number of 
pharmacies providing services and the numbers of services found by other researchers 
[40, 152, 217]. The PCHCM respondents thought the pharmacies offered far more 
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services in hypertension, dyslipidaemia and diabetes than acknowledged by 
pharmacists in the National Database study. The 3CPA evaluation data provided yet 
another set of levels of professional service provision. In addition, descriptions of the 
nature of the professional service was also lacking. Most, whether they be urban or 
rural, offered the service without payment. Although there was a three-year difference 
in compilation of this data, is was not expected that this increase would have naturally 
occurred. 
Respondents from the Current and Future Practice Survey provided a valuable insight 
into practitioner opinion, workload and aspirations. Rural respondents had overall, 
similar opinions to their urban counterparts. Neither group thought payments 
suggested by Duckett et al. (2013) [55] were sufficient for the suggested vaccination 
and disease management services. It should be noted these charges were higher than 
the PAART pharmacists in Chapter 5 suggested, for the cardiovascular professional 
services, on survey and on interview. Lack of pay increases, additional professional 
service expectations and increased dispensing commitments were examples of current 
issues, which discouraged the respondents from providing a more positive expectation 
of the future of pharmacy practice. 
Although there were suggestions to broaden the profession’s scope of practice the 
respondents, in many instances, did not think the changes were possible in their own 
working environment. This survey has provided an insight into individual pharmacist 
practice and their expectations of the future. Overall, there were few rural and regional 
differences in opinion and practice, but rural pharmacists were prepared to offer a 
greater range of disease state management services than their urban counterparts. 
The following chapter will bring together and discuss the initial literature review 
chapters, as well as the analysis of interviews and surveys undertaken, to enable 
conclusions to be drawn and provide recommendations and suggestions for further 
research from the data obtained. 
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Chapter 8: Discussion 
Much has been written in all forms of the pharmacy literature about the nature, 
purported differences, and staff shortages in rural community pharmacy practice [80, 
159-164]. There have also been many champions of rural and remote pharmacy in 
Australia, such as ‘Robbo’ [43], Karalyn Huxhagen [42]and Patrick Mahony [80], who 
have promoted the practice and lifestyle, which is often peppered with its frustrations, 
trials and tribulations. However, the lists of influential pharmacists do not usually 
contain these people, despite the acknowledgements they may have received in the 
past. The 2018 Australian Journal of Pharmacy Agenda Setters List [223], does contain 
two rural pharmacy owners (multiple pharmacies, PhARIA 1 up to 5), who are part-time 
community pharmacy practitioners. One rural employed community pharmacist from 
PhARIA 3, was on the ‘bubbling under’ list. However, these practitioners made the list 
for their ‘outside’ activities, not their practice in the rural community pharmacy itself. 
Little supporting published evidence has been discovered for this thesis, which 
compared the individual practice components. Any substantial differences between 
rural and urban community pharmacy practice, in either the Australian, or the 
international literature has not been found. 
The literature review for this thesis attempted to set the scene in the areas of health, 
rural health, health policy, and the practice, governance and workforce of pharmacy in 
Australia. A systematic review was then conducted to determine more fully, what had 
been reported thus far in the international literature on rural and urban community 
pharmacy practice. Then, various investigations were undertaken, to search for any 
further differences. Interviews took place with two groups, key opinion leaders, 
including a follow-up series several years later, and with the ‘at-the-coal-face’ 
practitioners. Analyses were also undertaken looking for any differences using 
previously unpublished evaluation data from the 3CPA, 4CPA, and the PCHCM. Finally, a 
practitioner survey was conducted to look for practice differences based on the views 
and opinions of the pharmacists themselves. 
The research questions will be discussed, using the results of the various investigations 
conducted. It should be noted that these studies were conducted over a significant 
timeframe, thus allowing a unique approach to investigate comparisons and differences 
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in rural and urban community pharmacy. 
8.1 Discussion based on the research questions 
What is meant by the concepts of ‘rural’, ‘rural health’ and ‘community pharmacy 
practice’ was initially studied and reviewed to set the background scene for this thesis. 
As described in Chapter 1, there have been many systems over the years to define what 
is classed as ‘rural’ Australia. Other classification systems, in individual countries have 
been developed (Chapter 3), with no consistent criteria denoting location, population 
size or health service availability. Population indicators were generally used, which 
were not necessarily particular to the pharmacy profession. Each country was found to 
have a different method of classing geographical zones as rural or urban (Chapter 3). 
These rural or remote classifications were specific to that country, and using the 
descriptions were clearly not transferable to another. 
Australia has used various rural classification systems over the years, and even now has 
several in concurrent use, depending on the community or funding requirements, for 
example, in areas of social housing, education or health. Pharmacy—in Australia—has 
used the same system since 2000, the PhARIA system, which was based on the ARIA 
system (Access/Remoteness Index of Australia) [24, 25]. In Australia, 83% of 
pharmacies are in PhARIA 1 areas, with the remaining 17% of pharmacies in PhARIA 2–
6 areas [64, 65] (Chapter 2), providing services for nearly 30% of the population 
(Chapter 1). However, while some areas receive the highest ranking of PhARIA 1 using 
this particular system, they would have a second or third level classification in other 
geographical systems, and would consequently enjoy a rural or regional status, should a 
system such as the Modified Monash Model [21]  be introduced. 
Community pharmacy program funding for those in rural areas is dependent on this 
PhARIA system. Available for PhARIA 2–6 pharmacies, the Rural Support Program 
currently provides a number of programs, including emergency locums, intern support, 
and pharmacy maintenance allowances (Chapter 2). Also available, is funding for the 
practitioners themselves (professional development and intern support), provided the 
practitioner is an Australian citizen or permanent resident (Chapter 2). These 
allowances have changed considerably over time, and were initially to support the 
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pharmacy itself, and now include the practitioner. This more sophisticated rural funding 
allocation model has evolved over the course of the CPAs (Chapter 2). 
Just under one-third of the population in Australia, live in regional, rural and remote 
areas [8]. The spatial distribution of the supply of the clinical health workforce study 
considered that up to one hour’s travel to a health service was reasonable [19]. 
However, the average distance to a pharmacy is 6.5km [168]. Consumers in other 
countries might consider this distance as too far to travel, depending on their 
population spread and expectations of care (Chapters 1–3). 
Consumers today have alternative methods of obtaining pharmacy goods (prescriptions 
etc.), such as online purchasing, or the use of a pharmacy depot in some rural areas. In 
addition, models of community pharmacy in Australia are changing with a rise in the 
numbers of discount pharmacies, which focus on price, a concept that seemingly 
appeals to many consumers. Many are now based in rural areas. Added to this, are the 
changing ownership models, with fewer individual owners and the evolvement of 
partnerships, absentee owners or quasi-franchises (Chapter 2). The suggestion is now 
that the pharmacist seen by the customers in the community pharmacy, is not 
necessarily the owner of the business. However, this occurrence is not unique to rural 
practice. 
Still today, the health of Australians in rural areas is worse than those in urban areas, 
with 54% having a chronic illness, compared to 48% of people who live in major cities 
[224]. The Health Survey (2014–5) showed that while more people lived with a chronic 
health condition overall, the impact on health and longevity was worse for those in rural 
and remote areas of Australia [6]. Mortality for those in remote or very remote areas 
was 1.3 times of that in major cities [224]. This differential has continued to exist over 
time, despite the many programs and policies that have been and continue to be put into 
place (Chapter 1). However, rural people were less likely to complain about health 
services [29] and use health and pharmacy services less than those living in urban areas 
(Chapter 1). Chronic disease risk factors, such as smoking, low exercise levels, alcohol 
consumption and obesity, were also increased, the more remote the community 
(Chapter 1). Policy documents and frameworks today which guide approaches for 
improvement of health concentrate on prevention and management of chronic 
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conditions. Regional, rural and remote people are listed as a priority area. [37]  
The following themes have emerged from the various forms of research undertaken for 
this thesis. Using the background information, these themes will be discussed, and the 
data found related to the research questions. 
Primary research questions: 
• How, and in what aspects, does rural community pharmacy practice differ 
from that in urban areas? 
Investigations undertaken 
The first investigation undertaken was an international systematic literature review 
(Chapter 3) which looked at studies in which rural and urban community pharmacy 
practice had been compared. Only those publications, in which a comparison in 
community pharmacy took place, with a current or proposed service, were accepted for 
this review. Dispensing and its associated services were excluded, as it was assumed to 
be a constant, wherever the practice location. Few relevant publications were found 
(20), and only four had these comparisons as the focus from the outset; the rest 
declared the comparison as a by-product of other research foci. A total of 17 studies 
were found in the initial review (up to 28 February 2018), with an additional three 
studies from the supplementary literature review (1 March 2018 to 31 July 2018). The 
studies used surveys, interviews and focus groups with a wide range in both the 
number of participants (10–708) and time frames (1993–2018). Many investigations 
undertaken were in specific geographical locations, which it could be argued, were not 
transferrable to other rural areas or even other countries but it would be difficult to 
control for this. The topics included areas of pharmaceutical care and cognitive services 
(professional services), public health or enhanced pharmacy services, which also 
included screening and support, primary health care and treatment services. Two 
papers were about proposed services. 
It was found that rural customers were more willing to talk about general health 
matters, and ask advice from the pharmacist, and it was the rural pharmacist who 
initiated conversations, and talked longer than the urban pharmacists [186, 190, 193]. 
Rural pharmacists considered this assistance was part of their role [190]. However two 
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studies found no differences between the groups in the areas investigated [192, 195] 
(Chapter 3). These abilities and time taken to talk to customers by rural pharmacists, 
were also confirmed with comments from key opinion leaders (Chapter 4) and PAART 
pharmacists (Chapter 5). 
Scott et al. (2016) [188] in Canada found higher levels of public health services, and 
Haag and Stratton (2010) [179] in the US found greater levels of professional services, 
in rural areas, despite pharmacists providing similar levels of dispensing. But as did 
others [188], the authors then challenged their own results citing these differences 
were accounted for by patient access to a pharmacy, and socio-economic status of the 
customers [179]. The literature reviews also found rural pharmacists were interested in 
innovative roles and delivered a higher level of pharmaceutical care, but in later 
publications, some authors stated there was no difference in professional service 
provision [198]. It was stated that if a pharmacy was part of a banner group, 
independently owned or of a certain size, this was as much a factor in any differences as 
its rurality, by the 3CPA analysis (Chapter 6) and Berbatis et al. (2003) [40], and also 
confirmed several years later by Guirguis et al. (2017) [194] and Stewart et al. (2018) 
[198]. 
However, overall, the statistical analysis of the smaller studies, with small numbers of 
participants, was often basic without controlling for confounding variables. For larger 
studies, examining rural differences was not a priority. 
Interviews, evaluation data analyses and surveys conducted 
Key opinion leaders (Chapter 4) were asked for their views and suggestions of the 
differences between rural and urban community pharmacy practice, as well as their 
opinions on the future, work practices, influences and barriers within the profession. 
The leaders chosen were from a mix of backgrounds and experiences, and there was no 
obvious consensus from these practitioners, but many held strong opinions. Never-the-
less, these practitioners were the key opinion leaders of pharmacy in Australia at the 
time the initial interviews took place (2008–2010). However, it was found that often 
these opinions voiced were not specifically about rural practice, but rather about the 
profession as a whole, for example, the lack of a seat at the national table when health 
policy is discussed and developed. 
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The particular rural interviewees in Chapter 4 liked rural practice, enjoyed the 
innovation, and adaptation that seemingly came with it, and the associated lifestyle of a 
rural area. All felt that there was more interprofessional collaboration in rural areas, but 
overall there was still a sense that others do not know what a pharmacist was capable of 
professionally, and there was still a distinct lack of local teamwork. Added to this 
overall, in Chapter 4 was the impression that pharmacy was not included in plans, 
committees and decisions in various levels of health care policy across this country, as 
confirmed by data presented in Chapter 2. Comments were made about the restrictions 
on practice by the CPAs, which essentially dictate community pharmacy funding and 
practice. They felt pharmacists usually did not, or could not charge for professional 
services, and these services should be at the particular industry standard, in order to 
support the value of pharmacist input in patient care. The role of some professional 
organisations within pharmacy was questioned. Interviewees thought that overall, 
there had been a lack of change within the profession over time (Chapter 4). 
In the second set of interviews with key opinion leaders, in 2016 (Chapter 4), some 
additional changes had occurred, but many themes were the same, despite the time 
difference between interviews. Customer service expectations, expanded practice, the 
pharmacy culture and teamwork with other health professionals were still identified as 
issues for all practitioners, not just those in rural practice. Overall, the comments did 
not shed any new light on the differences in rural community pharmacy practice, in the 
two sets of interviews, just inconsistencies in opinion within the profession as a whole. 
Another set of practitioners interviewed, had participated in the PAART study (2013) 
[203] (Chapter 5). Interviewed in 2009, the matters of concern for these practitioners 
were more day-to-day practice issues, the authority of the CPAs, which practitioners felt 
directed their own practice, and the influence of discount pharmacy. Customers were 
the primary focus, and any practice change could not affect this relationship, or business 
viability would be at risk. The pharmacists here also thought rural customers were 
more willing to sit and listen, than were the urban customers. Although these opinions 
were based on the PAART study, they were confirmed in the findings from the literature 
review [186, 190, 193] and by key opinion leaders (Chapters 3, 4). 
Many studies into wider roles for pharmacists, either in current or potential community 
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pharmacy practice, were conducted in either rural, or a mix of urban and rural 
environments. For some, this may be because of the funding source, using for example, 
the rural research funding provided as part of the earlier CPAs [33], which specified 
funded projects were to be conducted in rural or remote areas. Other studies contained 
subjects within a variety of geographic locations, without any indication of this data 
being used for any comparative research, such as those papers found in the systematic 
literature review (Chapter 3) or as background in the PAART study (Chapter 5). This 
approach to using mixed rural and urban data together for analysis had not altered over 
the time range for the literature review. 
Data from the CPA QCPP evaluations from two agreements (3CPA and 4CPA) (Chapter 
6) was also obtained, and additional analysis conducted to investigate for any 
differences in urban and rural community pharmacy practice. The rural ranking for 
each pharmacy location was checked, and adjusted for both evaluations and then 
altered if need be, to reflect the PhARIA ranking of the time. 
The 3CPA QCPP evaluation, by the pharmacists, found that a statistically significant 
proportion, 83% of rural pharmacies, considered two-thirds of their customers to be 
regular, compared with only 63.4% of those pharmacies in PhARIA 1 areas. It was found 
that significantly more PhARIA 1 pharmacies solved problems presented to the 
pharmacy (p<0.01), than did rural pharmacies. In the area of professional services, 
statistically more PhARIA 1 pharmacies delivered ‘nutritional services’ (p<0.01). It was 
also found that there was no statistically significant difference between urban and rural 
pharmacies for the delivery of other professional services, such as those for 
hypertension or asthma. 
The 4CPA data from Chapter 6 comprised of 36,668 customer responses to a survey 
handed out by pharmacy staff, or were made available in the pharmacy itself, for self-
selection. Again, a comprehensive re-organisation of data was required to ensure the 
rurality of respondents was correct, in what was provided by the original investigators. 
The PGA chose to promote that 95% of customers trust and appreciate their pharmacy 
[95] after this report was released. No differences in rural and urban pharmacy 
customer opinion could be found in any sub-analyses of this data. Unlike the 3CPA data, 
these rural respondents were not more likely to have a regular pharmacy compared to 
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the urban counterpart cohort. This could be due to the surveys being handed to regular 
customers at the pharmacy, and no random consumer selection. Rural consumers in this 
survey also thought that their rural pharmacists had significantly more knowledge 
(p<0.05), compared to what urban consumers however, this was a marginal result in 
absolute terms. No other statistically significant results were found for differences in 
service provision or practice. 
The PCHCM (2005) (Chapter 7), which was rurally funded, used both rural and urban 
participants. It developed a model for CVD care in the pharmacy, using a series of 
different investigations during the course of the project. Within the total of 505 
consumers’ responses, from a telephone survey, there were equal numbers of 
consumers with, or without CVD, and a substantial proportion of rurally-based 
participants, once the data had been correctly adjusted for geographic location 
consistency. Customers with CVD were more likely to ask their urban pharmacy for 
lifestyle (p<0.00) or prescription dispensing advice (p<0.00). Significantly, more 
consumers with CVD from rural areas thought their pharmacy was capable (p<0.00) of 
providing a service for hypertension screening, but there were no significant differences 
on likelihood of patronage of this service. Despite over 80% of consumers overall 
believing that their community pharmacy was capable of providing a lifestyle service, 
the trend was that rural consumers with CVD were less likely to use this compared to 
those without CVD. No statistically significant differences in results were found for 
other professional services. It should be noted, that a reasonable number of consumers 
did not have an opinion one way or the other, and were classed as ambivalent about the 
provision of additional professional services. In 2005, only about half of the consumers 
thought they would use pharmacists’ services for drug monitoring and prescribing, an 
area of practice occurring overseas [188] at the time, and now in some practice settings 
of Australia. 
In 2013, a report by an independent group in Australia, the Grattan Institute, suggested 
a widening of pharmacy services [55]. Similarly, a project in Queensland used a rural 
pharmacist as a health generalist [225], as examples of potential role changes for 
pharmacists. However, pharmacists interviewed and surveyed in this thesis thought 
that any change was limited by the CPA, because it is controlled by Government funding, 
rebates for services and ultimately their own community practice and income. The 
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major influence on the profession here was the PGA itself, because of its relationship, 
and its negotiations with the Commonwealth Government for the CPAs and the 
consequent funding distribution (Chapters 4, 5 and 7). 
As funds have already been allocated for programs within the CPA, the pharmacists 
themselves would have to promote and charge for any additional professional services. 
The pharmacists in the studies for this thesis, although interested in practice change, 
had a limited belief in this occurring (Chapter 7) and were not confident in charging for 
their services (Chapters 4, 5 and 7). Pharmacists from the Current and Future Practice 
Survey (Chapter 7) would prefer professional services to be reimbursed by the 
Government rather than charge customers, thus reinforcing this lack of confidence in 
their own ability, to provide a service that was worth charging the customer, and one 
which the customer would be prepared to pay. In the PAART project, pharmacists in a 
written evaluation survey [203] suggested the cardiovascular service provided was 
worth charging the patient. The pharmacists indicated that they would charge AUD$1–5 
(median) with a range from AUD$0 to AUD$6–10 per session (for up to 30 minutes) but 
did not have the self-assurance to charge when asked in the face-to-face or phone 
interview (Chapter 5). The charges suggested here are less than wages, and not 
congruent with other health professional service charges. 
Using the Duckett et al. (2013) [55] suggested charges for services, with the estimated 
time allocations of 15–30 minutes, was investigated by the survey in Chapter 7. It was 
interesting that again, no pharmacist suggested these charges were too low for any 
health professional to demand (a range of AUD$12.10–AUD$18.65 for up to 15–30 
minutes of time). Currently, pharmacists have no ability to claim for any service through 
Medicare in Australia, and if there was no existing program within the CPA, direct 
charging of the patient is the only option for recouping money for the service provided. 
Although a few pharmacists in the Current and Future Practice Survey (Chapter 7), 
thought the wider roles in vaccination and disease state management should be for 
rural pharmacists only, overwhelmingly, pharmacists thought this should be an 
opportunity for all practitioners. It should be noted, however, that numbers in this 
survey were proportionally small, compared to the current number of practitioners in 
Australia. 
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The community pharmacy model in Australia is also a barrier for change. An emphasis 
on dispensing, and the accompanying counselling, and use of the usual single 
practitioner model, does not enable one pharmacist to engage comprehensively in 
additional professional services. Pharmacists in the survey identified an expectation to 
include professional services into current work structures, but also noted a distinct lack 
of wage increases over time (Chapter 7). As this wage increase could be one measure of 
acknowledging the expertise required for this activity, pharmacists were reluctant to 
add more undertakings to their busy work life. The issue of wages will be discussed 
further, later in this chapter. 
Minor and inconsistent differences only, were noted for practice in rural areas despite 
extensive research and analysis of the various data obtained and examined for this 
thesis.  It is therefore postulated, that essentially over this time period, the practice is 
the same, but the geographical context is different. The systematic literature review 
undertaken found that there were very few studies in this overall area from the 
searchable literature, the earliest found was 1993.   
Although not specifically about rural practice, key opinion leaders expressed frustration 
at the lack of professional services and pharmacy industry change. Many of the 
pharmacist participants indicated that they wanted to see change, deliver more 
professional services and be regarded as an integral member of the health care team. 
However, these pharmacy practitioners were unsure how to progress this change, and if 
they had the capacity and imprimatur from the pharmacy owner. Overall any change 
that is conducted must ensure that any pharmacy businesses would be viable.  
The lack of customers’ experiences with, and support for professional pharmacy 
services was indicated in the consumer surveys and the literature review. Data analysis, 
supporting Heffernan’s views [96] that suggest customers’ experiences shapes their 
expectation of practice. Strong relationships with regular customers and doctors were 
reported as facilitators for a higher level of pharmaceutical care in Sisson’s et al. USA 
study [185] (Chapter 3, 4 and 5). However, this was not supported by the findings of the 
studies in this thesis when practitioners were asked if relationships would improve or 
deteriorate if professional services were introduced into the pharmacy (Chapter 7). For 
this Australian survey the response was small, and further investigation is needed to 
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confirm if these findings were similar to those found overseas.  
Other forms of pharmacy practice as previously discussed (Chapter 2) may be an option 
in some geographical areas if professional services were not practical or possible in a 
community pharmacy setting. A focus of this future research would ascertain if any 
further differences exist in the relationships between health professionals and 
customers with pharmacists in regional, rural and remote practice locations. More 
research is needed to find if rural community practice is indeed ‘different’. 
• What are the implications and significance of these differences for 
development, support and implementation of new programs for rural 
community pharmacy practice? 
In Australia, pharmacists themselves do not usually instigate any professional programs 
of significance, other than those found under the QCPP. The exact nature and detail of 
many individual programs is unknown, and was not found in the published literature. 
As mentioned, pharmacists would prefer payment from the Government and were 
reluctant to charge the consumer, at a rate commensurate with the time undertaken as a 
health professional, for fear of losing custom and business (Chapters 5, 7). Rural 
pharmacists were more likely to spend longer with patients for less remuneration 
(Chapter 7). 
The pharmacist survey respondents in Chapter 7, suggested a number of increases in 
what was then, the upcoming 6CPA, with the lowest increase being for Rural Support 
Programs. Although rural pharmacists were part of this respondent group, this lowest 
increase would suggest an inferior knowledge of the depth, variety and scope of various 
components funded within this particular program. 
Few respondents in this survey thought the professional programs, such as vaccination 
services or disease state management, should only be available for rural pharmacists. 
Respondents also suggested that the actual pharmacist performing the professional 
service should receive the payment, not the business owner (Chapter 7), a major shift in 
the current Australian funding approach. The majority of professional programs today 
are MedsChecks, according to the PPA (2018) [226], with ‘other services’ only 
undertaken by 12.5% to 22.7% of employed pharmacists as shown in Figure 8.1 below. 
This contrasts with other statistics and information previously found in Chapters 6 and 
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7 showing the prevalence of a variety professional services. These previous 
investigations did use data before MedsChecks were instigated, however it is interesting 
to note the proportion of supply of this service compared to the many other 
professional services noted in other chapters (Chapters 3–7). 
Figure 8.1: Additional professional services offered by community pharmacists 2016–7 
 
Community pharmacist employment and remuneration report 2016/17, PPA, 2018 [226] 
Lack of pharmacy involvement in policy, rural policy and frameworks 
Pharmacy, as a profession, has not been at the forefront of many health, and in 
particular rural health policy, and frameworks and, if included, it is mentioned in minor 
ways, relating to the community pharmacy shopfront. Community pharmacy is 
mentioned as somewhere to get a prescription filled or an OTC product or service 
(Chapter 2). A review of rural policies and documents over the past 25 years, showed 
the roles of nurses and doctors were more prominent, and at the forefront in these 
various papers and reports. There also was a lack of inclusion in the past, and now in 
current Government funded bodies such as the PHNs. 
Community pharmacy is essentially managed under the CPA and this, in turn, dictates 
pharmacy practice. Pharmacy as a profession does not appear to have used this lack of 
inclusion in policies and frameworks to argue for additional services or funding 
provisions. Although individual practitioners might provide various services, this has 
not transferred to inclusion or widespread change within the profession itself, whether 
this be in rural or urban community pharmacy. 
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Lack of definition of professional services in the literature 
Papers in the systematic review for this thesis, examined if a service was provided or 
not (Chapter 3). As previously suggested, the level and details of the service was not 
described in the various papers in any of the literature searched. This was reinforced by 
the investigations into the 3CPA monitoring and clinical service provision (Chapter 6), 
the PCHCM (Chapter 7) and the National Pharmacy Database (2003) [40] data. Although 
some of this data would now be considered as old, it was still relevant for comparative 
purposes and can be useful to review any practice changes over time. 
It is suggested that the professional services mentioned elsewhere in this thesis, range 
in complexity from a simple opportunistic blood pressure reading to a comprehensive 
disease management service complying with the current version of the Professional 
Practice Standards (version 5) (2017) [62]. However, any data and papers found did not 
differentiate between these two actions, and tended to describe them as the same 
clinical intervention service. This also confuses consumers, as their opinion of the 
prevalence of some pharmacy services did not match the pharmacists’ opinions and 
consumers thought pharmacies conducted more services, than the pharmacists did, but 
not in all cases (Chapters 6, 7). 
An example of this confusion is the website of Buderim Pharmacy (2018) [227], and 
how it describes it’s ‘Blood Pressure Monitoring Service’: 
At Buderim Pharmacy we offer complimentary blood pressure testing every day of the 
week and no appointment is necessary. [227] 
From this description, there were no details as to the full extent of the service. One 
cannot assume the multifaceted approach described by the following pharmacy 
organisations matches this current practice. The GuildCare programs protocol for Blood 
Pressure (2015) [228] includes screening, monitoring, recording, interpreting and 
discussing the blood pressure readings taken, relevant information given and referral if 
necessary. This protocol is used in conjunction with the following QCPP Checklists: 
Disease State Management Service Checklist, Screening and Assessment Checklist and 
the Equipment Calibration/Maintenance Schedule and Record (2016) [229]. This 
service should also comply with the PSA Professional Practice Standards (version 5) 
(2017) [62] on disease state management: 
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The pharmacist supports the patient to develop and, where possible, take responsibility 
for their healthcare plan. The pharmacist raises awareness of the risk factors associated 
with chronic disease states, and works with members of the healthcare team to facilitate 
patient health and wellbeing. [62] 
Figure 8.2: Disease state management—PSA professional practice standards, version 5 
 
Professional practice standards, version 5, Pharmaceutical Society of Australia, 2017 [62] 
Figure 8.2 above shows the extensive list of criteria essential to successfully adhere and 
practice to an acceptable professional level of patient-centred care in Australia. Also 
incorporated into a community pharmacy blood pressure service, should be the 
following professional standards: Fundamental Pharmacy Practice, Health Promotion 
and Education, Collaborative Care and the Screening and Risk Assessment Standards. 
Another professional service previously mentioned with unclear details as to the exact 
nature of the service was one for nutrition or weight management (Chapter 2, 4–6). This 
could be classified as vitamin sales, food supplements or a complex professional service 
provided by the pharmacist. From the previously data shown in this thesis and the 
examples provided above, definitions of service do not appear to be consistent in 
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community pharmacies in Australia. 
Secondary Questions: 
• What are the influences in rural pharmacy practice today? 
It appears that the main reason people practice in rural areas is because they want to, 
and the rural context and its associated lifestyle is paramount, but not because of any 
perceived difference in community pharmacy practice. Pharmacists’ personality, family 
proximity, culture, gender, generation type, and practice requirements may affect their 
employment choices. The influences in rural practice were found to be those in any 
community pharmacy: the practice, customers, practitioners, owners, professional 
organisations and the government. 
The current model of a single practitioner practice can restrict participation in the many 
professional services, which could improve pharmacy business and customer health. 
With support, both remuneration and time, involvement would improve practitioner 
knowledge and skills, job satisfaction and thus keep community pharmacists in 
pharmacies, wherever the location. This is fundamental to practice, not location. 
Another example found in the Australian literature, also might influence the 
pharmacist’s potential to practice and take advantage of specific rural funding 
opportunities. This also highlights the anomalies within the current rural classification 
schemes. The Grattan report (2013) [55] suggested extended health services, to 
alleviate shortages in which there was limited access to GPs, and should only be 
available in 7 identified locations in Australia. These areas were New England 
(Armidale, Tamworth), Southern New South Wales (Queanbeyan, Goulburn), and 
central and northwest Queensland (Mt Isa), as well as the Northern Territory and most 
of Western Australia, using the Medicare Local Area data of the time for their 
calculations. It was suggested that 1 in 20 Australians were affected by the lack of GPs in 
these areas. Unfortunately, as shown in the report, the number of pharmacists in these 
areas was low as well (Figure 8.3). An increase in pharmacist services assumed 
adequate staffing, but the number of full-time equivalent pharmacists in these areas is 
much less than 100%, as shown below. The lowest numbers of full-time equivalent 
pharmacists were in the Northern Territory, with just under two-thirds, compared to 
the national average. 
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Figure 8.3: Pharmacist numbers per capita in identified low GP serviced areas 
Access all areas: new solutions for GP shortages in rural Australia, Duckett et al., 2013 [55] 
According to the 2013–4 PhARIA data [25] (appropriate to the time of the report), the 
New England areas of northern NSW which contains the towns of Armidale and 
Tamworth, were ranked PhARIA 1. Thus, these areas would be excluded from any CPA 
Rural Support Program funding opportunities and consequently any practitioner 
support. Other areas also with this PhARIA 1 rating were Queanbeyan (ACT) and 
Goulburn (southern New South Wales). If another rural ranking scale was used, such as 
the ASGC–RA rating scale, all except Queanbeyan were RA2 (Inner Regional) i.e. ‘rural’. 
Urban Queanbeyan, the exception, was ranked RA1 (Major Cities) (2018).  
If the Modified Monash Model (MMM) [20, 21] for area classification  was used the 
following differences are noted for the geographical locations for the key opinion 
leaders. Compared to the PhARIA ranking scale used for funding in the community 
pharmacy profession, many of the interviewees are based in regional or rural non-  
metropolitan areas which still have a PhARIA 1 ranking. Since the MMM [20, 21] scale 
was only released in 2015, it could only be used for the second round of key opinion 
leader interviews. Using the current MMM rankings, the following classifications 
emerge: 
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Table 8.1: Pharmacist key opinion leader interview list: Interview series one and follow-up series: 
Addition of rural ranking scales 
Code 
Role at time of initial 
interview 
Role at time of follow-up 
interview 
PhARIA 
work base  
Modified 
Monash 
Model 
Scale 
(MMM) 
work base 
S1 
Key pharmacy opinion 
leader and academic, drug 
regulatory body 
representative, pharmacist 
Same role as listed for the 
initial interview 
1 1 
S2 
Past Chair AACP, accredited 
pharmacist, PSA committee 
and national representative, 
community pharmacist and 
rural pharmacy owner 
Clinical pharmacist, 
accredited pharmacist, rural 
pharmacy owner, educator, 
PSA national committee 
member on policy and the 
profession 
1, 5 2, 5  
S3 
Rural opinion leader, rural 
community pharmacy 
manager, PSA rural 
spokesperson 
Rural opinion leader, rural 
community pharmacist locum, 
HMR, RMMR, QUM 
pharmacist, PHN pharmacist 
1 2 
S4 
PGA representative, 
pharmacist  
ACP representative, 
pharmacist  
1 1 
S5 
NPS Facilitator, accredited 
pharmacist 
NPS MedicineWise Clinical 
Services Specialist (expanded 
role), accredited pharmacist, 
tutor School of Medicine for 
medical students 
1 2 
S6 
Past Chair NAPSA, 
pharmacy student 
Community pharmacy owner 
(PhARIA 1 but in a 
rural/regional location) 
1 1 
S7 
Community pharmacist and 
rural pharmacy owner 
Same role as listed for the 
initial interview 
1 3 
S8 
SHPA rural spokesperson, 
rural academic, rural 
hospital pharmacist 
Rural and pharmacy 
academic, rural hospital 
locum pharmacist, educator 
1 3 
S9 
Rural pharmacy group 
owner, pharmacist 
Unavailable. 
*Not interviewed for follow-
up series 
1  
S10 
Head of School, School of 
Pharmacy (not Tasmania), 
pharmacist 
Same role as listed for the 
initial interview 
1 1 
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Code 
Role at time of initial 
interview 
Role at time of follow-up 
interview 
PhARIA 
work base  
Modified 
Monash 
Model 
Scale 
(MMM) 
work base 
S11 
Past pharmacy owner, 
business lecturer, PSA 
branch director, pharmacist 
Same role as listed for the 
initial interview 
1 1 
A ranking of MMM 2 under this scale is classed as large regional, i.e. towns within 15km 
of a town with a population of greater than 50,000; MMM 3, medium large regional, 
15km to a town with a population between 15,000 and 50,000; MMM 5, small regional, 
other areas within Category 2 and 3 of ASGC-RA areas with populations of 5,000 to 
15,000 not covered by other categories [21]. 
 The current rural pharmacy PhARIA classification, and limited opportunities for 
practitioners within the Rural Support Program, thus hampers practice change. The use 
of other rural classification models, such as the Modified Monash Model [21] would 
allow an expansion of the funding to reflect the true regionality and rurality of Australia. 
Many extended roles have been suggested for pharmacists in publications such as the 
Grattan report [55], and other literature [135, 176]. It is of note that extended roles for 
rural pharmacists were suggested when there was a lack of another health professional 
in the area. It was assumed that the pharmacists could gain another professional 
skillset, rather than practice to the full extent of their own profession’s current expert 
standards. 
• What knowledge and skills define rural pharmacy practice today? 
An answer to this question was not found, in that there was insufficient evidence of 
rural community pharmacy practice being distinctively different, when compared to 
urban practice. 
• What are the implications on recruitment and retention of 
pharmacists in rural areas? 
Despite many recruitment and retention strategies, educational and funding sources, 
none has effectively altered the number of pharmacists in rural areas. Some areas do 
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not have the staff shortage cited a few years ago in the first round of key opinion leader 
interviews (Chapter 4), but other areas still cannot attract pharmacist staff (Table 2.6). 
This later data is based on those who advertise, and may not include those who use 
other means, such as word-of-mouth, or professional e-bulletins. It would also not 
include those employers who might have given up on finding additional suitable staff. 
Without suitable staff, no practice change could be contemplated. 
Currently, there is little financial incentive to the employed pharmacist, other than that 
offered by the pharmacy itself, to work in a regional, rural or remote area of Australia. 
Most monetary support goes to the owners (Chapters 2, 7), and is not always passed on 
[226]. If the pharmacist was not an Australian citizen or permanent resident, 
inducements under the CPA Rural Support Programs (2018) [23] are also restricted, 
thus hindering recruitment and retention. Monetary inducements in the past were not 
seen to translate into long-term staff retention (Chapter 2). 
Wages, or lack of any increase, was mentioned by pharmacists in the interviews and 
surveys of this thesis (Chapters 4, 5, 7). This was not an issue specifically related to 
practicing pharmacy in rural areas, but worthy of note. It was a point of concern for 
both the men and women in the PPA annual employment and remuneration report 
(2018) [226], using data supplied by 658 survey participants. Only 8% of pharmacists 
delivered professional services with personal additional remuneration. Pharmacists 
recorded that there had only been a 0.5% increase in wages in the past year (2016/7). 
This sentiment concurs with comments from practitioners in Chapter 7, who stated that 
there was a lack of pay increase, yet there was an expectation to undertake professional 
services in an already busy day. The PPA found that poor pay and stress were the major 
issues causing unhappiness at work. 
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Figure 8.4: Community pharmacist rates of pay 2005–16 
 
Community pharmacists employment and remuneration report 2016/7, PPA, 2018 [226] 
The graph above (Figure 8.4) from the PPA report (2018) [226] shows the mean hourly 
rate for a pharmacist-in-charge, in 2016, was AUD$35.95 per hour, compared to 
approximately AUD$33.63, 10 years prior, an increase of 6.4% over the whole period. It 
is suggested that this is less than the Consumer Price Index (CPI) which had a 2% 
increase in a single year, in 2017/18 (2018). 
This report, and other responses from surveys undertaken for this thesis, found many 
practitioners were disillusioned with the profession. This being the case, in this author’s 
opinion, it is understandable that practicing in a relatively comfortable urban 
environment would be preferable to one that is unknown, and away from family, 
personal, and professional support networks in rural and remote areas. Pharmacist 
participants in the various studies stated that recruitment of pharmacists to rural and 
regional areas was difficult, despite the employment evidence not corroborating this 
assertion [133]. Both key opinion leaders and pharmacist practitioners believed that job 
satisfaction through delivery of professional services may assist with the recruitment 
and retention of graduates. Opportunities to practice in extended areas professionally, 
may invigorate the pharmacy as a profession and thus keep graduates and current 
practitioners from finding other positions and careers. 
• What are the implications for undergraduate and postgraduate 
training? 
The training and support for undergraduate programs enacted since the 3CPA, at 
University level, have not altered the number of registered pharmacists seeking rural 
employment. There is some training apparent during undergraduate courses regarding 
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rural health, but not necessarily anything to prepare undergraduates for rural or remote 
practice beyond a possible placement for some and an understanding of the health 
differentials. The Rural Support Program within the various CPAs provides Australian 
or permanent resident students with an allocation towards a placement in a rural area, 
usually one that does not cover the actual cost of the placement. Not available for all, 
and despite many positive aspects, it could be assumed that out-of-pocket expenses 
could diminish this experience somewhat. 
Although there has been a 2.4% increase in generally registered pharmacists in the past 
year, there are still shortages in regional areas in some states of Australia (Chapter 2). 
In 2017, these were Queensland, South Australia, Northern Territory and Tasmania, but 
for other states and territories, it was interesting to note that there was no regional 
shortage reported (2018) [133]. 
The Rural Support Program (Chapter 2) has been part of the CPA for over 20 years, but 
clearly, the monetary strategies undertaken so far have not successfully addressed or 
impacted on these shortages to date. A publicly published evaluation of all aspects of the 
Rural Support Program over this time, would be of value to confirm these assumptions, 
and provide insight into potential changes that could be made to improve the future. 
8.2 Limitations 
The overall limitations of the studies are listed: 
1. There was a small number of interviewees within the qualitative analyses 
components of this thesis, but this allowed for in-depth analysis of the transcripts. A 
senior representative from a discount pharmacy group was not included in the 
cohort. There were no pharmacists interviewed who practiced in remote regions 
(PhARIA 6), but there were key opinion leaders and PAART pharmacists who 
practiced in PhARIA 5 areas. 
 
2. The two QCPP survey data was de-identified, meaning some assumptions had to be 
made to classify the data into rural and urban locations. Pharmacy staff 
opportunistically selected 4CPA customer survey respondents, which may have 
introduced some bias into the respondent group. 
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3. The PAART pharmacists were a purposive group, and thus could have opinions 
which were not representative of all rural and urban pharmacists. 
 
4. The numbers in the Current and Future Practice Pharmacist Survey suggested a very 
small proportion of potential respondents, which could in turn have provided a 
skewed opinion of community pharmacy practice. However, the data did reflect the 
makeup of the workforce in practice in Australia at the time. Pharmacists from all 
geographical areas were represented in this small cohort. 
 
5. The age and types of the data collected could be classed as limitations or strengths, 
thus enabling comparisons to be made over time. 
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Chapter 9: Conclusions and recommendations 
To revisit, the overall aims of this series of studies were to: 
• investigate perceived differences between rural and urban community pharmacy 
practice 
• propose suggestions on how some of the perceived disparity could be addressed 
The following conclusions and recommendations have been drawn from the literature 
reviews, and the results of the interviews, surveys, and various data sub-analyses. A lack 
of both data, and studies from the literature, were found to be evident during the 
research, and hence some conclusions suggest approaches to rectify this knowledge gap. 
9.1 Conclusions 
1. The investigations showed there was a lack of comparative data between 
urban and rural pharmacy regarding day-to-day practice, both in Australia 
and internationally. No substantial differences and evidence were found, 
even though various methods were used: interviews, surveys, analysis of 
unpublished Australian data sets, and the literature. 
 
2. This research has showed that: 
Key opinion leaders suggested that there were: 
• Some practice differences because rural pharmacists knew their customer 
base and had had better relationships with local health practitioners. 
Rural practitioners suggested: 
• The pace, lifestyle, customers and collaborations with health 
professionals were the differences. 
• They were prepared to provide more professional services for less 
remuneration, and spend a longer time with customers. 
The literature and studies showed: 
• Rural pharmacists had a greater number of regular customers compared 
to urban pharmacies and spent more time talking and initiating 
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conversations. 
• There were more professional services provided in rural areas, but then 
an explanation was given to diminish the statistical evidence, suggesting 
the pharmacy size and banner group membership were the reasons for 
the differences, and not the location. 
• Suggestions were made for additional rural pharmacist professional 
activities when there was a lack of other health professionals, not 
activities that were an extension of the current pharmacist skillset. 
 
3. It was suggested that collaboration with other health professionals was 
greater in rural areas from practitioners and key opinion leaders. The lack of 
partnerships with other local health practitioners was demonstrated by the 
degree of uncertainty about health practitioner relationships, should some 
professional services be introduced in the pharmacy. This need for 
collaboration was reinforced, by the absence of pharmacy involvement with 
national and local health policy. 
 
4. Pharmacists were reticent to charge a realistic rate for time taken to deliver 
professional services, and would prefer the Government to reimburse the 
pharmacy. This showed that a professional service paid by the consumer is 
not yet acceptable to many pharmacists. They were concerned that custom 
might be lost if payments for service were instigated, as historically 
pharmacists have not charged for additional advice or consultations. They 
were prepared to spend more time for less income overall, for provision of 
vaccination or disease management services. 
 
5. Although pharmacists would like to change their practice in the future, they 
thought this would not happen; overall, they were uncertain about the future 
and felt no real change would take place within the profession. Pharmacists 
were concerned about no improvement in wages or conditions over a 
number of years, yet there was an expectation by employers to introduce 
new services within existing practice conditions. Although some were 
ambivalent, pharmacists were interested, had confidence and enjoyed the 
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provision of new professional services, but were concerned about the time 
taken, considering the requirements of their already busy roles. The current 
models of single pharmacist practice do not allow for many professional 
services given the other activities such as dispensing, counselling and OTC 
sales and advice. There was no difference in opinion wherever the 
pharmacist practiced. 
 
6. It was found that there was a lack of definition around what a professional 
service in the pharmacy entails, using the data examined, thus hampering 
accurate comparisons: 
• Surveys used only the words, e.g. provision of a ‘Blood Pressure Service’ 
to gauge the extent of service provision. There were minor differences in 
types of services provided in rural and urban pharmacies, however 
without a detailed service definition, and the consistent use of minimum 
professional standards, this result is hard to validate. 
• It is suggested that that not all pharmacies may follow all the GuildCare 
[228] or Professional Practice Standards, version 5 (2017) [62] and offer 
a consistent complex and complete professional service in a community 
pharmacy. This requires further investigation. 
• It would be difficult to argue for more funds for professional services with 
the lack of evidence currently. The existing nature and depth of the 
services cannot be identified, and the exact scale of implementation is not 
known. 
 
7. Consumers and practitioners had quite different ideas on the extent of the 
availability of professional services within pharmacies. Some rural 
consumers thought their pharmacy was capable of providing a service, but 
then were unlikely to use it. They also only had an idea of service based on 
what was currently available, or what was asked in the surveys, and not the 
extent of potential complex professional services and the pharmacists’ 
capabilities. More research is needed to accurately map practice and assess 
acceptable future practice. 
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8. It was also found that pharmacy does not ‘have a seat at the table’ when many 
national, state and local rural health policies were, and are, developed. 
Consequently, the profession was not mentioned as a significant ‘player’ in 
rural health, other than the community pharmacy as a place where 
prescriptions can be dispensed, and some primary health care services 
provided. Measures must be undertaken to address this disparity, as a 
community pharmacy is a health provider of many types of professional 
services, independent of those supported and restricted by the CPAs. 
9.2 Recommendations 
The following recommendations have come from this research: 
• More comprehensive research is required in all areas of practice, to clarify 
the disparities found in beliefs of the practitioners, customers and 
professional associations on apparent differences in current rural community 
pharmacy practice. This is not just an Australian phenomenon. 
 
• Only professional services that adhere to all the aspects described in the 
current professional organisations’ practice standards should be entitled as 
such in community pharmacies. 
 
• The profession should accept payment for professional services, whether the 
service be in part paid by the CPA, by the Government or a charge levied in 
pharmacies or other practice locations, by individual practitioners. 
 
• There is a strong case for better remuneration and conditions for all 
pharmacists to enable a competent and sustainable workforce. New funding 
models should allow for those who travel to and from urban settings to 
practice in rural areas and are not covered in current funding models.  
 
• A new modelling of suggested pharmacist staff ratios should be undertaken 
when considering the incorporation of multifaceted complex professional 
services into day-to-day business across rural and urban practice in Australia. 
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• The profession and its associated professional organisations should clearly 
articulate the skill set of pharmacists to promote relevant competent practice 
at the highest level. 
In addition, for rural community pharmacy practice: 
• There should be a review of the PhARIA system, to enable those practicing in 
rural and regional locations to take advantage of the potential training, 
recruitment and retention opportunities available if, for example, another 
system was used such as the Modified Monash Model classification to define 
rurality.  
 
• Other practice models for pharmacist practitioners in rural settings, including 
those outside community pharmacies, should be supported with long-term 
funding options not just pilot projects to attract and keep pharmacist 
practitioners. Ongoing funding would allow these models to show 
improvement in health indicators for chronic conditions for regional, rural 
and remote areas of Australia for all populations including Aboriginal and 
Torres Strait Islanders. Funding may need to come from outside the CPA as 
this allocation is locked into a 5-year funding cycle.    
 
• More pharmacy/pharmacist involvement is required in rural health policy 
nationally by pharmacy professional associations, and locally, practitioners 
must improve their own links with other health professionals. As a 
profession, pharmacy should align itself with and address the current risk 
factors identified in national policy documents, especially given the health 
disparities for those living in rural and remote areas of Australia. 
This study and the systematic review found that some rural pharmacists had stronger 
relationships with their patients and local health professionals. Data was inconclusive 
as to whether this resulted in improved medication advice and increased pharmacist 
interventions. This data also did not show if a pharmacist outside the community 
pharmacy could achieve a difference. This particular investigation would have been 
outside the remit of this thesis.  
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Despite rural Australia having a smaller number of pharmacies and less health clinicians 
per capita, being older and with a higher burden of chronic disease, this research 
showed limited evidence that rural pharmacies deliver more professional services than 
their urban counterparts. This research did not investigate the rate of medication 
misadventure in rural versus urban Australia. It is well documented that rural 
Australians present later at primary health care services and have higher rates of 
hospitalisations. Further research is needed to determine whether more professional 
pharmacy services may assist in the improvement of health outcomes of rural 
Australians with chronic disease. 
Pharmacists are reticent to charge for their services and the cost of delivery of 
professional services is perceived by pharmacists as a noteworthy barrier to delivery. 
There are many areas of rural and remote Australia where it is not viable to have a 
community pharmacy. The lack of community pharmacies in some areas and the lack of 
professional pharmacy services even where there are rural community pharmacies, 
may support the need for pharmacists to be employed in settings other than community 
pharmacy. 
The real heroes of this thesis are the rural practitioners, who are often innovative and 
part of their community, and quietly going about their work, collaborating with local 
health professions and ensuring the best possible care for their patients and customers. 
However, there was little found to substantiate the assumption that rural pharmacy 
practice is overall different from that in urban areas. This lack of evidence, or at least 
documentation thereof, potentially jeopardises the profession, professional 
organisations, teaching institutions and the practitioners in attempting to lever off a 
‘difference’ for funding, recruitment and retention in rural and remote areas of 
community pharmacy practice. 
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Appendix 1: Poster for PSA18, Sydney, 2018. 
Pharmaceutical Society of Australia Conference, PSA18, Sydney, Australia, 26-28 July 
2018. 
Does rural and Urban Community Pharmacy Practice Differ? A Systematic Review 
Abstract: 
Objectives 
Anecdotal comparisons between rural and urban community pharmacy practice have been 
frequently reported. Therefore, a systematic review was conducted to examine published 
evidence comparing the nature of pharmacy practice in rural and urban settings. 
Methods 
A comprehensive literature search was undertaken across 4 databases. The key criterion for 
inclusion was a comparison of rural and non-rural community pharmacy practice. Definitions of 
rural used were specific to the country and year of publication. 
Key findings 
From 3830 publications found, 17 included a comparison of rural/regional and urban 
community pharmacy practice. Studies investigated current or proposed services, and topics 
included the provision of pharmaceutical care, public health activities and prescribing. It was 
reported that rural customers were more willing to talk about general health matters, ask 
advice and talk longer to the pharmacist, but not in all cases. There was limited evidence that 
rural pharmacists provided more public health or enhanced pharmacy services and appeared to 
have better working relationships with prescribers. Many of the authors challenged the validity 
of their own results, suggesting that other confounding factors accounted for the observed 
differences. In general, the statistical analyses reported were basic, with multivariate analyses 
being uncommon. 
Conclusions 
There was some evidence that rural pharmacists were seemingly more willing take on new 
roles, and deliver a higher level of pharmaceutical care and public health or enhanced pharmacy 
services. However, this conclusion is based on a small number of studies, often with a limited 
number of respondents and simplistic data analyses. Further high-quality research is required 
to ascertain and characterise any real differences in community pharmacy practice between 
rural and urban settings. 
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Appendix 2: Interview questions series one, key opinion leaders 
Formatted HH. 
Influences, challenges, changes and the future in pharmacy 
1. What do think are the major influences of community pharmacy practice? 
Are they, in your opinion, different to those in regional, rural and remote 
Australia? 
What do you think is different about regional, rural or remote (compared with 
urban or metropolitan) pharmacy practice? 
2. What do you think has been the biggest change during your career in pharmacy? 
3. What has been the biggest challenge over the past 5 years for pharmacy in 
Australia? 
Do you think this would be any different in rural practice? 
4. What do you see as the future of pharmacy in community, hospital, consultancy 
or other pharmacy roles? 
(Prompt: Consider metropolitan, regional, rural or remote areas) 
5. What are the biggest influences on the future of pharmacy in Australia? 
6. What do you see as the biggest factors holding back pharmacy from its potential 
over the next 5 years? 
Do you see this being the same for rural pharmacy practice? 
 
Examples of various practice activities were also discussed during the interviews to try 
to find if there were any different knowledge and skills required for rural or remote 
pharmacy practice. These were: 
 
Time spent in the dispensary 
7. Community Pharmacists spend 75% of their time in the dispensary according to 
the National Pharmacy Database survey [40] 
Do you have any comment on this? 
Professional services 
8. ‘Enhanced pharmacy services’ are also recorded in the same survey. 
9. What do you consider an ‘enhanced pharmacy service’, such as a healthy heart or 
other disease management service within a pharmacy, would consist of? 
(Prompt: Does it need a pharmacist?) 
Participants were provided with a copy of the National Pharmacy Database 
Report p. 35, Table D-B7-1: Enhanced Pharmacy Services Offered in Australia’s 
Community Pharmacies [40] 
10. There are many current professional programs in Australia. 
What do you consider the facilitators? 
What do you consider are the barriers? 
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Have you any suggestions how these maybe overcome? 
Health promotion and medication adherence examples 
11. Using your experiences, what are your thoughts about pharmacists delivering 
health promotion and medication adherence services? 
Is it their role? 
Are there particular challenges, learning needs etc.? 
How do you see pharmacy contributing to the following activities? 
a. A local Health Expo; 
b. Career Expo at the local High School; and a 
c. Weight Loss Clinic. 
(Prompts: Consider the role of the pharmacist, pharmacy staff, naturopath, local 
health clinic and the GP) 
Is this any different in rural practice? 
 
Interviewees were then asked if they would like to make further comments. 
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Berbatis et al. (2003) National Pharmacy Database Table D-B7-1 Enhanced pharmacy 
services offered in Australia’s community pharmacies by trained staff, fees charged and 
planning in 12 months. (p. 35) 
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Appendix 3: Interview questions follow-up interview series, key 
opinion leaders 
Formatted HH. 
Influences, challenges, changes and the future in pharmacy 
1. What do think are the major influences of current community pharmacy 
practice? 
 
Can you tell me how they are the major influencers? 
In your last interview you said (personal example from last interview). 
Have any influences changed as you predicted? 
In your opinion, have any influences changed for those in regional, rural and 
remote Australia? 
 
2. What have been the biggest challenge(s) over the past 5 years for pharmacy in 
Australia? 
 
Can you tell me how they are challenges and do you have any thoughts about 
how the profession may overcome them? 
In your last interview you said (personal example from last interview). 
Have any challenges changed as you predicted? 
In your opinion, have any challenges changed for those in regional, rural and 
remote Australia? 
 
3. What do you see as the future of pharmacy? 
 
Would you characterise the future as positive, negative or neither? 
Can you explain why you chose this category? 
In your last interview you said (personal example from last interview). 
Has the future changed as you predicted? 
In your opinion, has this changed for those in regional, rural and remote 
Australia? 
 
4. What do you see as the biggest factors holding back pharmacy from its potential 
over the next 5 years? 
 
In your last interview you said (personal example from last interview). 
Have any of these factors changed as you predicted?  
In your opinion, have any factors changed for those in regional, rural and remote 
Australia? 
Interviewees were then asked if they would like to make further comments.  
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Appendix 4: PAART interview questions for participant pharmacists, 
researchers and project management pharmacists 
Formatted HH. 
1. Introductions 
2. What is your current position? 
3. What are the activities of your role? 
4. What is the role of your organisation? 
5. What lead you to this position? 
Time spent in the dispensary 
6. Community Pharmacists spend 75% of their time in the dispensary according to 
the National Pharmacy Database survey. Do you have any comment on this? 
Professional services 
7. Enhanced pharmacy services are also recorded in the same survey. What do you 
consider a healthy heart management service in a pharmacy would have to 
consist of? 
a. Does it need a pharmacist? 
Participants were provided with a copy of the National Pharmacy Database Report p. 
35, Table D-B7-1: Enhanced Pharmacy Services Offered in Australia’s Community 
Pharmacies [40] (Appendix 2) 
Health promotion and medication adherence examples 
8. After your experience, what are your thoughts about pharmacists delivering 
health promotion and medication adherence services? 
a. Is it their role? 
b. Are there particular challenges, learning needs etc.? 
Influences, challenges, changes and the future in pharmacy 
9. There are many current professional programs in Australia.  What do you 
consider the facilitators? 
a. What do you consider are the barriers? 
b. Have you any suggestions how these maybe overcome? 
10. What are our professional boundaries? 
11. Do any programs overstep professional boundaries in your opinion? 
12. What are the major influences of community pharmacy practice? 
13. Are there, in your opinion different ones in rural and remote Australia? 
14. What is different about rural practice? 
15. What has been the biggest change over the time of your career in pharmacy? 
16. What has been the biggest challenge over the past 5 years for pharmacy in 
Australia? 
17. How do you see pharmacy contributing to the following activities: 
a. A Health Expo in a rural town; 
b. Career expo at the local High School; and a 
c. Weight Loss Clinic 
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Consider the role of the pharmacist, staff, naturopath, local health clinic and the GP 
 
18. What do you see as the future of pharmacy in:  
a. Community; 
b. Hospital;  
c. Consultancy; 
d. Other roles; as well as 
e. Metropolitan; 
f. Regional; or 
g. Rural and remote areas. 
19. What are the biggest influences on the future of pharmacy in Australia? 
PAART ‘Healthy Hearts’ project 
For this project: 
 
20. Do you now have skills in talking to people about diet, physical activity and 
medication adherence. Do you feel confident? 
21. Do you think pharmacies suitable places for this type of advice? 
22. Are these services really the remit of another health professional? 
23. What do you think is the best model for this type of service? 
24. How about for Point-of-care testing in a pharmacy setting? 
25. In your opinion what training is necessary for these types of services in a 
pharmacy setting? 
26. Do pharmacists really have to be credentialed to provide these services? 
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Appendix 5: 3CPA pharmacist survey (second survey) 
Formatted (HH) to reduce document size not content. $ amounts shown are AUD$. 
Coding sheet—2002 Community Pharmacy Census. [210] 
• Where only 1 box should be ticked from a selection, the boxes have been replaced 
with the code numbers in BOLD. Where more than one box can be selected, enter “1” 
where a box is selected and “0” if that box is not selected. If no boxes are selected at 
all for the question, treat as missing. 
• Where there is an “Other” category that is not ticked but the respondent has written 
in a type of “other” then enter the code for “other”. If one of the pre–specified 
categories is also ticked, and only one answer is allowed, then enter only the pre–
specified category. 
• Only use the codes for “don’t know’ or “not applicable” where the respondent has 
actually written these words (includes “N/A”) or similar on the questionnaire 
(except in Q9) 
• Note that some missing values will have already been followed up in Canberra so 
these annotations can be entered as actual data 
• Some extra data entry comments fields will be needed throughout the document 
(see bold in data entry instruction column). There should also be a 100–150 
character field at the end to capture any other data entry comments or fields for 
follow-up and cleaning. 
QUESTIONS INSTRUCTIONS 
Pharmacy ID number—a 4 character numeric 
field 
Enter Pharmacy ID number—please 
check that all pages have same ID 
number printed on them. 
1. What is the pharmacy postcode? 
 
If missing, enter 9999 
2. What is the Pharmacy Approval Number? 
(Write “None” if no approval number) 
____________ 
Alpha numeric code in the form 
9999A or if respondent has written 
“None” or “not applicable” or 
similar, enter “None” (note that not 
all pharmacies will have this 
number. If missing, enter “zzzzzz” 
3. Who completed this census?
Name:_______________________________ 
1 Owner/managing partner 2 Non-owner 
manager 
Enter first name (or first initial) and 
the surname. Please separate into 2 
fields. If names are missing, enter 
“missing” For boxes, enter 8=Not 
applicable; 9=missing 
4. Where is the pharmacy located? (tick the ONE 
box that best applies and specify if other location)  
1 Strip 
2 Neighbourhood shopping centre 
3 Medical centre 
4 Major regional centre 
For boxes, enter 7=if respondent 
wrote “don’t know” or similar; 8=if 
“Not applicable” or similar written 
by respondent; 9=missing 
If 5, then enter text of other 
specialist location—enter “missing” 
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5 Other specialist location __________________ if “other” ticked but no location 
given. 
5. What is the pharmacy size in m2? 
1  100 m2 
2 101-200 m2 
3 201-300 m2 
4 301-700 m2 
5 > 700 m2 
For boxes, enter 7= if respondent 
wrote “don’t know” or similar; 8=if 
“Not applicable” or similar written 
by respondent; 9=missing 
6. Is this pharmacy in any banner/brand 
group?
0 No 1 Yes 
If yes, which one?_________________________ 
Enter 7=“don’t know”; 8=“Not 
applicable”; 9=missing 
If Yes and no banner group given, 
enter “missing” 
7. What is the gender and year of pharmacy 
registration of owner/managing partner? 
1 Male 2 Female 
1 1960 or before 2 1961-1970 3 1971-1980 4 
1981-1990 5 1991-1995 6 1996 or later 
Gender: Enter 7=“don’t know”; 
8=“Not applicable”; 9=missing 
Registration year: Enter 7=“don’t 
know”; 8=“Not applicable”; 
9=missing 
8. How many people own this pharmacy?______ Enter number. 77=”don’t know; 
88=”not applicable”; 99=Missing 
(unless these values are found) 
000=board 
9. If the owner is NOT the manager, record 
gender & pharmacy registration year of the 
manager? 
8 Not applicable 
1 Male 2 Female 
1 1960 or before 2 1961–1970 3 1971–1980 4 
1981–1990 5 1991–1995 6 1996 or later 
Manager’s gender: Enter 7= “don’t 
know”: 9=missing. If data is missing 
and “owner/managing partner” 
ticked in Q3, enter 8=not applicable 
Manager’s Registration year: Enter 
7= “don’t know”; 8=“Not 
applicable”; 9=missing 
10. Is the manager medication reviews 
accredited? 
0 No 1 Yes 
Highest pharmacy qualification?________________ 
Enter 7=“don’t know”; 8=“Not 
applicable”; 9=missing 
Record highest pharmacy 
qualification: If none, enter 
“Missing” 
11. How many hours is the pharmacy open each 
week? 
Enter hours using decimal places i.e. 
54 ½ entered as 54.5. Enter minutes 
as decimal fraction of an hour e.g. 54 
hrs 30 mins as 54.5. 999=missing. 
Make a field Comments1 here to 
record any explanations (50 
characters) Note: Re Q11: for hours 
with 2 decimal places have entered 
.3 for .25 and .7 for .75 
12. On average, how many prescriptions are 
dispensed per week by this pharmacy?
1  300 2  301–800 3 801–1200 4 1201–2000 
5 2001–3000 6 > 3000 
Enter 7= “don’t know”; 8=“Not 
applicable”; 9=missing 
13. For each staff type, what is the usual staffing 
level at: 
Enter number of staff in each 
category at each time period. If any 
staffing details recorded but some 
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Staff type Peak  Off Peak  Total 
hrs/wk 
Pharmacist/s    
Dispensary Asst/s    
Pharmacy Asst/s    
Off Peak 2 chars allowed—decimals .5 or over rounded up. 
Total hrs/wk decimals—0.5 or over rounded up 
table cells left blank, enter “0”. If no 
cells have data, then treat as missing 
and enter “99” in each field. 77=not 
applicable 
NOTE: this column will be added in 
the second mail out. Telephone 
follow–up has been done to find out 
some of this information for forms 
already received. This information 
has been added in red. Please enter 
the annotated information where it 
is available. Add any explanations or 
problems in the Comments2 field. 
14. Please indicate the number of non-
pharmacist staff at each of the following 
qualification levels: 
Level PGA 
qualified 
Non-PGA 
equivalent 
Certificate I (Grade 1)   
Certificate II (Grade 2)   
Grade 3   
Certificate III (Grade 4)   
Dispensary Assistant 
Course 
  
Not yet trained   
 
Enter number of staff in each 
category at training level. If any 
staffing details recorded but some 
table cells left blank, enter “0”. If no 
cells have data, then treat as missing 
and enter “99” in each field. 
Make a Comments2 field here to 
record any explanations (50 
characters) for Q13 and Q14. 
On a usual full working day in this pharmacy:  
15. Approximately how many people sought 
advice from a pharmacist about their 
health? _______ 
If a range is given e.g. “15-20” enter 
a midpoint value e.g. 17 then record 
the actual range in an extra 
Comments3 field here (50 
characters) e.g. “Q15 15–20”. Record 
any ranges given for Q16 in this field 
and explanatory notes for Q17 here 
as well. 
777=”Don’t know”; 888=”not 
applicable”; 999=missing 
16. What percentage of people seeking advice 
were:  
(a) Referred to a GP? __________ 
(b) Had their problems resolved in the 
pharmacy: 
By the pharmacist?____________ 
By a pharmacy assistant?____________ 
If a range is given e.g. “15-20” enter 
a midpoint value e.g. 17 then record 
the actual range in an extra 
Comments3 field here (see above) 
e.g. “Q16a 15-20”.  If “<20” or 
similar written, enter “20” and write 
exact details in Comments3 field 
e.g. Q16 <20 Note: 5 or over 
rounded up for all these 
777=”Don’t know”; 888=”not 
applicable”; 999=missing 
17. What lifestyle advice or referrals to other 
health professionals or health services are 
most frequently given? 
Enter free text—annotate 
Comments3 field above if writing 
illegible or text can’t be read 
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Describe __________________ If missing, enter “Missing” 
Questions 18 to 20 refer to the last financial year 
(ending June 2001): 
18. What was your estimated turnover?  
(tick the ONE box that best applies)  
1 <$1.2M  2 $1.2-1.5M  3 $1.5-2M  
4 $2-$3M  5 $3-4M  6 $4-6M  
7 $6-8M  8 $8-12M  9 >$12M 
19. What percentage of turnover is due to: 
(a) PBS/RPBS prescription claims  _______ 
(b) Private prescriptions  _______ 
(c) PBS safety net items not claimed 
 _______ 
(d) Front of shop sales  _______ 
20. What is your rent as a percentage of 
turnover? 
________________% 
Make a Comments4 field here to 
record any explanations (100 
characters) for Questions 18-20. 
Turnover: Missing=”99”; Don’t 
know=”77”; 88=not applicable 
Q19 Missing=999; Not 
applicable=888; Don’t know=777 
Any decimals 0.5 or over rounded 
up 
Q20 One decimal point allowed or 
if less than 1% 2 decimal places 
Missing=999; Not applicable=888; 
Don’t know=777. Record any 
explanations in the Comments4 
field above 
21. Please give ONE phrase that best describes 
the goals/style of this pharmacy (e.g. ‘Speedy 
service’; ‘customer advice focused’; ‘profit 
focused’; ‘develop health care niches’; ‘quick to 
adopt innovation’) 
__________________________________________ 
Enter text.  If missing or illegible, 
enter “missing” or “illegible” 
22. Please write a number from 1 to 7 indicating 
your agreement with the statement:  
“This pharmacy has an 
entrepreneurial orientation” 
(1=Strongly Disagree, 7=Strongly 
Agree) 
Enter 1-7 
0=“don’t know”; 8=“Not applicable”; 
9=missing 
23. What percentage of your customers do you 
regard as regular? 
1 up to 30 2 30–60 3 >60 
Enter 7=“don’t know”; 8=“Not 
applicable”; 9=missing 
24. How frequently does a pharmacist hand 
prescriptions to patients? 
1 Always 2 Mostly 3 Only when not busy 
Enter 7=“don’t know”; 8=“Not 
applicable”; 9=missing 
25. What percentage of the pharmacy’s scripts 
have the ‘substitution not permitted’ box 
ticked or crossed? _______ 
Missing=999; Not applicable=888; 
Don’t know=777. If “<20” or similar 
written, enter “20” and write exact 
details in Comments4 field e.g. Q25 
<20. Treat ranges as described in 
Q16 & records details in 
Comments4 
26. Where is your pharmacy in the QCPP 
process? 
1 Accredited  
2 Completed but not yet accredited 
3 Partially completed (please estimate % _____) 
4 Not yet registered (Please go to Question 29) 
Enter 7=“don’t know”; 8=“Not 
applicable”; 9=missing 
If “Partially completed” ticked but % 
completed not given, enter “999” for 
missing otherwise enter “888” as 
not applicable 
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27. Please tick ONE box to indicate your 
agreement with these statements about 
QCPP and its materials as it relates to this 
pharmacy. 
SD=Strongly disagree, D=Disagree, N=neutral, 
A=Agree, SA=Strongly agree, DK=Don’t know 
 SD D N A SA DK 
The QCPP is a viable model 
for improving pharmacy 
practices. 
1 2 3 4 5 6 
It was easy to understand 
what we had to do from the 
QCPP material. 
1 2 3 4 5 6 
Without the reference 
materials, implementing 
QCPP would be very difficult. 
1 2 3 4 5 6 
QCPP has helped improve this 
pharmacy’s patient contact/ 
counselling content. 
1 2 3 4 5 6 
Assessors provide a realistic 
accreditation evaluation. 
1 2 3 4 5 6 
Overall, QCPP has had a 
positive effect on how this 
pharmacy operates. 
1 2 3 4 5 6 
 
Enter number corresponding to 
agreement level ticked. Note that 
“DK”=6. 8=not applicable; 9=missing 
 
Use 8=not applicable if “Not yet 
registered” is ticked in Q26. 
 
If respondent puts a mark on a line 
between 2 categories, enter the 
number for the category closest to 
the middle of the scale e.g. If ticked 
between SD and D then enter 2. 
28. How has QCPP helped the pharmacy to date 
for the following practice areas? 
Please rate each area from 1 to 7  
(1= not at all helpful & 7= extremely helpful) 
____Professional services ____Retail skills  
____Business management ____Loss prevention 
Enter number corresponding to 
agreement level ticked. Note that 
Don’t know=0 not 7. 8=not 
applicable; 9=missing 
Use 8=not applicable if “Not yet 
registered” is ticked in Q26. 
29. What questions does the pharmacist usually 
ask the customer when dispensing Mersyndol 
(not DayStrength) over-the-counter? 
________________________________________________ 
Enter text—If missing or illegible, 
enter “missing” or “illegible” 
30. To what extent does this pharmacy provide 
any of the following professional services? 
(Tick ONE box for each question) 
(a) Forward pharmacy 1 Always 2 Mostly 3 Never 
4 Only when not busy  
(b) Internet dispensing 1 Nil 2 Some 3 Often 
(c) Hospital in the home 1 Nil2 Some  3 Often 
(d) Nursing home service 1 Not done 2 60 beds 3 
61-150 beds 4 >150 beds 
(e) Private hospital service 1 Not done 2 60 beds 
3 61-150 beds 4 >150 beds 
(f) Dose Administration Aids—Usual No. 
packs/week? 
1 None 2 50 3 51-150 4 >150 
(g) Medication management by accredited 
pharmacist 
1 No 2 Yes, by staff 3 Yes, by contractor 
4 Not accredited but do reviews (in 
 
 
For (a) to (g) Enter 7= “don’t know”; 
8=“Not applicable”; 9=missing. 
Enter any other annotated details 
into an extra Comments5 field—
enter all additional comments or 
data entry notes for Q30 into this 
field. 
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home/institution) 
 
(h) Monitoring and other clinical services  
(Please tick all that apply) 
NOTE: Numbers in bold here are code numbers for  
(i) data entry 
1 Blood pressure 2 Diabetes 3 Nutrition 
4 Asthma 5 Wound care 6 Methadone 
7 Community Education 8 Complementary medicines 
9 Written patient medication profiles 
10 Other, please specify  ________________________  
(i) Which ONE of the activities ticked in (h) is the 
MAIN activity? ___________________ 
 
 
For (h), where any boxes are ticked, 
enter “1” for all those ticked and “0” 
for those not ticked. If no boxes are 
ticked, treat as missing and enter “9” 
for every field. 
If “other” is ticked by nothing is 
specified, enter “missing” 
For (i), enter corresponding code 
number from (h) above. 
Missing=99 Not applicable=88 Don’t 
know=77 
31. Which of the following resources or 
programs do you actively use or participate 
in? Please tick all that apply. 
 Quality Care Pharmacy Program  
 Pharmacy Self Care  
 Australian Medicines Handbook  
 Training by pharmacy organizations 
 Australian Pharmaceutical Formulary  
 Professional journals  
 Other web-based drug information  
 Martindale  
 CD ROM-based drug information e.g. MIMS, PP Guide 
 Other (specify):  _____________________________ 
Where any boxes are ticked, enter 
“1” for all those ticked and “0” for 
those not ticked. If no boxes are 
ticked, treat as missing and enter “9” 
for every field. 
 
If “other” is ticked by nothing is 
specified, enter “missing” 
Consent Form 
Name…………………………………………………… 
 
Pharmacy Name:………………………………..………. 
Signature……………………………..Date…………….. 
Enter first name (or first initial) and 
the surname.  Please separate into 2 
fields. If names are missing, enter 
“missing”. Enter pharmacy name. 
Indicate whether or not a signature 
has been provided—enter 0=No or 
1=Yes. Enter date signed as 
dd/mm/yyyy. Please annotate final 
comments field if names illegible 
Participation in the next phase 
1 Yes           2  No       
Enter 9=missing 8=not applicable 
7=don’t know 6=“maybe” or similar 
that indicates conditional 
participation or that future 
participation is possible 
 Make a Comments 6 field (150 
characters) for any additional 
annotations or data entry comments 
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Appendix 6: 4CPA QCPP consumer survey 
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Appendix 7: Pharmacy Cardiovascular Health Care Model consumer 
telephone script 
Formatted (HH) to reduce document size not content 
PCHCM Script for Phone Surveys. 
Project: PHARMACY MAIN—LIVE INTERVIEWING Job:50658M 
Good evening, my name is ________ from I-view, the social and market research company. 
Today we are conducting important research on a range of health issues on behalf of the 
University of Tasmania and Curtin University in Western Australia. We would like your 
help. 
The interview will take approximately 15 mins. Please be assured that your answers are 
completely confidential. [IF INCONVENIENT—ARRANGE CALLBACK] 
Location: 
Sydney  01 
Melbourne  02 
ACT   03 
Hobart  04 
Perth   05 
Adelaide  06 
NT   07 
Brisbane  08 
Rest of Vic  09 
Rest of NSW  10 
Rest of Tas  11 
Rest of WA  12 
Rest of SA  13 
Rest of QLD  14 
We may at any time during this interview be listened to by my supervisor for quality 
control procedures. 
Continue   1 
Refused to continue  2—Terminate. 
Q1 What is your year of birth? [ENTER 9999 FOR REFUSED] 
____Age, ____Year. 
Could I please speak to a permanent resident of the household who is over 30 years of 
age? 
Yes, transferred       1 
No, not available [ARRANGE CALLBACK]    2 
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No, refused/unavailable for duration or no one over 30   3 
Do you or anyone in your household work as Pharmacist, Doctor or Nurse? 
Yes  1 
No  2 
Phone Number Called:________ 
Edit phone number if necessary:________ 
Thank you for your help but need to speak to people that do not work in that industry. 
Q2 How often do you visit a pharmacy? 
Weekly    1 
Fortnightly    2 
Monthly    3 
About once every 3 months  4 
Less than once every 3 months 5 
Is there someone else in your family/household over 30 years old who visits a 
pharmacy regularly? 
Yes, transferred     1 
No, not available [ARRANGE CALLBACK]  2 
No, refused/no one visits pharmacy  3 
INTRO [WHEN SPEAKING TO NEW RESPONDENT] 
Good evening, my name is ________ from I-view, the social and market research company. 
Today we are conducting important research on a range of health issues on behalf of the 
University of Tasmania and Curtin University in Western Australia. We would like your 
help. The interview will take approximately 15 mins. Please be assured that your 
answers are completely confidential. [IF INCONVENIENT - ARRANGE CALLBACK] 
Q46 [AUTOMATICALLY RECORD GENDER] 
Male  1 
Female 2 
Q3 How would you describe your general satisfaction with the quality of the service 
provided by the pharmacies you have visited in the last 6 months? [READ OUT] 
Very dissatisfied    1 
Dissatisfied     2 
Neither satisfied nor dissatisfied  3 
Satisfied     4 
Very satisfied     5 
Q4 Do you have any ongoing conditions/illnesses that require you to take regular 
medications? 
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Yes  1 
No  2 
Q5 Does your illness(es) include any of the following? [READ OUT] [MULTIPLE 
RESPONSE] 
High blood pressure known as hypertension     01 
Chest pain known as angina        02 
Previous heart attack known as myocardial infarction    03 
Heart not pumping adequately known as heart failure (common symptoms swelling of 
ankles, shortness of breath)        04 
Abnormal heart rhythm known as cardiac arrhythmia    05 
Raised blood cholesterol or triglycerides known as dislipidaemia  06 
Poor blood supply to the brain known as transient ischaemic attacks  07 
A stroke known as cerebrovascular accident     08 
Raised blood sugar known as diabetes      09 
Kidney damage known as renal failure      10 
None of the above         99 
Q6 Do you have a regular (preferred) pharmacy? 
Yes  1 
No  2 
Q7 What are the features of that pharmacy, which attract you to it? [DO NOT READ] 
[MULTIPLE RESPONSE] 
Convenient location    1 
Friendly staff     2 
Professional advice    3 
Professional services provided  4 
Quality of the service   5 
Product prices    6 
Other (Specify)    7 
Knowledge of the pharmacy staff  8 
I would like to reassure you that the following questions are not a test of your 
knowledge of Australia's health system but rather your answers should be based on 
your perceptions and experience. 
The first set of questions is about the management of cardiovascular disease (i.e. raised 
blood pressure, angina and heart attacks, heart failure, and abnormal heart rhythm). 
Now I am going to ask you a series of questions and I apologise that they may be 
repetitive but I want to know how well do you agree with each of these statements? 
Q8-18 
How well do you agree with this statement? 
Pharmacists are capable of providing a service for: 
1 Strongly disagree 
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2 Disagree 
3 Neither agree or disagree 
4 Agree 
5 Strongly agree 
Q8 Providing screening or testing for raised blood pressure? 
Q9 Testing or screening for diabetes? 
Q10 Testing for raised cholesterol? 
Q11 Diagnosing cardiovascular diseases? 
Q12 Providing advice on lifestyle changes (weight loss, smoking, alcohol intake etc.)? 
Q13 Prescribing drug treatment for cardiovascular diseases? 
Q14 Supplying medicines for cardiovascular diseases? 
Q15 Providing advice on over-the-counter and herbal medicines to be avoided by 
patients with a cardiovascular disease? 
Q16 Providing information about cardiovascular diseases and their management? 
Q17 Providing advice on how to take medicines properly? 
Q18 Checking or monitoring the outcomes of drug treatment? 
The next set of questions is about how likely you would be to use certain professions for 
health related services and again I apologise if it seems repetitive. 
Q19-29 How well do you agree with this statement? 
How likely is it that you would use the service if provided by (named individually) a 
pharmacist, doctor, nurse, dietitian, naturopath? 
1 Strongly disagree 
2 Disagree 
3 Neither agree or disagree 
4 Agree 
5 Strongly agree 
Service offered: 
Q19 Providing raised blood pressure screening or testing service? 
Q20 Testing or screening for diabetes, raised sugar levels? 
Q21 Testing or screening service for raised cholesterol? 
Q22 Diagnosing cardiovascular diseases (raised blood pressure etc.)? 
Q23 Providing education on lifestyle changes (diet, exercise, alcohol intake, smoking, 
alcohol intake, weight loss etc.)? 
 Appendices   270 
Q24 Prescribing drug treatment for cardiovascular diseases? 
Q25 Supplying medicines for cardiovascular diseases? 
Q26 Providing advice on over–the–counter and herbal medicines to be avoided by 
patients with a cardiovascular disease? 
Q27 Providing information about cardiovascular diseases and their management? 
Q28 Providing advice on how to take medicines properly? 
Q29 Checking or monitoring the outcomes of drug treatment? 
If all of the following statements are true, how concerning is each to you using a rating 
out of 10, where 0 = unconcerned and 10 = very concerned)? 
Q30 Raised blood pressure (hypertension) affects about 1 in 4 Australian adults. 
Q31 Approximately 1 in 5 deaths in Australia is caused by a heart attack. 
Q32 More than 10% of Australians over the age of 60 years have heart failure, causing 
reduced life expectancy. 
Q33 The commonest form of abnormal heart rhythm, atrial fibrillation, affects over 2% 
of Australians over 45 years, putting them at increased risk of stroke. 
Q34 Around 50% of adult Australians have raised cholesterol, putting them at increased 
risk of heart attack and stroke. 
Q35 Does any pharmacy that you visit offer any of the following services? 
1 Yes 
2 No 
3 Don’t know 
Blood pressure monitoring 
Blood sugar testing 
Cholesterol monitoring 
I would now like to ask some specific questions about you. 
Q36 How tall are you? 
ENTER HEIGHT IN CM's OR FT/INCHES; ENTER ZERO (0) IN UNUSED CELLS] 
IF REFUSED, ENTER 1 IN "DECLINED TO ANSWER" AND "0" IN CM. FEET AND INCHES 
How much do you weigh? 
ENTER WEIGHT IN KG's OR ST/LBS OR POUNDS ONLY; ENTER ZERO ("0") IN UNUSED 
CELLS]. ENTER 1 FOR DECLINED IF REFUSED TO ANSWER OTHERWISE "0" 
Q37 Have your every sought help on weight control? 
Yes  1 
No  2 
Q38 From who? [DO NOT READ] [MULTIPLE RESPONSE] 
Doctor     1 
Pharmacist    2 
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Nurse     3 
Dietician    4 
Friend/relative   5 
Other[SPECIFY]   6 
Weight watchers or similar  7 
Q39 How often would you do 20 or more minutes of exercise in one session? 
More than once a day 1 
Daily    2 
4 to 6 times a week  3 
2 to 3 times a week  4 
Weekly   5 
Fortnightly   6 
Monthly   7 
Occasionally   8 
Never    9 
Q40 Have you ever sought help on exercise? 
Yes  1 
No  2 
Q41 From whom?  [MULTIPLE RESPONSE] [DO NOT READ] 
Doctor    1 
Pharmacist   2 
Nurse    3 
Dietician   4 
Physiotherapist  5 
Gym/sports instructor 6 
Friend/relative  7 
Other[SPECIFY]  8 
Q42 Have you ever smoked tobacco products? PROMPT FOR CURRENT SMOKER IF 
NECESSARY 
Never    1 Skip Q43, Q44 
Past smoker   2 Skip Q43, Q44 
Current smoker  3 
Q43 How many cigarettes do you normally smoke per day? 
< 1   01 
1-10   02 
11-20   03 
21-30   04 
31-40   05 
> 40   06 
REFUSED  99 
Q44 Have you ever sought assistance to stop smoking? 
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Yes  1 
No  2 
Q45 From whom? 
Doctor   1 
Pharmacist  2 
Nurse   3 
QUIT line  4 
Friend/relative 5 
Other[SPECIFY] 6 
Q47 What is your current work status? [READ OUT] 
Unskilled blue collar (labourer, cleaner, packer)   01 
Semi-skilled blue collar (driver, storeman)    02 
Skilled blue collar (carpenter, plumber, hairdresser)  03 
Lower white (clerk, secretary, shop assistant)   04 
Upper white (teacher, nurse, architect)    05 
Senior upper white (director)     06 
Unemployed        07 
Pensioner        08 
Retired        09 
Student        10 
Home duties        11 
Part time        12 
Full time        13 
Other[SPECIFY]       97 
DO NOT READ REFUSED      99 
Q48 How many adults aged 25 years or older are there living in your place of residence 
including yourself? 
USE "99" FOR REFUSED, ___ adults aged 25 years or older 
Q49 What is your postcode? 
____________[CHANGE IF NECESSARY] 
Thank you very much for your co-operation with our survey 
In case my supervisor needs to contact you to check the validity of this interview, could 
I please ask for your name? [DO NOT ENTER ON THE NAME TILL YOU HANG UP] 
_______________________________ 
Can I just check the phone number I called? 
__________ 
As a Market Research company, we comply with the requirements of the Privacy Act. 
Would you like me to read you our full Privacy Statement? 
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Yes  1 
No  2 
In accordance with the Privacy Act, once information processing has been completed, 
please be assured that your name and contact details will be removed from your 
responses to this survey. After that time we will no longer be able to identify the 
responses provided by you. However, for the period that your name and contact details 
remain with your survey responses, which will be approximately 2 to 4 weeks, you will 
be able to contact us to request that some or all of your information be deleted. 
In case you missed it earlier, my name is ________ from I-view. If you would like to contact 
my supervisor to check the validity of this study you can call I-view on: 
Melbourne: 1300 557 781. 
Thank you for your time. 
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Appendix 8: Current and future pharmacy practice pharmacist survey 
Formatted HH. $ amounts shown are AUD$. 
Your current and future pharmacy practice 
Recent reports have suggested pharmacists could fill additional roles to assist in the GP 
shortage in regional Australia. These roles include immunisation/ vaccination services, 
as well as roles in disease state management and continued prescribing in chronic care. 
Community pharmacy in Australia is reimbursed for most of its services under the 
Community Pharmacy Agreement (CPA). The current agreement, the 5th Agreement 
(5CPA), concludes on 30 June 2015. The next agreement, the 6th Agreement (6CPA), will 
then allocate funds for services for 5 years until 30 June 2020. 
This survey is part of a PhD study looking at the knowledge and skills required for rural 
pharmacy practice. The Tasmanian Social Science Human Minimal Risk Ethics 
Committee of the University of Tasmania has approved this survey (H0014020). 
References: 
1. Duckett, S and Breadon, P. Grattan report: Access All Areas New Solutions for GP 
Shortages in Rural Australia 2013 available at: 
http://grattan.edu.au/static/files/assets/31e5ace5/196-Access-All-Areas.pdf Accessed 
26 July 2014 
2. Fifth Community Pharmacy Agreement available at: http://5cpa.com.au/about-5cpa/ 
Accessed 26 July 2014 
Please give us your opinion of alternate practice options and suggest what you would 
like to see in the next Agreement. 
Please assist in this research to enable to capture a snapshot of current thinking from 
members of the pharmacy profession. 
At the end of the survey you can enter for the prize of an iPad mini 16G, white with 
WiFi. 
If you would like to read more before proceeding, here is an information sheet. 
There are 28 questions in this survey. 
Demographics 
1. Are you male or female? 
Please choose only one of the following: 
• Female 
• Male 
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2. How old are you? 
Only numbers may be entered in this field. 
Please write your answer here: 
Enter your age in years: 
3. How many years have you practiced pharmacy? 
Only numbers may be entered in this field. 
Please write your answer here: 
4. How many paid hours per week do you work in your main job in pharmacy? 
Only numbers may be entered in this field. 
Please write your answer here:  
5. What is your current work town/suburb for your main pharmacy role? 
Please write your answer here: 
6. What is your work postcode? 
Only numbers may be entered in this field. 
Please write your answer here:  
7. What is your main work PhARIA (if known)? 
PhARIA is a ranking of rurality in Australia, PhARIA 1 is metropolitan and larger 
towns, and PhARIA 6 is remote Australia. 
Please choose only one of the following: 
• PhARIA 1 
• PhARIA 2 
• PhARIA 3 
• PhARIA 4 
• PhARIA 5 
• PhARIA 6 
8. What is your current home suburb/town? 
Please write your answer here: 
9. What is your home postcode? 
Only numbers may be entered in this field. 
Please write your answer here: 
 Appendices   276 
10. What is your home PhARIA (if known)? 
PhARIA is a ranking of rurality in Australia, PhARIA 1 is metropolitan and larger 
towns, and PhARIA 6 is remote Australia. 
Please choose only one of the following: 
• PhARIA 1 
• PhARIA 2 
• PhARIA 3 
• PhARIA 4 
• PhARIA 5 
• PhARIA 6 
11. What is your primary pharmacy role? 
Please choose only one of the following: 
• Community pharmacy owner 
• Pharmacist manager/employee 
• Pharmacist locum 
• Medication review pharmacist 
• Pharmacist intern 
• Other 
Make a comment on your choice here: 
Pharmacy practice 
12. What is your view on immunisation in the community pharmacy setting? It is 
almost certain that vaccination (or immunisation) will take place in community 
pharmacy in an appropriate area with a trained pharmacist vaccinator in the 
near future. 
List your preference order where 1 is most preferred and 4 is least preferred. 
Please write your answer(s) here: 
• I would be happy as a Pharmacist Vaccinator to personally administer 
immunisations in a pharmacy setting 
• I would only provide this service if I employed a trained Pharmacist Vaccinator 
• I would only provide immunisations in a pharmacy with an authorised 
Registered Nurse or Nurse Practitioner 
• I would not provide this service in my pharmacy 
13. If this service was provided I would: 
Please choose the appropriate response for each item: 
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Yes Uncertain No 
Only provide this service if I was remunerated by the 
Government 
   
Be happy for the patient to pay the full price of the services 
   
Accept a rate of $12.10 plus the wholesale cost of the 
vaccine (administration rate suggested by the Grattan 
Report) 
   
Accept a rate of $12.10 plus wholesale and dispensed cost 
($6.76) of the vaccine (administration rate suggested by 
the Grattan Report) 
   
14. If you would NOT provide an immunisation service or would provide this service 
at a different rate than that suggested ($12.10), can you please say why? 
Please write your answer here: 
15. Disease state management in chronic care consists of many aspects. In pharmacy, 
pharmacists can monitor for adverse reactions and optimal medication 
management but there can be additional aspects to disease state management 
provided. 
Please give your opinion of the following statements. 
In the future, I would expect to: 
Please choose the appropriate response for each item: 
 Yes Uncertain No 
Adjust doses e.g. for hypertension medication    
Discontinue or alter medication to another for the same 
condition e.g. for hypertension 
   
Notify GPs and other health practitioners of any 
relevant information to add to the patient’s health plan 
   
Continue dispensing prescriptions for up to 18 months 
instead of 12 months 
   
16. If this service was provided I would: 
Please choose the appropriate response for each item: 
 
Yes Uncertain No 
Only provide this service if I was remunerated by the 
Government 
   
Provide a medication management service for $18.15 per 
15-minute consultation (as suggested by the Grattan 
Report) 
   
Provide a medication management service for $18.15 per 
30-minute consultation (as suggested by the Grattan 
Report) 
   
Continue dispensing repeat prescriptions at a rate of $12.10 
per 15-minute consultation (as suggested by the Grattan 
Report) 
   
Continue dispensing repeat prescriptions at a rate of $12.10 
per 30-minute consultation (as suggested by the Grattan 
Report) 
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17. If you would NOT provide a disease state management service or disagree with 
the suggested rates, can you say why? 
Please write your answer here: 
18. If the profession does take up the following services, should they only be 
provided by pharmacists in rural and remote areas? 
Please choose the appropriate response for each item: 
 
Yes, rural pharmacies 
only 
No, all pharmacies 
Vaccination/Immunisation service 
  
Chronic disease state management including 
continued dispensing of repeats and adjusting 
doses 
  
19. If you think these new services should only be supplied in rural and remote 
areas, please say why. 
Please write your answer here: 
20. Your relationship with local GPs is crucial to these additional roles of vaccination 
and chronic disease management. 
Please choose the appropriate response for each item: 
 
Yes Uncertain No 
Is your current level of relationship with local GPs good? 
   
Would provision of these services improve your 
relationship with GPs? 
   
Would it impact adversely on your relationship with GPs? 
   
21. If you think these services would improve or impact adversely your relationship 
with GPs, please say why. 
Please write your answer here: 
Future pharmacy practice 
22. We would like a snapshot of your current practice, what you would like to be 
doing in 5 years’ time and what you think you will be actually doing in 5 
years’ time. 
Please write the proportion of your time taken up with the following activities. 
You can select as many boxes as you would like. 
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What I am 
doing NOW 
(percentage) 
What I would 
LIKE to do in 5 
years 
(percentage) 
What I think I 
WILL be doing 
in 5 years 
(percentage) 
Dispensing and patient counselling for 
prescriptions 
   
OTC S2/S3 sales and advice 
   
Administration/Management/Stock Control 
   
Pharmacy Medication Review Programs 
(MedsCheck, Diabetes MedsCheck) 
   
Other Medication Review Programs 
(HMR,RMMR) 
   
Pharmacy Practice Improvement Programs 
(Clinical Interventions, Dose Administration 
Aids, Screening and Risk Assessment/ 
Disease State Management, Health 
Promotion Activities) 
   
Training of interns/students within a 
pharmacy setting 
   
Educator or Academic Activities 
   
Research 
   
Ward Based Clinical Services 
   
Continuing Professional Development 
   
Other 
   
23. Please give examples of other current activities not listed. 
Please write your answer here: 
24. In the table below are some of the major expenditure items of the 5CPA. What 
changes would you like to see in expenditure in the 6CPA? 
Please choose the appropriate response for each item: 
 
Increase Same Decrease 
Dispensing 
   
Pharmacy Medication Review Programs (MedsCheck, 
Diabetes MedsCheck) 
   
Other Medication Review Programs (HMR, RMMR) 
   
Clinical Interventions 
   
Dose Administration Aids (DAAs) 
   
Staged Supply 
   
Rural Programs (Workforce and Maintenance Allowance) 
   
25. What new initiatives would you like to see in the 6th Community Pharmacy 
Agreement (6CPA)? 
Please write your answer here: 
26. How do you see the pharmacy profession positioned in 5 years’ time compared 
to now? 
Please choose all that apply: 
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• Much worse 
• Worse 
• Neither worse not better 
• Better 
• Much better 
27. Pharmacy as a profession has the following professional qualities. 
How do you think these professional qualities will change in the next five years? 
Please choose the appropriate response for each item: 
 
Increase Same Decrease 
Altruism: Serving the interest of the patients 
   
Accountability: Accountable for your actions 
   
Excellence: Committed to lifelong learning 
   
Duty: Committed even when inconvenient 
   
Honour and Integrity: Fair, truthful 
   
Respect for Others: Respect other pharmacists, health 
professionals, patients and families  
   
28. If you have any other comments please add them here. 
Please write your answer here: 
Thank you very much for taking the time to complete this survey. 
Please continue for a chance to win an iPad mini 16G, white with WiFi. 
Submit your survey. 
Thank you for completing this survey. 
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Appendix 9: Ethics applications, copies of initial project approval 
letters and final report project approval letters 
Formatted HH. 
Social Science HREC Ethics Ref: H0010055 (University of Tasmania): What makes 
rural pharmacy practice different? 
Copy of original ethics project approval of project H0010055 
From: Frances Martin [F.Martin@utas.edu.au] 
Sent: Sunday, 18 May 2008 1:53 PM 
To: G.Peterson@utas.edu.au; Shane_lj@utas.edu.au; Helen.Howarth@utas.edu.au 
Cc: Marilyn Knott 
Subject: Re: New Minimal Risk - H10055 - Pharmacy 
Attachments: Letter of Introduction.SSHREC Howarth May 2008.finalfm.doc; 
Information  
sheet for SSHREC Howarth May 2008.finalfm.doc 
Dear Gregory, Shane, and Helen, 
I have reviewed your minimal risk application for ethics approval for this preliminary 
study. I am happy to grant ethics approval and to advise that you may now commence 
data collection using the attached information sheet and introductory letter with the 
name of the ethics committee that has given this approval changed to the correct one. 
I wish you well with the research, 
Frances Martin 
Chair 
SS HREC 
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From: Lauren.Townsend@utas.edu.au Lauren.Townsend@utas.edu.au 
Sent: Monday, 23 July 2012 12:18 PM 
To: Gregory Peterson G.Peterson@utas.edu.au 
Cc: Shane Jackson <Shane.Jackson@utas.edu.au>; Helen Howarth 
Helen.Howarth@utas.edu.au 
Subject: Ethics Request for Extension of Project Approved: H0010055 What makes rural 
pharmacy practice different 
Dear Professor Peterson 
Ethics Ref No: H0010055 
Project title: What makes rural pharmacy practice different? Defining the key 
knowledge and skills needed for rural practice. 
I wish to confirm that your request for an extension of ethics cover on this project was 
approved by the Chair of the Tasmania Social Sciences Human Research Ethics 
Committee on 16/7/2012. 
It is not standard policy to send a letter of confirmation for an extension approval but if 
necessary, this can be arranged. Your next Progress Report for this project is due on the 
anniversary date of your original ethics approval. You will receive an automatically 
generated email prior to this date to remind you of this responsibility. 
Should you have any queries please do not hesitate to contact me. 
Kind regards 
Lauren Townsend 
Lauren Townsend 
Ethics Officer 
Office of Research Services 
University of Tasmania 
Private Bag 01 
Hobart TAS 7001 
Phone: (03) 6226 7148 
Fax: (03) 6226 2765 
Email: Lauren.Townsend@utas.edu.au 
Web: http://www.research.utas.edu.au/ 
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Copy of final ethics project report approval H0010055 
Final Approval Replacement Email 
6 August 2018 
Dear Professor Peterson  
Ethics Ref No: H0010055  
Project title: What makes rural pharmacy practice different? Defining the key knowledge 
and skills needed for rural practice. 
This email is to confirm that your Ethics Final Report was approved by the Tasmania Social 
Sciences Human Research Ethics Committee on 20/5/2013. 
Should you have any queries please do not hesitate to contact me. 
Kind regards  
Katherine  
Katherine Shaw 
Executive Officer, Social Sciences HREC 
Office of Research Services | Research Division 
University of Tasmania 
Private Bag 1 
Hobart TAS 7001 
T +61 3 6226 2763  
www.utas.edu.au/research 
 
CRICOS 00586B 
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Social Science HREC Ref No: H0015844: Project title: What makes rural pharmacy 
practice different? Defining the key knowledge and skills needed for rural practice. 
Copy of original ethics project approval of project H0015844 
From: Katherine Shaw 
Sent: Wednesday, 29 June 2016 2:04 PM 
To: Gregory Peterson 
Cc: Helen Howarth; Shane Jackson; Tabish Razi Zaidi 
Subject: Ethics Application Approved: H0015844 What makes rural pharmacy practice 
different? Defining the key knowledge and skills needed for rural practice 
Dear Professor Peterson 
Ethics Ref No: H0015844 
Project title: What makes rural pharmacy practice different? Defining the key 
knowledge and skills needed for rural practice 
The above Minimal Risk application has been approved by the Chair of the Tasmania 
Social Sciences Human Research Ethics Committee, on behalf of the full committee. 
Approval is for four years and conditional upon receipt of an annual Progress Report. 
Ethics approval for this project will lapse if a Progress Report is not submitted. 
A copy of the approval letter is attached for your records. Because evidence of ethics 
approval will be necessary for thesis submission, all researchers have been copied on 
this email. 
The Ethics Committee wishes you all the best with the project. 
Kind regards 
Katherine 
Katherine Shaw 
Executive Officer, Social Sciences HREC 
Office of Research Services | Research Division 
University of Tasmania 
Private Bag 1 
Hobart TAS 7001 
T +61 3 6226 2763  
www.utas.edu.au/research 
 CRICOS 00586B 
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Paula Swatman <paula.swatman@utas.edu.au 
28/06/2016 12:42 PM 
To: Gregory Peterson; Shane Jackson; Tabish Razi Zaidi; Helen Howarth  
Cc: Katherine Shaw 
Dear Helen, Greg, Shane and Tabish, 
Thank you for submitting this minimal risk application – and for making the changes 
already recommended by Katherine Shaw! 
I have now reviewed your application and its associated documents and am satisfied 
you have put in place effective management strategies for the potential ethical risks 
associated with this project. I can therefore approve this application with immediate 
effect. 
Katherine will contact you separately to finalise the formal aspects of this approval, but 
you are welcome to commence your data gathering immediately if you wish. 
Good luck with the follow-up interviews! 
All the best, 
Paula 
Prof. Paula Swatman 
Chair 
Social Science Human Research Ethics Committee 
Research Integrity and Ethics Unit 
Office of Research Services 
University of Tasmania 
Private Bag 01, Hobart TAS 7001 
Tel: +61 (0)3 6226 2763 
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Copy of final ethics project report approval H0015844 
Mon 25/06/2018 10:10 AM  
Gregory Peterson, Shane Jackson, Tabish Razi Zaidi Helen Howarth 
Dear Professor Peterson 
Ethics Ref No: H0015844 
Project title: What makes rural pharmacy practice different? Defining the key 
knowledge and skills needed for rural practice 
This email is to confirm that your Ethics Final Report was approved by the Tasmania 
Social Sciences Human Research Ethics Committee on 18/6/2018. 
Should you have any queries please do not hesitate to contact me. 
Kind regards  
Emma Field 
Emma Field 
Administration Officer 
Office of Research Services 
University of Tasmania 
Private Bag 01 
Hobart TAS 7001 
Phone: (03) 6226 2608 
Fax: (03) 6226 2765 
Email: Human.Ethics@utas.edu.au 
Web: http://www.utas.edu.au/research-admin 
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Social Science HREC Ethics Ref No: CF08/0305–200800110 Healthy Hearts in 
pharmacy (Monash University) and H0009995 (University of Tasmania) 
Copy of original ethics project approval Monash University CF08/0305–200800110 
200800110 
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Copy of original ethics project approval H0009995 (University of Tasmania) 
 
-----Original Message----- 
 
From: Katherine Shaw [mailto:Katherine.Shaw@utas.edu.au] 
Sent: Monday, 21 July 2008 10:54 AM 
To: Gregory Peterson 
Cc: Helen Howarth; Shane Jackson; Kimbra Fitzmaurice 
Subject: Notification of Medical Ethics Approval: H0009995 Healthy Hearts in Pharmacy 
 
Dear Professor Peterson, 
 
Reference number: H0009995 
Title: Healthy Hearts in Pharmacy 
 
We are pleased to advise that this study has been approved by the Tasmanian Human 
Research Ethics Committee and a signed copy of the approval letter will be forwarded to 
you in the next few days. This will be sent to the first named investigator, except in the 
case of clinical trials where correspondence will be sent to the named data manager, 
where applicable. 
 
Please contact us if you require further information. 
 
Kind regards, 
Katherine 
 
Katherine Shaw 
Ethics Officer, Health and Medical 
Office of Research Services 
University of Tasmania 
Private Bag 01 
HOBART TAS 7001 
 
Email: Katherine.Shaw@utas.edu.au 
Telephone: (03) 6226 2763 
Fax: (03) 6226 2765 
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Copy of final ethics project report approval H0009995 (University of Tasmania) 
 
Dear Professor Peterson 
 
Ethics Ref No: H0009995 
Title: Healthy Hearts in Pharmacy 
 
I wish to inform you that the Human Research Ethics Committee (Tasmania) Network 
has approved your Final Report for the above named study.  Our file will now be closed 
and archived. 
 
It is not standard to send a hardcopy version of this approval. Should you require one 
please contact me.  
 
Should you have any queries please do not hesitate to contact us. 
 
Kind regards 
 
Adele Kay  
 
Adele Kay 
Ethics Officer 
Office of Research Services 
University of Tasmania 
Private Bag 01 
Hobart TAS 7001 
Phone: (03) 6226 1956 
Fax: (03) 6226 2765 
Email: Adele.Kay@utas.edu.au 
Web: http://www.research.utas.edu.au/ 
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Social Science HREC Ethics Ref No: H0014020: Your current and future pharmacy 
practice 
Copy of original ethics project approval H0014020 
On 18 Jul 2014, at 3:58 pm, Katherine Shaw <Katherine.Shaw@utas.edu.au> wrote: 
Dear Professor Peterson 
Ethics Ref No: H0014020 
Project title: Your Current and Future Pharmacy Practice 
The above Minimal Risk application has been approved by the Chair of the Tasmania 
Social Sciences Human Research Ethics Committee, on behalf of the full committee. 
Approval is for four years and conditional upon receipt of an annual Progress Report. 
Ethics approval for this project will lapse if a Progress Report is not submitted. 
A copy of the approval letter is attached for your records. Because evidence of ethics 
approval will be necessary for thesis submission, all researchers have been copied on 
this email. 
The Ethics Committee wishes you all the best with the project. 
Kind regards 
Katherine 
Katherine Shaw 
Executive Officer, Social Sciences HREC 
Office of Research Services 
University of Tasmania 
Private Bag 1 
Hobart TAS 7001 
T +61 3 6226 2763 
CRICOS 00586B 
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Copy of final ethics project report approval H0014020 
From: Human.Ethics@utas.edu.au Human.Ethics@utas.edu.au 
Sent: Monday, 28 May 2018 11:08 AM 
To: Gregory Peterson g.peterson@utas.edu.au 
Cc: Shane Jackson <shane.jackson@utas.edu.au>; Helen Howarth 
helen.howarth@utas.edu.au 
Subject: Ethics Final Report Approved: H0014020 Your Current and Future Pharmacy 
Practice 
Dear Professor Peterson 
Ethics Ref No: H0014020 
Project title: Your Current and Future Pharmacy Practice 
This email is to confirm that your Ethics Final Report was approved by the Tasmania 
Social Sciences Human Research Ethics Committee on 21/5/2018. 
Should you have any queries please do not hesitate to contact me. 
Kind regards 
Emma Field 
Emma Field 
Administration Officer 
Office of Research Services 
University of Tasmania 
Private Bag 01 
Hobart TAS 7001 
Phone: (03) 6226 2608 
Fax: (03) 6226 2765 
Email: Human.Ethics@utas.edu.au 
Web: http://www.utas.edu.au/research-admin 
